Form 10-Q Zeltiq Aesthetics Inc For: Mar 31

---

---

---

---

---

---

---

---

•	Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

•	Leveraged the services of consulting firms, until we can hire resources with the required skills to strengthen our internal controls, documentation and communication in our risk assessment process.

•	Provided training to key individuals that provide critical information used in financial accounting and reporting to reinforce pre-established and new controls to improve our ability to detect potential misstatements in our internally prepared reports, analysis and financial records.

---

•	our commercialization strategy;

•	the time, resources, and expense required to develop and conduct clinical trials and seek additional regulatory clearances and approvals for additional treatment indications for CoolSculpting and for any additional products we may develop;

•	the costs of preparing, filing, prosecuting, defending, and enforcing patent claims and other patent related costs, including litigation costs and the results of such litigation;

•	any adverse events associated with CoolSculpting or product liability or other lawsuits related to our products and the costs associated with defending them or the results of such lawsuits;

•	costs associated with obtaining components for manufacturing, including increases due to changes in foreign exchange rates or increased shipping costs;

•	the costs to attract and retain personnel with the skills required for effective operations; and

•	the costs associated with being a public company.

---

•	quarter to quarter variation in customer demand for purchasing CoolSculpting systems;

•	the inability for our customers to obtain necessary financing;

•	changes in the length of the sales process;

•	performance of our international distributors;

•	media coverage of CoolSculpting and positive or negative patient experiences, the procedures or products of our competitors, or our industry;

•	our ability to maintain our current or obtain further regulatory clearances or approvals;

•	delays in, or failure of, product and component deliveries by our third-party contract manufacturers or suppliers, whether due to their inability to meet our demands or other forces, such as port strikes, labor shortages or other factors that could impact shipping costs or the ability of manufacturers to ship components to us;

•	seasonal or other variations in patient demand for aesthetic procedures;

•	introduction of new aesthetic procedures or products that compete with CoolSculpting; and

•	adverse changes in the economy that reduce patient demand for elective aesthetic procedures.

---

•	hire qualified individuals as needed;

•	generate sufficient leads within our target customer group for our sales force;

•	provide adequate training for the effective sale and marketing of CoolSculpting;

•	retain and motivate our direct sales and marketing professionals; and

•	effectively oversee geographically dispersed sales and marketing teams.

---

•	the success of our sales and marketing programs, including our co-operative marketing strategy with individual practices, as to which we have limited experience;

•	the cost, safety, and effectiveness of CoolSculpting versus other aesthetic treatments;

•	the price of CoolSculpting relative to other aesthetic products and alternative treatments;

•	the willingness of patients to wait up to four months post-treatment to notice the aesthetic results of a CoolSculpting procedure;

•	the ability to obtain regulatory clearance to market CoolSculpting for additional treatment indications in the United States;

•	the adverse event profile of CoolSculpting, including warnings, side effects, and contraindications, which are subject to change;

•	the extent to which our customers recommend CoolSculpting to their patients;

•	our success in attracting consumers who have not previously purchased an aesthetic procedure;

•	the extent to which our CoolSculpting procedure satisfies patient expectations;

•	our ability to properly train our customers in the use of CoolSculpting such that their patients do not experience excessive discomfort during treatment or adverse side effects;

•	consumer sentiment about the benefits and risks of aesthetic procedures generally and CoolSculpting in particular;

•	the success of any direct-to-consumer marketing efforts we initiate to build awareness in the marketplace; and

•	general consumer confidence, which may be impacted by economic and political conditions.

•	we lack day-to-day control over the activities of third-party distributors;

•	third-party distributors may not commit the necessary resources to market, sell, and service our systems to the level of our expectations;

•	third-party distributors may not be as selective as we would be in choosing customers to purchase CoolSculpting systems or as effective in training customers in marketing and patient selection;

•	third-party distributors may terminate their arrangements with us on limited, or no, notice or may change the terms of these arrangements in a manner unfavorable to us;

•	disagreements with our distributors could require or result in costly and time-consuming litigation or arbitration which we could be required to conduct in jurisdictions with which we are not familiar; and

•	ability to collect amounts owed from third-party distributors, who may operate in currency controlled countries.

---

•	difficulties in staffing and managing our international operations;

•	increased competition as a result of more products and procedures receiving regulatory approval or otherwise free to market in international markets;

•	longer accounts receivable payment cycles and difficulties in collecting accounts receivable;

•	reduced or varied protection for intellectual property rights in some countries;

•	export restrictions, trade regulations, and foreign tax laws;

•	fluctuations in currency exchange rates, which could increase the selling costs of, and therefore lower demand for, our products overseas;

•	foreign certification and regulatory clearance or approval requirements;

•	difficulties in developing effective marketing campaigns in unfamiliar foreign countries;

•	customs clearance and shipping delays;

•	political, social, and economic instability abroad, terrorist attacks, and security concerns in general;

•	preference for locally produced products;

•	potentially adverse tax consequences, including the complexities of foreign value-added tax systems, tax inefficiencies related to our corporate structure, and restrictions on the repatriation of earnings;

•	the burdens of complying with a wide variety of foreign laws and different legal standards; and

•	increased financial accounting and reporting burdens and complexities.

---

---

•	interruption of supply resulting from modifications to or discontinuation of a supplier's operations;

•	interruption of supply, or increased shipping costs, resulting from port strikes, work stoppages or other unrest;

•	delays in product shipments resulting from uncorrected defects, reliability issues, or a supplier's variation in a component;

•	a lack of long-term supply arrangements for key components with our suppliers;

•	inability to obtain adequate supply in a timely manner, or to obtain adequate supply on commercially reasonable terms;

•	difficulty and cost associated with locating and qualifying alternative suppliers for our components in a timely manner;

•	production delays related to the evaluation and testing of products from alternative suppliers, and corresponding regulatory qualifications;

•	delay in delivery due to our suppliers prioritizing other customer orders over ours;

•	damage to our brand reputation caused by defective components produced by our suppliers;

•	increased cost of our warranty program due to product repair or replacement based upon defects in components produced by our suppliers; and

•	fluctuation in delivery by our suppliers due to changes in demand from us or their other customers.

---

---

---

---

---

•	administrative or judicially-imposed sanctions;

•	injunctions or the imposition of civil penalties;

•	recall or seizure of our products;

•	total or partial suspension of production or distribution;

•	the FDA's refusal to grant pending future clearance or pre-market approval for our products;

•	withdrawal or suspension of marketing clearances or approvals;

•	clinical holds;

•	warning letters;

•	refusal to permit the import or export of our products; and

•	criminal prosecution of us or our employees.

---

•	changes to manufacturing methods;

•	recall, replacement, or discontinuance of certain products;

•	additional record keeping; and

•	additional warnings.

---

---

•	others may be able to make systems or devices that are similar to ours but that are not covered by the claims of our patents;

•	others may assert that our licensors or we were not the first to make the inventions covered by our issued patents or pending patent applications;

•	our pending patent applications may not result in issued patents;

•	our issued patents may not provide us with any competitive advantages or may be held invalid or unenforceable as a result of legal challenges by third parties;

•	the claims of our issued patents or patent applications when issued may not cover our CoolSculpting system or the future products we develop;

•	there may be dominating patents relevant to our controlled cooling technology of which we are not aware;

•	there may be prior public disclosures that could invalidate our inventions or parts of our inventions of which we are not aware;

•	the laws of foreign countries may not protect our proprietary rights to the same extent as the laws of the United States; and

•	we may not develop additional proprietary technologies that are patentable.

---

---

•	infringement and other intellectual property claims which, regardless of merit, may be expensive and time-consuming to litigate and may divert our management's attention from our core business;

•	substantial damages for infringement, which we may have to pay if a court decides that the product at issue infringes on or violates the third party's rights, and if the court finds that the infringement was willful, we could be ordered to pay treble damages and the patent owner's attorneys' fees;

•	a court prohibiting us from selling or licensing our products unless the third party licenses its product rights to us, which it is not required to do at a commercially reasonable price or at all;

•	if a license is available from a third party, we may have to pay substantial royalties, upfront fees or grant cross-licenses to intellectual property rights for our products; and

•	redesigning our products or processes so they do not infringe, which may not be possible at all or may require substantial monetary expenditures and time, during which our products may not be available for sale.

---

•	fluctuations in our operating results or the operating results of our competitors;

•	changes in estimates of our financial results or recommendations or cessation of coverage by securities analysts;

•	changes in the estimates of the future size and growth rate of our market opportunity;

•	changes in accounting principles or changes in interpretations of existing principles, which could affect our financial results;

•	conditions and trends in the markets we serve;

•	changes in general economic, industry, and market conditions;

•	success of competitive technologies and procedures;

•	changes in our pricing policies;

•	announcements of significant new technologies, procedures, or acquisitions by us or our competitors;

•	changes in legislation or regulatory policies, practices or actions;

•	the commencement or outcome of litigation involving our company, our general industry or both;

•	recruitment or departure of our executives and other key employees;

•	changes in our capital structure, such as future issuances of securities or the incurrence of debt;

•	actual or expected sales of our common stock by the holders of our common stock; and

•	the trading volume of our common stock.

---

•	dividing our board into three classes, with each class serving a staggered three-year term;

•	prohibiting our stockholders from calling a special meeting of stockholders or acting by written consent;

•	permitting our board to issue additional shares of our preferred stock, with such rights, preferences and privileges as they may designate, including the right to approve an acquisition or other changes in control;

•	establishing an advance notice procedure for stockholder proposals to be brought before an annual meeting, including proposed nominations of persons for election to our Board of Directors;

•	providing that our directors may be removed only for cause;

•	providing that vacancies on our Board of Directors may be filled only by a majority of directors then in office, even though less than a quorum; and

•	requiring the approval of our Board of Directors or the holders of a super-majority of our outstanding shares of capital stock to amend our bylaws and certain provisions of our certificate of incorporation.

---

---

---

---

1.	Effective January 1, 2016, your base salary in Section 2(a) of the Agreement is hereby amended to $600,000.

2.	Effective, February 25, 2016, the reference to one (1) year in Section 3(b)(ii)(1) of the Agreement is hereby amended to eighteen (18) months.

3.	Effective February 25, 2016, Section 3(b)(ii)(2) of the Agreement is hereby amended, restated and replaced in its entirety to read as follows:

4.	Effective February 25, 2016, the references to one (1) year in Section 3(b)(ii)(3) of the Agreement are hereby amended to eighteen (18) months.

5.	Effective, February 25, 2016, the reference to one (1) year in Section 3(c)(ii)(1) of the Agreement is hereby amended to twenty-four (24) months.

6.	Effective, February 25, 2016, the reference to your Target Bonus in Section 3(c)(ii)(2) of the Agreement is hereby amended to two times (2x) your Target Bonus.

7.	Effective February 25, 2016, the references to one (1) year in Section 3(c)(ii)(3) of the Agreement are hereby amended to two (2) years.

8.

Effective February 25, 2016, the reference in Section 3(c)(ii)(4) of the Agreement to “three (3) months following any termination of your employment that is a termination without Cause or Good Reason resignation that occurs prior to a Change in Control” shall be amended to read “the earlier of (A) three (3) months following any termination of your employment that is a termination without Cause or a Good Reason resignation that occurs prior to a Change in Control or (B) the expiration of the term of such equity award.”

9.	Effective February 25, 2016, Section 4 of the Agreement is hereby amended to add the following subsection (e) at the end thereof:

1.	Effective January 1, 2016, the reference to 70% in Section 2(e) of the Agreement is hereby amended to 75%.

2.	Effective February 25, 2016, the reference to nine (9) months in Section 6(a)(i) of the Agreement is hereby amended to twelve (12) months.

3.	Effective February 25, 2016, Section 6(a)(ii) of the Agreement is hereby amended, restated and replaced in its entirety to read as follows:

4.	Effective February 25, 2016, the references to nine (9) months in Section 6(a)(iii) of the Agreement are hereby amended to twelve (12) months.

5.

Effective February 25, 2016, the reference in Section 6(b)(iii) of the Agreement to “three (3) months following any termination of your employment that is a termination without Cause or Good Reason resignation that occurs prior to a Change in Control” shall be amended to read “the earlier of (A) three (3) months following any termination of your employment that is a termination without Cause or a Good Reason resignation that occurs prior to a Change in Control or (B) the expiration of the term of such equity award.”

6.	Effective February 25, 2016, Section 8 of the Agreement is hereby amended to add the following subsection (e) at the end thereof:

1.	Effective January 1, 2016, the reference to $310,000 in Section 2(a) of the Agreement is hereby amended to $325,000.

2.	Effective January 1, 2016, the reference to 45% in Section 2(c) of the Agreement is hereby amended to 50%.

3.	Effective February 25, 2016, the reference to nine (9) months in Section 7(a)(i) of the Agreement is hereby amended to twelve (12) months.

4.	Effective February 25, 2016, Section 7(a)(ii) of the Agreement is hereby amended, restated and replaced in its entirety to read as follows:

5.	Effective February 25, 2016, the references to nine (9) months in Section 7(a)(iii) of the Agreement are hereby amended to twelve (12) months.

6.

Effective February 25, 2016, the reference in Section 7(b)(iii) of the Agreement to “three (3) months following any termination of your employment that is a termination without Cause or Good Reason resignation that occurs prior to a Change in Control” shall be amended to read “the earlier of (A) three (3) months following any termination of your employment that is a termination without Cause or a Good Reason resignation that occurs prior to a Change in Control or (B) the expiration of the term of such equity award.”

7.	Effective February 25, 2016, Section 8 of the Agreement is hereby amended to add the following subsection (e) at the end thereof:

1.	Effective January 1, 2016, the base salary in Section 2(a) of the Agreement is hereby amended to $280,000.

2.

Effective February 25, 2016, the reference in Section 7(b)(iii) of the Agreement to “three (3) months following any termination of your employment that is a termination without Cause or Good Reason resignation that occurs prior to a Change in Control” shall be amended to read “the earlier of (A) three (3) months following any termination of your employment that is a termination without Cause or a Good Reason resignation that occurs prior to a Change in Control or (B) the expiration of the term of such equity award.”

3.	Effective February 25, 2016, Section 8 of the Agreement is hereby amended to add the following subsection (e) at the end thereof:

1.	Effective January 1, 2016, the reference to annual salary in Section 1(a) of the Agreement is hereby amended to $300,000.

2.	Effective January 1, 2016, the reference to 40% in Section 1(c) of the Agreement is hereby amended to 45%.

3.	Effective February 25, 2016, Section 5 of the Agreement is hereby amended, restated and replaced in its entirety to read as follows:

5.	SEVERANCE.

a.

Termination Without Cause Outside of Covered Period. If: (i) at any time other than during the Covered Period your employment is terminated by the Company without Cause (and other than a result of your death or disability); and (ii) not later than 60 days following your termination of employment you execute a general release of claims (the “Release”) in favor of the Company in such form provided by the Company, return such Release to the Company within the applicable time period set forth therein, and permit such Release to become effective in accordance with its terms; then, on the sixtieth (60th) day following such termination of employment, you shall receive or commence to receive, as the case may be:

b.	Continuation of your then-current base salary, less required deductions and withholdings, for a period of nine (9) months after your employment termination date, payable on the Company’s regular payroll dates;

c.

Provided that the Company determines to pay bonuses for the year in which your employment termination occurs, you shall receive a pro-rata portion of your annual target bonus in Section 1(c) (“Target Bonus”) for that year, less required deductions and withholdings, based upon the actual number of days that you provided services to the Company under this Employee Offer Letter during that year, which will be payable to you at the same time that the Company pays bonuses to other Company employees for such year as determined by the Company, but in no event later than the end of the year that follows the year in which your employment terminates; and

d.

The Company will pay your COBRA health insurance premiums sufficient to maintain your then-current coverage for a period of nine (9) months months following termination of employment, provided that you timely elect COBRA, continue to be eligible for COBRA during such time period, and do not become eligible for health insurance benefits through another employer. You agree to promptly notify the Company in writing if you become eligible for health insurance benefits through another employer during the time you are receiving Severance Benefits. Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the foregoing COBRA subsidy without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall instead provide you with a taxable monthly payment equal to the monthly COBRA subsidy, which shall be paid regardless of whether you elect COBRA coverage, shall commence in the month following the month in which you incur a Separation from Service (as defined in Section 8(c) below) and shall end on the earlier of the date you obtain other employment and the date that is nine (9) months following your Separation from Service.

e.

Termination Without Cause or Good Reason Resignation During Covered Period. If: (i) at any time during the Covered Period your employment is terminated by the Company without Cause or by you for Good Reason (and other than a result of your death or disability); and (ii) not later than 60 days following your termination of employment you execute a Release in favor of the Company in such form provided by the Company, return such Release to the Company within the applicable time period set forth therein, and permit such Release to become effective in accordance with its terms; then, on the sixtieth (60th) day following such termination of employment, you shall receive or commence to receive, as the case may be:

f.	Continuation of your then-current base salary (as determined without giving effect to any reduction in base salary that would give rise to your right to resign for Good Reason), less required deductions and withholdings, for a period of twelve (12) months after your employment termination date, payable on the Company’s regular payroll dates;

g.	Your Target Bonus, less required deductions and withholdings, for the year in which your employment terminates;

h.

Full acceleration of the vesting, if applicable, of all of your then outstanding equity awards, which includes any equity awards granted to you prior to or following the consummation of a Change in Control, in each case effective as of your last date of employment. To the extent necessary to give effect to the intent of the foregoing provision, notwithstanding anything to the contrary set forth in your equity award agreements or the applicable equity incentive plan under which such equity award was granted that provides that any then unvested portion of your equity award will immediately expire upon your termination of employment, no unvested portion of your equity award shall generally terminate any earlier than the earlier of (A) three (3) months following any termination of your employment that is a termination without Cause or a Good Reason resignation that occurs prior to a Change in Control or (B) the expiration of the term of such equity award.

i.

The Company will pay your COBRA health insurance premiums sufficient to maintain your then-current coverage for a period of one year following termination of employment, provided that you timely elect COBRA, continue to be eligible for COBRA during such time period, and do not become eligible for health insurance benefits through another employer. You agree to promptly notify the Company in writing if you become eligible for health insurance benefits through another employer during the time you are receiving the COBRA premium benefits. Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the foregoing COBRA subsidy without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall instead provide you with a taxable monthly payment equal to the monthly COBRA subsidy, which shall be paid regardless of whether you elect COBRA coverage, shall commence in the month following the month in which you incur a Separation from Service (as defined in Section 8(c) below) and shall end on the earlier of the date you obtain other employment and the one year anniversary of your Separation from Service.

j.	Definitions. Definitions of Cause, Change in Control, Covered Period and Good Reason are as follows:

k.

“Cause” shall mean: (A) a willful failure by you to substantially perform your duties hereunder, other than a failure resulting from your complete or partial incapacity due to physical or mental illness or impairment; (B) a willful act by you which constitutes gross misconduct and which is injurious to the Company; (C) a willful breach by you of a material provision of this Amended Offer Letter or your Confidential Information and Invention Assignment Agreement; (D) a material and willful violation by you of a federal or state law or regulation applicable to the business of the Company; or (E) termination of your employment in connection with the bankruptcy, insolvency, liquidation, or similar winding-up of the business of the Company.

l.

“Change in Control” shall mean: (A) a sale of all or substantially all of the Company's assets; or (B) any merger, consolidation or other business combination transaction of the Company with or into another corporation, entity or person, other than a transaction in which the holders of at least a majority of the shares of voting capital stock of the Company outstanding immediately prior to such transaction continue to hold (either by such shares remaining outstanding or by their being converted into shares of voting capital stock of the surviving entity) a majority of the total voting power represented by the shares of voting capital stock of the Company (or the surviving entity) outstanding immediately after such transaction other than any transaction involving the issuance of any newly issued equity securities solely for cash.

m.

“Covered Period” shall mean the period commencing three (3) months prior to the consummation of a Change in Control and ending eighteen (18) months following the consummation of a Change in Control. For such purposes, if the condition triggering your right to resign for Good Reason occurs within the Covered Period, and your employment terminates within thirty (30) following expiration of the Cure Period (as defined below), the resignation for Good Reason will be deemed to have occurred during the Covered Period.

n.

“Good Reason” shall mean: (A) any material reduction in your base compensation (which includes base salary, Target Bonus and any other base compensation); (B) a material diminution of your job duties or responsibilities; or (C) a change in the location of your employment of more than 20 miles (which is material) from its current location unless such relocation is within 50 miles of your principal residence; provided, however, that in order to terminate your employment for Good Reason you shall first give the Company written notice stating with reasonable specificity the basis for the termination with Good Reason within ninety (90) days of the first occurrence of the event giving rise to Good Reason; give the Company a period of thirty (30) days to cure or remedy the problem, unless such problem cannot be cured or remedied within thirty (30) days, in which case the period for remedy or cure shall be extended for a reasonable time (not to exceed an additional thirty (30) days) (the “Cure Period”); and terminate your employment within thirty (30) days following the expiration of such Cure Period.

4.	Effective February 25, 2016, Section 9 is hereby added to the Agreement as follows:

a.

Exemptions. The severance and other benefits under this Amended Offer Letter are intended to qualify for exemptions from application of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the regulations and other guidance thereunder and any state law of similar effect (collectively, “Section 409A”), provided under Treasury Regulations 1.409A-1(b)(4), 1.409A1-(b)(5) and 1.409A-1(b)(9), and this Amended Offer Letter will be construed to the greatest extent possible as consistent with those provisions, and to the extent not so exempt, this letter (and any definitions hereunder) will be construed in a manner that complies with Section 409A to the extent necessary to avoid adverse personal tax under Section 409A.

b.

Deferral. Notwithstanding anything herein to the contrary, if at the time of your termination of employment with the Company you are a “specified employee” as defined in Section 409A and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary in order to prevent any adverse tax consequences under Section 409A, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to you) until the date that is six months and one day following your termination of employment with the Company (or such earlier date as is permitted without incurring adverse consequences under Section 409A).

c.

Separation from Service. Notwithstanding anything to the contrary herein, a termination of employment shall not be deemed to have occurred for purposes of any provision of this Offer Letter providing for the payment of amounts or benefits upon or following a termination of employment unless such termination is also a “Separation from Service” within the meaning of Section 409A and, for purposes of this Offer Letter, references to a “resignation,” “termination,” “termination of employment” or like terms shall mean Separation from Service.

d.	Timing of Payments. For the avoidance of doubt, any severance benefit payments otherwise scheduled to be made prior to the sixtieth (60th) day following your termination of employment shall instead accrue and will be paid on such sixtieth (60th) day following your termination of employment.

e.

Other. Your right to receive any installment payments will be treated as a right to receive a series of separate payments and, accordingly, each installment payment shall at all times be considered a separate and distinct payment. With respect to reimbursements or in-kind benefits provided to you hereunder (or otherwise) that are not exempt from Section 409A, the following rules shall apply: (i) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any one of your taxable years shall not affect the expenses eligible for reimbursement, or in-kind benefit to be provided in any other taxable year, (ii) in the case of any reimbursements of eligible expenses, reimbursement shall be made on or before the last day of your taxable year following the taxable year in which the expense was incurred, (iii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.

•	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•	The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

v3.4.0.3

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2016	May. 05, 2016
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Entity Registrant Name	Zeltiq Aesthetics Inc
Entity Central Index Key	0001415336
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		39,455,079

v3.4.0.3

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 33,508	$ 35,710
Short-term investments	4,663	12,867
Accounts receivable, net	32,572	33,359
Inventory	32,562	28,095
Prepaid expenses and other current assets	13,709	11,771
Total current assets	117,014	121,802
Long-term investments	857	3,490
Restricted cash	444	452
Property and equipment, net	7,511	6,969
Intangible asset, net	4,930	5,092
Long-term deferred tax assets	41,256	40,475
Other assets	473	547
Total assets	172,485	178,827
CURRENT LIABILITIES:
Accounts payable	13,554	10,903
Accrued and other current liabilities	31,326	34,691
Deferred revenue	10,637	7,682
Current portion of capital lease obligations	125	124
Total current liabilities	55,642	53,400
Long-term deferred revenue	214	226
Long-term capital lease obligations, less current portion	106	138
Other non-current liabilities	847	761
Total liabilities	$ 56,809	$ 54,525
Commitments and contingencies (Note 6)
STOCKHOLDERS’ EQUITY:
Preferred stock, $0.01 par value: 50,000,000 shares authorized and no shares issued and outstanding at March 31, 2016 and December 31, 2015	$ 0	$ 0
Common stock, $0.001 par value: 500,000,000 shares authorized at March 31, 2016, and December 31, 2015; 39,420,312 and 39,217,630 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	43	43
Additional paid-in capital	217,208	215,621
Accumulated other comprehensive loss	(1,979)	(1,636)
Accumulated deficit	(99,596)	(89,726)
Total stockholders’ equity	115,676	124,302
Total liabilities and stockholders’ equity	$ 172,485	$ 178,827

v3.4.0.3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	39,420,312	39,217,630
Common stock, shares outstanding	39,420,312	39,217,630

v3.4.0.3

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Revenue	$ 64,469	$ 51,558
Cost of revenue	18,229	14,378
Gross profit	46,240	37,180
Operating expenses:
Research and development	6,203	6,080
Sales and marketing	40,655	24,406
General and administrative	10,546	8,388
Total operating expenses	57,404	38,874
Loss from operations	(11,164)	(1,694)
Interest income (expense), net	(36)	13
Other income (expense), net	646	(420)
Loss before income taxes	(10,554)	(2,101)
Provision for (benefit from) income taxes	(684)	28
Net loss	$ (9,870)	$ (2,129)
Basic and diluted net loss per share:
Net loss per share, basic and diluted	$ (0.25)	$ (0.06)
Weighted average shares of common stock outstanding used in computing net loss per share, basic and diluted	39,288,853	38,383,022

v3.4.0.3

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Statement of Comprehensive Income [Abstract]
Net loss	$ (9,870)	$ (2,129)
Other comprehensive loss, net of tax:
Foreign currency translation adjustments	(365)	(588)
Changes in unrealized gains on available-for-sale securities	22	5
Other comprehensive loss, net of tax	(343)	(583)
Comprehensive loss	$ (10,213)	$ (2,712)

v3.4.0.3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (9,870)	$ (2,129)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	709	513
Stock-based compensation	4,202	4,150
Deferred income taxes	(781)	0
Amortization of investment premium, net	22	22
Provision for doubtful accounts receivable	284	123
Provision for excess and obsolete inventory	27	128
Loss on disposal and write-off of property and equipment	20	0
Changes in operating assets and liabilities:
Accounts receivable	36	(3,359)
Inventory	(4,794)	(2,100)
Prepaid expenses and other assets	(1,972)	(391)
Deferred revenue	3,076	503
Accounts payable, accrued and other liabilities	(47)	710
Net cash used in operating activities	(9,088)	(1,830)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investments	(741)	(4,070)
Proceeds from sale of investments	8,683	0
Proceeds from maturity of investments	2,894	5,911
Purchase of property and equipment	(1,424)	(285)
Net cash provided by investing activities	9,412	1,556
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on capital leases	(31)	(29)
Proceeds from issuance of common stock upon exercise of stock options	37	1,346
Tax payments related to shares withheld for vested restricted stock units	(2,651)	(4,345)
Tax effect of employee stock plans	0	16
Net cash used in financing activities	(2,645)	(3,012)
Effect of exchange rate changes on cash and cash equivalents	119	(306)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(2,202)	(3,592)
CASH AND CASH EQUIVALENTS—Beginning of period	35,710	28,649
CASH AND CASH EQUIVALENTS—End of period	$ 33,508	$ 25,057

v3.4.0.3

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying interim condensed consolidated financial statements of ZELTIQ Aesthetics, Inc. (the "Company") are unaudited. These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The December 31, 2015 condensed consolidated balance sheet was derived from the audited financial statements as of that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments of a normal recurring nature considered necessary to state fairly the Company's financial position as of March 31, 2016, results of operations for the three months ended March 31, 2016 and 2015, comprehensive loss for the three months ended March 31, 2016 and 2015, and cash flows for the three months ended March 31, 2016 and 2015. The interim results for the three months ended March 31, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016 or for any other future annual or interim period. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations," “Quantitative and Qualitative Disclosures About Market Risk” and the Consolidated Financial Statements and notes thereto included in Items 7, 7A and 8, respectively, in the Company's Annual Report on Form 10-K for the year ended December 31, 2015. Out of period adjustments During the three months ended March 31, 2016, the Company recorded certain out-of-period correcting adjustments totaling $0.2 million to increase cost of revenue by $0.4 million, with a corresponding increase to warranty accrual, and to reduce other operating expenses by $0.2 million, with a corresponding decrease to other accruals, relating to prior periods. The Company does not believe that such amounts are material to any prior period consolidated financial statements, and the impact of correcting these errors in the three months ended March 31, 2016 is not material to the current consolidated financial statements or expected to be material to the financial statements for the year ending December 31, 2016. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. The functional currency of the Company’s international subsidiaries is evaluated on a case-by-case basis and has been determined to be the local currency with the exception of Malta which carries a U.S. dollar functional currency. All assets and liabilities of these foreign operations are translated to U.S. Dollars at current period end exchange rates, and revenue and expenses are translated to U.S. Dollars using average exchange rates in effect during the period. The gains and losses from the foreign currency translation of the foreign subsidiaries' financial statements are included as a separate component of stockholders' equity under "Accumulated other comprehensive income (loss)." Gains or losses arising from currency exchange rate fluctuations on transactions denominated in a currency other than the local functional currency are included in other income (expense), net. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. The primary estimates underlying the Company's financial statements include the value of revenue elements, product warranty, inventory valuation, allowance for doubtful accounts receivable, assumptions regarding variables used in calculating the fair value of the Company's equity awards, fair value of investments, useful lives of intangibles, income taxes and contingent liabilities. Actual results could differ from those estimates. Concentration of Credit Risk As of March 31, 2016, no individual customer accounted for more than 10% of accounts receivable. As of December 31, 2015, Ideal Image, which is a large aesthetic chain, along with its affiliated franchises, accounted for 10% of the Company's accounts receivable. During the three months ended March 31, 2016, no customer accounted for more than 10% of total revenue. During the three months ended March 31, 2015, Ideal Image accounted for 11% of total revenue. Significant Accounting Policies There have been no material changes to the Company’s significant accounting policies during the three months ended March 31, 2016, as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. Recent Accounting Pronouncements On May 28, 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. On August 12, 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. In March 2016, the FASB issued ASU 2016-08 which included amendments to the guidance in the new standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. In April 2016, the FASB issued ASU 2016-10 which includes additional amendments to the guidance in the new revenue standard on identifying performance obligations and accounting for licenses of intellectual property. The objective of this update is to provide a single, comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries, and across capital markets. This standard update contains principles that the Company will apply to determine the measurement of revenue and timing of when it is recognized. This guidance allows for two methods of adoption: (a) full retrospective adoption, meaning the guidance is applied to all periods presented, or (b) modified retrospective adoption, meaning the cumulative effect of applying this guidance is recognized as an adjustment to the fiscal 2018 opening accumulated deficit balance. The Company expects to adopt this guidance effective January 1, 2018, and is currently evaluating the two adoption methods as well as the impact this new guidance will have on its consolidated financial statements and related disclosures. In July 2015, the FASB issued Accounting Standards Update No. 2015-11 to amend ASC Topic 330, Inventory ("ASC 330") to simplify the measurement of inventory. The amendments require that an entity measure inventory at the lower of cost and net realizable value instead of the lower of cost and market. This guidance is effective for public companies for years, and interim periods within those years, beginning on or after December 15, 2016, with earlier application permitted as of the beginning of an interim or annual reporting period. This guidance will be effective for the Company beginning in its first quarter of fiscal 2017. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements and related disclosures. In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases. This ASU requires lease assets and lease liabilities arising from leases, including operating leases, to be recognized on the balance sheet. ASU 2016-02 will become effective for the Company on January 1, 2019, and requires adoption using a modified retrospective approach. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and related disclosures. In March 30, 2016, the FASB issued Accounting Standards Update No. 2016-09, Improvements to Employee Share-Based Payment Accounting. This ASU will change how companies account for certain aspects of share-based payments to employees. This guidance will require all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also will allow an employer to repurchase more of an employee's shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election to account for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 2016, and interim periods within those years, with earlier application permitted in any annual or interim period for which financial statements haven't been issued or made available for issuance, but all of the guidance must be adopted in the same period. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements and related disclosures.

v3.4.0.3

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: •Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company classifies its cash equivalents and investments within Level 1 and Level 2, as it uses quoted market prices or alternative pricing sources and models utilizing market observable inputs. The following tables set forth the fair value of the Company’s financial assets and liabilities by level within the fair value hierarchy (in thousands):     As of March 31, 2016   Level 1   Level 2   Level 3   Fair Value Financial Assets               Cash equivalents:               Money market funds $ 2,244   $ —   $ —   $ 2,244 Short-term investments:               U.S. Agency securities —   750   —   750 U.S. Treasury —   —   —   — Corporate bonds —   3,913   —   3,913 Commercial paper —   —   —   — Certificates of deposit —   —   —   — Long-term investments:               U.S. Agency securities —   —   —   — Corporate bonds —   612   —   612 Certificates of deposit 245   —   —   245 Total $ 2,489   $ 5,275   $ —   $ 7,764   As of December 31, 2015   Level 1   Level 2   Level 3   Fair Value Financial Assets               Cash equivalents:               Money market funds $ 1,342   $ —   $ —   $ 1,342 Short-term investments:             U.S. Agency securities —   1,549   —   1,549 U.S. Treasury —   500   —   500 Corporate bonds —   7,763   —   7,763 Commercial paper —   500   —   500 Certificates of deposit 2,555   —   —   2,555 Long-term investments:             U.S. Agency securities —   497   —   497 Corporate bonds —   874   —   874 Certificates of deposit 2,119   —   —   2,119 Total $ 6,016   $ 11,683   $ —   $ 17,699 During the three months ended March 31, 2016 and 2015, the Company did not have any transfers of financial assets measured at fair value on a recurring basis to or from Level 3. The Company did not hold any Level 3 assets or liabilities as of March 31, 2016 or December 31, 2015. The carrying amounts of the Company’s cash equivalents, accounts receivable and accounts payable approximate fair value due to their relatively short maturities.

v3.4.0.3

Balance Sheet Components	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Investments The Company's short-term and long-term investments as of March 31, 2016 are as follows (in thousands): Short-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ 750   $ —   $ —   $ 750 U.S. Treasury —   —   —   — Corporate bonds 3,914   1   (2 )   3,913 Commercial paper —   —   —   — Certificates of deposit —   —   —   — Total $ 4,664   $ 1   $ (2 )   $ 4,663                 Long-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ —   $ —   $ —   $ — Corporate bonds 611   1   —   612 Certificates of deposit 245   —   —   245 Total $ 856   $ 1   $ —   $ 857 The Company's short-term and long-term investments as of December 31, 2015 are as follows (in thousands): Short-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ 1,551   $ —   $ (2 )   $ 1,549 U.S. Treasury 500   —   —   500 Corporate bonds 7,776   —   (13 )   7,763 Commercial paper 500   —   —   500 Certificates of deposit 2,555   —   —   2,555 Total $ 12,882   $ —   $ (15 )   $ 12,867                 Long-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ 499   $ —   $ (2 )   $ 497 U.S. Treasury —   —   —   — Corporate bonds 878   —   (4 )   874 Certificates of deposit 2,119   —   —   2,119 Total $ 3,496   $ —   $ (6 )   $ 3,490 For each of the three months ended March 31, 2016 and 2015, gains or losses realized on the sale of investments were insignificant. The contractual maturities of the Company's short-term and long-term investments as of March 31, 2016 are as follows (in thousands):   March 31, 2016   Amortized Cost   Fair Value Due in one year or less $ 4,664   $ 4,663 Due in one year to five years 856   857   $ 5,520   $ 5,520 When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below the amortized cost basis, review of current market liquidity, interest rate risk, the financial condition of the issuer, as well as credit rating downgrades. The Company believes that the unrealized losses are not other-than-temporary. The Company does not have a foreseeable need to liquidate the portfolio and anticipates recovering the full cost of the securities either as market conditions improve, or as the securities mature. Inventory Inventory is stated at the lower of cost (which approximates actual cost on a first-in, first-out basis) or market. Inventory that is obsolete or in excess of forecasted usage is written down to its estimated net realizable value based on assumptions about future demand and market conditions. The components of inventory consist of the following (in thousands):     March 31, 2016   December 31, 2015 Raw materials $ 10,698   $ 9,117 Finished goods 21,864   18,978           Total inventory $ 32,562   $ 28,095 Property and equipment, net Property and equipment, net comprised the following (in thousands):     March 31, 2016   December 31, 2015 Lab equipment, tooling and molds $ 3,375   $ 3,228 Computer software 2,499   2,019 Computer equipment 2,844   2,757 Leasehold improvements 1,825   1,670 Furniture and fixtures 1,057   950 Vehicles 35   35 Total property and equipment 11,635   10,659 Less: Accumulated depreciation and amortization (6,179 )   (5,635 ) Construction in progress 2,055   1,945 Property and equipment, net $ 7,511   $ 6,969 The table above includes property and equipment acquired under capital leases which totaled $0.4 million as of both March 31, 2016 and December 31, 2015. Depreciation and amortization expense related to property and equipment was $0.5 million for the three months ended March 31, 2016. Depreciation and amortization expense related to property and equipment was $0.3 million for the three months ended March 31, 2015. Accrued and Other Current Liabilities The following table shows the components of accrued liabilities (in thousands):     March 31, 2016   December 31, 2015 Accrued payroll and employee related expenses $ 9,506   $ 14,887 Accrued marketing expenses 6,157   5,554 Accrued royalty 4,693   5,453 Sales and other taxes payable 3,507   3,703 Advance payments from customers 864   1,585 Accrued warranty 1,052   527 Accrued legal expenses 2,527   1,465 Other 3,020   1,517 Total accrued and other current liabilities $ 31,326   $ 34,691 Deferred Revenue The following table shows the components of deferred revenue, including long-term deferred revenue (in thousands):    March 31, 2016   December 31, 2015 Deferred extended warranty revenue 2,901   2,902 Deferred training revenue 3,408   3,115 Other deferred revenue 4,542   1,891      Total deferred revenue $ 10,851   $ 7,908 Deferred Extended Warranty Revenue The Company offers standard extended warranties which allows customers to receive service and support which extend beyond the contractual term of the product warranty. The Company recognizes these contracts over the life of the service period. Changes in the Company's deferred revenue, including long-term deferred revenue, related to extended warranties were as follows (in thousands):   March 31, 2016   March 31, 2015 Balance at the beginning of the period $ 2,902   $ 3,272 Extended warranties issued 1,004   732 Amortization (1,005 )   (789 ) Balance at the end of the period $ 2,901    $ 3,215 Product Warranties The Company provides a standard limited warranty on its products of one year for both control units and applicators for its direct customers. For indirect customers in international markets, the Company provides a standard limited warranty on its products of generally 3.2 years for control units and 1.2 years for applicators. The Company accrues for the estimated future costs of repair or replacement upon shipment. The warranty accrual is recorded to cost of revenue and is based upon historical trends in the volume of product failures during the warranty period and the cost to repair or replace the equipment. The Company bases product warranty costs on related freight, material, technical support labor and overhead costs. The estimated product warranty costs are assessed by considering historical costs and applying the experienced failure rates to the outstanding warranty period for products sold. The Company exercises judgment in estimating the expected product warranty costs, using data such as the actual product failure rates, and average repair costs, including freight, material, technical support labor, and overhead costs, for products returned under warranty. Changes in product warranty accrual was as follows (in thousands):     Three Months Ended   March 31,   2016   2015 Balance at the beginning of the period $ 527   $ 569 Settlements of warranties (225 )   (100 ) Provision 750   (29 ) Balance at the end of the period $ 1,052   $ 440

v3.4.0.3

Intangible Asset, Net	3 Months Ended
	Mar. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Asset, Net	Intangible Asset, Net The Company's intangible asset consists of an exclusive license agreement with Massachusetts General Hospital, or MGH, for commercializing patents and other technology. All milestone payments payable by the Company pursuant to the terms of the agreement subsequent to the date of the Food and Drug Administration, or FDA, clearance were capitalized as purchased technology when paid, and are subsequently amortized into cost of revenue using the straight-line method over the estimated remaining useful life of the technology, not to exceed the term of the agreement or the life of the patent. Intangible asset, net comprised the following (in thousands):     March 31, 2016   December 31, 2015 Purchased technology $ 8,050   $ 8,050 Less: Accumulated amortization (3,120 )   (2,958 )      Intangible asset, net $ 4,930   $ 5,092 Amortization expense of the intangible asset was $0.2 million for both the three months ended March 31, 2016 and 2015. The total estimated annual future amortization expense of this intangible asset as of March 31, 2016, is as follows (in thousands): Fiscal Year   2016 (remaining 9 months) $ 488 2017 650 2018 650 2019 650 2020 650 Thereafter 1,842 Total $ 4,930

v3.4.0.3

Related Party Transactions	3 Months Ended
	Mar. 31, 2016
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Brazilian Distribution Agreement The Company entered into a distribution agreement with ADVANCE Medical, Inc. and its wholly owned subsidiaries, Immunotech and BIOGEN, or ADVANCE, dated March 18, 2011, as the Company's exclusive distributor of CoolSculpting in Brazil and Mexico, as amended on August 29, 2011, February 27, 2012 and September 4, 2012. The distribution agreement was further amended on August 15, 2014, whereby ADVANCE is no longer a distributor in Mexico, effective November 13, 2014. As the exclusive distributor in Brazil, ADVANCE is required to purchase a minimum quantity of the Company’s products each calendar quarter throughout the term of the distribution agreement which expires on December 31, 2018. Venrock, a principal stockholder of the Company, owns an equity interest in ADVANCE Medical, Ltd., the parent company of ADVANCE. Dr. Bryan E. Roberts, who is a member of the Company's Board of Directors, is also a partner of Venrock Associates. ADVANCE purchases product with payment terms up to 180 days, and to date no amounts have been determined to be unrecoverable. The revenue recognized by the Company under this distribution agreement was $0.9 million for the three months ended March 31, 2016, compared to $1.3 million for the three months ended March 31, 2015. The accounts receivable balance under this distribution agreement was insignificant as of March 31, 2016 and $1.7 million as of December 31, 2015.

v3.4.0.3

Commitments And Contingencies	3 Months Ended
	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating Lease Obligations The Company leases facilities under non-cancellable operating leases with various expiration dates. Specifically, the Company occupies a facility in Pleasanton, California, under a lease which extends through March 2019, a manufacturing facility in Dublin, California, under a lease which extends through May 2017, and a warehouse space in Livermore, California, under a lease which extends through May 2017. The Company also occupies office and warehouse space near Gatwick, United Kingdom, under a lease which extends through December 2018, as well as office space in London, United Kingdom, under a lease which extends through April 2016, Taipei, Taiwan, under a lease which extends through August 2016, Seoul, South Korea, under a lease which extends through August 2016, Reston, Virginia, under a lease which extends through September 2021, Galway, Ireland under a lease which extends through September 2016. Rent expense for non-cancellable operating leases with scheduled rent increases is recognized on a straight-line basis over the lease term. Rent expense was $0.6 million for the three months ended March 31, 2016, compared to $0.5 million for the three months ended March 31, 2015. Future minimum lease payments under the Company's non-cancellable operating leases as of March 31, 2016 are as follows (in thousands): Year Ending December 31, Amount 2016 (remaining 9 months) $ 1,804 2017 2,182 2018 2,040 2019 896 2020 529 Thereafter 408 Total future minimum lease payments $ 7,859 Capital Lease Obligations The Company has entered into certain capital lease obligations to purchase equipment for operations which include a bargain purchase option. The underlying assets and related depreciation are included in the appropriate property and equipment category and related accumulated depreciation account. Property and equipment includes amounts under leases that have been capitalized as follows (dollars in thousands):   Useful life (Years)   March 31, 2016   December 31, 2015 Computer equipment 3   $ 382   $ 382 Total capital leased equipment     382   382 Less: Accumulated depreciation and amortization     (181 )   (149 ) Capital leased equipment, net     $ 201   $ 233 Total depreciation of assets acquired under capital leases was $32,000 for each of the three months ended March 31, 2016 and March 31, 2015, which is included in total depreciation and amortization expense. Future minimum payments required under capital leases as of March 31, 2016, are as follows (in thousands):   Year Ending March 31, Amount 2016 (remaining 9 months) $ 99 2017 141      Total future payments $ 240     Less: Amount representing interest $ 9 Present value of future minimum payments 231 Less: Current portion 125 Long term portion $ 106 Purchase Commitments The Company had non-cancellable purchase obligations to contract manufacturers and suppliers for $4.1 million and $5.9 million at March 31, 2016 and December 31, 2015, respectively. Unrecognized Tax Benefits The Company's gross liability for unrecognized tax benefits totaled $0.3 million, including estimated interest and penalties, as of March 31, 2016, and is classified in other non-current liabilities. The Company is unable to make a reasonably reliable estimate of the timing of payments in individual years due to uncertainties in the timing of tax audits, if any, or their outcomes. Legal Matters From time to time, the Company may be involved in legal and administrative proceedings and claims of various types. Additionally, the Company may be subject to insurance related claims resulting from matters associated with CoolSculpting treatments. The Company records a liability in its condensed consolidated financial statements for these matters when a loss is known and considered probable and the amount can be reasonably estimated. Management reviews these estimates in each accounting period as additional information becomes known and adjusts the loss provision when appropriate. If the loss is not probable or cannot be reasonably estimated, a liability is not recorded in the consolidated financial statements. If a loss is probable but the amount of loss cannot be reasonably estimated, the Company discloses the loss contingency and an estimate of possible loss or range of loss (unless such an estimate cannot be made). The Company does not recognize gain contingencies until they are realized. Legal costs incurred in connection with loss contingencies are expensed as incurred. Product Liability Contingencies The Company has historically been and continues to be predominantly self-insured for any product liability losses related to its products. The Company obtains third-party insurance to limit its exposure to these claims, but this insurance is subject to a cap on reimbursement. Product liability losses are, by their nature, uncertain and are based upon complex judgments and probabilities. The Company accrues for reported claims and estimates for incurred, but not reported claims, to the extent that such losses can be reasonably estimated. The Company determines its accruals for probable product liability losses based on various factors, including historical claims and settlement experience. The total amount of self-insured product liability claims settled in the quarter ended March 31, 2016 was $0.9 million. The total amount of self-insured product liability claims settled during the quarter ended March 31, 2015 was insignificant. The amount of reported and estimated incurred but not known self-insured product liability claims pending was $1.8 million as of March 31, 2016 and $1.1 million as of December 31, 2015, which is recorded in accrued and other current liabilities on the Company's condensed consolidated balance sheet and expected to be paid within one year. Indemnifications In the normal course of business, the Company enters into contracts that contain a variety of representations and warranties and provide for general indemnifications. The Company's exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but have not yet been made. To date, the Company has not paid any claims, and the Company believes that the estimated fair value of these indemnification obligations is minimal and it has not accrued any amounts for these obligations. Separation Agreements On February 25, 2016, the Company's former Chief Financial Officer and the Company mutually agreed that the former Chief Financial Officer would cease to be an officer and employee of the Company which resulted in the Company incurring $0.3 million in termination benefits. In addition, stock-based compensation expense relating to the modifications of the former Chief Financial Officer's stock options and stock awards totaled $1.1 million, of which $0.8 million was recognized as stock-based compensation during the quarter ended March 31, 2016 and $0.3 million will be recognized in the quarter ending June 30, 2016.

v3.4.0.3

Stock-Based Compensation Expense	3 Months Ended
	Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation Expense	Stock-Based Compensation Expense Share-Based Awards Available for Grant A summary of share-based awards available for grant is as follows:           Shares Available for Grant Balance, December 31, 2015 3,517,305 Additional shares reserved 1,000,000 Options granted (302,226 ) Restricted stock units granted (379,569 ) Options canceled 217 Restricted stock units canceled 39,189 Restricted stock units withheld for tax 112,546 Balance, March 31, 2016 3,987,462 Stock Option Awards A summary of the stock option activity is as follows:     Options Outstanding     Number of Stock Options Outstanding   Weighted- Average Exercise Price Balance, December 31, 2015 2,641,592   $ 6.86 Options granted 302,226   22.25 Options exercised (6,594 )   5.67 Options canceled (217 )   6.38 Balance, March 31, 2016 2,937,007   $ 8.44 Restricted Stock Activity Activity related to restricted stock units and awards is set forth below:     Number of Units and Awards   Weighted- Average Grant Date Fair Value Balance, December 31, 2015 1,312,651   $ 19.09 Restricted stock units granted 379,569   22.79 Restricted stock units vested (308,634 )   24.17 Restricted stock units canceled (39,189 )   23.49 Balance, March 31, 2016 1,344,397   $ 20.82 During the three months ended March 31, 2016, 308,634 shares vested subject to previously granted restricted stock units. A majority of these vested restricted stock units were net share settled. During the three months ended March 31, 2016, the Company withheld 112,546 shares based upon the Company's closing stock price on the vesting date to settle the employee's minimum statutory obligation for the applicable income and other employment taxes. During the three months ended March 31, 2015, 330,201 shares vested subject to previously granted restricted stock units. A majority of these vested restricted stock units were net share settled. During the three months ended March 31, 2015, the Company withheld 133,035 shares based upon the Company's closing stock price on the vesting date to settle the employee's minimum statutory obligation for the applicable income and other employment taxes. Subsequently, the Company remitted cash to the appropriate taxing authorities. Total payments for employee's tax obligations to the relevant taxing authority were $2.6 million for the three months ended March 31, 2016. Total payments for employee's tax obligations to the relevant taxing authority were $4.3 million for the three months ended March 31, 2015. The payments were for taxes related to the net share settlements of restricted stock units. Stock-Based Compensation Expense Stock-based compensation related to all of the Company's stock-based awards and employee stock purchases was recorded as an expense or a reduction to revenue and are categorized as follows (in thousands):     Three Months Ended   March 31,   2016   2015 Revenue $ —   $ 80 Cost of revenue 232   134 Research and development 501   350 Sales and marketing 1,383   1,551 General and administrative 2,086   2,035 Total stock-based compensation $ 4,202   $ 4,150 As of March 31, 2016, the total unrecognized compensation costs related to outstanding stock options, awards and employee stock purchases was $26.2 million, which is expected to be recognized using the straight-line attribution method over 2.9 years. Performance-Based Awards From time to time, the Company will issue performance-based stock options and restricted stock units to senior executives.  During both the three months ended March 31, 2016 and 2015, the Company granted 40,000 performance-based restricted stock units to a senior executive, which was accounted for as an equity award. The number of units that ultimately vest depends on achieving certain performance criteria and can range from 0% to 100% of the number of units granted. The performance criteria are specific to the roles of each of the executives and are set by the Compensation Committee of the Board of Directors. The performance-based restricted stock units have no dividend or voting rights during the performance period. Each of the performance-based restricted stock units represents the contingent right to receive one share of the Company's common stock if the vesting conditions are satisfied. Compensation expense related to these grants is based on the grant date fair value of the award. Stock-based compensation expense includes charges related to performance-based stock options and restricted stock units granted to certain executives. Stock-based compensation expense related to these stock options and restricted stock units was $0.4 million for the three months ended March 31, 2016, compared to $1.5 million for the three months ended March 31, 2015. Employee Stock-Based Compensation The Company uses the Black-Scholes option pricing model to determine the fair value of stock options. The valuation model for stock-based compensation expense requires the Company to make assumptions and judgments about the variables used in the calculation including the expected term (weighted-average period of time that the options granted are expected to be outstanding), volatility of the Company's common stock, an assumed-risk-free interest rate and the estimated forfeitures of unvested stock options. The Company's assumptions related to the expected term and volatility are detailed below. The fair value of employee stock options was estimated using the following weighted-average assumptions:     Three Months Ended   March 31,   2016   2015 Expected term (in years) 4.8   4.8 Expected volatility 63 %   63 % Risk-free interest rate 1.21 %   1.29 % Expected dividend yield — %   — % Expected Term. Subsequent to the Company's initial public offering of its common stock, or IPO, and through 2014, the expected term used was based on expected term of a group of similar entities, referred to as its “peer group.” In evaluating similarity, the Company considered factors such as industry, stage of life cycle and size. In 2015, the Company modified its approach by including its own historical data along with the expected term of the identified peer group companies. The Company will continue to apply this methodology until a sufficient amount of historical information regarding its own expected term becomes available. Volatility. Subsequent to the IPO, and through 2014, the Company continued to estimate its volatility based on its peer group as the Company did not have sufficient historical data regarding its specific volatility. In 2015, the Company modified its approach by including its own common stock trading history along with the volatility of the identified peer group companies. The expected stock price volatility is estimated using a combination of historical and peer group volatility to derive the expected volatility assumption. The Company believes the blended volatility is more representative of future stock price trends over the expected life of the options rather than just using historical or peer group volatility. The Company will continue to apply this methodology until a sufficient amount of historical information regarding the volatility of its own stock price becomes available. Risk-Free Interest Rate. The risk-free interest rate is based on U.S. Treasury zero-coupon issues with remaining terms similar to the expected term on the options. Dividend Yield. The Company has never paid any dividends and does not plan to pay dividends in the foreseeable future, and, therefore, used an expected dividend yield of zero in the valuation model. Forfeitures. The Company is required to estimate forfeitures at the time of grant, and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company uses historical data to estimate pre-vesting option forfeitures and to record stock-based compensation expense only for those awards that are expected to vest. To the extent actual forfeitures differ from the estimates, the difference will be recorded as a cumulative adjustment in the period that the estimates are revised. During the three months ended March 31, 2016, the Company granted 302,226 stock options to employees with a weighted-average grant date fair value of $22.25 per share. During the three months ended March 31, 2015, the Company granted 45,622 stock options to employees with a weighted-average grant date fair value of $18.19 per share. During the three months ended March 31, 2016, the Company granted 379,569 restricted stock units to employees with a weighted-average grant date fair value of $22.79 per share. During the three months ended March 31, 2015, the Company granted 353,757 restricted stock units to employees with a weighted-average grant date fair value of $31.95 per share. As of March 31, 2016, the unrecognized compensation cost related to the Company's employee stock purchase plan, or ESPP, was $0.2 million, which will be recognized using the straight-line attribution method over 0.2 years. Stock-Based Compensation for Non-employees Stock-based compensation expense related to stock-based awards to non-employees is recognized as the stock-based awards are earned, generally through the provision of services. The Company believes that the fair value of the stock-based awards is more reliably measurable than the fair value of the services received. The fair value of the granted stock-based awards is calculated at each reporting date using the Black-Scholes option pricing model. During the three months ended March 31, 2016, the Company granted stock-based awards to a non-employee which will vest over two years. Stock-based compensation expense for non-employees was insignificant for the three months ended March 31, 2016 and $0.1 million for the three months ended March 31, 2015.

v3.4.0.3

Net Loss Per Share	3 Months Ended
	Mar. 31, 2016
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss per Share Basic net loss per share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per share is computed by giving effect to all potentially dilutive securities outstanding during the period, including stock options, restricted stock units and common stock issuable pursuant to the ESPP. A reconciliation of the numerator and denominator used in the calculation of the basic and diluted net loss per share is as follows:     Three Months Ended   March 31,   2016   2015 Numerator       Net loss (in thousands) $ (9,870 )   $ (2,129 ) Denominator       Weighted average shares of common stock outstanding used in computing net loss per share, basic 39,288,853   38,383,022 Dilutive effect of incremental shares and share equivalents —   — Weighted average shares of common stock outstanding used in computing net loss per share, diluted 39,288,853   38,383,022 Net loss per share:       Net loss per share, basic and diluted $ (0.25 )   $ (0.06 ) The following outstanding potentially dilutive securities were excluded from the computation of diluted net loss per share of common stock for the periods presented, because including them would have been anti-dilutive:     Three Months Ended   March 31,   2016   2015 Options to purchase common stock 2,937,007   3,025,095 Restricted stock units 1,344,397   1,498,245 Common stock issuable pursuant to the ESPP —   8,874 Total 4,281,404   4,532,214

v3.4.0.3

Income Taxes	3 Months Ended
	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded income tax benefit of $0.7 million and income tax expense of $28,000 for the three months ended March 31, 2016 and March 31, 2015, respectively. The income tax benefit for the three months ended March 31, 2016 reflects a year to date pre-tax loss in the Company's operating entities in various taxing jurisdictions, while the income tax expense for the three months ended March 31, 2015 reflects the mixture and distribution of pre-tax income. The Company continues to maintain a valuation allowance on its deferred tax assets relating to its California R&D credits. The Company generated pre-tax year-to-date ordinary losses in its zero-rate jurisdiction, and the Company has elected to exclude these pre-tax year-to-date ordinary losses from its zero-rate jurisdiction from its estimated effective tax rate computations. The exclusion is based on the notion that a loss in a zero-rate jurisdiction ultimately will not provide the Company a tax benefit. At March 31, 2016, the Company had $3.2 million of unrecognized tax benefits. The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. To date, such interest and penalties have not been material. During the fourth quarter of the year ended December 31, 2015, the Company released its valuation allowance against U.S. federal and state deferred tax assets, with the exception of the California research and development credit carryforwards.  Based upon the evaluation of positive and negative evidence supporting the realizability of deferred tax assets as of the quarter ended March 31, 2016, there remains sufficient positive evidence to support the realization of U.S. federal and state deferred tax assets, with the exception of California research and development credit carryforwards.  The Company files annual income tax returns in multiple taxing jurisdictions around the world, including the U.S. federal and state jurisdictions, Ireland and the United Kingdom. A number of years may elapse before an uncertain tax position is audited and finally resolved. While it is often difficult to predict the final outcome or the timing of resolution of any particular uncertain tax position, the Company believes that its reserves for income taxes reflect the most likely outcome. The Company adjusts these reserves, as well as the related interest, in light of changing facts and circumstances. Settlement of any particular position could require the use of cash. As of March 31, 2016, changes to the Company's uncertain tax positions in the next 12 months that are reasonably possible are not expected to have a significant impact on the Company's financial position or results of operations.

v3.4.0.3

Segment Information	3 Months Ended
	Mar. 31, 2016
Segment Reporting [Abstract]
Segment Information	Segment Information Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company has one business activity and there are no segment managers who are held accountable for operations. Accordingly, the Company has a single reportable segment structure. All of the Company’s principal operations and decision-making functions are located in the United States. The Company’s revenue by geographic region, based on the location to where the product was shipped, is summarized as follows (in thousands):     Three Months Ended   March 31,   2016   2015 North America $ 51,469   $ 35,229 International 13,000   16,329      Total $ 64,469   $ 51,558 North America includes the United States and related territories, as well as Canada. International is the rest of the world. Revenue for the United States was $51.3 million for the three months ended March 31, 2016, compared to $33.2 million for the three months ended March 31, 2015. The following table sets forth revenue by product (in thousands):     Three Months Ended   March 31,   2016   2015 System revenue $ 24,689   $ 26,156 Consumable revenue 39,780   25,402      Total $ 64,469   $ 51,558 Substantially all of the Company’s long-lived assets are located in the United States of America.

v3.4.0.3

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying interim condensed consolidated financial statements of ZELTIQ Aesthetics, Inc. (the "Company") are unaudited. These interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, for interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The December 31, 2015 condensed consolidated balance sheet was derived from the audited financial statements as of that date, but does not include all of the information and footnotes required by GAAP for complete financial statements. The accompanying unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, reflect all adjustments of a normal recurring nature considered necessary to state fairly the Company's financial position as of March 31, 2016, results of operations for the three months ended March 31, 2016 and 2015, comprehensive loss for the three months ended March 31, 2016 and 2015, and cash flows for the three months ended March 31, 2016 and 2015. The interim results for the three months ended March 31, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016 or for any other future annual or interim period. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations," “Quantitative and Qualitative Disclosures About Market Risk” and the Consolidated Financial Statements and notes thereto included in Items 7, 7A and 8, respectively, in the Company's Annual Report on Form 10-K for the year ended December 31, 2015.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.
Foreign Currency	The functional currency of the Company’s international subsidiaries is evaluated on a case-by-case basis and has been determined to be the local currency with the exception of Malta which carries a U.S. dollar functional currency. All assets and liabilities of these foreign operations are translated to U.S. Dollars at current period end exchange rates, and revenue and expenses are translated to U.S. Dollars using average exchange rates in effect during the period. The gains and losses from the foreign currency translation of the foreign subsidiaries' financial statements are included as a separate component of stockholders' equity under "Accumulated other comprehensive income (loss)." Gains or losses arising from currency exchange rate fluctuations on transactions denominated in a currency other than the local functional currency are included in other income (expense), net.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. The primary estimates underlying the Company's financial statements include the value of revenue elements, product warranty, inventory valuation, allowance for doubtful accounts receivable, assumptions regarding variables used in calculating the fair value of the Company's equity awards, fair value of investments, useful lives of intangibles, income taxes and contingent liabilities. Actual results could differ from those estimates.
Critical Accounting Policies	Significant Accounting Policies There have been no material changes to the Company’s significant accounting policies during the three months ended March 31, 2016, as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.
Recent Accounting Pronouncements	Recent Accounting Pronouncements On May 28, 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. On August 12, 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. In March 2016, the FASB issued ASU 2016-08 which included amendments to the guidance in the new standard on assessing whether an entity is a principal or an agent in a revenue transaction. This conclusion impacts whether an entity reports revenue on a gross or net basis. In April 2016, the FASB issued ASU 2016-10 which includes additional amendments to the guidance in the new revenue standard on identifying performance obligations and accounting for licenses of intellectual property. The objective of this update is to provide a single, comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries, and across capital markets. This standard update contains principles that the Company will apply to determine the measurement of revenue and timing of when it is recognized. This guidance allows for two methods of adoption: (a) full retrospective adoption, meaning the guidance is applied to all periods presented, or (b) modified retrospective adoption, meaning the cumulative effect of applying this guidance is recognized as an adjustment to the fiscal 2018 opening accumulated deficit balance. The Company expects to adopt this guidance effective January 1, 2018, and is currently evaluating the two adoption methods as well as the impact this new guidance will have on its consolidated financial statements and related disclosures. In July 2015, the FASB issued Accounting Standards Update No. 2015-11 to amend ASC Topic 330, Inventory ("ASC 330") to simplify the measurement of inventory. The amendments require that an entity measure inventory at the lower of cost and net realizable value instead of the lower of cost and market. This guidance is effective for public companies for years, and interim periods within those years, beginning on or after December 15, 2016, with earlier application permitted as of the beginning of an interim or annual reporting period. This guidance will be effective for the Company beginning in its first quarter of fiscal 2017. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements and related disclosures. In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases. This ASU requires lease assets and lease liabilities arising from leases, including operating leases, to be recognized on the balance sheet. ASU 2016-02 will become effective for the Company on January 1, 2019, and requires adoption using a modified retrospective approach. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and related disclosures. In March 30, 2016, the FASB issued Accounting Standards Update No. 2016-09, Improvements to Employee Share-Based Payment Accounting. This ASU will change how companies account for certain aspects of share-based payments to employees. This guidance will require all income tax effects of awards to be recognized in the income statement when the awards vest or are settled. It also will allow an employer to repurchase more of an employee's shares than it can today for tax withholding purposes without triggering liability accounting and to make a policy election to account for forfeitures as they occur. The guidance is effective for public business entities for fiscal years beginning after December 2016, and interim periods within those years, with earlier application permitted in any annual or interim period for which financial statements haven't been issued or made available for issuance, but all of the guidance must be adopted in the same period. The Company is currently evaluating the impact this new guidance will have on its consolidated financial statements and related disclosures.
Fair Value of Financial Instruments	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: •Level 1—Quoted prices in active markets for identical assets or liabilities. • Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company classifies its cash equivalents and investments within Level 1 and Level 2, as it uses quoted market prices or alternative pricing sources and models utilizing market observable inputs.
Inventory	Inventory Inventory is stated at the lower of cost (which approximates actual cost on a first-in, first-out basis) or market. Inventory that is obsolete or in excess of forecasted usage is written down to its estimated net realizable value based on assumptions about future demand and market conditions.

v3.4.0.3

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Fair value of financial assets and liabilities by level within fair value hierarchy	The following tables set forth the fair value of the Company’s financial assets and liabilities by level within the fair value hierarchy (in thousands):     As of March 31, 2016   Level 1   Level 2   Level 3   Fair Value Financial Assets               Cash equivalents:               Money market funds $ 2,244   $ —   $ —   $ 2,244 Short-term investments:               U.S. Agency securities —   750   —   750 U.S. Treasury —   —   —   — Corporate bonds —   3,913   —   3,913 Commercial paper —   —   —   — Certificates of deposit —   —   —   — Long-term investments:               U.S. Agency securities —   —   —   — Corporate bonds —   612   —   612 Certificates of deposit 245   —   —   245 Total $ 2,489   $ 5,275   $ —   $ 7,764   As of December 31, 2015   Level 1   Level 2   Level 3   Fair Value Financial Assets               Cash equivalents:               Money market funds $ 1,342   $ —   $ —   $ 1,342 Short-term investments:             U.S. Agency securities —   1,549   —   1,549 U.S. Treasury —   500   —   500 Corporate bonds —   7,763   —   7,763 Commercial paper —   500   —   500 Certificates of deposit 2,555   —   —   2,555 Long-term investments:             U.S. Agency securities —   497   —   497 Corporate bonds —   874   —   874 Certificates of deposit 2,119   —   —   2,119 Total $ 6,016   $ 11,683   $ —   $ 17,699

v3.4.0.3

Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Investments	The Company's short-term and long-term investments as of March 31, 2016 are as follows (in thousands): Short-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ 750   $ —   $ —   $ 750 U.S. Treasury —   —   —   — Corporate bonds 3,914   1   (2 )   3,913 Commercial paper —   —   —   — Certificates of deposit —   —   —   — Total $ 4,664   $ 1   $ (2 )   $ 4,663                 Long-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ —   $ —   $ —   $ — Corporate bonds 611   1   —   612 Certificates of deposit 245   —   —   245 Total $ 856   $ 1   $ —   $ 857 The Company's short-term and long-term investments as of December 31, 2015 are as follows (in thousands): Short-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ 1,551   $ —   $ (2 )   $ 1,549 U.S. Treasury 500   —   —   500 Corporate bonds 7,776   —   (13 )   7,763 Commercial paper 500   —   —   500 Certificates of deposit 2,555   —   —   2,555 Total $ 12,882   $ —   $ (15 )   $ 12,867                 Long-term                 Amortized Cost   Gross Unrealized Gains   Gross Unrealized Losses   Fair Value U.S. Agency securities $ 499   $ —   $ (2 )   $ 497 U.S. Treasury —   —   —   — Corporate bonds 878   —   (4 )   874 Certificates of deposit 2,119   —   —   2,119 Total $ 3,496   $ —   $ (6 )   $ 3,490
Schedule of Contractual Maturities of Investments	The contractual maturities of the Company's short-term and long-term investments as of March 31, 2016 are as follows (in thousands):   March 31, 2016   Amortized Cost   Fair Value Due in one year or less $ 4,664   $ 4,663 Due in one year to five years 856   857   $ 5,520   $ 5,520
Schedule of Inventory	The components of inventory consist of the following (in thousands):     March 31, 2016   December 31, 2015 Raw materials $ 10,698   $ 9,117 Finished goods 21,864   18,978           Total inventory $ 32,562   $ 28,095
Schedule of Property and Equipment, Net	Property and equipment, net comprised the following (in thousands):     March 31, 2016   December 31, 2015 Lab equipment, tooling and molds $ 3,375   $ 3,228 Computer software 2,499   2,019 Computer equipment 2,844   2,757 Leasehold improvements 1,825   1,670 Furniture and fixtures 1,057   950 Vehicles 35   35 Total property and equipment 11,635   10,659 Less: Accumulated depreciation and amortization (6,179 )   (5,635 ) Construction in progress 2,055   1,945 Property and equipment, net $ 7,511   $ 6,969
Schedule of Accrued Liabilities	The following table shows the components of accrued liabilities (in thousands):     March 31, 2016   December 31, 2015 Accrued payroll and employee related expenses $ 9,506   $ 14,887 Accrued marketing expenses 6,157   5,554 Accrued royalty 4,693   5,453 Sales and other taxes payable 3,507   3,703 Advance payments from customers 864   1,585 Accrued warranty 1,052   527 Accrued legal expenses 2,527   1,465 Other 3,020   1,517 Total accrued and other current liabilities $ 31,326   $ 34,691
Schedule of Deferred Revenue	The following table shows the components of deferred revenue, including long-term deferred revenue (in thousands):    March 31, 2016   December 31, 2015 Deferred extended warranty revenue 2,901   2,902 Deferred training revenue 3,408   3,115 Other deferred revenue 4,542   1,891      Total deferred revenue $ 10,851   $ 7,908
Schedule of Product Warranty Accrual	Changes in product warranty accrual was as follows (in thousands):     Three Months Ended   March 31,   2016   2015 Balance at the beginning of the period $ 527   $ 569 Settlements of warranties (225 )   (100 ) Provision 750   (29 ) Balance at the end of the period $ 1,052   $ 440 Changes in the Company's deferred revenue, including long-term deferred revenue, related to extended warranties were as follows (in thousands):   March 31, 2016   March 31, 2015 Balance at the beginning of the period $ 2,902   $ 3,272 Extended warranties issued 1,004   732 Amortization (1,005 )   (789 ) Balance at the end of the period $ 2,901    $ 3,215

v3.4.0.3

Intangible Asset, Net (Tables)	3 Months Ended
	Mar. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets, Net	Intangible asset, net comprised the following (in thousands):     March 31, 2016   December 31, 2015 Purchased technology $ 8,050   $ 8,050 Less: Accumulated amortization (3,120 )   (2,958 )      Intangible asset, net $ 4,930   $ 5,092
Schedule of Total Estimated Annual Future Amortization Expense	The total estimated annual future amortization expense of this intangible asset as of March 31, 2016, is as follows (in thousands): Fiscal Year   2016 (remaining 9 months) $ 488 2017 650 2018 650 2019 650 2020 650 Thereafter 1,842 Total $ 4,930

v3.4.0.3

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases	Future minimum lease payments under the Company's non-cancellable operating leases as of March 31, 2016 are as follows (in thousands): Year Ending December 31, Amount 2016 (remaining 9 months) $ 1,804 2017 2,182 2018 2,040 2019 896 2020 529 Thereafter 408 Total future minimum lease payments $ 7,859
Schedule of Capital Leased Assets	Property and equipment includes amounts under leases that have been capitalized as follows (dollars in thousands):   Useful life (Years)   March 31, 2016   December 31, 2015 Computer equipment 3   $ 382   $ 382 Total capital leased equipment     382   382 Less: Accumulated depreciation and amortization     (181 )   (149 ) Capital leased equipment, net     $ 201   $ 233
Schedule of Future Minimum Payments Required Under Capital Leases	Future minimum payments required under capital leases as of March 31, 2016, are as follows (in thousands):   Year Ending March 31, Amount 2016 (remaining 9 months) $ 99 2017 141      Total future payments $ 240     Less: Amount representing interest $ 9 Present value of future minimum payments 231 Less: Current portion 125 Long term portion $ 106

v3.4.0.3

Stock-Based Compensation Expense (Tables)	3 Months Ended
	Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Options Activity	A summary of share-based awards available for grant is as follows:           Shares Available for Grant Balance, December 31, 2015 3,517,305 Additional shares reserved 1,000,000 Options granted (302,226 ) Restricted stock units granted (379,569 ) Options canceled 217 Restricted stock units canceled 39,189 Restricted stock units withheld for tax 112,546 Balance, March 31, 2016 3,987,462 Stock Option Awards A summary of the stock option activity is as follows:     Options Outstanding     Number of Stock Options Outstanding   Weighted- Average Exercise Price Balance, December 31, 2015 2,641,592   $ 6.86 Options granted 302,226   22.25 Options exercised (6,594 )   5.67 Options canceled (217 )   6.38 Balance, March 31, 2016 2,937,007   $ 8.44
Restricted Stock Activity	Activity related to restricted stock units and awards is set forth below:     Number of Units and Awards   Weighted- Average Grant Date Fair Value Balance, December 31, 2015 1,312,651   $ 19.09 Restricted stock units granted 379,569   22.79 Restricted stock units vested (308,634 )   24.17 Restricted stock units canceled (39,189 )   23.49 Balance, March 31, 2016 1,344,397   $ 20.82
Stock-based Compensation Expense	Stock-based compensation related to all of the Company's stock-based awards and employee stock purchases was recorded as an expense or a reduction to revenue and are categorized as follows (in thousands):     Three Months Ended   March 31,   2016   2015 Revenue $ —   $ 80 Cost of revenue 232   134 Research and development 501   350 Sales and marketing 1,383   1,551 General and administrative 2,086   2,035 Total stock-based compensation $ 4,202   $ 4,150
Summary of Fair Value of Employee Stock Option Assumptions	The fair value of employee stock options was estimated using the following weighted-average assumptions:     Three Months Ended   March 31,   2016   2015 Expected term (in years) 4.8   4.8 Expected volatility 63 %   63 % Risk-free interest rate 1.21 %   1.29 % Expected dividend yield — %   — %

v3.4.0.3

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2016
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	A reconciliation of the numerator and denominator used in the calculation of the basic and diluted net loss per share is as follows:     Three Months Ended   March 31,   2016   2015 Numerator       Net loss (in thousands) $ (9,870 )   $ (2,129 ) Denominator       Weighted average shares of common stock outstanding used in computing net loss per share, basic 39,288,853   38,383,022 Dilutive effect of incremental shares and share equivalents —   — Weighted average shares of common stock outstanding used in computing net loss per share, diluted 39,288,853   38,383,022 Net loss per share:       Net loss per share, basic and diluted $ (0.25 )   $ (0.06 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following outstanding potentially dilutive securities were excluded from the computation of diluted net loss per share of common stock for the periods presented, because including them would have been anti-dilutive:     Three Months Ended   March 31,   2016   2015 Options to purchase common stock 2,937,007   3,025,095 Restricted stock units 1,344,397   1,498,245 Common stock issuable pursuant to the ESPP —   8,874 Total 4,281,404   4,532,214

v3.4.0.3

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2016
Segment Reporting [Abstract]
Revenue By Geographic Region	The Company’s revenue by geographic region, based on the location to where the product was shipped, is summarized as follows (in thousands):     Three Months Ended   March 31,   2016   2015 North America $ 51,469   $ 35,229 International 13,000   16,329      Total $ 64,469   $ 51,558
Revenue By Product	The following table sets forth revenue by product (in thousands):     Three Months Ended   March 31,   2016   2015 System revenue $ 24,689   $ 26,156 Consumable revenue 39,780   25,402      Total $ 64,469   $ 51,558

v3.4.0.3

Basis of Presentation and Summary of Significant Accounting Policies Out of Period Adjustment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss	$ (9,870)	$ (2,129)
Cost of revenue	18,229	14,378
Operating Expenses	57,404	$ 38,874
Correcting Adjustment to Increase Cost of Revenue, Warranty Accrual and Reduction to Other Operating Expenses [Member] | Restatement Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss	(200)
Cost of revenue	400
Operating Expenses	$ (200)

v3.4.0.3

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Customer Concentration Risk [Member]	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Number	0
Concentration risk, percentage		10.00%
Total Revenue [Member]
Concentration Risk [Line Items]
Concentration Risk, Number	0
Concentration risk, percentage		11.00%

v3.4.0.3

Fair Value of Financial Instruments (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	$ 5,520,000
Assets, fair value disclosure	7,764,000	$ 17,699,000
Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents, fair value disclosure	2,244,000	1,342,000
Short-term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	4,663,000	12,867,000
Short-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	750,000	1,549,000
Short-term Investments [Member] | U.S. Treasury [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	500,000
Short-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	3,913,000	7,763,000
Short-term Investments [Member] | Commercial Paper [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	500,000
Short-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	2,555,000
Long-term Investments [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	857,000	3,490,000
Long-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	497,000
Long-term Investments [Member] | U.S. Treasury [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure		0
Long-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	612,000	874,000
Long-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	245,000	2,119,000
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	2,489,000	6,016,000
Level 1 [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents, fair value disclosure	2,244,000	1,342,000
Level 1 [Member] | Short-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 1 [Member] | Short-term Investments [Member] | U.S. Treasury [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 1 [Member] | Short-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 1 [Member] | Short-term Investments [Member] | Commercial Paper [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 1 [Member] | Short-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	2,555,000
Level 1 [Member] | Long-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 1 [Member] | Long-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 1 [Member] | Long-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	245,000	2,119,000
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	5,275,000	11,683,000
Level 2 [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents, fair value disclosure	0	0
Level 2 [Member] | Short-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	750,000	1,549,000
Level 2 [Member] | Short-term Investments [Member] | U.S. Treasury [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	500,000
Level 2 [Member] | Short-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	3,913,000	7,763,000
Level 2 [Member] | Short-term Investments [Member] | Commercial Paper [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	500,000
Level 2 [Member] | Short-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 2 [Member] | Long-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	497,000
Level 2 [Member] | Long-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	612,000	874,000
Level 2 [Member] | Long-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value disclosure	0	0
Liabilities, fair value disclosure	0	0
Level 3 [Member] | Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents, fair value disclosure	0	0
Level 3 [Member] | Short-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member] | Short-term Investments [Member] | U.S. Treasury [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member] | Short-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member] | Short-term Investments [Member] | Commercial Paper [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member] | Short-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member] | Long-term Investments [Member] | U.S. Agency securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member] | Long-term Investments [Member] | Corporate bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	0	0
Level 3 [Member] | Long-term Investments [Member] | Certificates of deposit [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities, fair value disclosure	$ 0	$ 0

v3.4.0.3

Balance Sheet Components - Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 5,520
Fair Value	5,520
Short-term Investments [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	4,664	$ 12,882
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(2)	(15)
Fair Value	4,663	12,867
Short-term Investments [Member] | U.S. Agency securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	750	1,551
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(2)
Fair Value	750	1,549
Short-term Investments [Member] | U.S. Treasury [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	0	500
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	0	500
Short-term Investments [Member] | Corporate bonds [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	3,914	7,776
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(2)	(13)
Fair Value	3,913	7,763
Short-term Investments [Member] | Commercial paper [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	0	500
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	0	500
Short-term Investments [Member] | Certificates of deposit [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	0	2,555
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	0	2,555
Long-term Investments [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	856	3,496
Gross Unrealized Gains	1	0
Gross Unrealized Losses	0	(6)
Fair Value	857	3,490
Long-term Investments [Member] | U.S. Agency securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	0	499
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	(2)
Fair Value	0	497
Long-term Investments [Member] | U.S. Treasury [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost		0
Gross Unrealized Gains		0
Gross Unrealized Losses		0
Fair Value		0
Long-term Investments [Member] | Corporate bonds [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	611	878
Gross Unrealized Gains	1	0
Gross Unrealized Losses	0	(4)
Fair Value	612	874
Long-term Investments [Member] | Certificates of deposit [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	245	2,119
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	$ 245	$ 2,119

v3.4.0.3

Balance Sheet Components - Investments, Contractual Maturities (Details) $ in Thousands	Mar. 31, 2016 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Amortized Cost, Due in one year or less	$ 4,664
Amortized Cost, Due in one year to five years	856
Amortized Cost	5,520
Fair Value, Due in one year or less	4,663
Fair Value, Due in one year to five years	857
Fair Value	$ 5,520

v3.4.0.3

Balance Sheet Components - Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Inventory, Net [Abstract]
Raw materials	$ 10,698	$ 9,117
Finished goods	21,864	18,978
Total inventory	$ 32,562	$ 28,095

v3.4.0.3

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 11,635		$ 10,659
Less: Accumulated depreciation and amortization	(6,179)		(5,635)
Property and equipment, net	7,511		6,969
Property and equipment acquired under capital leases	382		382
Depreciation expense	500	$ 300
Lab equipment, tooling and molds [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	3,375		3,228
Computer software [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	2,499		2,019
Computer equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	2,844		2,757
Property and equipment acquired under capital leases	382		382
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,825		1,670
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,057		950
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	35		35
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 2,055		$ 1,945

v3.4.0.3

Balance Sheet Components - Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued payroll and employee related expenses	$ 9,506	$ 14,887
Accrued marketing expenses	6,157	5,554
Accrued royalty	4,693	5,453
Sales and other taxes payable	3,507	3,703
Advance payments from customers	864	1,585
Accrued warranty	1,052	527
Accrued legal expenses	2,527	1,465
Other	3,020	1,517
Total accrued and other current liabilities	$ 31,326	$ 34,691

v3.4.0.3

Balance Sheet Components - Deferred Revenue (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Deferred Revenue Disclosure [Abstract]
Deferred extended warranty revenue	$ 2,901	$ 2,902
Deferred training revenue	3,408	3,115
Other deferred revenue	4,542	1,891
Total deferred revenue	$ 10,851	$ 7,908

v3.4.0.3

Balance Sheet Components - Product Warranty (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Movement in Extended Product Warranty Accrual [Roll Forward]
Balance at the beginning of the period	$ 2,902	$ 3,272
Extended warranties issued	1,004	732
Amortization	(1,005)	(789)
Balance at the end of the period	2,901	3,215
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance at the beginning of the period	527	569
Settlements of warranties	(225)	(100)
Provision	750	(29)
Balance at the end of the period	$ 1,052	$ 440
Direct Customer [Member] | Control Units [Member]
Movement in Extended Product Warranty Accrual [Roll Forward]
Product warranty term	1 year
Direct Customer [Member] | Applicators [Member]
Movement in Extended Product Warranty Accrual [Roll Forward]
Product warranty term	1 year
International [Member] | Indirect Customer [Member] | Control Units [Member]
Movement in Extended Product Warranty Accrual [Roll Forward]
Product warranty term	3 years 2 months
International [Member] | Indirect Customer [Member] | Applicators [Member]
Movement in Extended Product Warranty Accrual [Roll Forward]
Product warranty term	1 year 2 months

v3.4.0.3

Intangible Asset, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 0.2	$ 0.2

v3.4.0.3

Intangible Asset, Net - Intangible Asset, Net Comprises (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Purchased technology	$ 8,050	$ 8,050
Less: Accumulated amortization	(3,120)	(2,958)
Intangible asset, net	$ 4,930	$ 5,092

v3.4.0.3

Intangible Asset, Net - Estimated Annual Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Intangible Asset, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2016 (remaining 9 months)	$ 488
2017	650
2018	650
2019	650
2020	650
Thereafter	1,842
Intangible asset, net	$ 4,930	$ 5,092

v3.4.0.3

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Related Party Transaction [Line Items]
Related party payment terms	180 days
Distributor [Member]
Related Party Transaction [Line Items]
Revenue from related parties	$ 0.9	$ 1.3
Accounts receivable, related parties			$ 1.7

v3.4.0.3

Commitments and Contingencies - Operating Lease Obligations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 600	$ 500
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2016 (remaining 9 months)	1,804
2017	2,182
2018	2,040
2019	896
2020	529
Thereafter	408
Total future minimum lease payments	$ 7,859

v3.4.0.3

Commitments and Contingencies - Capital Lease Obligations (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Capital Leased Assets [Line Items]
Capital leased equipment, gross	$ 382		$ 382
Less: Accumulated depreciation and amortization	(181)		(149)
Capital leased equipment, net	201		233
Amortization of assets acquired under capital leases	32	$ 32
Future minimum payments under capital leases
2016 (remaining 9 months)	99
2017	141
Total future payments	240
Less: Amount representing interest	9
Present value of future minimum payments	231
Less: Current portion	125		124
Long term portion	$ 106		$ 138
Computer equipment [Member]
Capital Leased Assets [Line Items]
Useful life (Years)	3 years		3 years
Capital leased equipment, gross	$ 382		$ 382

v3.4.0.3

Commitments and Contingencies - Purchase Commitments and Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation	$ 4.1	$ 5.9
Unrecognized tax benefits, including estimated interest and penalties	0.3
Self-Insured Product Liability Claims Paid	0.9
Self Insurance Reserve	$ 1.8	$ 1.1

v3.4.0.3

Commitments And Contingencies - Separation Agreements (Details) - Management [Member] - USD ($) $ in Millions	3 Months Ended		4 Months Ended
	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2016
Loss Contingencies [Line Items]
Termination benefits		$ 0.3
Stock-based compensation expense due to modification		$ 0.8
Scenario, Forecast [Member]
Loss Contingencies [Line Items]
Stock-based compensation expense due to modification	$ 0.3		$ 1.1

v3.4.0.3

Stock-Based Compensation Expense - Stock Options Plan Activity (Details) - $ / shares	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Shares Available for Grant
Balance at beginning of period (Shares)	3,517,305
Additional shares reserved (Shares)	1,000,000
Options granted (Shares)	(302,226)
Options canceled (Shares)	217
Balance at end of period (Shares)	3,987,462
Number of Stock Options Outstanding
Balance at beginning of period (Number of Stock Options Outstanding) (Shares)	2,641,592
Options granted (Shares)	302,226
Options exercised (Number of stock options outstanding) (Shares)	(6,594)
Options canceled (Number of Stock Options Outstanding) (Shares)	(217)
Balance at end of period (Number of Stock Options Outstanding) (Shares)	2,937,007
Weighted-Average Exercise Price
Balance at beginning of period (Weighted average exercise price) (Per Share)	$ 6.86
Options granted (Weighted average exercise price) (Per Share)	22.25
Options exercised (Weighted average exercise price) (Per Share)	5.67
Options canceled (Weighted average exercise price) (Per Share)	6.38
Balance at end of period (Weighted average exercise price) (Per Share)	$ 8.44
Restricted Stock Units (RSUs) [Member]
Shares Available for Grant
Restricted stock units granted (Shares)	(379,569)
Restricted stock units canceled (Shares)	39,189
Restricted stock units withheld for tax (Shares)	112,546	133,035

v3.4.0.3

Stock-Based Compensation Expense - Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Weighted- Average Grant Date Fair Value
Payments for employee's tax obligations to relevant taxing authority	$ 2,651	$ 4,345
Restricted Stock Units (RSUs) [Member]
Number of Units and Awards
Balance at beginning of period (Shares)	1,312,651
Restricted stock units granted (Shares)	379,569
Restricted stock units vested (Shares)	(308,634)	(330,201)
Restricted stock units canceled (Shares)	(39,189)
Balance at end of period (Shares)	1,344,397
Weighted- Average Grant Date Fair Value
Balance at beginning of period (Weighted average exercise price) (Per Share)	$ 19.09
Restricted stock units granted (Weighted average exercise price) (Per Share)	22.79
Restricted stock units vested (Weighted average exercise price) (Per Share)	24.17
Restricted stock units canceled (Weighted average exercise price) (Per Share)	23.49
Balance at end of period (Weighted average exercise price) (Per Share)	$ 20.82
Restricted stock units withheld for tax (Shares)	112,546	133,035
Payments for employee's tax obligations to relevant taxing authority	$ 2,600	$ 4,300

v3.4.0.3

Stock-Based Compensation Expense - Allocation of Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 4,202	$ 4,150
Options granted (Shares)	302,226
Revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 0	80
Cost of Revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	232	134
Research and Development [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	501	350
Sales and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	1,383	1,551
General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,086	$ 2,035
Stock Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 26,200
Unrecognized compensation cost, recognition period (in years)	2 years 11 months
Options granted (Shares)	302,226	45,622
Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (Shares)	40,000	40,000
Performance Based Stock Options and Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 400	$ 1,500
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	100.00%

v3.4.0.3

Stock-Based Compensation Expense - Assumptions (Details) - Stock Options [Member]	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term	4 years 9 months 20 days	4 years 9 months 20 days
Expected volatility	63.00%	63.00%
Risk-free interest rate	1.21%	1.29%
Expected dividend yield	0.00%	0.00%

v3.4.0.3

Stock-Based Compensation Expense - Employee Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (Shares)	302,226
Stock Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (Shares)	302,226	45,622
Weighted average grant date fair value (Per Share)	$ 22.25	$ 18.19
Unrecognized compensation cost, recognition period (in years)	2 years 11 months
Employee Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units granted (Shares)	379,569	353,757
Weighted average grant date fair value (Per Share)	$ 22.79	$ 31.95
ESPP [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 0.2
Unrecognized compensation cost, recognition period (in years)	2 months
Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (Shares)	40,000	40,000

v3.4.0.3

Stock-Based Compensation Expense - Non-Employee Stock-Based Compensation (Details) $ in Millions	3 Months Ended
	Mar. 31, 2015 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense related to non-employee grants	$ 0.1

v3.4.0.3

Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Numerator
Net loss	$ (9,870)	$ (2,129)
Denominator
Weighted Average Number of Shares Outstanding, Basic and Diluted	39,288,853	38,383,022
Dilutive effect of incremental shares and share equivalents	0	0
Weighted average shares of common stock outstanding used in computing net loss per share, diluted	39,288,853	38,383,022
Net loss per share:
Net loss per share, basic and diluted	$ (0.25)	$ (0.06)

v3.4.0.3

Net Loss Per Share - Outstanding Shares of Potentially Dilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	4,281,404	4,532,214
Options to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	2,937,007	3,025,095
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,344,397	1,498,245
Common stock issuable pursuant to the ESPP [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	8,874

v3.4.0.3

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ (684)	$ 28
Unrecognized tax benefits	$ 3,200

v3.4.0.3

Segment Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($) business_activity segment manager	Mar. 31, 2015 USD ($)
Segment Reporting Information [Line Items]
Number of business activities | business_activity	1
Number of reportable segments | segment	1
Number of segment managers held accountable for operations | manager	0
Revenue, net	$ 64,469	$ 51,558
North America [Member]
Segment Reporting Information [Line Items]
Revenue, net	51,469	35,229
United States [Member]
Segment Reporting Information [Line Items]
Revenue, net	51,300	33,200
International [Member]
Segment Reporting Information [Line Items]
Revenue, net	13,000	16,329
Systems Revenue [Member]
Segment Reporting Information [Line Items]
Revenue, net	24,689	26,156
Consumable Revenue [Member]
Segment Reporting Information [Line Items]
Revenue, net	$ 39,780	$ 25,402

begin 644 Financial_Report.xlsx
M4$L#!!0    (  HQJTB\#5@"[P$  "T@   3    6T-O;G1E;G1?5'EP97-=
M+GAM;,W:S4[C,! '\%>IR$-6Y(-*1I*CFJB_/;#85@6II<[@(E]Z+2WO>FT5?CYWM6!^G%-[(Q_+G6]S5EB_FU1Y6A\
M4X7]C?_KS-@R-#^L_MI1SC]X+7LW<6/[JZ ?S5Z!S='&5(ZUU68X-*I'%]:_
MG%M_Y6-"Y:I::J<^Y(4AF0-/25Y\EZ.1Y=2?JOWRI#0NT)L*EH5'?"DZ':C]
MF4*>[^%WX\\%Q^NCS'7\_J^AC\'(QL,1D7A7'P*D#PG2AP+I8P[2QPE(']]!
M^O@!TLQW8OG*\M"_V/Z'D4X$G1H>)%]2-F Q+M*;V"^GH 
MA3&^.R6:E((C-Z."N[_8_ )02P,$%     @ "C&K2+>K)I[H 0  V1\  !H 
M  !X;"]?FN'T]-F2['?1B:S6NS
M3T'K>AG&RSG5X\/'V8OG[;H:G[=2+7XVXSZ5=?6['U]SFU+)X7R2FVF!Z?';
MD+ZS?+_;'3;IJ=_\.J6N?%$1_BU0A?D@G0]22I#-!QDER.>#G!(4YX,B)6@Y
M'[2D!-W.!]U2@N[F@^XH0??S0?>4(*F!C#4G"6'-T5H U\+Q6@#8PA%; -G"
M,5L VL)16P#;PG%; -S"D5L W<*Q6P#>PM%;@=[*T5N!WDKZUD8?VQR]%>BM
M'+T5Z*TBM'+T5Z*TBM'+T-Z&TAM
MI+T2M%G"T=N WL;1VX#>QM';@-[&T=N WL;1VX#>QM';@-[&T=N!WL[1VX'>
MSM';@=[.T=N!WD[:ZT:;W1R]'>CM'+T=Z.TCM'+T=Z.TKOS7GJ7]#PJ>_^(_O4$L#!!0    (  HQJT@:TR7<_P(  )0-
M   0    9&]C4')O<',O87!P+GAM;+U746_:,!#^*Q9/FS0:2&FW(1J) M4J
M=2L:K'MVG0M83>S(9Q#LU^_B (/6A(:']:7.Y;X[W_>=SZ&GL-4=&YV#L1*0
MK;)489>,-XVYM7DW"%#,(>-X02Z*WB;:9-S2HYD%.DFD@*$6BPR4#<)6ZSJ 
ME0450]S,=T$;4:_(TL_S5 INI5;1=RF,1IU8-EH)2'O!:P>'H,@3$ LC[3IJ
ME3[[)N6*$IXBE%[_C,YGH+.<@O[J,,79?0Y
M-Q!3TH/H.Z/S^;:F.M,".YAS-8-XW_?MRRT73V"PJ+0=7K3H;T?!UE[&!AY+
M-1MS:3#J+6UW"<)JLY%I:<]5*=:B$!V?IK0_;+!GCE L;QI+;B17ML%0_J''
ML%&F+:UNG>9H3?1;FQ>< UCL!3NC6^[[[J]E)[H*G0>M#CV#7671AK:#N@O+
M5-H4\#$9)3"=L; ")/\<6
MXT3B9)%EW(NYHR9@3SQ=0 &\DXI*ESPEONGM(CN2IR1U4G0H*\Z_5I0.O<[W
MM \UD\\IL#XBV$_L!UBOYT](78U%$Z[9U'"%7!0E^ -3WDS:HD_0-0KQ9*FK
M@?8/?L3$:O'2))8J%#H#-N6K8[EA
MYEKZ5!]7:MC^7%_#]I=:&K(/4TY:O5_*#0 _GA2)OQ:)?:@O4QB^4Z;J?7GD
MJ 94ZA+ZSW UQG^&*[4,_?H?U;))L*5?RTI,^+4^YK)5%U-<#'4Q?2%,7"S-"*ZE?:PY0M\$S#FBS/J;C[X-J3+O^
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MM^B'_K^&0P;1<5-G#A;I-&IN6FSP22$(17#I4U%^$2YILXP<+NXQ,$7@[J
MA>FR;:%KK9>A3O=KC XO)ZYL;7UW3/V(SEY5_0502P,$%     @ "C&K2)E<
MG",0!@  G"<  !,   !X;"]T:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X
M9_9M"\8V@;:T$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0L
MZ?O.14?GZ#AY\^XN8NB&B)3R>	+]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#0
M5%%:;U\@M.4?,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@
M?\YOI^1.6HCA5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSV
MQ.V?C,K:=#1M&N#C\7@XMLO2BW A(5M>5 TR  6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^
MQL4$UFG2&98T1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"
M(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RC
MEU@5 9<8WS2J-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<
MTT#PE"\D^DJ1CVFS(Z=T)LWH,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&
M(81IN_ >KR2.FJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@
MR.S-D77.UI$.$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&
MU3-L+([W1]072N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*
M-Y;&O%"N@GL!_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y
M/%_GM,T+,T.WF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!
M4;"C[SR6'<>(\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D
M8"V@!X.O40+R4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2
M.<)IF!-GJ\K>9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S
M&5.^YRM)Q%4XOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL
M6XA9$N)-7>W5YYNTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R
M0]A4)?.NVB8+A=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@
MF_S6VZ3VW> ,?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS
M#*%F.-^'19H:,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O
M#;#"Q([A[8N_ 5!+ P04    "  *,:M(S(5"C5P"  !"#   #0   'AL+W-T
M>6QE+8R>&M$EW,:8P4:1GD5P;52Y4?/J](U
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ME>A"HFTPG>\EV$'7383,L.PJ!W#GBD.*Q\[>Q,7
M-'E70&>CLJ3;3Y04G&$GUKF6HGUZ#1\CK^"_WI[_6GS_;.S7$ [TG' 4
M#S5+L%S:7][SA4%2$ZH(WTE YAWKP_F+D!XLN:M4A(MC;7W%&:N9>&OM_#?$O4$L#!!0    (  HQJTA&>5#%
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M1OJ@*0-( 4CM"RH!5 *HW!O"9XNV2M.0C#Q=_'51/1OB@).7P.^I_I$X;S2GB2^]KH+:<52
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M^O@$:T2A[05;M-GBE] W7$86V%XSM;Z'.0[2TM!&%
MMA>,[6^_K8=9(@IM+QC;Q\OG :+0]H*Q?12ET':%MJM]B[K*$86VJWU[$H5%
M7:'M:M^N1&%WK=!VQ17V491"U$Z#S=@^CL+:KM!VQ74MHRBL[0IM5XSMXRBL
M[0IM5XSMXRCL8!3:KAC;N=LFHCATF
M.Y@2#2^YMH5K$C@0^EW*YWWNSZTM[>YM9^JT\0_#0VCG7*5_ ^ACV[6K,C5V
MZ?QO5].3TS:>=NQ]TWRF:]^Z+TX/F]TM^67__^D_4$L#!!0    (  HQJTAP
M/O)S0P(  (X'   8    >&PO=V]R:W-H965T&ULC97+CILP
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M6D/B,K/S^D(4*0O!^TAVQ/QM^*SEP@31D2,]&6F[=KGR09T0
MM0\)5LK.23(G>:!4-C/$QD>D0<1$DBTC()AO*.!'R(.+-6CR(1&88?S @L%_
M]B[T4>':FFH>J"Z(YA3D1P@7V$2#'[email protected]_%$/L1@C6V'S1NV? FS3*PVLQ8
MB7?\,2HN]EJ0T9%?6^7.N7%TO'I>D#T^/^5ET9$+_4'$I6YE=.!*'\+V_#US
MKJA.!3SI/5OIRW'L-/2L3'.EV\)=%ZZC>'>__<8KN/P+4$L#!!0    (  HQ
MJTCTNP8D-@0  $04   8    >&PO=V]R:W-H965T&ULC9A=
M(/'VWY>O>(^40ZV;
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MDKK\.7^>SM/G=?XE8TL970!+ =P*N/S? K$4B* @G9--]_6E[,O=MFVN27C'7R_OU(J@74[V(LFLPR
M(WI"I-:"C((A#IDV]Z.H((K"40P91:&K"% &R"P>-?2>O9]%!UDTSD)V?J[]
M+)K.@BG(F%7WLY@@B\%9+)G%X-X7AI%4X5'<&'X_2Q9DR5 6P<@LF7\5QB49
MQL. 9PSNI[%!&HO3<#*-19?)%#FJ"LP(:2-F$6>AEQB.0@Z%?&&6B23I;O$A
M%=$I_(,C.;+&,7)SBL\2EL=,9%X*$L.. UYT_G"+#=MZ8%5>)1B
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M?LEG+,44:\QZDE#$8)#*5]LLR%)\7A?V%6
M$GD<2!&SAQ*A/P7V)[U#RA?&W%OV!1RQ[$O1^YY+^>+^*MN7T[E+GIJ^;^KI
MK=&A:7HWM,8^#PH\NG)_.ZC>#'P;MD*,&P#XH<4]XBLZXD$^.5'6(R&'
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M&7*'(;<9$B]#_B['(4#@,AAF,I+PM_\)'LJQ:9%D[+&N;)?.RK#V+
M[W\OSY6+3*7#5-I,N9>IM#(E91K#)/)^4,VC,(Z*//D$403=O0G:3(67:=9\
M LI1>JF M7F.Z(Q_(G;N!A[LJ9#[L-Z"3Y0*+./!E?PI6GD^W@<$GX3J%K+/
MS(EA!H*.MP/P?@K7_P!02P,$%     @ "C&K2&=E$$4N P  C@P  !@   !X
M;"]W;W)KNDB=FZ;L_FY$+2^K&,?7B9_5X:C[B62]3,:X7=6(5E6RC3JQ
M7\7/^*D@J)=8Q:]*7!2XCWKX5RG?^L'WW2I&/8.HQ5;W2Y3F\BX*4=?]2B;S
MGV'1SYQ](+R_KO[5EFOP7TLE"EG_KG;Z:&A1'.W$OCS7^J>\?!-##:Q?<"MK
M93^C[5EIV5Q#XJ@I/]RU:NWUXK[A: @+!Y A@(P!8YYP0#H$I)\!U%;JR&Q=
M7TI=KI>=O$3J5/:[C9^,O.L7,2M'IAAEA_;GRPYW&-Z/YY[\1S6PH*U<$"9$10LN)B(T)Q*%A[) I)D
M09(%_%51QH*\!501:G3W63#RCS^"-'F09M ,CQ)B- A=3&0\Y3,>./R?&V&(
MP\,X&.1A.44TC -EAF;.0X.)ST,@3_"@;0:-2_2 ,V"THPND,%-\U,;1-'K;-03,B:%Y\K!Y8NB+#QF_@0-59,ZI\KT3YY EF&4S
M:-R[ZV'!\["33V4$DQFO:^Q[,>; S#F;L8+OH1B:* ^;Z*#A#A4]DK"+^K(Y
M-DI\&R701GG81@GTQW1!..=6NUYJ
MG!U;[&?2MXG>_,:TWJY1_EQFO3R5!_&C[ Y5JZ)7J4T3:OO/O91:&$3T:,[(
MT?PY& >UV.O^-C?WG6N7W4#+T[7['_^"K/\!4$L#!!0    (  HQJTC-!T\/
M+ (  *@&   8    >&PO=V]R:W-H965T&ULC57+CILP%/T5
MBWT',.^(($VHJG91:32+=NTD3D!C8VH[P_3OZT="#'*5V6#[O'CN TB+0$3?) Z U+#.VXQ(3J1
M*OSGFO->4A/=^2W[-^-6J=\C@5M&?O='V2FQ40".^(0N1+ZRZ3N^6LATP@,C
MPCS!X2(DHS=* "CZL&,_F'&R;\KH2O,3X)4 9\)$:$*KFW
M EQ6V$&'#GT%6A>15X\K)"L/B>$GUL,G^.F*GQI^:OGI4N)@35A(82!?JK*(
M?*AV@8(Q_(26;*4E<[Q4T6-^ON+GCIT1G_1/S<#P+LF53]R;2F$V,2*WG1DSK"G;HVY@7!)ZFGA9ISVTGM0K+Q
M=B_,EU/S#U!+ P04    "  *,:M(^R8/CSL$   Z%   &    'AL+W=OQU4E3X*$?E5<:Y7VXU^]JW=
M;IIK7YYK]:WUNFM5%>U_F2J;V^L*5O<'W\_'4S\^\+<;_Q&W/U>J[LY-[;7J
M\+KZ#"^Y#$>)5OQ]5K?.N/9&\V]-\V.\^7/_NA*C!U6J73\V40P_[RI793FV
M-&3^=V[T(^<8:%[?6_^BRQWLOQ6=RIORG_.^/PUNQVKFFO0
M#G=-V>F_WN[:]4UU#UEY5?%S^CW7^O.YC ^ .< ? 0\\O !<@Z0'P&!
MKG1RINOZH^B+[:9M;EYW*<;1AI=!WHZ-#"U[0S&=OM7=-3U]WZ;AQG\?VR&2
M;)*@EL!#X0^-LQF09LC0"$\%B)?$P0O:7I!XX4$PBV8O/ :(QF&F@ TT,(D&(G1HPF8:!*28B"\F
M,(Q*5I,3S5K*T %J8%,-0L,-\EB:-7.B($X7)AV1H;FBE_W8E(2(] X[I3(P
M(;B&-.87))7)U.$5"38MP<1EP+,!3!1*$2\,EZD*A+-
MF*(87$;*IB90;/)O$C"AN$Y%PGK.J0P2Z6 (;7RB,->F2TUH0P\)]( ?;C2!
MMH[Y29%352!B%S\V^)" #_@W II02Z*$176.OXD^M-&'DGCA7PBSZ/YV6B %
M484IN.Q=;8PBP2CP[P0DB(0 %_P0&28.6$<;I!@2/R'OQT1D&O #FA,5A*'#
MQAEMCF)$%H-+$S;Z,"85\2C&F#!V82T0DL9&'Q+T 8\^)$S#*%SH&R(+9. P^:2-/DEVCOSF)Y.")8!IADA<)HVT"2H)
M09$GJ 3:-0&[6G(JDP(<-M721J@D".6W[IDTX;@PH#D1#797#V("4>0A
M*B7IGJ4/,"H;MG\NW6-C5!*,\GS,)-F-AN9^@1@*"/RCP.7$P.:H)!Q%GJ.S
M:/J>'W:^_%8H)S(,16A_MOO&D4REVJ,^JNJ\77.M^^GMY
M!B_Y=*CUTE.O3C
M93Q9T!  "Q P  
M&    'AL+W=OZ:EE42$Y*HD9:5_7SYDQ3:"Y"+NKF9F9_DH)[2OK@?PY$TK
MXW:T]W[8,N;J'K1P-SB "7]:M%KXD-J.N<&":!))*\:+XHYI(0VMRE1[ME6)
MHU?2P+,E;M1:V'][4#CMZ(J>"B^RZWTLL*ID"Z^1&HR3:(B%=D$R9W%)'H_(+[&Y&>SHT6T  IJ'Q5$6([P!$I%H=#X[ZSYWC(2S^.3^O4/V1C>^#V8*2!EHQ*O^"TP^81[B-@C4JE[ZD'IU'?:)0HL5;7J5)
MZY3_/!0S[6,"GPG\BL!RHV3SF_"B*BU.Q TBGMUJ&^ VB@1E$KRYE*;I<_58
MK?A=R8Y1Z *SSQB>,0N"!?4/6_#+%GM^1N=?T]=7#M>)OIX=WG\ML+D2V"2!
MS:KIJPLSW58+MT=1RI<30^;]Y276[G(T]G\@ZORD%T\$O83AI'#NC#
MR:9#;1$]!!/%S2TE?7@_2Z*@]3&\#['-5RHG'H?3 UE>:?4?4$L#!!0    (
M  HQJTB/W%'NH0$  +$#   8    >&PO=V]R:W-H965T&UL
MA5/+;MLP$/P5@A\0RI23MH8L($X1M(<"00[MF996$A&2JY"4E?Y]^; 5VPB:
MB[B[FIF=Y:.:T;ZX <"3-ZV,V]+!^W'#F&L&T,+=X @F_.G0:N%#:GOF1@NB
M322M&"^*.Z:%-+2N4NW)UA5.7DD#3Y:X26MA_^Y X;RE*WHJ/,M^\+' ZHHM
MO%9J,$ZB(1:Z+;U?;7;KB$B WQ)F=Q:3Z'V/^!*3G^V6%M$"*&A\5!!A.< #
M*!6%0N/7H^9[RT@\CT_JCVG:X'XO'#R@^B-;/P2S!24M=&)2_AGG'W KXTB#D_%Y\Y;J
M3J3=WA=C:*'7\+VTCBR1Q].-AUJA^@AF"AN;BD9POM9$@6=C^&7$-M\
MI7+B<3P]D.65UO\ 4$L#!!0    (  HQJTB/I\A&G0$  +$#   8    >&PO
M=V]R:W-H965T&ULA5/+;MLP$/P5@A\0RI33%(8L($X1I(<"
M00[MF996$A&2JY*4E?Y]^; 5VPB2B[B[FIF=Y:.:T;ZZ <"3-ZV,V]+!^W'#
MF&L&T,+=X @F_.G0:N%#:GOF1@NB322M&"^*;TP+:6A=I=JSK2N)']X&.!U15;>*W48)Q$0RQT6WJ_VNS6$9$ OR7,[BPF
MT?L>\34F/]LM+:(%4-#XJ"#"W&D
M?4S@1P*_(K#<*-G\(;RH*XLS<:.(9[?:!+B-(D&9!&\NI6GZ7#W4JY)7[!"%
M+C"[C.$9LR!84/^P!;]LL>-G=/XUO;QR6"9ZF;OSNZ\%UE<"ZR2P_G3$2TQY
MU82=[:D&VZ>KXTB#D_%Y\Y;J3J3=WA=C:*'7\+VTCBR1Q].-AUJA^@A
MF"AN;BD9POM9$@6=C^%=B&V^4CGQ.)X>R/)*Z_]02P,$%     @ "C&K2,%<
M>/B@ 0  L0,  !D   !X;"]W;W)K&ULA5/+;MLP
M$/P5@A\0RI*<%H8L($Y1M(<"00[MF996$A&2JY*4E?Y]^9 5VPB2B[B[FIF=
MY:.:T;S8 <"15R6UW=/!N7''F&T&4-S>X0C:_^G0*.Y\:GIF1P.\C20E69YE
M]TQQH6E=Q=J3J2N!;]X$*!U15;>:U0H*U 
M30QT>_JPV1W*@(B WP)F>Q&3X/V(^!*2G^V>9L$"2&A<4.!^.<$C2!F$?.._
MB^9;RT"\C,_JW^.TWOV16WA$^4>T;O!F,TI:Z/@DW3/./V 981L$&Y0V?DDS
M68?J3*%$\=>T"AW7.?W9%@OM?4*^$/*5\#6+QE.C:/,;=[RN#,[$CCR&7BO=F8QNE3]51OBK)BIR!TA3DD3)XP*X)Y]7=;Y-
MX'4U\AY^<=,+;*@=H@-O(KO;4C+X][,F$CH7PB\^-NE*I<3A>'X@
MZRNM_P-02P,$%     @ "C&K2*9!A,Z@ 0  L0,  !D   !X;"]W;W)K&ULA5/+;MLP$/P5@A\0RI+3N(8L($Y0M(<"00[MF996
M$A&2JY"4E?Y]^9 5VPB2B[B[FIF=Y:.N6'+F*U[4-S>
MX #:_VG1*.Y\:CIF!P.\B20E69YEWYCB0M.JC+4G4Y4X.BDT/!EB1Z6X^;<'
MB=..KNBI\"RZWH4"JTJV\!JA0%N!FAAH=_1^M=VO R("_@B8[%E,@O<#XDM(
M?C4[F@4+(*%V08'[Y0@/(&40\HU?9\WWEH%X'I_4?\1IO?L#M_" \J]H7._-
M9I0TT/)1NF>JQ6Q5W)CD'H K-/
MF#QA%@3SZA^VR"];[/,S>OXUO;AR6$1Z,3O8KY?-6%G
M>ZK =/'J6%+CJ%W:O*6ZW,[[/)[).[PJ!][!;VXZH2TYH/,G&P^U173@360W
MMY3T_OTLB836A?#.QR9=J90X'$X/9'FEU7]02P,$%     @ "C&K2!&ULC5/+;MLP$/P5
M@A\0RK+<%H8L($Y0-(< 00[MF996$A&2JY*4E?Y]^9 5VS"07,3=U6IV- L60$+M@@+WRQ$>0,H@Y!O_G34_
M6@;B>7Q2_QFG]>X/W,(#RC^B<;TWFU'20,M'Z5YQ^@7S")L@6*.T\4OJT3I4
M)PHEBK^G5>BX3NG/)I]IMPGY3,@7PH\L&D^-HLU'[GA5&IR('7@XN]76PTT0
M\[,QC=.GZK%:%5G)CD'H K-/F#QA%@3SZC=;Y)SP"_V+*X$B"A2S0'YSQ$O,^JH).]M3!::+5\>2&D?MTN8MU>5VWL=#9!_P
MJAQX!\_<=$);:HOHP)O([C:4]/[]+(F$UH7PNX]-NE(I<3B<'LCR
M2JO_4$L#!!0    (  HQJTA,4[:OH $  +$#   9    >&PO=V]R:W-H965T
M; _@R+N2VNYH[]RP9*T
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M3!>OCB4UCMJES5NJR^U\R..9?,*K&PO=V]R:W-H965T[*VT[!_CR]I:"L$+_',Y)PS9WPI)S2O
MM@=PY$U);;>T=V[8,&;K'A2W5SB ]G]:-(H[GYJ.V<$ ;R))299GV0^FN-"T
M*F/MR50ECDX*#4^&V%$I;O[O0.*TI2MZ+#R+KG>AP*J2+;Q&*-!6H"8&VBV]
M6VUV14!$P(N R9[$)'C?([Z&Y+'9TBQ8  FU"PK<+P>X!RF#D&_\;];\:!F(
MI_%1_7>;$9) RT?I7O&Z0'F$:Z#8(W2QB^I1^M0'2F4
M*/Z65J'C.J4_ZVRF?4[(9T*^$&XC@:5&T>8O[GA5&IR('7@XN]7&PTT0\[,QC=.GZJ%:%3'
MM]\+%!<"110HOASQ'//SH@D[V5,%IHM7QY(:1^W2YBW5Y7;>Y?%,/N!5.? .
M_G#3"6W)'IT_V7BH+:(#;R*[NJ:D]^]G222T+H0W/C;I2J7$X7!\(,LKK=X!
M4$L#!!0    (  HQJT@31-O,GP$  +$#   9    >&PO=V]R:W-H965TV.]LX-6\9LW8/B]@8'T/Y/
MBT9QYU/3,3L8X$TD*:5F6L/9NJQ-%)H>'9$#LJQF\TH::#E
MHW0O./V$>81-$*Q1VO@E]6@=JA.%$L7?TRIT7*?TIRAFVM>$?";D"^$VB\93
MHVCS!W>\*@U.Q X\G-UJZ^$FB'AEXKW9F,;I4_58K399R8Y!Z *S3Y@\818$
M\^I?ML@O6^SS,WK^;WIQY;"(]&)V^!_]UU<"ZRBP_NN(EYAKE^QL3Q68+EX=
M2VH1':SH:3W[V=)
M)+0NA-]];-*52HG#X?1 EE=:?0!02P,$%     @ "C&K2-@ 0  L0, 
M !D   !X;"]W;W)K&ULA5/;;J,P$/T5RQ]0$X?L
M)2)(35>K]F&EJ@^[SPX,8-7VL+8)[=_7-H0F4=6^X)GAG#-G?"E&M,^N _#D
M12OC=K3SOM\RYJH.M' WV(,)?QJT6OB0VI:YWH*H$TDKQK/L&]-"&EH6J?9H
MRP('KZ2!1TO
M$0GP5\+HSF(2O1\0GV/R4.]H%BV @LI'!1&6(]R!4E$H-/X_:[ZWC,3S^*3^
M.TT;W!^$@SM4_V3MNV VHZ2&1@S*/^%X#_,(FRA8H7+I2ZK!>=0G"B5:O$RK
M-&D=IS_\YTS[F,!G E\(/[)D?&J4;/X27I2%Q9&X7L2S6VT#W$:1H$R"-Y?2
M-/U4/9:KS;I@QRAT@=E/&#YA%@0+ZA^VX)2 /IQL.M0&T4,PD=UL*.G"^UD2!8V/X?<0V^E*38G'_O1 EE=:O@%02P,$
M%     @ "C&K2+:@8  !D   !X;"]W;W)K&ULC971;ILP%(9?Q>(!:G ")!%!:CI-V\6DJA?;M4-. -7&S'9"]_:S
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M@UR9WZBF>29%AU1+[>%%.R.7-L0D(U.;LV@
MP"9]%D%\Q(&,[&39OII4N'+V54\GZ7+ >A*P=@'KVQ;3V2WZFLTR))Y 8B]@
M.POQ-$FX#$DFD,0+B&8AON:!_SN=0%(O8#4+\37K95.C4039S&/&FBB=/F)XU!LX
MR-*U0(4*<6ETWP2&U:'-/A/76S[E>=;2$GY16=:-0D>A38=RS>DLA 931?AD
M'O3*? B&"8.SML/4C&7?&ON)%NV]TP^?F_P_4$L#!!0    (  HQJTCTH'=^
MH $  +$#   9    >&PO=V]R:W-H965TZ:EE42$Y*HD9:5_7SYDQ38,Y"+NKF9F9_FH
M9C3O=@!PY$-);7=T<&[<,F:; 12W=SB"]G\Z-(H[GYJ>V=$ ;R-)259DV3>F
MN-"TKF+MU=053DX*#:^&V$DI;O[M0>*\HSD]%=Y$/[A08'7%5EXK%&@K4!,#
MW8X^YMO])B BX+> V9[%)'@_(+Z'Y&>[HUFP !(:%Q2X7X[P!%(&(=_X[Z+Y
MV3(0S^.3^G.;$9)"QV?I'O#^066$>Z#8(/2QB]I)NM0
MG2B4*/Z15J'C.J<_W[.%=IM0+(3BBL!2HVCS!W>\[email protected](X\G%V^]7 31+PR
M\=YL3./TJ7JL\X>\8L<@=('9)TR1,"N">?6;+8K+%OOBC%Y\32^O'):17J;N
M9?:UP.9*8!,%-LN(Q&PO=V]R:W-H965T
MO;0@;6TCL!7N&[V>LP4,^H.&,M+#8S()]Y!
MJ]]8D:8-BMSF7D61\U[1IH57@63/&!'_3D#Y
M< RBX)YX:ZI:F00N(@'78_ <'4Y1:" 6\;N!03[LD2G^S/F[
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M>&PO=V]R:W-H965T0'* Y.NC9R+#6=
MINUB4M6+[9K8QS8J<#S P!'WI74=I?U
MS@U;2FW=@^+V#@?0_DN+1G'G2]-1.QC@320I25F>WU/%A3%7BZ*30
M\&*('97BYN\>)$Z[;)6=&Z^BZUUHT*JD,Z\1"K05J(F!=I<]K;;[34!$P"\!
MD[W8DY#]@/@6BA_-+LM#!)!0NZ# _7*$9Y R"'GC/R?-#\M O-R?U;_%:7WZ
M [?PC/*W:%SOP^89::#EHW2O.'V'TP@Q88W2QE]2C]:A.E,RHOA[6H6.ZY2^
MW!8_AMQF^A-1\"C8?UKH
MVA0;!JB DG1,OXG^!886=E8P%TRY)\H[I06_4 +$R:<_:>/.WK])DH&V3H@&
M0C02[D)7N#=R93X13;)4BAZIEMAOM]D;N+0B1AF9VI0+7?<^>\XV]W&*SU9H
MACEZ3.0Q(P(;]56+:&YQC";TZ#I]NZAPZ^A;[Q[_PC]>",1.(!Y:W*VV.,X4T-*3.,,DCO>8TU9$>>9S;RK/9&]8*^!-
M(=US3M7?$S Y'*--=$V\MW5C7 +G&9YX9@3$G9(W_C)HW2T>\WU_5O_EN;?5G
MJN%5LM]M:1I;;!RA$BK:,_,NA^\PMK!S@H5DVC]1T6LC^942(4X_P]H*OP[A
M39J,M'4"&0ED(CS'OO!@Y,O\2@W-,R4'I#OJ_MWF8.'*B5AE9&O3/O3=A^PE
M)_$FPQ(%D
M;)&LMCC';!^;[!8FNYE LFHRQ_Q')_N%R7XFL%\UF6/2QR;IPB2="3ROFLPQ
M7Q8F^.X(>L 0  %@0  !D   !X;"]W;W)K&ULC53+
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M:R_BE)'+9D(9IH_=4TFRM, G+[3 '"*&!$PV([!3OVI!EA8'X%\)9 '@7P:,;LZXA+S@Y3;EWV.M[;6%C5GU_A_%=0?@)02P,$%     @ "C&K2&;8GO"O 0  %@0 
M !D   !X;"]W;W)K&ULA53+;JLP$/T5BP^HP0E]
M1 2IZ575N[A2U46[=F  JWYP;1/:OZ\?A(8H4C:Q9SBOD>T4H]*[email protected]$MP
M:;9)9VV_P=A4'0AJ;E0/TGUIE!;4NE*WV/0::!U(@F.2IK=84":3L@B]5UT6
M:K"<27C5R Q"4/V] Z[&;9(EQ\8;:SOK&[@L\,RKF0!IF))(0[--'K/-+O>(
M 'AG,)J3/?+9]TI]^N)OO4U2'P$X5-8K4+<KZ\+K,\$
MUD%@/8UX>W'$)>;NNDE^9I(O!.XOFBPQ#V^?V.M[;
M6%C5'U_A_%=0_@!02P,$%     @ "C&K2!E;/D8[ @  %0<  !D   !X;"]W
M;W)K&ULE57+CILP%/T5Q'X&8PB0B"!-J*IV46DT
MBW;M)$Y 8V-J.V'Z]_6#$,-0D6[P@W/./=>/Z[QC_%U4&$OO@Y)&;/U*RG83
M!.)088K$,VMQH_Z<&*=(JB$_!Z+E&!T-B9(  I $%-6-7^1F[I47.;M(4C?X
ME7OB0BGB?W:8L&[KA_YMXJT^5U)/!$4>#+QC37$C:M9X')^V_DNX*4,#,8B?
M->Z$T_>T^3UC[WKP_;CU@?: "3Y(+8%4<\4E)D0KJ]%[3$UT^S?UKR9=
M97^/!"X9^54?9:7< M\[XA.Z$/G&NF^XSV&E!0^,"//U#A 'L"' A#G'E"U!.B.R$VF5IG)J\O2*(BYZSS1(OT;H<;!>=:
M1"E[*AEAAF:Y[.RU@!#DP54+C3 [BX$&$PZ(0*G/AH#C$#OHT.%<@-)%).OE
M"-$DB9W^@4P5>PN
M4^0M.N,?B)_K1GA[)E4M-&7PQ)C$RAYX5F>\4F_4,"#X)'4W57UNJ[8=2-;>
M'J'A)2S^ E!+ P04    "  *,:M("*4/4OT!   /!@  &0   'AL+W=OD9_Q#5  2?5+2B*-32=D>7%=D%5 L
M7E@+C7I3,$ZQ5%M>NJ+E@'-#HL0-/"]V*:X;)TU,[(VG">LDJ1MXXTATE&+^
M[P2$]4?'=VZ!][JLI ZX:>*.O+RFT(B:-8A#<71>_R4MEZ#LJAP!V1[ZS_ 4,-&RV8,2+,+\HZ(1F]41Q$\:=]UHUY]O;-SAMH
MZX1@( 0C8?19)X0#(;P3(E.ISX6 KNO=G*_$-@_T\M#[SW1RSDH7!Y\=W+/*/#2
MS!^!,M8UTI[E,3K.N-= W]-%_*1GG[F_=YDT:7$)OS OZT:@"Y-J"I@!4# F
M067GO:C35*GI/&X(%%(OMVK-[;RR&\G:V_@=OP'I?U!+ P04    "  *,:M(
M"HYYZ,8&   6,@  &0   'AL+W=O;S^,>M_OR4&^KP^I8/EVO?X&O=Z!Z
M32_Y:UM^U).?5UWW]U7UHWOPQ^/U6G1-E+ORH>EJ%.VW]_*NW.VZ4NVI_QFK
M_G_2[L#ISZ?JO_7K;?N_+^KRKMK]O7UL7MIVQ7KU6#X5;[OF>_7Q>SDNPG0%
M'ZI=W7]=/;S53;4_';)>[8N?P_?MH?_^,?S&B_&P\P?(\0#Y>0#HV0/4>( B
M!VR&SOIU_5HTQ&KZW\V!5I*Z_:Q=3]PWY-'#3G%'=(H3XEF[:!LUU(TH7LCU?C\8P"BA10?0$]%M"XR<.PC$'C
M>HTQ[?4LQ/*)-#F11B9B90Z.9.I#I26K)%XTI!'#?GE H$4"+DC 4&Y$HPK
M"641
M F6C)*4!8EY(Y&1B^;DC&:431WN2 )]W*1
M%&N)L-:":50&LY,S/),IA)IC.$-A1(M$=%:,TI0#*7+'@K%4'K.
M4/QDQ=ZX%$)(I_I_N)S)4*XEXEJ;Y1**4JA$MF^D%"I@3&84S5TN2*(#[_59
M4: 5 EHSS)R*G+#*[email protected]=PI?78FZ;-04!4"53M&"0J7RK:NBL*E'.?O
M/W6E%F2*#*3S3O,N @JK0K!JAGU5E"V5;6 U94MS#*R>^M*6X>2=#M(!\$R:
MIK!J!*MFV%=-"=/9]E53PC2VKXE[0(4FXT-R-%.A%6!YHXGN2Q&SAE." JFS
M_:NF0&KL7\_?"NJI.9V[%T1"]LV@IHAKA+AAV%A-D=39-E93)#7'QNJP^$*3
MD*2W"RC8!H%M&-;54 Y-MG4UE$/#L:YFV;HF).E&*,T&T6PX:Z'LF6S7:J)-
M'(YK-QE)V+6+7<+8<*74VVZ5:2IUEN-1;>]ZEHJ%D
M&EE+V;6(7<,PLC;:@LTVLI929SE&UKKE<9R7I!NA[%K$KF'85TNIL]GVU5'J
M',>^.J9]=1?95T8H
MS0[1;#DE*(WO/^:D*0;B=Y2031;AF=UE$.7[5D=Y=!Q/*M#
M.ZKIC7JD8V_4>PJV1V!;AGWUE$.?;5\]Y=!S[*M?MJ_^DIU73Y'V"&G+61#E
MSV=[6$_Y\QP/ZZ<&=6ZC'@G9&_6>$NT1T9;A9SUET6?[61^](F".%[ RQ>(Q>LEI9EI)DH5"(2RY<0*1)0K$/G! A$E"P3'W)Y4\V,Y
MKYEI)HH4"(2T.WNBVY-JOIG,>U0043A!(*(=Y\U\$<431#;3(*)4@>#DA4ZJ
M^;%DWJN"B/() O'L&'821)10$/E$QX$A7F((&$0G-#/-Q#DA1+1CK2@B^H*H
M4)P5XH6%@$%T0C/33$0T3@DYAIN$."9T04XH#@KQDD*&ULE5I-(/'LOU^^XJ7;(FHN-N"GUI.Z]= #;R]E
M]:,^.->L?A7YJ7Y8'YKF?!]%]?/!%5G]I3R[4_O+2UD56=.>5J]1?:Y'+?JE7]5A19]>^CR\O+PUJL/RY\/[X>
MFNY"M-M&UW;[8^%.];$\K2KW\K#^3=RG-NX@/>+OH[O4D^-51_ZI+']T)W_N
M']9QQ\'E[KGI0F3MU[M+79YWD=J>?XY!_^^S:S@]_HC^>S_K_;N)7O+F^_EY0\WCD%W 9_+O.X_5\]O=5,6'TW6JR+[-7P?3_WW
M9?C%PMC,WT".#>2U@?B\@1H;*-(@&ICUX_J:-=EN6Y6757W.NFR+^Q9>=4':
MR*MV,'5_VD_7-#I BAKI"H)>!E(0D+V;=7(PL1
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MFA45)A4O-@944I1@%*X*2PJ"L%:RHJ*B)*-H55A49B#S1&[$G1>"W'&FA&H2<)P7&)0@Z^=B<((X\T+E#;#SXM0]5258[+R Z@EPG!>$
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M/!&J)X9C#;O,335Y6G[-7]U=6O1Y/]>JI
M;)JRZ%]YOY1EX]I8\9>V=@\NVU]/V/:Z&-_3#25.>/_YP&PO=V]R:W-H965T90V@T$?+.GGT:J7Z \;R4D-+Y1/OH=-_
M*BY:JG0HKECV FAIDUJ&B>\GN*5-YQ6Y77L51,HKFQ8ZV? .":B.WI?@<,J,P@I^-3#(V1R9VL^F'KCPW<86XB-X84S:;_H #DCTU9Q<0>*8^/N49$5)%JT$FY1D1M$;%NY3
MTA4E75"V>TD7&_:)L\]6D&RQ8>$F))N=_<:&X=F=Z.D5?E)Q;3J)SESIZV5O
M5L6Y FWE/^G-K_4C-@4,*F6FJ9X+=Z]=H'C_>*6FI[+X!U!+ P04    "  *
M,:M(4SI:"M !  #,!   &0   'AL+W=O7!;Y4:]@C)4PN,R"<^0*_O-%PPHG0ISD@. DAM
M38PB' 0I8J3K_;*P:Z^B+/A%T:Z'5^')"V-$_'T&RL>#'_JWA;?NW"JS@,H"
MW7UUQZ"7'>\] CA
M"A50:H+T@S^FS*]'&N-\?DO_;KO5]$+T3U>K5L,&OE=#0RY4O?'Q!TPM
M6,(3I])>O=-%*LYN%M]CY-.-76_'T=W)\&3;-N#)@.^&,/ZO(9H,TBWQ+BK0U00M-,].@YUF2U$M
M%%\A2 -L4N 5!;;^:**('P=$JX#(!L130+*$[%T;3I-931BDNWQ+58J
MG >SE^Q@T&SC#>0,OX@X=[WTCESI/6RW;\.Y IT5/.FP5A\M]X)"H\PTTW/A
M_C97*#[:??*3H1P[[VI6[;R
M3YR?%T' =B?2E.R!GDDKOCG0KBFY.';'@)T[4NZE45,'@% 2-&75^L52WCUU
MQ9)>>%VUY*GSV*5IRN[/FM3TNO*Q?[MXKHXGWE\$Q3*8[/950UI6T=;KR&'E
M/^+%-D0]1")^5N3*E'>O)_]"Z6M_^+Y?^:CG0&JRX[V+4CS>R(;4=>])1/X]
M.OV(V1NJ[S?O7V6Z@OY+RSHU6/GLF\/O!#PKGR:/LK[#[5L!>;8,WGI'&F8]
M8$!B\(0(A'=K"-!#K$$Q!UN C8I(.)0E-9BD6EG 2B55HH29%;.=P\P2
MR0PBF4;$7I-,"1+;&VJ3*:VB-MTLD=P@DFM$HL\=8&0."'2O&Q.$WSW.,'F/,$N V4$#>E"E-LUK*,0=J%C
M3A2LCY3$P84Y!W!R=U%, >/4I2BJ/"&+(GM1-%0:IPYT3!GCS&&@X,QAHLR"
MYLF84L:ZEAWR 5/+<+>6P=0RN&@95)7B#.Q:UE%)ZC#>P-0RZ%IV& =@:AGN
MUC*86@87+8.J4HR4AM2*HJ+RV*4FII1!E[)+0J:4X6XI@REE<)$R:+^T,VTR
M@YFG8LH8-!ECEYJ:XH/\WH*$IOA"Y%"0$92.HSRVET1#X3PRBQ(H.T!#NJ-<
MIIBWHY>6#W^BI]MI87N$?H*!<;BEQ.
M#I1R(NBA!]& )[%J3H>:''C_FHKW;EB^[email protected]]LN.2VTQ5]02P,$%     @ 
M"C&K2+MX"1A8 @  $P@  !D   !X;"]W;W)K&UL
MC9;?DIL@%,9?Q?$!5E!1DS'.-'8Z[45G=O:BO28)B)M_;2
M"#41567T\)W:G@R\I4/ R'D7?H+;&FJ)5OQHR<2-?J#@#Y2^J\&WTRX$BH%T
MY"A4""R;&ZE)UZE(,O.O)>C?G,IH]N_1O^AR)?X!ZN6:9V]5 F$9W50@
M2[.?-;'6Q#Y%;2F2AR22 %Z*V*&(M3_1?ACGSP,D3H!$!TB7,AS(82YCUN1:
MLT$@\XEJ4P33HEC!DCHLJ<62>%EF3:8U&42YE\44(832YRC(04$62NI%04:6
M--MX>6M3A%*TXA5G#DIFH2 O2F9D21#PKXHERL$*E-Q!R2T4[W>PSXTL1>9=
MN=K40%2@YR2%0U)8)-YZ]X69!2#OMUV;(K1F VT+
M+9/;#3I D7%\C_A"OF-V:0<>'*B0-X&^!,Z4"B*#@1>Y*QMY0S\&'3D+U&PO=V]R:W-H965T=:('DC:'Z O:5[E5
M.,'/CHYJU@>6_2C$NQU\KP]1;!$HHR=M$XAIKK2BC-D@L_#'E/EW26N<]V_I
M+ZY:0W\DBE:"_>IJW1K8. (U;$6!G3^9*/#C
M@&05D+B = I(EI"]+\-K-AYR%Z.0J%J)_@,E7:&D"Y0TB.(UN=>D\3:(LA A
ME#U&R58HV0(E"Z)DLU72+,5!E+D(;7?H,4J^0LD7*'D0)9_M/8JW6?@+S56;
MW6SO/ N<_?\#.=,?1)Z[7H&CT.8HN5/4"*&IB8J?3%VMN>'N T8;;;L;TY?^
MT/N!%L/M"KO?H^4?4$L#!!0    (  HQJTC])4DSX@(  !$,   9    >&PO
M=V]R:W-H965T'***; QX0O2='//(W.S(-B/'IM(_H<<)H*XV&/H)QG$<#ZL:PKN3:TU17
MY,3Z;L1/4T!/PX"F/PWNR7D=@O"R\-SM#TPL1'45S7;;;L C[<@83'BW#A_!
M0PM3 9&(GQT^T\4X$.)?"'D5D^_;=1@+#;C'&R8H$'^\X1;WO6#BGG]KT@^?
MPG YOK!_E>%R^2^(XI;TO[HM.W"U<1AL\0Z=>O9,SM^PCB$3A!O24_D;;$Z4
MD>%B$@8#>E?/;I3/LWI3E-K,;0"U 9P-0/%?@T0;)!\&#=HG(R^L>$BN(1-HG.HC5=8+4(D@E0:H)2E/DJ,)0F$*%4<;0!6J7
M(+Z=\+J4S)*2+:4DL5.*PN3J0.(X=4I9@HK$0TEN*-2,J<4
M U6L/$ZXL+04AA;GWC?%P@L_(*?@=@E*(,BN2UE94E;+RY8DUPE*BZ#TN&SE
M0F9FIZ4.Q<#XI V([>2/C6UUWJ-&@_3I0>@^8A/%;X*'G$^U"!ARG(X:#=+W
M.G,F2&N [J#/WD!;#/2XT
M$QG&MT8+[>2#P"-:$Y3Z- -V7D$CKU*/[Q*TDP'>_+V'=C+ U"=: Y3:I3Y:
M=%H#GO:R Z7!AIQ&IKJ9>77N,3$L^'A2':N:,'*\-.#SOX#Z+U!+ P04
M    "  *,:M('()!]\8!  !#!   &0   'AL+W=O2,WGOSAAPZGX1\4QV 1A^,%+G+O<@B%Z.F/8<7B=3(&)'_3D#%= RBX)IX[=M.
MVP0N"?%"6.IL$Y*9D-P(
M[NBP=^;Z>B::%+D4$U(#L9<='0Q<6A&CC$PSRH7NN'SV4B1IFN.+%;K#G#PF
M=IAH06"COEDBOB]QBE?T>*M N4;LOW]=(7EH(G'\Q!M,LJ\%T@>!U FD\RED
M]R:Y;\-CHM"!PEV\!2H_!7DK>'4Y#&3KAE:A2HQ<^P-8LLN[>(KMY3[D3^:]
M^/&^R13Y0%KX363;5_H_@/4$L#!!0    (  HQJT@1004_RP$  ,@$   9    >&PO=V]R
M:W-H965T@0@,/9N 1FAQODP+D+L@]^&S+_/=(9I_-[^C??K:4_,0VY
MY+_KPE06-@Q0 26[HMH_$FQ3<7--,\]1KB-61-D<\4=)1@"[!*0184Q/NI]TL_&:+S0BZRPS%=DGN\]A
MD@5,,H-994DF'<=[NHXR%27AGBQ(\&33M>P"/YFZU(U&)VGL_O5;MY32@(T*
M'VQ698^5L>!0&C?=VKGJ_[2^,+*]GQOCX97]!5!+ P04    "  *,:M(/!H2
MEO((,U05>VBTF@6[=H))J"Q,;6=,'W[^D)20-:DV<07SCG?_\?$
M*2?&WT6'L?0^*!G$WN^D''< B&.'*1)/;,2#>M(R3I%42WX"8N08-<9$"0@A
M3 %%_>!7I=E[Y57)SI+T W[EGCA3BOB?%TS8M/<#_[KQUI\ZJ3= 58*;K^DI
M'D3/!H_C=N\_![NZT HC^-GC22SFGJ[]P-B[7GQO]C[4)6""CU(G(#5<<(T)
MT4$*_'O._(?4QN7\FO[5=*NJ/R"!:T9^]8WL5+'0]QKL+
[email protected]\,2)]V,%.R;D.4:D:8I?FZ[.ZEBN*B!!<=M-*\6$UH-*%+4:\4
MT4T"5 '.*L)-%:'Q1[:*!-X/B#8!D0F(YX!@7>1@V[":S&CB/+\/B?U5P'-L
M E+;)0PR)V4I2O^GE61#2=:4W$E)'J6D&TJZIA1.2OHH)=M0LA4EA$Y*]B@E
MWQQ^OCK\T G)%Y @C\/[E&)#*9:4V DIEF]8$3G;K9>B!!;;2L#B]SNB$_Z!
M^*D?A'=@4ET%YA9H&9-81<$G]1ITZH:^+0ANI9YF:L[MI647DHW7*_CV/U#]
M!5!+ P04    "  *,:M(9M?..  "  #D!0  &0   'AL+W=OJ52SPU@6)3 B5[R!6K^Y
M<,&(TJ&X8MD((&=+8A2'OI]@1JK:RU*;>Q-9REM%JQK>!)(M8T3\/@#EW=X+
MO'OBO;J6RB1PEN*!=ZX8U++B-1)PV7NOP>ZX-0@+^%%!)T=[9&H_>;$H!"H8P"T
M.L.%M%2]\^XK]"VLC6#!J;1/5+12<7:G>(B13[=6M5T[]R8)>MHR(>P)X4 8
M?)8)44^('H3XKX2X)\0S G:MV(,X$D6R5/ .R8:8OR/8:;@P(EH9Z>ZE#>WY
MNNPMB]91BF]&:((Y.$QH,<& P%I]T2*<6AS"$3U<,LC'B.1E"7*%!33/+<9#TS64\$-L\%DIE \K]M;F8"FTD%
MVVF;M6O380+?@OS5RQ(HGX""U3]\LNVLE.VDE$67XW;J,C\Q/+H,#,353A6)
M"M[6ROU-0W887*^AN4RS_"'8Y6[^/&2RM"%7^$[$M:HE.G&EKZJ]I1?.%>CJ
M_)7^GJ4>N4- X:+,=J/WPDTA%RC>W&?J,-BS/U!+ P04    "  *,:M(J/67
MYD<"  !7!P  &0   'AL+W=O9_=H2R81/"\!YX:RZUU(&H*J.)=VI:
MTHF&=0$GYTVXA>L]1!IB$#\;,@AG'>CD#XR]Z\WWTR8$.@="R5%J":P>-[(G
ME&HEY?Q[%/WTU$1W?5?_:LI5Z1^P('M&?S4G6:ML01B2+%9"&0&(%D/ 4X3[*S95A,
M;I,$P(?9NYC4P?PWD7212.I4$F?HL4"V$,C<2E)_)1:3V>,J0/+8)0]G"MO<
M44  YEZ;&0@63Q13+&R*N4WAM9F#DB<.?;6P6&PO=V]R:W-H965T"2 M1U1XJK?;0G@T8B#:):6R6[;^OOPBV:Y;T
M0F+SYLV;&6<\BPL9WN@18Q9\=&U/E^&1L=,\BNCVB#M$G\@)]_R?/1DZQ/AR
M.$3T-&"TDT9=&R5QG$4=:OJP6LB]EZ%:D#-KFQZ_# $]=QT:_JQP2R[+$(37
MC=?F<&1B(ZH6T6BW:SK1-++[O
MEF$L-. 6;YF@0/SQCM>X;043]_Q;D]Y\"D/S_C/(9&I4*#(1-6*H6@SD$M 3$L<#S#E\$"2<
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M( !:7J#?"[2.\I2LN8T&6)TF3_U^4K,ZRKU4;E/M ]5W0
M?3%NPP!6Q[AS+6G0Y_?279 2$QFC1X>'@YSA:+ EYYZI>WG<'>?$YT2,+L[^
M"LS7:MJ[T52+$SK@'V@X-#T--H3QP4C.1'M"&.;JXB=^>HY\PAT7+=XS\9KS
M]T'-?&K!R.DZPHYS=/474$L#!!0    (  HQJTB5Q'XY]@$  ((%   9    
M>&PO=V]R:W-H965TNC42<4XQ5(M>>V)G@,N#8D2+_3]O4=QVSE9:O;>>):RJR1M
M!V\C%S_+D^-H"$"BDCH#5<(,<"-&!E/#?,>9#4A/G\WOT[R9;
MY?Z"!>2,_&E+V2BSOH-*J/"5R'9L,:'!!!/"4]$W)<*EQ#F&ULE51;
MCZ(P%/XK#3_ P^;#*9A]WGJDCM=QXI5+-&F-Y*($1N> -U/K-B0M&E-Z*,Y:- '*T)$9Q
MZ/M+S$A5>WEF:V\BS_A%T:J&-X'DA3$B_A1 >;OQ N]6>*_.I3(%G&>XYQTK
M!K6L>(T$G#;>2[#>I09A ;\J:.5@C4SV/>G>;
M.)7V%QTN4G%VHWB(D2_WK&K[;-V;U.]H\X2P(X0]H?>9)T0=(;H3XG\2XHX0
M3QRP:\4>Q(XHDF>"MT@VQ'P=P5K#A1'1RDAW+^W6GJ^K7O,HC3)\-4(C3.$P
MH<4$4VBC>WT=O/__PO4$L#!!0    (  HQJTA5FTE;#P,  %P,   9
M    >&PO=V]R:W-H965TXD]SN<*
MD!:JJCU46O70GK-@(-HDIK%9MO^^CF.RMNL5+@<2FYEYQK'?R;"\LN&%GR@5
MT5O7]GP5GX0X/R0)WYUH5_,%.]->_G)@0U<+.1R."3\/M-XKIZY- *$\Z>JF
MC]=+-?
M@\IPQUJNOJ/=A0O6W5SBJ*O?IFO3J^MU^J5$VLWO -H!9H>9XW<@VH&\.Z1J
MI5-F:EV?:U&OEP.[1OQ&1E]3'+%C(E!2A'R
MDXA)"CI3V!4]3BT0]H-,V4-%"H1"6*[N<68I^9T&@IUOO?S\AV+]
M%U!+ P04    "  *,:M(T$![4-0"  !Y"@  &0   'AL+W=O><:_N:6]W8\,+/E(K@K6M[O@G/0EP>XICOS[0C/&(7
MVLM_CFSHB)##X13SRT#)00=U;8P R.*.-'VXK?3(X[-!WM>
M V7^F;$7-?AVV(1 >: MW0M%0>3CE=:T;1635/X]DKYKJL#E^\3^1:ZN4RLZ_;!*(J?E5$%F9G,$ACX(R();M7 MD2.[0(]PK42T16WE? 
M3A)8Q^,Q"7R?('$($DV0C 2);;(W:1A,;M+(4N@#U4M0@I/TOI74L9(NK8#B
M/D'F$&368JQPD#L$^<(!+I%W,0PF,T<"0VL]/A0J'*'"2K7T"A4+(9R7Z9KC
M43HZI;6[F5>G7.A\PJ#(L/<4U#8. P16) Z!6W7 L@2\ED;0I%7"8D7N\)\"
MA]9V^K,?0=-^)@DN\Q5:R-5"_UN(T"UEB*U#@?UV#:@P=LL(K%D8M^:A7?2Y
M7\F X'A[H2A?(^76-+2*&A9^J=222B*X9@O9)>4OJA$T2>$H69.5>T_ 
MW-JJ#Q8P7VP5 E&!5BBY%P6T;@KHO7IW<'E50(C2Q'O6:QLG2QBON".A>Z? 
MG;NI1Z0Z F=^
MI[HLW2F\TVRK"SG1[V0X-3T/GIF0_89N-8Z,"2KM@4B>R[/L ^=!2X]"O>;R
M?3"=D1D(=ID:O;G;W/X%4$L#!!0    (  HQJTA7&HJ&2 ,  /,/   9    
M>&PO=V]R:W-H965TVF<'!'AB6]06(?W[RI(AUD8)\@NVQ-FCW8,/ZYV?1?O2'3B7P5M=
M-=TB/$AYO(^B;G/@=='=B2-OU#<[T=:%5,MV'W7'EA=;'517$2,DC>JB;,+E
M7.\]MLNY.,FJ;/AC&W2GNB[:?RM>B?,BI.%EXZG<'V2_$2WGT35N6]:\Z4K1
M!"W?+<('>K^&K(=HQ.^2G[O1?= G_RS$2[_XN5V$I,^!5WPC>XI"75[YFE=5
MSZ1._CN0OI_9!X[O+^S?=;DJ_>>BXVM1_2FW\J"R)6&PY;OB5,DGB_[7IO8*W/8EB#E0QG5YJNHQ(9[=/ %0$Z'@8BO!(,48$L2:(!P*49&/*
M,)CLHI03M+9 -"&W4TE0*LDH%9C%SE0,)C48PAA+;Y^3HG-2JV2X39 A@FRJ
MZ#DBR#U$ST=Z$J?B^4B+W$/O&AI-A5C*)!P4V))WL2(HM27T\.8!,M0FA;DG&(/#Q),6FI(F5C(?=
M*/8;32=+@AU',Q]),NL!R,&MB85*$I]TL'^I;>#,@P*;C\ZFBL*P^QCQ$&4 
M#=8A>>H494!E PH\GGR&G%-A_C$T6!?N/@97%S"T*C,M-U?N=QTG8
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M%,?+B'V=\Y?_ 5!+ P04    "  *,:M(BD8Y-O8!  #V=RSR#-^5;1IX5D@
M>66,B+\%4-X?@DUP3[PT5:U, N<9'GGGAD$K&]XB 9=#\+39'W<&80&_&NCE
M9(^,]Q/GKR;X<3X$H;$ %$IE%(A>;G $2HV0+OQGT'PO:8C3_5W]F^U6NS\1
M"4=.?S=G56NS88#.<"%7JEYX_QV&%K9&L.14VB9?*L(Q7\)*)J6HE.7.D[;:_SA7,%VESX
MH+]7K4?M&%"X*+/=Z;UPT\<%BG?W63H.]/P?4$L#!!0    (  HQJTB)9+H1
MJ@(  #L*   9    >&PO=V]R:W-H965T2A?28VMC61A O83O^^7&0%$27&?K  G3U[%NW"
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M*X-!&@-'1"399UV@J8L5LLS1G(.UCQ.&P60& Q!"V6T_J>,GM?PDJ+A-D#D$V;V1Y@Y![A%I_GFD%FQMPY(T
M0^BVFL)14]C[D92S:@RF,.F#%BB=%6.C8+& 'EE4.F)*6TP,9DMABO'8?PC<
M@@,V10H\*#[4++PW"R!R*9"M LSO_  :$B$OTVP6MY[BTCA/]VK\&!#3[TP]]ZX.O9#CTC=Z<[Z2O9)IJMYIZFK(]Z37YCM
MFYX'+U3(CD$W"SM*!9'ZP$)FX4%V&ULC5/+;MLP$/P5@A]@2K34%H8L($Y0-(< 00[MF996$A$^5)*R
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MZA^VH-/ML:C1DW)I_];J>D'O:#R6=WA=C:R')V9ZKBPZ:NCR_D?6AUO\!4$L#!!0    (  HQJT@0
M2+(N/ (   ('   9    >&PO=V]R:W-H965TF<TG5*=J1IE)*L_&<4O==4Q/GXIOY-QY7V]YB3'6U^UT=12;? ]X[DA"^->*/#
M=S)F2)3@@39<_WN'"Q>TO5%\K\4?YEIW^CJ8.PB,-#8_6TP[6$,R4BE3T9ANNIWBZS>BWC)"V"JQ):8+8&
M S4FG!"!5'>6@,L26SBC0U>!W1R1YH\K1%:(2/.C,43V6""V!&(M$&L!%"\]
M=B:%@60:\B5'&7"A=@L4#.$381++2[((@QX+I)9 .@L3)[DSC<&D&A/E$"&4
M1,Y "R"2/P#A8TN992F;6TJ=6[?-9I7W1?T7_N2
M6Y;R^;-.GQ (@7U^P?S539VA1@PR;R58P<09R8:!U/(3S%I+2]A9MUSN'>BE
M$^;X3JM36W^!JC59ZUO5[G7+NLN418_/Y"=FY[KCWIX*V?ATSSM1*HCT!U;R
M9%3R@S1-&G(2:IC),3,MVDP$[6]?G.FS5_X#4$L#!!0    (  HQJTCP?WZ^
M0P(  (8'   9    >&PO=V]R:W-H965TG0IF+(,^"GG>8,>U_PI76X@-Q")^E^PJ!WO/F-]Q_F$./P]K'Q@/K&)[922H7BYL
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M_-QC#=P!  "F!   &0   'AL+W=OJV4P\'W1=D"Q>*!#="KG9IQBJ5:\L87 P=<&1(E
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M"@  &0   'AL+W=OVZ<0R/DIY>DP2L3VREHH'?F*=^F;/^Y9*M>P/B3CUC.Y,4=LD,$U)
MTM*ZBZN%V7ONJP4_RZ;NV',?B7/;TO[/BC7\LHQ!?-UXJ0]'J3>2:I&,=;NZ
M99VH>1?U;+^,G\#C&D(-,8B?-;N(R7VDF]]P_JH7WW?+.-4]L(9MI::@ZO+&
MUJQI-)-2_CV0?FCJPNG]E?VK.:YJ?T,%6_/F5[V31]5M&D<[MJ?G1K[PRS7LMB:.6OMMKW9GKQ7Y#RJ%LO@ .!7 LP/"_!6@H0&,!
MM">UG9ES?:&25HN>7R)QHOK7!H\*WFL2Q1RIPPBS-';9W;A*K."D/,O!G,3:P>#LM@CRSH$, 1I$X&V"S"/(#$$V$""W
MR\Z>Q&)(J!'8D\".1#8K@>^3()X$<23PK 292*2W)7)/(G0&0[*,
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MA"(5DBJ7&GGH'S$O \R\S$_K7W+/]FU.%]7B5I\>L7#V6Y?O755\7\(5J%12=;1RE\L\SR
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M*LJ'J(SG!0!\WC+4!:PEAW5?9;7YGD;YO>1-YW/(W@*GEGP\VW+SE8K0)[;,IO_Q?=N":.]#YNR
M* '-XK1V^!<9["\M8%3XJ\B2>$%3?!TF83J/8 "X3@72R].
MO;N';%/ >/5#C.;Z-@QK4WV\N;E\?^=-;V\O[VY?U;X.BP>Z"W/\(_KK)OX4
M)@#@VB2W#UE>GI51OH*U?(*S7#4]!0!#*E)X>32/8*A9$OE>&I75YZY@B+1L
M@/MU'JW#>.%%G]<(H(+6E@'BY-YAH?,FM:1,L(5K_PRO!SRP8^
M$"!V :#Y.X4$;Z^F7U^]O;J[NJQC@CZZ=;C%1ELR2^)]*\Y\1W+*(!Q"W+
M,4^VKL*'CXI"3RL+;SZH-$O/#E@?;V3' TA>8L96OJO &H&J1.D<'O9.WF=E
MY(U.*V\A#W]5K,-Y].L7P*2+*/\4O?B-5[O7=Q\N?O_;#V]?7][<_OC#?WJ7
MWWZ\NOMC#3O@7@KH"B9R+[N=;@]P)?> 8&RB5]ZPZW>[]+^P="_G)X"Z1:L90+.5PC'QM=957=C.E54G]9MG
M_5>O/_$'0=?O]P)Z OX9],[]4;_[9;;E U(6ZVA>QI^BI$87IXM%C(@&B(+T
M\0SX@:!HPSW=K#8),12YI]D*$. !Z"D,[259T42V]3MP1^)Y7*-3C*0$Y(7(=XJTB>")-38)4OO:]:1,G;$D8@(0>H
MRYLXA7%B%'6R(MXC\M607F.5=P('L,B2),R!8 *,:>KJ%:P/4,._0]]@W#KT
MZ6R7Z&'?EF,WY+Z]=S>-CS=OI?'1G?MHQ!-]V 6>]HK:!IX/(%,'!EW!$!.D3&>RT479B+GO0HS3Y+ )%+U(O@)A57R2(
M=Y_B LD"/.J=S  *#"G!]].AY8W#MA^(S^T,$/"%QP/SK5V$F\ 8>+[5.2]^=9#
M/;=(V%@0+OZ\:=$B+AY ]$=BEWJ;-(_"A(2-^S &4H1O?@KC!*7L,T"SLP*N
MHU=$,$>C^'?(PAO(Z1Z>?]B9H5;X)LD>#R>@%]/;WWIOWG[XPZWWYN;#.^_#
M]>7-].[J_3?>].+NZKL6Y<- TBLSU!XSX-( %8V.\"G^36JJPEI#VDP9\!OJ/V!R $ #4^I_6:721A:DV$P#1*
M)U#X:!5O5HVDRB5!BVPS*Y<;(,1UU7KWF]'G.6HJ)([.X("C,J(E-.K=1!_A
MQ451]%"&"D1CF->
M6(4E$IGMOI>LQ1QV[AI0:\3!!0!KMI49C@/6FZOWT_<7^X"5P[V+UZ0,;858
MI:[.O@<0*(220E'ECILU_!E]CO)YS/L7IKENMD&$G\T2\H@UJ%(KNH]Q^? 0
M)0NZCP@+,CUH^Y+,F,8-UAP8.%HN01W$-42K=9)MHTC>6(,NM!]5EZSJ[(3^
MI9GB\YRNKH?63F\NUYB@>J"%\/WEG??Z\N+F7[N]M&%&AZ\,\$_NF]N.#Q7YQZ<$$ ]1=$^RA%K@H*+6,_
M;B5?T!7'6^C=LSZ3;/&;:$URLH'-F@E*PIP+5_HQC;4X1/N:KF!E\]#WX"I_
M,YU>LYT('PW7:X L*PK"&!C\
M]O+")X*A@&%V'1M/58>.-D2J*FM%VGN99:5
M\&B$1 MN=,[T&K=%,R,6D+S0!' ZJ[K]JNW,9F*Y(1^A]Q@6H)CF()0NF! 3
M !D)FH\W%/B%I8<#@C:R@;\R6/K/ME?G6FB<_5+(FC'"%2'(D3.ZFK!E&RS[
M1X5M^@IQLS7HZDQ<5F$*>B#[)_)HF2"I1T!9>@L^%@(D 6 )REV@YI 6B')"
M1#,#,\]):T5I$BD,LC>5:_W+PEK?6AG8^ 0K-E R=VX27H$Q
M"-"1X(CE0P[\;L5.X B=P$U65$(\OT$W>MHXFLTM2>5YPAB,, HSU!:/& B@
MCGBMP!TG*$8M@+R@Z46AN!J7;L4JW )&D4A,4H6:;(N^T8CU_.IM'2&AP0?A
MT$0*7F[HR,,TW: YQY ?9IYJ8^9NR=5;,.(!VGZ["7-X)4&/,/I%$+-!?UYY
MZ!V'^Y]M0!*:X>I#,3JD?]ZD*SPSGWO?$I/CEW+
MO[[(YDY-^4SJ4/U][;"C!L\"(.6'36GD(.?^O][0A3\,.WU[8:2EY_C4'/2#
M$)6C30G:XIG, E_FN"D40!WU'F1T_/!EMQ-XJSA)\.081CEYV^:NC12I-3P[
MT,_ZC"TASP#Z*N.X?A_&>@QSC$?8LK87)L*LT;*PV*#43RA?MUG*7,&^N1:1
MF4O43YZH\%D-()AF*%?  3% A)DHZ&D6-HN2&';*E[G8H/[email protected];/ V
MG#Z,AJ_9(^[G#$9(B6%6EO2MM[TR?%%Y.@^0$G-#
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M;N6T\\+[AJW?N=H;K(^ 17O4^W(-$L!MSB36T$JGW45:#E 
M45,+29ONC ,'9&'M+J6.]Y$M0I=%&:_H//'(6([7Y]!"19#4H.B$X*,[0OJ'
M*"2%):DC0JW"OT2:J49Z-C)>%\5FQ;8H9A@AXQ-+A2@?1 O-/U"V;[X^[,M1
M @]S!8DI*5O?X5F06&J$:U%&6I?3>*.LNZ#?<5@F\#RR;1A0$ 8F6_5:D_K1
M0L39VVTM)4H4JUSG&0@'I18>?&,N]YA2DHH.&E3V2"KM/ON\[QQ7'MV'I*_#
M8,#K9LB?M/\M3.8;)38\L&IEENIN42YA",MY(D\92A'J<#K(ZU_T%H7<=Z!V9H2X&
M^][5(L+@TA7<-5_8$3(Y+Z%HSU"9K-#\&=-)9W >=%V1O\-5 Z"PK  (,@>=
MASB%LT19F'MDC\K.+&*?+;K8XI)MJ5/#+HX#7U@0=R*+B\RV=X:HF.?Q3&FX[O*>KY/=1/.H
M K(\2^'ON9"M#REL8^L%8WIE(-J7T3BM-V_1H8_TP/LZ@U]D1WPSO?W:5T%I
MC<]^7!,Q?Y]U:(*S[L3W)&Z%;S9<9+)#LR?#NQ#\@RL.:YMN[N'?7B_0F$/+
M@UGUI+.$_U9:W\6F62\D*@PB32*35F"#S+%
M&-$95T2V$5;NBH;AF:$6>A@2].\IR@BF0H\Z"?H$CRDL(]D'CU[7A0)UOX(-!]0$R0ZXMH+=J>^\D["4Q#+$^0F)>Q2C&#Z
M 1^7DRHR;W"I8)\+DW*$OXB+WIH]6A%3P)/9*9X3T'CRN^Z?0?09?, X7PE0
M_(2]/6?OI$+9 4'&D$%Y*G!UQJBBINR.K47;*B^):R)B(PDA$:VWL@)#[7X7
M C,"*969RU@LV;$.4X>#%EU?L\S'3,- 'PULXC$BG=LV&=&D>&_UQ(0_Q-#Q
MYI),>("'0OO'C>+!=.=W&UA?&PO9S[> O?0(1$A\@%!=>,Q#^OTNNAZ5!'_R
M K^"#U^BWVB_O'4#51V$3UTE16WK?T!;EQ< /0SKADFR;9
MA8'D'EN9CSN*;&C);QC!)C>4(7)$Z6#=^ >YLH'2NBT1G)2EGPK
M9$LSVX\?IGHEQ.]2UB\HEX+IOQA$[,T2TLVBRHYMLF;FB!DMEW$.\/LKNR58
M.5>W\=R]:;NNRL]U#=Y$LYQN<0L'WG\30%H!8>PMA;\(^)!O:RL#)[/8ZCU]
MX"CYMDV& VE\8?5T>-IBKKYC2Z!%"<6=Z;A].Y8\%:B3)/6S_31A')>L3911
M3G:CR9>8W%I)_1KX;SA_./K$E:R@#_R+'+-H)EW_6><,P+ABN4*+6Y13R181OK@Z  "P9DTZCCE B/\I(&-,LA9)KG%]'V020EQWC:LDQ0
M*KE"IW>1B=2#0@E1;EYJSDZAM0IX(UV:293:#.CO$LY%.G:,85;HL%J ;D9(
M"WN@0*\LH3L"8ZVS0J*_T(\(LMS]?43:JKIJ6UN0%=<46?U"5C^W:)9BSRAR
M-NLTX/]E%)?DIF0^#5<%!(I<#,C[>,,,;PO&A1+K4CQ""".Q (N.5FB_28\Z
MA)$$*,NK"&L.I9%P/XX>L8)%
M-+Q6J,O.1# T*$=1&;:%_N^%8]0"U=$,^)TR QHCP16(%OFF,L5V?K='
MGQTPA_?&F"/C@L3;E 6!D@VY'DTT )K$)&R2I$]6F.DB4[ OBM*H_:+!
M,;2NT E>TL]QR<.>,C9YZ)*FL!2C,,,TY2/B"(M1F/54QJAO$X!MXSGY=@'6
M)NY'[J@1NN%LX"(!6T/%G2Q/9W"-T*ST +^0N&^598)\M7#)OH]$H$[7F](8
M?94Y.K2$\"S)[F/V%+%02D@.'(PT)%N@9*S$(A"(!24%#[9-2?H4B[ 52'X#T,;4FJ2ZRV*S%
MBP&+@?=+7BW9/6DY$H^[%5>)>LTR1RKML>8&:%D=N;6YE(&5T2VFM#F23M:(U/#9OFETK"F0"+H7$GD7,+9,RK^BB4&YO->
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M15,KM&WD@,TQQEG>Z'[email protected]+K*E/PF/Z[ME=!99FQS^$S^%EK 09EC4N)%% B03DG)-093@+/>/)B^6(X-J'[_E."&+4+7<
MMI?$-5PZ=#P?0/5;_/>$>\"NAF:C!ESK
M?$3?G@#NG;9QL=HP1W Q=3R]P!^/#>L^ 9">RL>C\Y\5&0>3215VR#"/N[KC
M\S'#;0 #/)6?]OW!9&36,J*UX(==#.[PHA"(G[")HSCJ?27N44-)9_[4LGB]
MQXC<299VU5&QRV2;V9 G6/&+>L313T;5*T]7\,,V*9%?2T=HIK$M$LD(D@X4>8=!5__^ UI^JV8W:VM+94(X0Q,&;'V%^ *8A+:Y
M..><*#>9X5,.E9A+9F
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MSSF!T)R3L9NTDQ6'U]^$CSI8D%AM%W2;,?PQ $+\:# ?P\
M!\I)[F#2HF+;80B@"H;PP9,:3F#V I1DM[[<0I[W/\0; [H>X@\E@]TFB?638ZY'"/!E-"%]+UM)FV2<=_E^T;2B<2]8P
MISVX52:$_%-(+#SBY*DQ>YT!J3RH "!HICMKU:B >;O.1,N2,99P;1Q=DD,!0J;8-$X F
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M$)1 RA?Z3GW*DLU*50DC]  ]."'AT4K/T0M0Y0#&+9C)PX+).FD1V6H>1W +%PILDB8L?G2[4&<5AA31I1 1
M],-*=)(J8%9X?]XL[E>232(;LA+X&5%#QAFT-"G6)A'[F=.*W2G^5D
M93A#90\_'+_A='QW]WD$%R/5\KEA)A8#J.U0W0444G?0[#L25>U6)%5YF>35
M@\DXRD_P$[206PI/U#5X+$)^$@1$J'O=+OPR-1W1H7$2'$B\699[Z0T&W1UM
M":;"^!YIXF',\(8H3HI342K FFC90PH'460(3 A*R4*B%JWN68,(0QZP9<23V%"<82P,NJPM\?'P=K['/QG.---=-8'SIC>%>
M=?7ONG7#-6: J!_@)3X!66HXAC^:EXJF\$F?C=O=245R4PJWKFY6N3"B9@>.
MFDV2U)&."N8@G-QK#E)BB%$X-+$]D).8G&
M8TKD\$9P$)3U)'],Y ^ //YQA^G'',@,:A4H5\85"S"O5U#G<[P.T:!Q9U6;
M./S)G57A6U_Z.@^_Q_3R%(EKF<>S#0%YJF^ P]_)+2"W-<3 8/-&A4!.7W\W
M?7]QZ;V+L(I8(M48W9HU7KUF#>87K#98Q4K*R7]]]>&;R_=$A61(W^.X93[@
M'J2). _IV"O>,DU1RKETU,, FF6&68VX N841)2
M)'G*K\D.4=3)T'I*I3-DI>J(+,4%KZ;(%"(K;-9XFKUQ%Z[55E7NRE@^2#,=
MJ&0**=3J,:&[CAQE7&#B[J&6NOP]*RJVX,)2,Q'P'7<#.,SD"=9DWRFZ\++W
M1&OPG0G&=V*O5)+987MPW.DMSF^ .:SRO&+#;[#5[^K1-$VIJ+[IT;2OH9/S
M\&'"]#R6X5R9<1GNU.8*SR'AA)MJDB C.Q:]
M 2[/A((%B 7?DEM00^E4$JED:TR5(%FMN5B8S(J4P+O&<>$,J<0R2+Z 2FD<
M^K*<4-(:;6MDH>B:*?J Z818=VF#'G^59V'F>(WI4D\:GQ(XST701L4N0ND&
M1&?LQ85#OP4:GV.BV=-'KQB-D!AI6&7+I3+,5B=/4:CZ)BP?8R3%4N+X][#U
M1;8Z; %V+MC8B3&0:Q*%'=AO(YB^OT8I@>^+T("#7 ;91M@
M$K? TAZ\WP/8#X2U,\@-J8&^]UV<@VY_Z'$9(03$42 =WX3)8P@X?H56JG1Q
M]!CDG[M!>J9D[V5VZ/W#)JZ+34*Z&9F#N()E42ED0*$*KI;' ;O&YLZ%+P&%
M*VL1/C%Z/I]XBNL2^<0;UE*4&,0KU9J[XA(V>]\+NZ?$2*FNI+4"E5/BX3O5
M&M!1N@-6; *_-PY8@ K\[D"4F_%DQ,K-,)C8R@VZEEBU6>Z$ GJ-QL,)D![V
M8^^F^1C,Y"@;*ANXM4&B(Y(:;S %9)D:C4X-&<"X69ACF)QYDW.[FGXJROU_,B(@&$Y0%%0D&KQ54ONU-89.&R-6F!1I-,2=F"5QA&9C3%/
M,(KB>HP45S'?:)Q2S=@JN/71,J><(*(!UE2PTT&YAN@03!7H4_ G_I0VFO9Q
MVGO!1_#_HP,Y>N,>63$':+&\:!E>V3\"\C0%_;YV>EIC6V4,=X=B(/WI!]3H
MP%GW+ "JCY%
MU_=(F^8\6ZQUB=:B1M@-87%)E7(J6Z(@N@V56QN3U]D;]W+0Z1FU /6$H:42
M'=CDTW-K?7M<*1^I;I:R-
M \;8]_3!X7H!9\.DY,I3+1@H=854^J95-+6EVVTM;7Z3TH&8B@H[Z^N/:61AZMGJ8J1[%N5!!NLH4=LJHQ- ( 9@AHL8W,%U.71S;#U
MQ;Z,;LA-B54F8-UO*?KE75B6B -OJ-0EQO^BX1Y^NZJ*5.&/TT]9\HG!PM$S
M1!J#8 D?TDQ@%7*DJH>% "WF//,
MIIHLND:15]A%(,55[92WL[L?Z%<_$LBQJ6-I[CN>'-&#.EX5TOSG-13
MU[OCS'8N#=^X*=\%/[^N7?J"[GL/@19A(*ZGGXGI3X +6)EP_;G=2[*Q4PI5
M1!8P3,_JK81W.W=\#<^0YR"1TH0Y5:51DY]L4DH>8#>T]:I9%5;].&T)0==T
MDG(Q*OVS\<037"A7@U81[^K^L_<>2.=&&O[AZVEDM:VH["^6,'D1 0B)U.L=
M'4?S5I^?:XRI"M\FCB#9LL!H:O5N(E4K!SCQ@DIADS>OB)+E&=&#:*&[?"C+
MHT$KQE0>U/PKE*KO
M5N,/*O C=2[LXKR+:,4P9D']2JK'\-@&9QG82"P9QRN=#57[8*PQE@JUO+<325PG8]R/UE\CZI%R(6F2",E
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M/@9FGNI!V'P$WP6]\[;7]3/]B=\;3]H>9/U"P;K0X@\/C
MN-Y+U1_YF@KZ[3B_P!\->OYP@M;F46<\JIV0.J @Z 1#_:V*7UY@0N!P@EG]
MP\[HO'XT)W@VIS!T?]P*R\"?],\!/3#T=MP9#.Q#XEU/%<3T'Y92U-RPF54+
M/H[8+@!&6=^O+,!^U(_+Z1EX[@!^K#T
MH(9K,?9'?01K,.@<@-TG@M[P?+\SF+2"&HL_#?S^Y)QL^IUQ<&R7$[4PN>*R
M7DM%7*,1!]05X,-JY\T'U(%;L@K_G.4F#@H0=F<3;HZG18\$36]*R#ZC2:*^
M^>K&R\XLC;0B20,CH/)TW.J;+I@\I+JI<\9\)NMC*Q.#()\PR/[B"#E=?1H_,/>XC5.ECF$/M]O]L?_D,>XJT5
M\%VM?2'U>*GBE4A\MM<41B#GZZ9\R')E(N$D<)UFFN7V^I''53PM)86C)=&G
MD-=DC[CE4WL9/"EZX"=:S. 9T6IZ*324<'W7V$8*;05-=3Y(VW78+]"U"<76
MS%;]8ZMBC/6BDNILY410641BL$-6$.I
M+[1]66%M8>HH*&W-Z=6T A%+)Q6*2$
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MIRW$6<7HH=S#%BNUN/:ICXGU8H)TWV)=N"9L5K *KPYTM\=S=JG'*D&U9
MZJTF(D2=E8I6/Q@SK]O+UA%C7;C@?-8&0JH@!E<+#0ED'[email protected]!3&\
M)6;=1L@P^9RU0[#6>; $>>D>+"#"ED,K!YTQ_:\?L#8VZGN_X!\W+9#O=8(>
M? V_)O!+CZ'YQC9&I1*%UE_(3_W,'2[$5MHJ/5(I=SHNJ2HH=W:ANBX2X<3Q
M.#:>P'VZNOZ@'#H<6LXI;?4#I,N D-=DW/V>6@OVK?9BOZI5F:4/HG89*(,
M)58$HV+GV[F$"!4@F9+C \^X$C^E>D61;4XZ1*'X8"X\?H.^.FI23,04$U$+L/'_%"X"DZIXT&&HG +#VBX$O3=O]?W'?ZEB@\,@&
M0,/](V;R!IG)E6(F-WA_)*&SA=780K=;._G[*,_.0%5$*R4IRY(09$+!.?]4
MT?%&GBZBO!8-7BL6]D=B89U:W%H:X9GJ> +%\E@6TX%YZX1:J:&YS'I$13-8
M%6-59 .\3?<76 PET!&K"BVJ5N&M ';.7$1R6OA*H4$>^(Y/<_#4_5DN@*LW161
M[UU8%UE;->27[!;%JN^DSS_+BZ$M44-_% 1?=IV]<:>(Z6P$J'LUV ]DS
M(7O^U!6W0;8_[%/-W9]FQ?U>9^+@P@ZK\6Y[<55_LV+6FLW"1*A)B;B\O;[V
MZT5GM&&R'D%SK&6XJROE[7!W( %ZGZ5G!I['F&H:?!WP:>J,5^OOK>,L*DX2
M)'HA%B#SK7* 2C@F$J3S "@PE:I4[BV]7K>4-4TQXU7 OK*^&K3?0H\(!5]4G+@%3
M*>](/[$C>DP/M]8/PU4$K0K=EHGZ@@W-+C[,1)Q3YZE?$ -]C>H95X&XUJFT
MOJ5OV5XM!2%E3G\=)QNRI7<,^S&Z'RU>\;3L"AUPK/#:GE1Q%IX8JR%=GRXV5IGXX_,N-5531\;:U>A4?I*I('8(3:,9\U?E+?DB\;[T_\8#SVQ\.^UQ^C9]?O@C3T
M6AV\X :U,9ASZTH3]K;[QJ^,QO.'@X@FXG
MX-X_\%<7 R7O'/.JO=9]%X5B':B,%>*'EN=Y:QH%=R!=%5#N1MU-B@6ZPX"3]N\.K>%I
MQFI(!"7E6,1S81$@BTCL
M5P-\#A<$](+Q\17W[Y![;E7#HC+-O .>K=*2U\XI1-.03I11-A.J!T^.;#';
MZAKIE%'--1KLS(&86HFJ$D?>S?\.5^M_?2WMB"HB,,O.>'O4(A'V9V5VQA52
MT:J&$<^2OB9)QV3<(@.8#=EZW@K5,4FT94*(E/AL#YJ0R%G[E.9[8Z U9?]P
M='K%HH7:Y$ME_\@XY_K-TXS#I\BTHI$N;%N %=1!PJWD%%/:D@V*T+X5(%[4
M*A=44X. 3?0M58\7&;!U,I.TB0-2MS;VW1949<_4/]7W1.M5
M5E(3.8=:)M,949(-Q:6G';UCF6$-2)WM(7,2$>"+5PO4KD922H432H5;RU![>#Z GPY<^PXL8XXGI"JZ%O)RU7*ZT2N\N>LD:N017IAG
M&R%FCUF>. H'?MBRT0JC417'%%UTJ[*ADF$T,#:^8,HAO+,N4))"8SN:V9LO
M*2D+6$\CX@FPVD!"U3P**H;1\?Y ?"[F?F9+:E 6X]'"SB4>')?*5Q!?5E4X
M5-EG4[N#QM3\C!+; 9]PI#!O69Y[15U3"P=641Z1SM^6(R+R1'R5V2K:S9+X
M+TA?9765/'%3_X&L33RH4R./\31Q"J_X5"J$(KA0_,6:]5*+4.F*<3[?K% (
M)[.1*1S?  !](G.2@\6#P19!EK@PQ+O5RZP(/J(&@["J1%H&U P3Z-\[*>:&PJ6>B]4EX^)DER1Q%=9*R>EA=Q
M*X0KX[!K>^1&&[)V)-?5A[-J:1:1"C>B^)2BRM.QLQWE&E@IOT-Z%UN<(Y=218Z@FTJDJFX=1WUE9S6HNZE'K,JAVR5QV,^
MPS YD^-8PB4TP9E\ -K,(_3\MJSY!VD2%0:/)K HN\_#-> 8(@F11T?JI($E
M;)^J72L;MC30**B]S!IU<"K>@7F(7RB._STET$U7$3HRL1H^MAK#[L#]H1\$
M$_:'ZT8^O3ZICB U] /3Q'&&*\_KHRIHTAK,',J_\$T>8S^U K]O@#$
M682=RD)B1=A-HTOBU!V=F* T.7=&VT(7@/IZ)>CKT!+IGDM$Q<,9;6J,Y&NNB+I4E>Y,$47%=G_]8BW"QHN6A>$A(W4C
M<.AJ??'JJ))=,.B_7;Z]N_K6FP*B/T0@QX:VPE)/670B+&W  %)7?C=8-OL%KNPJGDQ?0U,87@VHZ9F. WT^FU
M,1]8&7;Y)M%4XEXLZEJIN35&4'SB\C-+4IQ[4!2QM&^YO;SP1E>N"LJ9MPE@*=815_%J2@^*UW5SM=:"@+*!,"P>*E*YN21JA;"1;+LP-HTPH[22+7(
M-:XB#Y+M?M&[I4IDHSA^I)%73+MX/'GT (= 3:#0"/:D<3AAJ7CPEB2A/&$,
M95AFS%!;/&(@47P4N.-D2P4LYSI 4J0(&M5NN164 6V_9:--LA7%"#'[#3SN];IGWV);5M0VN6B9
M*I'W9Q%7F4;_^,-_F4*,Q)'1_; ATLBU$4"2V@KS,J5D+G1S>WSFQJ#5!XU6
M_@L<_%ON>!)JLQ5\D*A_&T]'X4U)Q7K';4SJ4/U][7#;K(^ E)6A8=KP^^H
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MY_S+%G9MUY]GVX"RXVC#CTZ!X]9',)2D[7*=N!=VD74IP>MJU#J"'R#I$UWIEJ'
MGU]4*Y=#/Z7R[[5[^I$ME981&JM)IA#HKU,0-IPLG%XZMG1)1]*"L0-%"5Z[+EFVW35RT5NTO*ZNW[1V>
MQ6X;V28XMBZG\0):5T>_(X$7DA\-(@-*B0845F.&-E&QA47H,$.UE$B*7_BU
M7JW(->$9RK+1;BK?\JDAHUQDFUF)C1$:VD3YE=1%E:%1S_[4P5+*'5B+B+0B
M9:U4>VQ)ZSP:4T:E;$AWP/S$!-;T2>1BJ\;?8$K[WM>JJ$\Y<%[)AVS@WY4D
M4&L"A0HJWM<&8T3-M+W'=G%'AD'#==-,^U-;G C$-IW^6Y:*KH9='!:M]#&7%G;?J2OSC!G\*"!O9,[T'OGWJ@[.GT%0$?_;:@M
M IP4>O21V?=L=N^9L$=
M(_F$! _O-S%;J+2'[-%TEL]L/\GC0T2\D3U!JFR?[1:@[\)[26H)-#82
M: IU374P"?G/BH;AF;@;GP#)J-Q? @.;L8H&RJ@$#[L15RL\>ET7'D[-_,- 
MH]9B@T@2)K<59Y)3R8EXL<%CO*72)UI1VBA!VXCT*Z=F/FK6*E<$$J"H87/
M]0,^+B=57,+@4L&VVD@7N&J(&85I3V:G)N7WD!FLY#(3&4R XB?L[=521O#>
MFHPTP?\E-SBFOEZ D323VVH*8UY*95UUO9UL"N*T!EQO906&VOTN3*GZL6K!
M:EJWL(Z&9>5-^CUQW,=,PT ?325X0;SR-"G>6STQX0_) YGN!K+?LJD=;D8(
M9KKSNTVR;64A^_D6L)<>@0B)#Q"J"X]Y"!8FA.&5-'GR K^"#U^BV"JHKOFJJ9& M4 S25E?8LO??6&H?5!XP U N#B$#K/G#ZD"!_!",<46"@BQ,*D/#>+[N.4\)2C
M+;CAG)9_I#OR2 *IX!WLFJ1\)YSI@^2$2@R:0#!K5(J#4"LA?I>RK*N",(PN
M;V]6)9NY.W:#?=0<$B^ZC'. GQ7?9VYCI:GFKJOR@53LF^O7:<.(&<=Q%'4N>"M1)
MDBK4?IHPCDO6)LJ>)+O1Y$N51F@C]5+GX>@35[*"/O O17Q1(9M1\ 3"K!@H-/X&NNRRTL:T"R'D!&:7^04OUQ5B.-2L%%$J+X,893NEY2KNA&M;H=;:*]1E9R(8&I0C;ZYM7/Y[X1@U?X-T8"Z)B5>#%56Z0%3* T58U#J7W+98H^X)E>"(2Q[V
ME$\14RC(9V@IJC!-^TFX^05RJR.I0Q_I)0SQCE2::DR#W-
M'3E.57ECT\#6"?7!J%#F5HI(VNBGD;>6$81: $:AT^9)*UEOI(-87.Q9M:70
M5/*^5"]/#KJE( D[NY6)N[9GJS4K5,2O!65]KO;&%6D$S=0]9VPCVXBX3C]%
MN@" '41,5A2XF5@WZ7NJ#L CU$ZY2N^:(^*,MF?^8B.)U"VH:U$4)D03#+.355Z+19^_&
MK]K-.'8Z<!6;+FL\KNJCDM-U@SZR59;A0O"SOC_I]:V_, P2&[I0C7Y,]ZX- @H%]Y=BP^TB
MHA"SVG/8$OJXC>Q;ZJ@7Z-]MJ\"4;34&_JTBD0-_0!',0S\X'VJ8G_OGHX&<
M?MU']!,B &::!Q4$X,^>@  ]?SB86'_5D6#8[>K?39!%./2MOQJ1P!FD#?S^
M<&@= /WK>$083,[U[Z;E8HJ]^MV^DEYO8JT$_Z7#TGV\WP#QGC\:]\T!G/NC
MR:0>X8M?)IRU_N(.Y1YWY!C KN:#Y;Y5+(W
M'HYDF])N8WCN/1GQZA3R[PGWN.>'VJB<:A-!5'2LC2 ""3P?T;0X+GUXLIYL?QY"'3EZ1(J 5 !%H6'05;_W,3'2C)KA9^?(
M&A<:)2V8+#LC^+?OWZ$O-^&CCE.BZ]T%YCR&/R: +>*$U:>'=9VC!#'IP
M8X!KC/T)X""CDED+X _-"QB,QGNVNVUQ!YP=A!(@!
MD9GTX;O!L&]UX!+#)X5&PGIHRWV8#ZMNG7?[WG3QB=OJZ+YO'/&L(FWH]OK#
M\5#/IV)*"<4";QB8%2?1/>"67BW<[8!*=HV&W@=:!U;ZZN)X0"D8$0_KE?X2
MX=H/$$A]W&=O%R*\5O5))#;N.5B@:YU(Q([MM36LIOK4H8BB5TJ%G1"DOGL82'4B>O9F>]*'Q1[I!,:87(9
MD*\&Q&5'$ZL."!VVU:_^)*"*?B>]+E99O-;59U%M.J%RBY7IJ(5592*^(,#^
M!R"%&CBX\LO3,,RWRSY5L4?7$3Q(NC%_'0Q!1D?B<.>!=]DPO;@-L:OTP#OO
M!TI\$D:!GQ-\S\<'PI+O 4W9JXD)5SH:G,T])!0<: =PWRP:Y0GKJ9#'_P*2
MQ+4XQ[%4POPAY7X)H D"TG3U[SH+=CDN7/D ,?0$X#,Q2KE"&Y=N/*#MH2
M9..=1.,-N][_B((VO7!B>C5,)":>E*GQF *7O!% FZ+\Y(^)_ '@Q3\H6I\=
M]T!#!X%EL@# UJ@>]ZLIDX.QR;5
M7 <\A&J#RU%)FL]SHI1+B[ B,_>K9A]_-2[I27H4'<%E0Z+ME!N![#H= #70
M#SH?4$9!(Z<3 N%Q(&&B5T&00^*P<>+3? /^8.F'?(;>E)D$K_!NMI'_<7O@P0S-4D:$LPF3G,6?;A=[8=*Y\(3U>7DM*W>
ML7E2VG>/\ G\T !UT@H1OU!F/:B>D#H@[QZAO(YE@@8:.X01MJ&
MDJ\LL'_4C\O9&FCO "MHZ(! (](?>Y-.MQ7QJLUIN(U,R\/25A,NS=@?]1'H
MP:!S .Z?"/+#\_T.L)ZV@S"UQ9'Y=,9UX=CJ9=%$Q78][_2^^&?W^+_?[O&U
M0S2DS(W><1O^:A)H H4:K4W_;--::].ZO^_*07I2O1F++PU6$#^DJTE=VUB-24\,G62S:^082'E4.+LC?*_5!U?
M4EW/$KG9$5>?W/O3.]*<_MW[F[,%:V;UQ$]3--4\EH7
M,57E@6YT>:#69YN&W7%2]<=]44MW/YG3DP!I_ S$A.K3/6#$W9K(R;=$7?RV
M+?1Z3>\>%--?OP#MP_@J4IF202S?]SM..B$R?*-+D.)3[[/4U"1EU-@%7&WE
M.@."=5:$BI+)B.N-H8XR0YZF".LI4[D&XJP;L632GCV@3-8@8Q6.%GK
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M"UJ_+C=?Z70Y!;F]\Z*11U7;E)%$U
MFZUT%M41.]N10O6$O:K1?.\ZH5K1]J [[ZUY[PEEZSM<9U9ML/Z
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M)+:E<(W/7J3!. ;3D#;!=MI VQO3>N_*>CH4=VP:WK/
M&F'J0* .=M*$WVW2CJ[<7T>WHJ@L=A>UN*.>.Z&4R>9CJ0&L+2=$9<\LL#%4
M)HT/YHTX<#N'@P2]PD>E@&K.MH?1[,N"/*NDN:$U3:=[.4?PTOM* N#K1NBV
M1,8=BI*CH$FEA1,>J6X/;L]T;'NEEO>XYSF3NM7RH+5TT>_V+/J 1,)CP7/ 
MD*=[=VIE$IKQW&R@[)CQ#.2>M;QV^#YK6)T\V)RI>>P)U%)"%#15X?P3G16Q
M'R6_Q:7Z)XT]K-\SJBUK%36WT]N;C\"@6H7_7=G.;?@S=X,S^/>
MJZ4[M[U_ ,%[email protected]*%H-G)(>L[?(T/7OK=SC5ME-.VK>:9]/V[-V7O+4S4O>*1JZ\"7AK^UY1_-P #=O
MB'_8_;3O]-U4S$&G ]=,76**[?5:3*+75GM11L46(MEJPJX-X,H:G%]SU)#*
MX-+NP"Q4:[R6Q)'&O)%W0#1W#=OK-KYVR+VV&D[8E]:%1-N\3FIW70?C U0V
M2M"V&FUY#>G?U4=&_:;MM62&UX#3"7JU=S%MO/9A2Q+Y$\#J)NTW/7L<"3K14>*
MZ $  -D?   :              "  0X#  !X;"]?&UL4$L! A0#%     @ "C&K2&L&B/,^
M 0  :0,  !$              ( !6P@  &1O8U!R;W!S+V-O&UL4$L!
M A0#%     @ "C&K2)E&PO5#%.P0  $@1   /              "  9 2  !X;"]W;W)K8F]O:RYX
M;6Q02P$"% ,4    "  *,:M(<#[R&PO=V]R:W-H965T&UL4$L! A0#%     @ "C&K2/2[
M!B0V!   1!0  !@              ( !<1D  'AL+W=O&PO=V]R:W-H965T
M&UL4$L! A0#%     @ "C&K2,T'3P\L @  J 8  !@     
M         ( !G2,  'AL+W=O9T!  "Q P  
M&               @ %P*@  >&PO=V]R:W-H965T&UL4$L!
M A0#%     @ "C&K2(_<4>ZA 0  L0,  !@              ( !0RP  'AL
M+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ "C&K2!&PO=V]R:W-H
M965T&UL4$L!
M A0#%     @ "C&K2!-$V\R? 0  L0,  !D              ( !(3D  'AL
M+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ "C&K
M2/2@=WZ@ 0  L0,  !D              ( !"3\  'AL+W=O&PO=V]R:W-H965TUL $  !8$   9              "  0A#  !X;"]W;W)K
M&UL4$L! A0#%     @ "C&K2.?FTR"^ 0  >P0 
M !D              ( ![T0  'AL+W=O&PO=V]R:W-H965T9(  !X;"]W;W)K&UL4$L! A0#%     @ "C&K2&;8GO"O 0  %@0  !D             
M ( !R4H  'AL+W=O&PO=V]R:W-H965T
M&UL4$L! A0#
M%     @ "C&K2 J.>>C&!@  %C(  !D              ( !55$  'AL+W=O
M&PO=V]R:W-H965T&UL4$L! A0#%     @ "C&K2%,Z
M6@K0 0  S 0  !D              ( !E5\  'AL+W=O&PO=V]R:W-H965T D86 (  !,(   9              "  0EE  !X;"]W;W)K&UL4$L! A0#%     @ "C&K2#/C,X[B 0  4P4  !D 
M             ( !F&<  'AL+W=O&PO
M=V]R:W-H965T&UL4$L! A0#%     @ "C&K2!%!!3_+ 0  R 0  !D              ( !
MQVX  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%   
M  @ "C&K2*CUE^9' @  5P<  !D              ( !+G4  'AL+W=O&UL4$L! A0#%     @ "C&K2/Q)L?0$
M @  "P8  !D              ( ![GP  'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ "C&K2%<:BH9( P  \P\  !D     
M         ( !>H4  'AL+W=O&PO=V]R
M:W-H965T&UL
M4$L! A0#%     @ "C&K2+UF=(6J 0  M ,  !D              ( !!XX 
M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#%     @ 
M"C&K2/S<8PW< 0  I@0  !D              ( !U90  'AL+W=O&PO=V]R:W-H965T



/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em; 
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}







  3.4.0.3
  
  html
  169
  241
  1
  false
  53
  0
  false
  7
  
    
      false
      false
      R1.htm
      0001000 - Document - Document And Entity Information
      Sheet
      http://coolsculpting.com/role/DocumentAndEntityInformation
      Document And Entity Information
      Cover
      1
    
    
      false
      false
      R2.htm
      1001000 - Statement - Condensed Consolidated Balance Sheets
      Sheet
      http://coolsculpting.com/role/CondensedConsolidatedBalanceSheets
      Condensed Consolidated Balance Sheets
      Statements
      2
    
    
      false
      false
      R3.htm
      1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
      Sheet
      http://coolsculpting.com/role/CondensedConsolidatedBalanceSheetsParenthetical
      Condensed Consolidated Balance Sheets (Parenthetical)
      Statements
      3
    
    
      false
      false
      R4.htm
      1002000 - Statement - Condensed Consolidated Statements of Operations
      Sheet
      http://coolsculpting.com/role/CondensedConsolidatedStatementsOfOperations
      Condensed Consolidated Statements of Operations
      Statements
      4
    
    
      false
      false
      R5.htm
      1003000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)
      Sheet
      http://coolsculpting.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss
      Condensed Consolidated Statements of Comprehensive Income (Loss)
      Statements
      5
    
    
      false
      false
      R6.htm
      1004000 - Statement - Condensed Consolidated Statements of Cash Flows
      Sheet
      http://coolsculpting.com/role/CondensedConsolidatedStatementsOfCashFlows
      Condensed Consolidated Statements of Cash Flows
      Statements
      6
    
    
      false
      false
      R7.htm
      2101100 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies
      Sheet
      http://coolsculpting.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies
      Basis of Presentation and Summary of Significant Accounting Policies
      Notes
      7
    
    
      false
      false
      R8.htm
      2102100 - Disclosure - Fair Value of Financial Instruments
      Sheet
      http://coolsculpting.com/role/FairValueOfFinancialInstruments
      Fair Value of Financial Instruments
      Notes
      8
    
    
      false
      false
      R9.htm
      2103100 - Disclosure - Balance Sheet Components
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponents
      Balance Sheet Components
      Notes
      9
    
    
      false
      false
      R10.htm
      2104100 - Disclosure - Intangible Asset, Net
      Sheet
      http://coolsculpting.com/role/IntangibleAssetNet
      Intangible Asset, Net
      Notes
      10
    
    
      false
      false
      R11.htm
      2105100 - Disclosure - Related Party Transactions
      Sheet
      http://coolsculpting.com/role/RelatedPartyTransactions
      Related Party Transactions
      Notes
      11
    
    
      false
      false
      R12.htm
      2106100 - Disclosure - Commitments And Contingencies
      Sheet
      http://coolsculpting.com/role/CommitmentsAndContingencies
      Commitments And Contingencies
      Notes
      12
    
    
      false
      false
      R13.htm
      2107100 - Disclosure - Stock-Based Compensation Expense
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpense
      Stock-Based Compensation Expense
      Notes
      13
    
    
      false
      false
      R14.htm
      2108100 - Disclosure - Net Loss Per Share
      Sheet
      http://coolsculpting.com/role/NetLossPerShare
      Net Loss Per Share
      Notes
      14
    
    
      false
      false
      R15.htm
      2109100 - Disclosure - Income Taxes
      Sheet
      http://coolsculpting.com/role/IncomeTaxes
      Income Taxes
      Notes
      15
    
    
      false
      false
      R16.htm
      2110100 - Disclosure - Segment Information
      Sheet
      http://coolsculpting.com/role/SegmentInformation
      Segment Information
      Notes
      16
    
    
      false
      false
      R17.htm
      2201201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)
      Sheet
      http://coolsculpting.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies
      Basis of Presentation and Summary of Significant Accounting Policies (Policies)
      Policies
      http://coolsculpting.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies
      17
    
    
      false
      false
      R18.htm
      2302301 - Disclosure - Fair Value of Financial Instruments (Tables)
      Sheet
      http://coolsculpting.com/role/FairValueOfFinancialInstrumentsTables
      Fair Value of Financial Instruments (Tables)
      Tables
      http://coolsculpting.com/role/FairValueOfFinancialInstruments
      18
    
    
      false
      false
      R19.htm
      2303301 - Disclosure - Balance Sheet Components (Tables)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsTables
      Balance Sheet Components (Tables)
      Tables
      http://coolsculpting.com/role/BalanceSheetComponents
      19
    
    
      false
      false
      R20.htm
      2304301 - Disclosure - Intangible Asset, Net (Tables)
      Sheet
      http://coolsculpting.com/role/IntangibleAssetNetTables
      Intangible Asset, Net (Tables)
      Tables
      http://coolsculpting.com/role/IntangibleAssetNet
      20
    
    
      false
      false
      R21.htm
      2306301 - Disclosure - Commitments and Contingencies (Tables)
      Sheet
      http://coolsculpting.com/role/CommitmentsAndContingenciesTables
      Commitments and Contingencies (Tables)
      Tables
      21
    
    
      false
      false
      R22.htm
      2307301 - Disclosure - Stock-Based Compensation Expense (Tables)
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpenseTables
      Stock-Based Compensation Expense (Tables)
      Tables
      http://coolsculpting.com/role/StockBasedCompensationExpense
      22
    
    
      false
      false
      R23.htm
      2308301 - Disclosure - Net Loss Per Share (Tables)
      Sheet
      http://coolsculpting.com/role/NetLossPerShareTables
      Net Loss Per Share (Tables)
      Tables
      http://coolsculpting.com/role/NetLossPerShare
      23
    
    
      false
      false
      R24.htm
      2310301 - Disclosure - Segment Information (Tables)
      Sheet
      http://coolsculpting.com/role/SegmentInformationTables
      Segment Information (Tables)
      Tables
      http://coolsculpting.com/role/SegmentInformation
      24
    
    
      false
      false
      R25.htm
      2401402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Out of Period Adjustment (Details)
      Sheet
      http://coolsculpting.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesOutOfPeriodAdjustmentDetails
      Basis of Presentation and Summary of Significant Accounting Policies Out of Period Adjustment (Details)
      Details
      25
    
    
      false
      false
      R26.htm
      2401403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)
      Sheet
      http://coolsculpting.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails
      Basis of Presentation and Summary of Significant Accounting Policies (Details)
      Details
      http://coolsculpting.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies
      26
    
    
      false
      false
      R27.htm
      2402402 - Disclosure - Fair Value of Financial Instruments (Details)
      Sheet
      http://coolsculpting.com/role/FairValueOfFinancialInstrumentsDetails
      Fair Value of Financial Instruments (Details)
      Details
      http://coolsculpting.com/role/FairValueOfFinancialInstrumentsTables
      27
    
    
      false
      false
      R28.htm
      2403402 - Disclosure - Balance Sheet Components - Investments (Details)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsInvestmentsDetails
      Balance Sheet Components - Investments (Details)
      Details
      28
    
    
      false
      false
      R29.htm
      2403403 - Disclosure - Balance Sheet Components - Investments, Contractual Maturities (Details)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsInvestmentsContractualMaturitiesDetails
      Balance Sheet Components - Investments, Contractual Maturities (Details)
      Details
      29
    
    
      false
      false
      R30.htm
      2403404 - Disclosure - Balance Sheet Components - Inventory (Details)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsInventoryDetails
      Balance Sheet Components - Inventory (Details)
      Details
      30
    
    
      false
      false
      R31.htm
      2403405 - Disclosure - Balance Sheet Components - Property and Equipment, Net (Details)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsPropertyAndEquipmentNetDetails
      Balance Sheet Components - Property and Equipment, Net (Details)
      Details
      31
    
    
      false
      false
      R32.htm
      2403406 - Disclosure - Balance Sheet Components - Accrued Liabilities (Details)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsAccruedLiabilitiesDetails
      Balance Sheet Components - Accrued Liabilities (Details)
      Details
      32
    
    
      false
      false
      R33.htm
      2403407 - Disclosure - Balance Sheet Components - Deferred Revenue (Details)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsDeferredRevenueDetails
      Balance Sheet Components - Deferred Revenue (Details)
      Details
      33
    
    
      false
      false
      R34.htm
      2403408 - Disclosure - Balance Sheet Components - Product Warranty (Details)
      Sheet
      http://coolsculpting.com/role/BalanceSheetComponentsProductWarrantyDetails
      Balance Sheet Components - Product Warranty (Details)
      Details
      34
    
    
      false
      false
      R35.htm
      2404402 - Disclosure - Intangible Asset, Net (Details)
      Sheet
      http://coolsculpting.com/role/IntangibleAssetNetDetails
      Intangible Asset, Net (Details)
      Details
      http://coolsculpting.com/role/IntangibleAssetNetTables
      35
    
    
      false
      false
      R36.htm
      2404403 - Disclosure - Intangible Asset, Net - Intangible Asset, Net Comprises (Details)
      Sheet
      http://coolsculpting.com/role/IntangibleAssetNetIntangibleAssetNetComprisesDetails
      Intangible Asset, Net - Intangible Asset, Net Comprises (Details)
      Details
      36
    
    
      false
      false
      R37.htm
      2404404 - Disclosure - Intangible Asset, Net - Estimated Annual Future Amortization Expense (Details)
      Sheet
      http://coolsculpting.com/role/IntangibleAssetNetEstimatedAnnualFutureAmortizationExpenseDetails
      Intangible Asset, Net - Estimated Annual Future Amortization Expense (Details)
      Details
      37
    
    
      false
      false
      R38.htm
      2405401 - Disclosure - Related Party Transactions (Details)
      Sheet
      http://coolsculpting.com/role/RelatedPartyTransactionsDetails
      Related Party Transactions (Details)
      Details
      http://coolsculpting.com/role/RelatedPartyTransactions
      38
    
    
      false
      false
      R39.htm
      2406402 - Disclosure - Commitments and Contingencies - Operating Lease Obligations (Details)
      Sheet
      http://coolsculpting.com/role/CommitmentsAndContingenciesOperatingLeaseObligationsDetails
      Commitments and Contingencies - Operating Lease Obligations (Details)
      Details
      39
    
    
      false
      false
      R40.htm
      2406403 - Disclosure - Commitments and Contingencies - Capital Lease Obligations (Details)
      Sheet
      http://coolsculpting.com/role/CommitmentsAndContingenciesCapitalLeaseObligationsDetails
      Commitments and Contingencies - Capital Lease Obligations (Details)
      Details
      40
    
    
      false
      false
      R41.htm
      2406404 - Disclosure - Commitments and Contingencies - Purchase Commitments and Unrecognized Tax Benefits (Details)
      Sheet
      http://coolsculpting.com/role/CommitmentsAndContingenciesPurchaseCommitmentsAndUnrecognizedTaxBenefitsDetails
      Commitments and Contingencies - Purchase Commitments and Unrecognized Tax Benefits (Details)
      Details
      41
    
    
      false
      false
      R42.htm
      2406405 - Disclosure - Commitments And Contingencies - Separation Agreements (Details)
      Sheet
      http://coolsculpting.com/role/CommitmentsAndContingenciesSeparationAgreementsDetails
      Commitments And Contingencies - Separation Agreements (Details)
      Details
      42
    
    
      false
      false
      R43.htm
      2407402 - Disclosure - Stock-Based Compensation Expense - Stock Options Plan Activity (Details)
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpenseStockOptionsPlanActivityDetails
      Stock-Based Compensation Expense - Stock Options Plan Activity (Details)
      Details
      43
    
    
      false
      false
      R44.htm
      2407403 - Disclosure - Stock-Based Compensation Expense - Restricted Stock Units (Details)
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpenseRestrictedStockUnitsDetails
      Stock-Based Compensation Expense - Restricted Stock Units (Details)
      Details
      44
    
    
      false
      false
      R45.htm
      2407404 - Disclosure - Stock-Based Compensation Expense - Allocation of Stock Based Compensation Expense (Details)
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpenseAllocationOfStockBasedCompensationExpenseDetails
      Stock-Based Compensation Expense - Allocation of Stock Based Compensation Expense (Details)
      Details
      45
    
    
      false
      false
      R46.htm
      2407405 - Disclosure - Stock-Based Compensation Expense - Assumptions (Details)
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpenseAssumptionsDetails
      Stock-Based Compensation Expense - Assumptions (Details)
      Details
      46
    
    
      false
      false
      R47.htm
      2407406 - Disclosure - Stock-Based Compensation Expense - Employee Stock-Based Compensation (Details)
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpenseEmployeeStockBasedCompensationDetails
      Stock-Based Compensation Expense - Employee Stock-Based Compensation (Details)
      Details
      47
    
    
      false
      false
      R48.htm
      2407407 - Disclosure - Stock-Based Compensation Expense - Non-Employee Stock-Based Compensation (Details)
      Sheet
      http://coolsculpting.com/role/StockBasedCompensationExpenseNonEmployeeStockBasedCompensationDetails
      Stock-Based Compensation Expense - Non-Employee Stock-Based Compensation (Details)
      Details
      48
    
    
      false
      false
      R49.htm
      2408402 - Disclosure - Net Loss Per Share (Details)
      Sheet
      http://coolsculpting.com/role/NetLossPerShareDetails
      Net Loss Per Share (Details)
      Details
      http://coolsculpting.com/role/NetLossPerShareTables
      49
    
    
      false
      false
      R50.htm
      2408403 - Disclosure - Net Loss Per Share - Outstanding Shares of Potentially Dilutive Securities (Details)
      Sheet
      http://coolsculpting.com/role/NetLossPerShareOutstandingSharesOfPotentiallyDilutiveSecuritiesDetails
      Net Loss Per Share - Outstanding Shares of Potentially Dilutive Securities (Details)
      Details
      50
    
    
      false
      false
      R51.htm
      2409401 - Disclosure - Income Taxes (Details)
      Sheet
      http://coolsculpting.com/role/IncomeTaxesDetails
      Income Taxes (Details)
      Details
      http://coolsculpting.com/role/IncomeTaxes
      51
    
    
      false
      false
      R52.htm
      2410402 - Disclosure - Segment Information (Details)
      Sheet
      http://coolsculpting.com/role/SegmentInformationDetails
      Segment Information (Details)
      Details
      http://coolsculpting.com/role/SegmentInformationTables
      52
    
    
      false
      false
      All Reports
      Book
      All Reports
    
  
  
    zltq-20160331.xml
    zltq-20160331.xsd
    zltq-20160331_cal.xml
    zltq-20160331_def.xml
    zltq-20160331_lab.xml
    zltq-20160331_pre.xml
  
  
  
  true
  true







begin 644 0001628280-16-016132-xbrl.zip
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M8?PCU^A:$4XQOF9_O_P\&MW_\/WWZ:7OAL75=Y_Z7[XO7_R>
M($Q?(?R*XI?5V\:# 2"Y['WEJ^F-;/Z-UT6W_CWP0LWCQ=>KS_7/IU=JWM#M
M?2F&H_JW/+Y6@TUWV&<$R^F[_OKKK^\F[^P//L'CB'Y?/E&]X;;;^W/%T^GE
MCYUA43W>ZW2OAO4P35Y*(.%YD'K]7F]\5_\=UZ/!]Z.'^^)[>.@5/%4,NE?3
M]ZU_T_P;!L7-4DS$]_!J]>"P>U6/ KQ0@\!P=#]8\CR\4O.&\?#5IT[G?OJ>
MF\[PXP20\H4:9L,K@_YM,:Q]S^25^C[JP2T-QQU>E=3D?N:B>A?=/(TUEI_/WEU
M^NCPNNY!^%C\_?_]^:?W5Y^+N\ZWA[OK'WZU",U_;D?_GK[MJM^_'5Z-;^]'
M8"&_N^K?)7H+1(':/_[/__&W!-H/P\GGO"MN7DQ _>'S1$S3Q[RJ'OX.X'Y9
MOIS8]O>7P^[=_2U\Y_?I8QXMW56_-RJ^CEYT <7HTUM_Q7]\\.F+JD? #G='
M#^D7U6^ZU^EW-]UB\&("1S&'<27&[O7_>?DC KP9YI2*OWV_^.;)=WR_^"7E
M=]R##O:O9[\5*#88>7 '/R8PD_@A7+W]VVLS;RAZUS./4Y#6;]]V73U<_6KZ
M?=4O2LK4D^KUA%+DY\X#/T52/8K7J,2_!-
M,?Y5QE__^X3W'@XZD.8FCW[^%D'8\94$8M/*5^;_.KQ=]?P
MS5_O;[M7W1*_%]==>.0Q!RS1^&$=Q5[^6#U92[*_?5_[37N HB+X-P#64'P5
M*%.+](U(YVKCOD6(K=2W4G\HJ3]RL%\G];^..TD@'B!#^[D[!(A&1<+R=<]-
M2CNC/XK.('9[D.-U.[?OJY>']N&7SF@\*-[@]L+X8+NC:%YSTPM0.DF-.R=\44G6^PG)>&[8\[+W],
M[/GA$.S9DU[7,O>;1J_@[@5I<]/(#9B:2KY@DZ^*[I?.Q]NB=6/KW=@RJEV>
M)SOG^*V5_5;VS]GNEQ6\J2C:Y)ROBO>?BV+T4_]J0I0Y69TXZY_ZO4\?BL'=
MZ\G9V"1,6!#[V.D._MFY'1?V8?KC?X&8=097GQ]^@J#@=NY3I\^\[MV/1\/)
M WCA(W_N_'=_D/@X?'/CBX\CT[L._QX#M=\75^-!=]0MAO-:U1_<]X&MA>WW
MKK\](-I2&&7U?)0Y/I^U/68?>6GG?
M?^X/1D^NN&1GQ;T#NYRRD+<=H,@O?RYZ,:!TKZ+$H%=#R!^
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MD6:WUTDN16W;DZKGH[7M*=6%*.W^?&VKL:V??;Y-02?4$=*.U#Z5\O33A%L0]DVW=N'1(M?\2FZHG:IZ_-R1D?OB3AVVB=>(7IUSMYK]':Z.<=8%V"Z6_#J]8AG4IQK>TWNMR=CL=W3.=RT-LVJY[%
MF=+13X%/NGWV+-2]/<\]AU+!D4]/CR_)YW.?_E+.=LXFJ6H'7R=DSJ!A<=+IX/M?=3VF/3<_
M41?6#G=Y+C[JV ?CK<*>A\)>QF7F5F7;J]5[/1PX%]4X4 G]?$2@7?QRB?E#
M6[0^J^:'"XE*VMZ'-C+9N]*=BWH<2"XO2@3PY8G !K7X\Q&!$RDJ[*\!ZOGZ
M[K.H*)Q,\]/S=-HGHJ[MJN]GI+(G
N9!,L7HKAMK-PJ[>DH;7N9]AEI[2YO8USBL+>WGTYD1)(>[email protected] CMWB<_&UR_,XVF^CO--1V;9F
M>3XM6>V\O'.M\EWTO+PS<4J7$$FV+JF-(D\I_6N[SIY9!MAVGCV)^O)?V;[4
MMU6*/3*;O\+DE)G==M\?VZB>6[_[\25Z>8SZ?$2O61Q^$4S>UUE;*S('/D9[
M3O+[=M"'3Q@]O 6N5(2X3S#;AT2A!;F#KQ^,KQ++7O?@G9\&Q?#,+-8&^,[R
M?3G"E\?^#_W^[= GY>A=_]R_/;?BZE:<7X+KY3']G\7G[M7MN87$6_%Z'L7S
M9?%LY6L;%O\$07CQ&83\]=W]H/^E.,,X="M^K\#W?.LF39D/H%0,WO=O
M1G]U!L7K'@#SJ?OQMC##87%FQP);.O<-,+\\@6@-_MFPN'DL[,7X[N^;*^:8#7LOZLPSO_J/5_?/#S!\5N/!SU[XK!
MXYGP?VY'__[7Z]YU=U!WG5O7'_=&@[/KF\FI^?+'A-P/
M]>3O7,K+*;[+F?ETN@/Z,1AY@*PTG!C^FW[B]+69-Q2]
MZYG'9^UL]BY[44>+IM20G9"NC>W,(.7%;CW!$
MC["=K+F3E?9C]]DI)EH.6HVR5R3^CF*E&0M\5M_"9UV\!DHS"OP KJ/M;3B1
MWH:3'.32G1?NM?CSOPLCI\[OTIQ3U9NV79R*UY1M#>Y+<4V%A\)?_6_QSV*6O%MQ7;R]GT)REQX]KIWU;\KICI=?T36.;OK@RO0FC%5G0/<&3RY
MG+R! +PKAD4:I0?:Y=.HO/Y$=<+7>R![\0P%8P-\+TA@1"LPYR,PIY$";BTP
M_RAZQ0#"N=ZUN;[K]E+)%![Z4CQ?D=D(XPL2F@9NR?6'HS%>DMJ^K47$](=KDQM>[][\]"S%8B5MK#6;Z[\/=_6W_
MH2AJ*38."
M8[N#Q2;65@(.( %/WWQ>"F/[A+=Q=M9UCZOC?WDQL!D#35.<6S
M9O?$Y3=&^D)LP5J'T(:&AP\-3T$H-@H-V\3Q>8>+FT4*;8)PTI'!2DUN(X-3
MC0R.K?O-1.;,CRM#1[?=3[>%N^*+T5O?&;7
M,U?[_[*I2BV6QU76(?E@E$]
M\4M_,/IL[N";KCK/1B*J1W+D6AO1BL)A1>&LK$+K+B[+1FPL&%<3$CW\Z[?W
MST "2F1^^.W]!;%Z8W?0LOK,S/VXUWWD\WAX/\^Q]O.IQ>E1KTK;N8Z&E\^&D\0O5<124ZM\]9['9PF
M$F/C) ^!!$F8"2]_O.G<#D$3L@^OOM&-!X/TJ^X0;-,?16<0'E5]@R\W*G*L
MC&)((J.\T!KQQR^/2!'M7O[XJNK47_5-%22^?S6^FS[P=F)>(OQNN $H/!(7
MG!7,1!9Q]"):,@&%DA $X2]__+6$8NFWU(.1X-P4"*^U]$Q'PWER*4K**3TD
MQ&/[email protected]'6=N^])L6P4C=
MQAM\NP5B2^&]8XQ8*2T.IB1 ((01\_)'C%[].O^]Z:.KKPL3G^;@MX/.[>O>
M=?'U_Q0/&WPO0XA1AT00G&+#&>$^5EA+3/F\HU_Z30M@]._N^KW)P=W$/ W?
MC$?I3L)UMS>OF8^W1\C/G0?^\L5U<=6] Y6#7_\29T&,C+F O2:.**=C$$B4
MI.'<"_/R13(#D\^K+#C5C',D]1S$*X":!S]V;XN! UY^Z@\VH:''P3/F*5;"
M8R5)] &7-#2!*O+RQY\Z@T_%"W-U5=PFXUE89U8:=XMA+:WW
MN %ZE@)\E@*.\$ ]9C(&1I06R+!2%XAQQ&*)+998HI$8VAG0X33[/GFY'704B M+?@CKGB@H;@
M2H7@TG.;F3E>XT>6@M(1& N=P'Y[:!_
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M6$C&JFH_8\[13#34.>&_;N?74J)@ ?&\QQ#1*QDA(Q&Z,B409;JL"( YQ\T^<"U5L@E%P*J]:\\5*W<'(LY>U@":1QV78P(C%/,O^""7G0X;=/([VSBI+#(_1*8NIJ J?!#(T;3,-@G!*
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M[%?/K4SC&AF-O4'2>>C"J4[V3)-#9^D75&<(X)02S&13W ?AA*'$*@S.6
M<()HHP-WAFA*+<^ZE-2[]7X08%-;E
MT0 76$5:M_S8>43<$IX@D'9* C?2FQB1(W+:\43 +.L:GF"F%6%G
MR),3&3JUS%093:C&PJL(9DH2T!!:F2H)(4H-)U#+@Z>P4Y$AB)FCDHHH3"CV
M%)>=3RQZ:F0-)\"_2(1DRX\GLU.>IW,K!$D8>&[JH_[&$^UJ>8(I8U2?)T_^
M6!Y<>D&8)Y(1J9D+#$RQ#-,>5<@#ZH)+D&.&GC2JJ5*> 355.2$(5@M)NZSW[X%6*O(Q"@S:G()
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MF@I'F?RZ*^K.T2IP_%X&[FPL7
M-[AB*+_XQ?1"G7\I0B> ]A,8S9DU-O_='Z3SK^&;&U]\K+IY1P]+QI:-!FYEP(%"T&X
MUCS-6$%5:)KN_66],%I>)G_H$80E@?1J*3T8&=DB(;C2'D94&%FN,D;]=
MQY15AQ/I=O3SB($.I-Y1.ZG3=#R/,6@')BX:EXW,I'X
M;.Y--H2@Y=M3Q0)1Z1@AST&<,?119[B)N)I=$[T!BF2I?CM4 GW%BV 4L.(;5_1W=[+HJ%4:(I>&''HR 8M[%4/8  545
MRZ^-G%TT>@)ABD),2VXY,X&Z0*3U055'&3J:;,KS)1"Y26!AC Z6FV @4/<,
M?DS[<\IN3\ECUA9UA@6' \4")BAL(:>)5C(O@TGC!ZM80/E\DKU?=$*4T,JZ#B=1;%0T)1%='=Y*+NJ4L
MY #@[JNW9?F)91+UX+S5EFGCF4J;]ZG#+6IW1&UJCF(K"W
MU!AGN(;(@_-8+91"R$M5
M:#ES, ^N(3@WE 4&G,%"@R>J-@DB%OR!3_Q/E#7'.&)&5' "V:=@2@AC G:T
M.G1B)IPBIK+=K1
M#EH@?U$FIFW"6-F %)6ZFNV)O$/99866,X<+SZ+WR7!92Y$CS"I23<&@/L1\
M',_9L>8@L520G"-BE68J&*.,BJ'R",B$['CW/+/# ]5.%>$\BF5 9K81P!H<+5W'F$I
MT%F*X4GQ9/]'@0@B9J919%)9C1TCD(N6U6A*97YDT++L(+>:>-KH3:*6A"I"
MHW:VNO5+J#*'L(H,=((BRR,#0Z:J+8S$Q1,N YP)
M3_8?!J2[S4HKJ25P#EP-PZKL-0]IUOP)G]Z<"\N:A &*6)R6_,8H@V'&2LRJ
MZX&8Q?SLAFI\@9G.D8X'L.-@SP(+7LNT18=J(:KV%81I9N7DX@[OEC=/TP3E
MF&-:BA!5$-P00\HU)\0S$?(UT9?&DF, ())Q@Q&AUU.F06ST1
MO.7)42("<#D8Q30O'ISI%.UWB,6B$43? !:Z*^^9S@D=0M6PX?!CAD0XC68(=W0";G6)"3D9K)2!DA!=
M! <*L4]9)V2:Y5/ +XET>SFT,$&Z2)6.VJ0;=-2QJDM;6WKFAQ8'&M)J-4UG
M[YQ[YCUGEM-2NP-0EV;'[V=86CC8 &8F"7@;;RDG,5J&4=63KC .SZ .<(@A
M)!:2#4^")0S^%3B2\F2%1(,]?+6[Z@^)#Y^MQ5DMISG5DJ4>8B1@-B;J:HT<01:OW'.Z*\?F0[Z!Q$04N
M.!$D5DX9QBT$_64*AK5BOF7)40[,!4>$$F:QQ9%C(A2AU;5QI'&SP2LM4W9T
MC0J"78H)D@$KIKR"/URUI17XTRP':[FRBY]5RAI+@S<>84V0E^6X7#!>X%DN
MAB,-V@Z-4(YX*BWU45O'G3'3BU1&RV8%T6=%NL,>*6AGE(8$VS,=4D-VC-4U
M:D)"OM:Q9<=3%3N"U2X0GQH_L>X595C
M.62G%5/,>:Y<:9 &1QVXD. ]"1B<@'A TSUJ42*?
MSW%_OC)](IFP4-%J9+FU.@8L>$35BD"*?=,YNBT[ML^$.69!*ZJI!4], D^3
M3$M&4&-4LRZ@EA'-_2]CUEJ65F@J[I'UW)=MIY0HL%Y9WM7:J@/X7A1#L,(;
M'$$MI V6L142TU#=33Z+1W
ML>**-22;;]VRY!"MZ]%$H4@@[email protected]"*SZ&C3I> M7W9TR-%@9#2G
M ;MHG(\(@MBJH*=*Q!*5@@C&B+.4/3K@FLN6W69]LRHGE49 )QR&OJ+?8,L@A#
M8EF\(YQCDV7#&W?AMTS9(20RD,WQ@, Z"6.1IYPQ5'%%XMR%/..0Z#3*%,X:
M00WC*D2FK$&(BO+ AA+BT;Z;[P[)C4.;H0@T(1HRKS4I&RBPDI3R<5%B(J*B'#4FF.)X\A?NMC<32[U=_:
MJD.:%75.'&P*#\ZH4QO?"P_B]VI
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M)'8]G9266^4%=1X1Y9#A47%3T9CR4'/DSOG&%P.>,8TWIF\ DD:'199%3^>;3J%XZXFT8N2D%IH#]FU,XR**)"K&K0\
MD3P_L-EXQ>@SI7$C-TN%U89CK C3U =F("*OZFA$XIKEH\?S *= Y::>U@]APHW"#GH\$0I8D'&C@IL%:.1<,;2LLH
MZSKWW5'G]B< LGCS\;;[:4*6H1L/!H!^;=Z\8ELZ@3Q44F4HP=[%*%$9_;$@
M2#[['I-YW5L-RRY0KTI'K4$Z%3 E0Y!^&>&#*>VQW'Q6NJGW#F$?$%J4S<:(5G(RLETX21D[Y!.S>';
M01\"I-'#6[#$E>V\3W;6/B2CNAA5W8]'Q6#ZS+KS"289X2#\:4L4TR2Z2AVH
M,-%G$Q>>%NM5PD^9U=1(3M(,N6 B9,%A>BI*4799[,DA/0A_B#82202XX&"8
M)Q;':HJ/AJPB,U>[8CV<]?>/S]N'B?]VMYWA\)=B2W.K@C&.(VFL0H%KKZPL
M+Q9P!)%/)E_ W:7PKX=MGUBMDD4I#,,$@6O0QD#D'+$KM2;UH>B:YD#\%%C%
M\6@\*'[N]KIWX[NWG8=)[.7'Q9:N7'!N(;ORP1O'P 0:5+)($$MQSB*VW$0O
M!6EK'%[W/OS5_Z/H#+8T$VG)7?+KWO%@&80HS)5QMF!I2FCF(]D*UJP';CN\
M7@,B PB2JYU3KWO5*ULBR:RRA A'A?(HXJA0%7T)@?.MLGI+%)?#N1V^;^%#
MX,_) KXW-R#*"Z]O>03"L+72$ZRU#(I")*?*2%E@KUV6IA*Z+6O7P;L=]N^*
MNTZW=UT,WMS$[O"J[?-@!OKY@!X_Y8@1F(J0:$4* V)4G:.U;6 :6UQ&8'
M5$^$V4\%^)1BM9.9:;KUQ?V@>$SSM_/T8(%H$,A82O1D/UNTUS
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MJ\7=1.37_C!EB\YI0\J=)KG)8TM"N\!)!+^D&%(F5;.L0M.%8DBMFNQT3$(_-54TR;T@8UKT!S"?!8X?')/13:WL40FD'A&$0O::)@JI]JW1Z7OCB
M\<^M2S)>!TZI5&"Y0*<@-8*DJ#IFC)9G)V&O*->;.(QZ\/:'UIIZ3/"!20=9
MAJ!*"65HK(ZZA(L&9P=(KPA!>T*K?W?7?>R,2&\'N"$;*7I7W;I]Z9-,;Z:(
MQ 11QH8H0Q0>8RNJ\Q..G%KTW2^^#KL_]+JW?W\Y&HR+ER^^;PS&)%7[)A+6
MFJ@"T>^]'_6O_GS;&;P93*I:UQ-A!U*^_]Q9
M$B[-,O;U+W&62,;8M#L)WQ
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M8DFTI9"R52MK!4-19K7M[0"['Q2?B]ZP^Z5X/-3YI1B]N)
M1H=@G**@79I48S1UYO52/",Q681T&32-@5X3A %6&@(8'94F'$&\3)BOU@%C
MKK+3D5<8$9S1=S.H>U<0Z@PFIR'ONL,_P?>E7W0^%7@9K6?:=!;>;!\L1$J?
M[R OF,L6S-55?SPY1[TJ("#\>%LL)&4UGY0W!8V'(\!BD#V;YQYD+O4 XH M
M4L)JB XFHR)E"AFTC!"ZS_JMWGCR01 IX#E*+B?1X4F9>F^!CE^*WC@Q]'!T
MA+1&JS3+A(8(YAUQRP3046-,HN!S\Y5GZ(B;T'$([[MP!LC4Y++M*<'4N#Q)X8L-W./0(6X 66
M=S K0O0> 9OR_]=Q!W*:FW36\W-W.*Q.RU_WRK;BU-L0N[U.+]TZF1ZF#^W#
M+YW4&O'F)@P&_<%$I/YS._IWNDTQ**Y2EF2N_WO\V-L^ZE>97H*M7\'V>V
F^7HX?H
M";'(T\1JRJNL)A+!L[J!6K@OMP&JH1J=)UQJFAJV;4K@%E)ZC7V!$'68RS;%)CDEQ&YZK%],)"4IF=
M4[R2"ZT3#6 OI3O50^!OW;J6M)5-+X@X"/^PYX1PYYGR+%V)$"2-Z<#L^F]%R\Q%Y$)%26"<%%(R56E7-&0?$0>$:L K;\SL@6LJSN2)0J0
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MI4K%8#GQ:2P?IAJB=C&]CL8TH\O. EZA[Y#XAL4:J'9"(&? + (>7$A*
MC4KC8SRMYDQ 'K*HAG,($-X,@9L;R-8@B_MZ];G3^U2\@X3I3:_^T&YKG=!@
M_[QAED"RS;&@H,#5H:CU/)\C]8HN7+[5
M>6;S1&%Q;FYCI.[N;_L/1?&NF/0MS_B$9G>HO4NS4B'^0BYU,W);#:9-]\+S
MF2:8*34?AZT%:$?H5T:1/D;/!#PDE03(5:Q& PAP6#JS5)HOBE83X-\7@R_=
MU%3^J%3IDOM=RI8FA@W<=C")I*$O?WQ+_L#XYYQ2AT'^Q,C^QUJR3X%,Y,_(G8X/&,2P!/R1
M2P4D1DN/BB(/FB1R/V]:?_NDQS=-"GL?P/*]N9_(1H>B]LH)'<*G%3",:J73E%JOI9Q0
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M.4+U\.P(_"IF> ?_.^1863Z5AK.5XP$V@V@?.*R[Q2B)#SXZS!6Q
MAAH/:5W5VA=9=B'PQU<+L4D#1(I>,>CNGB$JZ6B@3/0N:*%%UPOVL V@GV=>>ET3IAO(@^W;2B$8FJJ8 R%7AF
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M#>GFOV=&*P]_&+5]B3V&J4+LC8!FZ[.
MJ%C-19-1ZGPN&N5Z$?"U4.V.Q=JCI,@@0Y4!(X\B2J,9JA8=@Q7-(J]D@/:+
MQ$([[=9\"$1"NAV8D"!',:)$_JI-(^C\XA)'= T&"Q#M"/XZV^08@ ^R3J)"
[email protected]!Y"/2D5S'@:W@3WLU>J/^H,GIJ^+.0+PK015\E-%'8\I*!P,[
MDZ^2)GCA='HE.#O O8;F@H,1= $1#0%"C *;Z@HN8\&C_&XPQ)+[@OOMH+CO
M=*\K'E75J][UI*GA,8'3^A3QWD#&%3EB3%?33A5XQPPICO0B4NM!VAV%E34C@A0VV-@8
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M="E NX*_HFG;P?_[H#LJ?/^O[>\"
M188@%G.1IMT+:;X==M6]!R4DRX^QLT1U$81M 5P7*A+"P(4AQ:@G$#5&X:O+
M@EA9F5\67"(0]? -A^-T:?O-S:2;$F*.\MQ]F);%/79L#M^D.>S=N\V"0CX7
MG0MDC<':"LV)EBZ2ZJ#9.YJ/KLR"\VV@FT5KYH; EA=EA#=A(A9E< ['W&^=TX2II:R?1O@&W7R!2N,%<%XY03F
M'OY%U?&^C6 @,I&@BY,O5M^@V?6^3P0C*BSAQ(E O9=*ET$BB"R"A#V#CXN%
MQHN-X3OBS.\5XQJE$2 VJ>.+)N3MS I&*_(@N1[Q-1-2MR7"T\SF74X$QBB-
MBFLW22!-E-17*:741JV:IKL%$?+=ZUN:+<^CE])09"4)2D.,4L5;EB*5[["9
M+/F8A36'8&L 5^F22-1CG E0>[L8E;SG3*FA-K4)62ST]
MK!;.0KB93RE:F'^P.6S[PF@[email protected].@CT-[4K8\UI/S5I4EN>'XO7K/-Q*X9
M1M.I6+MH4F R0H8"850TD%^10"I3&@5QF9%ZA=5";6MSX/:%TKKF82UIB.FZ
MGU92,Y)FTU:S,3$*^6Q'C1::)!JC].T<=?N)E$SI0() #IP[1S9&Z
M7*/_>&$0W-SW;P'8NL8#%SP$>6!ME-:>)%M;#5- 4MM,YE_IR?7PO0'63JBK
M3X EI)!(0G KG<7@OKWQ7BL"44=()U%98O%J\?+DJZ,SS#'PS:::IJ:\07.S@!^_!/S #(Q+09D%."/^
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MK>%K@-P'<$1%)UWI$VFL?1(A+1E556*ATA-I^_"6-2MP=L6MSW<
M(I-22*M\-.!Z"+A,845E7$0P,:^*JV71S"[[N1<^Y!V\:B]D0 *5F5*ZX
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M3^BWBX;?%FT.ND-XR<-?>Y\>Q_@UMB8J6,.6T$&1-8FJI)"-;6$ZY-"; 5
M!F;#KA/%_$IQVFA "62TNE&4L$BRJ,5*6KH6PM'4VA7
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M4A'MP9%X(P*V&%*3:@B'T*%[email protected]/,L9[A+P%UT(CLBA-O"R7
M*OF:TW;)Z@5V:Z#G9HQ DKG#!!?AD1'IZ@?X1V]ET-51/ =G7K,92-7;XO6@
M[0NA=6?BDEEI&;4Z39'VJ<<251=T1<3Y%0!&V#XP&I3QXC[7L >!*<.0D&(P
M@)X:ZLLJ+)5<>[^@YW/KRV?:)38#;1_(K%X*3H.C7FB-+(>;;PKZ2 =A"
M4L\%PH )2#2+U=#J[8>BI@&V^F)U[1T,:1^ZH#C@8::8)
M'>2BJ&[!^1J(ERPWWQKLE80FS'(NHY>".D^E$DI-\U#X%7LBL!NL91=1,Q>D
M1),+EE;QJ$,5UT:>C^=:"F:V_'PCT%8F\YA*8#+$AUQ 'J\)A-[5$#JK:!9(
M;@5:&C%[email protected]!!?-+P *(:F@((P9^G2]6DA(OFJYU(.V,P[email protected](O1(D
M5BOL-+?YX>7";M%MH:\/&QM,NN2:&:.H<0Q9"&N1-Z1JM\;&JKPS @F^*#JK
MH-D1[FDZN_2]=;OE(:\>$HY3,# =MA"QSE?NZ<5ZXLG1(8X'
M /)XD&Q\['Y-/ZVC@G(N8C89&!\(Y%F1H.K6/N3V(J."YHN!_:D18=(ZE"I2
MK^_N!_TOCZWB:ZA J%(>@ECJ+ [8$[#NU3XO!2J2WRX3BW6DDR/#AW[_=N@?
MKWG_#-181P+@JS/&INT(U C$-)[>WT?:B>RL@Y*% 1.G1X)_%I^[5[?K52 (
ME18_^C0%4AAN(,4M3V6%KUD=1@]E!E:&X%Q@JX5*TXV00I&2$"HKCI3/CUR@[!2":JNYA>ZGQF[-[QWGHPG2((@D_&+,%:4:D]8]4M>L^]RSR[T&)#
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M'*GFK#H%Y%'45(WF;=(6H.T-HW5K';$'9*3!V$1DK&1A.@U=<)A<)L598PDP@+.V_+AL4.7(\OUUG"QBL0UP>\5KY8U*&\%[
M.1_30$P7 A=5WRL7TJ.\U7(AK]X)KU&GVRNN0P?RG=ZGV3V-OKCI7BWNS5@[
M@Q ID62+04I,O.,.Z>KHAHG \\DF$,H0L8#-.I!V16#E]C5M$$W'K! TI6MS
M:>9)B0#%BN7;=K7F>C<$)H,QTF%5V>?WMC-8.@]J-M*8>7SV-M/0/LR^\FU,
MAT]+E](=E_Y@3>>BL&F/LH.D7J)T5XUQ7DU^<4+6G8&B13NW!*F&F(M#80Z9
M"C&2R\C!2V&N ZZ.'B%3"2ZK3"\&-!LAGC:0#7'K4N;G>6!
M6B,T!#E2D)C&YCRBI<%AY3$/Q$3D\&B]?QBFE4EKD&&"&&LLL8("=YB)=GK0
MHU7$65I)!%Z8H+='9*8S<_Y1]#\-.O>0RW<>9WE.-N(,'O[UV_OE=^,9DXJ 
M/:0^QHB)1]7UU30NG^0K/.CB?)R#8%(]\4M_,/IL[@IPB)UU=4L(TFJL3J38B:QN23E9B+,/@ME$ZB8;$GJ3 +=SZR98"[I'!,53&0ICN40, @P+\1^EDZ[H;E=,%VX;ZQ>W-:S _@]0E5NZ2V*X(9F+JQP21#P;"9J&(2]6-Y/@]H9 &
MY4?#BZ2K 6%[$%<5PCC64AL#'!88$4ZLA@0:0#0(DC)7TY6IM@\GAR7/]8E4Y?OA\^=WIO[23(:^X.;HCM*TX7#A1:,\AS:+.I5"P:JPQ#KBX[,X5
MH=^Q0_)K(\(=AI63[QTNUZR%Y&J>69,X*=S=W_8?BJ*68\-Q3<2T<%$.DY@L
M*=A1H2BW*1(L;1,68FZJ[U2_>"IL'()A\^0Y#9:()V=), $27LJQT11;#7%9
M>86'>,G-W/;4*4NDYN(@.G2B+'DR_Y/""^-EQ#H(FW8G081<^A_G'*^[@WE)
MS&C@@)["ILVZ(ZETRI:J:9+;R+B>ID;HO@[S0_/M9/T1,WBBB=E
MJV 8DF8F;>!2!Y16]U8M)-:&Q=/%F>B"?">/H(S/B*U/%"ZF2W$,4EF35QA$B'I7)>F[0?&*6%Q]/Y#%@OS8BQ_@X=Q,1M
M3K/3Y^$>=6V.AXH%QQ2%?)@2+2UWK%KWJ/)
MLC7CO<42IX6%$8*(M(ZJK&908SFIF]Z2]HJ@@[BH><*,G4&:^>(BUH:
M1KBECE%1;9$P'N&Z@($B)2B[#&:<5##.C>&89X7!\]PA'.L]*M/7=M)BQ=_T.OK6AC:ORX0F;'M%<6QJD
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M6K# &3&ZK(L03:[I%B2U Y#KE6CM_TF'(10$%-5"R-
M(9"^&L8-*NO7\];X[>+P+NBZ!7T$ZAP2G'DX(/LP$,L)< SZ+@^.)H?P\/:;
M_N N-4!/OJFN6K2VRAJC589JPY P1@?K55K3%&F:G"!0W=AIMB=O?T*T7MGP
ML),L.Z11!(='A38DL(A=%4]Q9'3M#'**""'BV1%XI6L#K0Z.8 Y2!Z0)V/AJ
M^CG#6E)Q461Z:IW__]E[TR:WC21A^//NKT!H[+4WZ%__9%8!('@UCP9(@,S9\*I)XJC*ROML]7OM?G_0
MU[M#0^NJW5%/PQ)JHZ=V.IW54.8UT'S>>6U'\H.5M&JP38=:LXG1K&:SU1H.
M.ZVDRVA7-YH[@\C&O9:'7^""V3!GR4U[Q=&TU%[3Z'7[S88VTMLJT$62\=Y0
M]8TN"RLI3'H>EMSECR8SQN"%A*3=;&4TU$'7&9-,R-'
MY># G94"F&LXN)( TVQK:AO,*V. Z4N]?K.K)KZJ47LXW 5,X[Z11R3_ L 4
MC-^S[(EMBEL^N*8O;L!*Y.63^EZPZLB2HD8?\;'>O/N?R*VKF]7.7TSN,F#3
MJZ(G_A)G>YLLB/OG+1MWVJ'#?YU\@-T_V5:T5@#^D;E,[F=/4YA15\<&6L-1
ML]]KZ8UZM]/0V@V]VP"F@AW ]E?XG@&@%SW ;'"/R6UNSU>MI&U^F-TN4;@;V^M4? ):FFWP9C?-1O]8=:NST:PL$8XN"&
M#;TU4C>:2&TT@RC;P05[.&W"3XMQFM8[:K??!YUYU&CWM7J_J2:261NTUV?B
M+(5)\[YUC$*3ZQYSA>Z+NOJK0-MO#35L+M'JUD?8N*XW3+HCXH .8R=HCS5&
M\MOA!F#'^\ED?$S& ';7U/*/W6=:?8U4==A"/UVKU=<'!O"'=J-;;_6Q!4$=
MV_@V_MWYJ*N#-?@6LM%+@?.U$?FE7]EHC.K#3J_5PN9B?;W7:;<%.'O-NCIJ
M-"\,SN 3LRT0-B49WKUF)PX&]2[.J1KV.MV>UFMTVTD"9]8/I"(SDK760.\:0TUO#-&],&@WDTD7]5'7:&\+NVN:WFRL&X6O I+G
MAXA?.T=![^M-JF$W-*W5-48&2M/AL#P,]$ZCJW=5K:>V.J-.TN(6;([^1OO11JM5/VZ): NBDB3;EOT?0X(/
M%UW3]$'3VUQLXP6 =@>]YA 4$:VWFEI_1@-U*ZFC39!O.Z.+W#5NV'=;M0'AM;N:@V]
MUP-R-_JMV-^G]MK-S1Y#.(/D/*M^"9U!-^T,.R/@!2"3>FJCI\9>2GTTZ -[
MV#(312]DV2<-,U4-D R#3J-5[S0'K4$;^^\G@^-[_ZP*S3.6.-9KV^;2K-,2=P]":2N>W'=\3'A/%&I]?L#52@
MTA[&RV,"Z'0-;7-^X+HY>="R\MC(GJ96]5%/[?; @-.&@V9;Q1;9PX22@=5L
M3LAJ:/
M7N3&%E$!Y'[email protected]:VG#8'0Z,#MH\HYZF]9/$XU9[9&S.D-0;]?7N9J?3Z[='G88Q[((V5#<:1K+ @=[0-J;#:1HLO'7, J/YW(D=6[^Y
M7-B)PG#C+I^ 7O^%H^L V>F#1-SH=S3"P7S2.^6CHG;[6
M'6'"TUZWW[&[RH($[ JT,1:89WJ2R&_5>R!EAH;1[O;@N/KZJ)O4B37JH\WY
M!?7VVJ2,+2LX>H$O:E3=-FHCHQ;8^R,P6_K#@9Z45 U@T5LF;+6/6>!OKL]-
M[]'%_&^X]$74>6'P3A]4_>:PT6RIHT:W-6C&G83T4:/7'6TV:%[O&+YC%0C,.7WSB+G-".;0M*080G'>=5^[;3%MO&@-#;PU'P' &=:.C#1.3#/X9
M;-#Q.D*_8J'9_:[Y V4\>6 [$=KR@N5F(GU=Z_=(&G^'2',U>W2CMM&L=_OU
M=E.O-YL@RI/^&+#U9GM;VG-FKRX([,"6T1P-FL"FC&1F
MI3[2NNW1A?;YZV370XX]1\#8?A_$HG!YJ(.V9O22&1$@D49;<_P,^#\UF]E[
MY!ISW=[+QZ?K[8[:ZC;Z:JO1 "8]ZJ<+0)/G(8P\1V.>P!P)H.*HW@0$U@(W&OLEANPMJ]VL.<<]2B]CLRTDHZ\UPEG*S7JK,^JVNFJG;Z0S0EL:R/O8>I[T6/TY']Q%][DG5-UT:@AX$=TA\9/2QJZ<>[;(/&L*$R&O&<
MEQP6>M)^3SQ,;&4^Z#<'O8$*UJ*.P7P]/4]3E8
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M )"H7[THL%T>!%TSM)\.WM4JN?= YU757G/8 )VO!Q0$4B?>5D,=KO
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MS4:]TVSVM/IPE.A1]>% WPC1ZT8CQVWNF$,=YV#@P0=!HKH3*PR<$D;]8[O8:N&\U>5VWBG,'A<&#T1[T-'U$R/?OP)2TW
ML"]]>;PC?3G3%E6F+* G !1H;R+S[_%[RWY2@G#A\!_?3."1=Q,VLYW%
MNP=[!JKW+_Q9^>R!*?E>_!;8?_%WFCH/W[_YK\?P_=KM#IC&=U,127FGZ>JW
M[W%]=\RQ']UW&,JT)XN=C\'OMRW#=J? @<+U^^1'O/R='<(;3/G-LWSYV',L
M^6CIE_?!PAR/ 9\WP]X??+R'V 3E]U/>M_85TR',Q]PSW/YFQ_2)99P
MO0]3KC# TMF6#:]XK;^&C\J8OG__F>P4("TB311:.@+Q7X/4!
M/^F=4_;$E3'GKC+W^1P>:\%CQ%9\"U.$E&<[G"J/W.4^ S>D+&&\8KA5W.*+$"%>93F3! ATG>77F1O'N
MB>>%<"FLQ.=_1C8";[P0^Q-O1G1P>,BW0EX]%F]0[J1^#G@IA %2^C6M9J".O!K5R >OPOEQLP12!1,.0^59Q: )/+M
M)T1&WYO)\Y>:8L(K0BM7HM6N&R3!5-E
MXGC/A%*$4J]=M=3]$]TGD8>$5V7"*U#=T,9(=#:X 0[,$OUP0+;$YD9R=,)"
MF;$%J*4*CQLYI.>Y #4=X8M*X<7MO9S  UO#[8&^JGB8Q*),(J'M,M?%"N>,
MV3T77O/[S9V7Q#BIHC&5M7)C(]B2M@M8/O^,F ^@!WS]S.>>'Z)Q-(++%4V]
M^R=8XE[D6(BG/F?B)C!0?H]<$?20SAZ),X:NJ^^7)6O)EUK[?: ,[,",A*M%
M\-^NRYQ%[%PU-]F6P<#>T0TE@> ]\X22?\96@
MT &.!4IW[$6A(E,1%,P]3!^BO4_]2OVLQ;=)-Q!PIWD3Q)HHW7<$95=.+2_$F0BN*-Q%*E1^E*-Y4?KRB>!/%F\JX
M7HHW4;RIA!Z@VR1PAT]VO_3(QMH+(1@"!\\]@?9@$45;05A$5)K%# (ZS/[7DZ]OH#C5VVA%Y[*NHA?#+!2+6UM&02/QP>[R/8
M ?%FO0#?EF9C)/M,(9VL(09Q]IKL.7^W(ZCN\Z53A>%I!!BQQ\@W4CG0@BLT
MJB S%>0[ALV((@R4K
MTJR7H! LTUDDMVU+*=JAQ#V)]NF9I7 G,8#GLG55ZIM US=<$WKP:BG:1!N3A&-3\*))\$?FI&B3-@
M*M.EEDM=W6(L-1CV-()5KUYJ+T>'UO#IN#('I$<@?PQ!%-CXYEK"E$.<*20C
M_TL,R!P[)HZ&D4CXDH$-4\15+!OPSD_DJ8>^@>1PB+'?WGH/%40KW=N%D>MS
MRXZ#6^7;5M6.0=S7S26%\@S>^UP>XWHY^073V7F@SI@E+CU,<9I[/I0ZL
MJ=\*V;K)\8%;Y@?]@B.9->6#Q6&['V:@>M1BBM RV6E .]\#GE#EFX]PDQ8+)?7EC7_
MZ-9(_%"Z%C'!1#^\'71X73I: 3RI$%:BYW2SV!QARUDZ3)/+TA""_$2$-J8[P=T(<3,O:)\+\,@0?H8D4_PZ&.=
M)[S*Y:',)[A'>'1A&&CJ*CQ@^98L6H#5'P::9"U9$-D6+G@BXC!S[HMB
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MD44=HD(/I+K/X6#_$CVB9$0?9$*(Y8NQ+K5YEY0KZTP*I=5J$6N0R#D9V8^O&_-'VQ6L$$.W($$G<(^2&..*UJS%6H@0
MIG /L'H_:7LE^,,<)5882L8;;RGSU D"+EF)4*E9^4N\[QQ\K:QLHH)L;<3'/HK*
M7;KR?H8"=@787C]C.4^BR:&&G69Q.:+0)YL^);Y82:+*)FF*GV4J#BCE@@;2
M@J?D-YD:G-%9XA90*QW'[C.6CYX0A$COV4T4\)Q8=U"DRM!)LG3CW:1B/<[!
MW:F4S4%39N;T:,))M/J4;HA:2K+>U,Q&2?D:<@&<^B -J=2^'()X]1:<*V)*
MWUT/Q_0I\9R^S%,S]"7P.+R$8*LH240Y6BC+)+F8DJ0E)%+O-DDSMI;CFU)\E8:7J""1-V**GA!P
M\!;@%:	M@'[+<6>+&9AU:8T"/D4GU9&CF/X%"0I8B8M128R6:^"^1^ QG+
M!NO$Q'1MSV(+2?NP!Y3,F'TNA&GDSSTTPO%+[#, QNOC(QUR@
M*9)3F0PD+#![4G940#TK\T,L3;I7=O;Q<[\+91 M)A_,
M.V#HO'ABMB,4/M'"$WY$L,C^CYEVCRF\9D#MB'6".2]13C0$S%8^5$)_V=GL
M^J36U=D6V*)'JDR#Q?&_7IS9BM7>CA(Q;FLX(O?B@VXE$_X7&!XZ.SLP]Y!/+@VJ\7+8;%I(:4.@(>[
MJ)!,?2]ZG"Y#)*C28VU)!$\.9;I%]AT#E+4G/5\84>W8TXT%$QQ4"+@^ (DB
MH@8_@SSW44LY_>FK@DSH1BFLO G 4OJWUU_N8D+"/UCX;)M_U)(&W?\+6[>\
MV6$+R"H21BWKS8Q?N]REYUIX0*>\)1NW>6#VG-OBWV?F'GB_" O&#_C"O&>#X!U0'
MX'P.>48N/L+L0O)J?@ P@;OB2B6AHAW&" )SRJW($;:RB G*)B#!6OQ!Q/6"
MT&?(Z^Z0[\6%PF P26M=0@U#/6MKP1[CN>SQ&_6^E6_/&NKOF$=";5ZY8=G$
ML'/M"'"J23A5/IRB%GCE6N](-A.=@;2=1;$_>.FIDI)SM6!EK_BYG@;ZPCW&
MT/$C4Q+>2L]-!%JQ%7S_KJQG>DD)_<$WIS?/#7Y8-#@6R(=?$U/[Y1WXC/J LGGX]W?3S;5CB%/V&;8^S>
MY]^9V/AC'O!WR1\;;2B7B_+3O[!Z&9?B_OBF\4;Q 5W$WUIZ[0^AM?S3W_J$
M>/5R24;GV_=^^!R*@BX9HN<:',/;"T)LEYR4_O=/F
M7Q7A(E02IK&"@(T&8%,6O?3,Y_@1V:]\@9;XS=Y]9'"^R(:E&XZ9?Z.=.92-
MW%*+$1C@RQ[/E3-+=U-_DR.L]5Q _3)X,6N;^\4"N"O:1AP*SM-PF)E_/(()
MZEIWL<0S38.K$EASDN+X6@[email protected]
M+"]KGR)_]3WR]Q0H'2%-\REYD59;3O0B!%*PBE 6V6U/&P@Y_E9>_VBZQ_!RI^V![_9[6=LUHYJE+FJA(N9MM+H-M
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MVA6!=MO[F.]2R[>6;YW9GU_Y4!BZ&B)L%I-:?KD)\%(",'\W_RE2;E5B?E;^>3ER9X'.HU^+J4A]SY,=EX1I%JW=$#\72P^'Y8!4F
MEEM+>B.G8_:^GWD0O,/6YCLR?+"'Y@Q'7/PEOB##]-(.-@)<#M56K_6S54:I
M>JL9VL6];9MH5IR?('<&F5NDGRB7*/K;7(\PZ_5@T'OY&Q
M2LZM,L"GD!+$LE#@^8H)JQ2BT=6"E-P5)R_.:HS+24TQ7C(9C+,2[PYR'.M2UVM #+D\2Q34D9TU*HZH^,PE?; %>ZI%:E.8J-)BC+%"C!/SL?1UJ
M%%LH*[HZCD/C,_ ^K9%;4*0L9WL1\K@129TQ)P_\:Z6M+#62K9!60(UD]1S'
MH% ;V2M02=:#S['_2K@.+N"U.]%:/X\U7EY8D8#?6\$A7!N*CR&6  0V&N6V
MZ%<;7#2#K_2F&=GD*S8YF>3GDW]5=E^+^SY)7J,\,2?B&#><;(\YDMV.JFF=
M['82ZT>*]7[D^TAA0
MUP6<7%7P*I0JP;@:+BM-S:VK[WZ7515P*$?61JG)%5FO_(B7OSS@Z%,R%J?O
MS69VN-^Z(/"?..[(4F#%=R9S,6=/)/,M1Q*M#CDRX5D^,T-EQMQH G^ ">C+
MT41!-)\[-G["+.V-C1^YRD.S2K]IW&M@@SK.-I%^"F1RR;T^>/7-^T[.JP\/
M7_R>],O5362H-DX(S5)M_%6%T^4//;+MS=)S3*KW>3#G9F@_<6=QO[FMDC"0
M"C&\0^7-;ZX/!_[HVCA.ZX%]57K[0 &3.P@4QV9CV['#A9 :
M4?8(0CB"<7P$LJHDA_(>R7;5^WJN;+<65\!@)(8#X&:BNU82DQ'\:'#DQO,><0')/,7E(Q M&1QU""=I3V!/BYH"J L7V;[B1:'IS7#=927"
M"C&-0QGWS_P1SO C"T/4/DNXD:H!7MPW\KT9HKV@"?RW)@@AH<496P!W!O)X
M\IPG2S2^+' ^!7=G)!7R#F A8 M96,6(_G=7
MN%?$PR>V"ZNR 1)!"%](=C.1' (,JF0YSU/NXE-1" )?^\/UGF6A)#[,ML3P
M68#;6# T_%Y,=961?[#4$!@9UI<*G7N@ Y<]BM?"!4\V?P[B-R?7")XFJFCC
MF:ZX_SG@@2>FB++T#."Z"0H,4;(YYH*Q91;*+$0[\72Y#5CNDQW@Q7)SRQ&T
M]\J'R?(ZV*[KA5B9Z.)7.S956P6_O%V>S'+B[=Y#$(M80CQ]_3@*L\ %
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M\R9189_<:0=9*O!J2YU7
M\BI8REBTAXOF'M+_;.[PK\KOD?4HQ9DP: 3_W*JG@USQ$=((2)]CP&TIG<6X
MZU02X14)KY"[E>QKY9Y:#!> 4XAB34S!%IPQWM.+\G"%07(, 0+^!@+N8IW,
MDA(F8Q!Y+AS[,P+TPFERN;3 *-YAEU]W$35G!VH>AV)%OE ISWDP^7@?
MQ<' /H%/@WT.9!5*>"PAD9)FEHZMI;J0D+!4$P^#&Z@-@G;RPPKMWLC9K9Y+
MJXQJ>,(3$.8=5\D/A(7[X-/&-EDC0THUB?G2:;7%887B(5SQ<^XP$\?,$>(\
MF'(N/80H&Y4^P+'-)!N4X<\2[J5JL(\!
M*RA$^J*!*%!I1=8PC@+4S()5TUJTBD"AE(D^!U(%Q(]"914*&0>!(@64S%2.
M3PTIZYGYH#L+\HPUUR?;XD+K ^.'^\+5L7K:*WKC=QD57792DEHZ>_1Y[. 1
MKFDI],;<9!'\BLJ]](X%B:03RXY=66B_PQ/01@A7=ASK=#*_6BK%4_;$A5A=
M\%":-'@WK-%3D)NL0@QM(.%?00:"7R1:=.)%2BX<<\?F3SQ>EE"P4X$^86 =
MI+G>L167=8YAG4#>Q\S.T+!X-4GF(W
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M&JU11^NU]*X&_PT[_79S.*RW6GWX_.:G-:F%)=M6>DE5*H^ 26;]MSA
M@@^OP+.LJDK55*L'&>@]..X>-R:6\5T9[0[6]0IIKV!$W@-UY@Y,.([9S./ 
MMFRT*S$O ;A)QBDJ,[O,9;1#/E=H2&!H!LR4*2[!V(CE_;$[?HMM2T5Z,U\^>9-N7*U0ALV
MW61[Y2V&Y2[9L=46HHE6A)=%X.7VT/ +J'EP&XF*\-$B,^T2&T,F8J&3*HZL
M+1*-]Q0\OK[N/[5.?L,,RW+V)UD&Q-E/XNQ721$Z440. N5&.F*EDB;TXZD3
M!0J8Z^F*5:\U5",O.KOZOE@5HK7JRJIK(B[M<&OAYHF+S*7WOXHDX?6@0"%$
M5H"I?U%::]2:C=P4QGW0*0N^D(E5(K%U;12EU8Q.;DZ)6Z$H,M'R'S;T"GEX
M!$X6/6VH+*=0C8%")6K 6C.:!;'!8V!6%O0A$_IRN@AQ,^)FKP-7N];)T=UW
M\\SLH&;2+V=K'IF%N9+ F?[\ZZ2?J1#X+)N-]+$MSY1$QKC0+\U(%AXBY\5%T99%1]XG9LMLTEH/^ _,(\MA@.=C*I1;;58)H-F.^
MJ(4.!-!ET5%12R*O\;IEM7]9JN
MYU[JN3SQXJ"1.X)\3^+LM2#\S(/0MT5#7-F;+'*Q2TO.)'>=(NUMO=VI-5N=
MLT&)B/0FY)T<$4L"3]RG:^V\X% 6BB#C[,S2+&^"NDYQ5N_4-*-X8494>"7B
M:@>QX3"%*7?D@*>0?.T:XU6@556!X#Y%N+6>Q.+#[;PBBQ-=?$5J%@2 ,YSFS-
M8S?EP.%29+%B-][LO (%VRL_Q9. I1^[K4TE:K4JFM);N=>M1N
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M)?2P'^BVOAC,3<>#V($2\! ;9(139:^4X3_S:\RK(
MXUTB9;#TV%:*4IGR<)O.O4H]<(M7 *XD@^L\XQ,J+;]S'I)P+:1#=E]^CH?*
M)6WI^GV;*")787+-!3 [I,P3?$W%,'OG91FU5IW*8:@4Q*P(MUS$])+;(V+I\E/>R0JI^W\C/Y4>3=RCT1U4V%Q>36JW>
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M$0UL[GI" T(!R-U :B?#K_CWP0/MZ"CVJ!L"SE+3-+-PSI *+/KJ/'$W
MD@HGDJ<)2WD$0?"7O'?B.8[W'"AO;51ZP:J#ZX+O3VNL&YA9='UCQ37DG*$B:^"A,/;KIT
M'*,\]_R("[+/S](GZQ,:(C>T>::$2]\J#>QVODUV7ZM7W@E!&)(]5P:ZXI5(]MP*8LAQST4*>
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M,54!9!9D LH
MJ"76&=N%? +=$OL7N":/FX9T!:V5<$M5.P)QW\CW9DIHST1/.?QWO9>>XP#-
M!Q%7YIF3D'Z %28HF-^.-HJB79UK8Z>HK]R,T/\>W"^9>]).$32CJ63-&WV0
M\ND05:10$?O/Y4D%M45,NF/F\[email protected]_@-A%K-QJQ#41*!!.*5V::7B0V
MB9VAXEXT?T;89DQ(Z S.83,I-YJ-00J!5A,_?\I")7* "D#D.PO1X>.R$DO3;
M67]W?#IK*]S^?&QK!2+8GMAFVE_-PP0*>!J'12;O6!);VF\GX*$R7J1XD2H[
M\$'T(.3)O3T/X(4?!C8(^-#S@]U+>_G4INP)MNLIP.1LBV.C25]Y\D0O2V&P
M!8JU[*::W3#\;7O6O3+,;.G@M_I\#K^(ME]XGPF(!^_ MI;BI;(7D*1EQZP/(0N #"8V=H==@6S2"VFU0QE\(4X\
M0(5*;B3N\RF^EET^)\P&4#$G2E9GMFDYDP;F#[ND_KO9'>P4?
M3U@(/"6A@ Q#W[^L#1@<_.8\E&>I&:OW#6H2N&T?I9>P-8%40&L"@?+!!NV^
M2=AP9FS(JQ]D657J"ID AUIAP\2IL:M[8PGW5K6SD,'6C,(>H==(Z&(. Z!_
M,:=2R1/24C0'1S5DYEG<089H<5 /9^ANP7M6=8<5.2L[J>)O4CK+)R#CVA7D
MS0APT*;]>%G).N'=,_8'*"=@)LXRHOSWR'J4C5?9V(M"J3PQT&#'N(T(7V)+
MG<=DCADY\E52=4GTP:6O"?:FO)6(R:T[T"E]]ICHB$(]$C8L:O!X7Z)2)!H+
M:FAK?JN,.^_[&FBD^'YG.1M@AQ980YM"[!16X=O!'W<39, V-CQ!<\%'Q0UW
M+U8?2%M"V",3;H>1+[7TR$T&&6P>S/*]68"N-;A=A0N^+[,!W"Q@ [,=N&#,
M'>^9F&6>!+I*6VL.WP3S4&-=GO_2,RI;G.*G#63.G/>[\AX8]3P]<\_35CEZ
MGNJ5[CIZWM57I#-?Z3(WTN4VJ>OH;D 1=A6,7=1UE+"OO)GJ!<#R\OA(C44)
MV:Z@=^A5-ED>KCIA;%39TF>>&VX55D5Z2>)KY=:#9"]\EMA2H?J^;TN)/K55UN5'[/U ZLB_8'[LXUEGP*3
M3/'AEV@<\#\C+.6+DZ&7&=.V:X?MP0Q!B@C$LS;$G7#$7@%QBWPCF>WP1AL17
MGSOS+!OK&<5BV7SN>UB'.5YD,O3Q%^_95:8V@-1'CH:%BTQACH?YS79EJ'+&LY(5*K#>APL8[6#N*$$,,S'A1+!%0X6
M"4>3B6W:B"-LAB7!^-;,*FU7E$"*@@.?/S)_93NKZQUS6!26T#XQ@#_P)4JF
M+XYS_&MW1"9WMO$"\6=H2Z"
M.H.@Z\2SBH]IH??RA:^GUY6RYM!GXD>YCL4Z\6X6QAQ$N2D-Q6UP8(,KS[(W
MJR,8/F-LNY(L5PD6CRGSLLR#1.63CW7<*ZPF6PZ3EE6L,I4Q=VS^%!QUP%
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MZSDUMENM:T?.%%>\Q^HX]
MKR./,G[M2:K9R(=7?OU2IP+= ,VOESK5NDMCU];DA#J#?KM7:S353W_INZ=M_)
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MUH31$=;[MB* )RP-%>22[,S$Q-NELSU&=A.A&_=L2R@O"A>
MU*,MIB[QR82;(GT7U ]E[F%"@BTT$0L?A0D$ 3=!P&+._H 4X
M&.*<+TP8XZXWP]1A^+QKLD!\XUC0@KCI100$+4?V:@_>%0.;SFF@6=Y&G=C/
MW(G=*$?N%.[+>T^8KTG2E=07&ZW#;U@=\-J(I@5Z%M$@O%+NH#3]A7
M'/;52]&:^_!NJ)='5FH23YA8&DPLJ(,\;+],O68*8I_RXT9-T"^)45\(%I\1
MJE4@_]( ZWKY)F'<:]C@U7"[-+PAO(QOA6_2BP+F6OD-T5B5T740H)87H6=FM%6SPZ:2K8AN^BPFBN3?\2'B ^M\"&]IN77$9CX
M$%F-1S8N609_28N_-/LO#Q*6#G"$<<7;C5<99_B_..]*2?*N#LBV2K)@9!X5
M?K.9YE*3R3"GH/"^N:(%A\;R5V+JG9INCF=O,G;)@#]Y'0QG/P]FOCRR,
M6MVHU]0MO3!NG"QHIL<+[2F2?-PX91=;A;JFSS%3GCF)^!(-J$6Z)79J>V(.
MYM$7077%C2 X-SG^UQG'#I0%F8J67R6BR>H*-B*Q6R8QLM$*M-'B,H5"J+8(
M9WU>>3Q5L/'V O FAHV7C](K+$AOC"1SMR^))(^7R"4+'Q4;+OIE0\:^RX$!
MDG/_1,Y8&F!55J00QE$XZ:1,Q/5 4+8J^FSBF/*!KBX?2-W6GIW2@;;<1VF)
ME)9(;*@P-J3F5BY(;&A=>Z(AS55:K^A]*-K9H)LYZX3>UT?IF8NQ4-@M"4<,
M)U.>I,\Z[:SS0B^==0_X:A^H0(FG:V)OR3$W613P3',FN'"F/'N18\G!J6/.
M75!30_LN66M!W7G.)L2H/T]N_7E:Y>C/HU>Z0\YY5U\1<[QTRFZZW"9UR"%G
MS\6PBSKD$/:5)59*?4FH0PYA8HDPD3KDO!9I?UW.C$SGU61MZ=R\6WF"LXC\
MBOR]@WJM4V_75'5S@%?>,+R)?!,*Y%J+MD>O) YN:'+92O4+DEV
MC9IN@%ZIYD=Z5*Q&=AI1Y&LHLEG7:[I&%%F4Q-R=Y_OR&-V=LV^S W)'S/;_
MA=.XNT' PZ#K6C_;;&P[(O7THQCTS:U?W<^8CHHC/.&"7SS73S[B7-/@ ==W
MS&1=U>B,1O7ZJ&?TZH->M]>GQ=/'4=FN_#Y2)[3+7M)FC,'$\HC[,61X0SF9U^!-WE&<[G-H;H]BG-OV:QUO.>!FJN/N9F$W:U?#)V&\U;&BI9LMNKO7K:?%4V7Y%LRM)9#LOE4C+O
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M(8\W]<8B.X9B!Y(31!=$%R0G"K8T2F3A7TLAA.=;W$_ HLV_
M*H'GV);R-U7\[XK< 7JCF9L;X%2@E07!R!-7 2EW.Z19A*>.2)1(E$B42)1(
M],9)]&I(,$\%]MI)Z_5QK'JKZE;D@Q\/35>_?9_9Z.]1$-J3Q>7WFM-Z,X]9X4@J$(]XC.T"LY6?L^]Q/7_&G!42
MU/":],$"Z(K)'2>^YL.!\@M_5CY[,[;!YY]M*YS"
MG[#-&)$!21TV#_B[Y(_WZXBY7%360[I$[M96;_?A3E:YID;SV_WDLY60XSV]
M\O;7WE_IVZN]>MI\539/94.OC&)JS5=F&A0$+&TY%QQ&Q?^1=S(EZ,%@I *%.69Y%]
MA#=A:[O,%0,HNT' PY,:+>S%Z&)A^RI4+AV?H%SDPADLH2.A(Z$CH2.AXX6!
M6'K ':]'7I>Z*"Y_>>Q$GP53A?\9V4_,H8D3U/&]E$R-\(?PA_"'\(?PI\RZ
M4XGT]R)S%#YZ+E\H,^;_P4-E$AW7W31W-"M]$7)^.;O[T.O0)(U+IN-JM7HC
MMP!BZ<\>[Z/>#EA2-C>2-B7J>>'-(&]2BS[RD0:X0_A#^$/X0_ASQ7J4R6RY6@8^\MF#;E.
MRD^ Y#K)@<_?#HEIM68COV:Z1%Q$7$1<)+^(Q(C$2'Z5C[@JTL6F<#OLP>N&BQUBZVLVX[[H"CMG<^Z3^X+<>N36([<>N?6('H@>2$X071!=D)RX
MA)U1(K.^4 ,$=SZ!O8= IM>:S8/G]-V\C4\.-'*@D8^:
M2(Q(C$B,2(Q(["9(C%3$8LVSJ['"Y$>\_.6>5S][N#EJ>44M9R[-Q E_"'\(
M?PA_;AM_KDN=*I'U0BVORF7)D+. G 7D+"B4Q!J=-I$6D1:1%DDO(C$BL8J1
M&$DOVE+^IXG]7Y /0:YJ67]/K4\%6%A0C!UP%Y-SM
M$&<1/G B42)1(E$B42+1&R?1JR'!?%78:R>N5P:RZJVJFY$/7LB<8GAU'7BU
MY45CAZ?,^M74=$%(?7-V*.4/E/S93:NF:JVS0:8LN$".WL)%-S$:8C39^S2M
MUC+RZTA*G(8X#7$:XC27<&(0NR%VOV6O__^0Q3"^S@ 5_] '#J.9[YQT__
M^1]_WWCZP Y,Q\.'!>F% '@7H?N93WY\,QKH8)O_4_OWP^"-8EOP!3/#NZ'1
M:(Z:6E=K#WJ=>J]I='K-?KLY'-;5YK#7'[WY:>VTLI!_L&<\4'[AS\IG;\9V
M,]/,[8[M\KNI; .BZ>JW[S.G_WL4A/9DD1<"B(\;'4<08(J &*9)C&R7N:)1
M_0($NP@RD0 8,[?<[O@*B!
MG)4I_,-\<[JH*<]3VYSBNCRLR_Z+R^W;[CR"-T8!7 R+Q:\04DRL<<;#J6=Y
MCO<(+ )_G@DV@2^?I#!]N4O.D<>^ZL960>:5&G$WE[ME3UN7O OE7][%JLZI
M&:AT9FT#O;6YEU, ]3-_XHZB94R.?T9>""@BT%J@ J+Q$X_1-U F0!DV*+)"
M@DMB"9!:G*6,N7\1S$*J*2906[S)']^H;\1G$-EF\OD YJ_L.OEMD91GVPJG
M[QK&(=K[JM)R^,5'!W..45HV4'('QBPQ-!?$)=K"K?%A98-\B0$]H\DXB:?:DH0
M 3\&*?3G.FDE-)4^U/7"F-YJ^!#Y_IAS;WDS7F,R%#$ 4=_WQJ(F#"3;(GM1
M+'A M#!!O4$T!CD"!,P<%%4@""81B#[1% TT%/QB.UDKKU9BB?:)]LM(^_4,
M[?_F9FAGG?:":(ZJFJ0Q((M0$J'K)50FJ!<51.9:F=M@^2)9&A:(&B72W%)7
M+9CHR( X/!L!C@$SVA]!=?Y+JL9P., V4ZO-3JTVY1FX_H8FG>KA:(&,&6K;
MGKS&\9Y!?U<<@7#P5(%:$D7@TI]&;"B!2P:B _ 
MCV(92-!DP53A?T8V0)\+.\VULOU"DZ-/E +\.58B:BCHP2P$.RL5^(GE)^4^
MT#=S0-BZ3.C5^"W:68$7^?@S/FOF6=P!6RT$)O 7_A@_88,Q25-QXCF 7'B=
MH'M )K@6)'TXW<%IXFVG3*_]/LB@>,R'<"$91B08GMAC!N\SCUXB_EOQHQ<%
M\(3@^URMQN4Y=DX[_LZJC-OK.L\)/S./69'5J2$)ZB(@EOBK[M1M^M@2W'?VIJ7>+@.%:MQ
MS6^/U>)6[M=>>?MK[Z_T[=5>/6V^*IL_J?"28KN9Y39?61-2<-ZY"=*.^\4&
M7KJB+O4C*B5*7:LI^A&9HH2 !7<7+@+_]L#R\AB9>-M?ZU0A?"-\.QS?=,(W
MPK,37"'\(?PA_"'\(?\H(
M'W*9[8;F1\_EBR0[;Q(=-XHE=TPK?;>T_&JL]Z%7%?H\Z#6]D5O+]=*?/=Y'
M;2BO1/Z7'MN(TQ3=4:;L&$#\AO@-\1OB-\1OB-\0O[EN?D.6U#&[8Q-(I<)N4PNPMQOA\3:395(BTB+2(ND%Y$8D5C%2(RD
M%WFXC[7!'GS1-W)1!&55CH *D%%E.>RB11%)'*(+H@NB"Z(+H@NB"Z(+H@L*
M"AT+V[[GS\5X$F7L'53,("I3(V"_4)L'-X]3CD(MA;1:?>X$=DN5/SC5RKE5.:A&)$8D1B1&)$8D1
MB1&)$8E5D<1N.U D/^+E+S?'^MG#S5%O+.I-^)#'
MFWICD1U#KH+*,WXG8-'F7Y7 
M+R>\UIO9G'K' D%8A'/,9V@=G*S]GWN)X_8\X*"6IX
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ML+5=YHH!E-T@X.%)C1;V8G2QL'T5*I>.3U NKX7DJF1OA#^$/X0_A#^%-FW:E$
M^GN1.0H?/9AU:)+&)=-QM5J]D5L 
ML?1GC_=1;XEB4[@=]N!S%D3^
MH@C:JAP)%2"ERG+810LCDCE73!=-525Z('H@>B Y071!=$%RHB@[XX:B0'W/
MGWL^"[DR]HXKD+I!VY[<9^0^*Z6(NAX2PRD8N75#).(BXB+B(OE%)$8D1O*K
MA,1UP\4.L?4UFW%?=(6=LSGWR7U!;CURZY%;C]QZ1 ]$#R0GB"Z(+DA.7,+.
M*)%97Z@!@CN?P-Y#+L;167SN!79(-OY+0--KS>;!<_INWL8G!QHYT,A'321&
M)$8D1B1&)'83)$8J8K'FV=588?(C7OYRSZN?/=P-/]>E3I7(>J&65^6R9,A90,X"2$X071!=D)PHRLPHGUE_
M+14/GF]Q/P&+-O^J!)YC6\K?5/&_*_(!Z#5-RZ_I]:E@*PN*D0.N G+N=HBS
M"!\XD2B1*)$HD2B1Z(V3Z-608+XJ[+43URL#6?56UTT-%W]]GT&BK]'06A/%I<'
MY 77.XA\(&(EG')E8XF[GO=@SWB@_,*?E<_>C&W(AMCE&6.X6+_%3VM'9]_&1^>9T*=/J6DW1MWEW3MH,XOG*Q/=F
MRL_\B3M*_5YYV/9JS['$J^.KDG?!S8[-QK8CRKSA6US1:T%0"J2 G9UK'P-N
M\MF8^QM;R0>9[CYH4#X#+&F%EK[?0#7!E.%
M_QG90('83*JF,-.4=P$A
M"%_YW %4 GI<*,'4\T,%KHX;+MR_K%3$?__]ARBX>V1L_FX$K_@7OF%@!Z;C
M(?\('@"8/<ZPW:CW6GU!GU-'=3[_>&PWVX.AW5U9.C-
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MS>5NV=/6)>]"^9=WL>KCT QT0,D=&+/$T%R7->(W)4,0 1'W?
M&XL:9)!LB^Q%L> !T<($]0;1&.0($#!S4%2!()A$(/I$$\Y8K]I.UB^KM(%P6,;=8Z=FE_(,7']#DT[U<+1 
MQ@RU;4]>XWC/H+\KCD X>*I +8DB<.G+&!)[E_"U+RM7=-9'G77B<3,=(#X 
M/XKE<-.%((@YTY\Z.?I$*<"?8R6BAH(>S$*PLU*!GUA^4NX#?3,'A*TKW CB
M6[2S B_R\6=\ULRSN .V6@A,X"_\,7["!F,ZV>/PDB-AQ?/@^7 B;C_R?>PN
M^;"T:X.N:XF/CD#\^-[4?7& -Z+;[K!@J7;$:R%(98RN_&BSO\
M-_8L(_), 0''Z'"P.*ITP@4"'&7,8RYD9M>"B"R^YU]-/D\8WD= 4!;[$=#U
M)KS,BN@R:GF.P_QM^[I7NDYJ$.)"LCYJN6=8YT0BE.+-N73)!D) AC$FR;6*
M-PW$FX2/1+X"* A@[5D84L'U@EK^R!74>-''!]_Y0()N)'U[_.NYX>
M!<*M"%H+>^1K3T45G4\FH,4KUC*:)!90CI<
MTDJ" &X1 
M>Q@WX#X\"ED8J"*1"Q^5-UW3C&:1!(.T+/!6GT\!4,B)X/G>C"MO<2O?W[]1
M_B$VA^J(W!NL3P!+[#'=UPK(E(D3F6$4'RP*O@S# (1T/4'L9(']G7ITCV&)8[4
MMMX8-MM-==#2NUI_H'<&@B7J(U6M&\T*LT3Q<6/\@X27 @"#I9=54ZBR9N-C
M[$L2BX!TR+Z"*'#YQ [SB!K*5!WUOJW 50X01W[!X65F^#S8,Y-&7F4RL<6BB9<+"$N^GSBP,FA
MTK8 "8(J*(;YP/+C=WAXJ%XE(;F8;7\7) HRZ%L8:PGCN-P3*&%>%."AXT^_
M@UH:6+;44D3DS^%QM&^#>2:XL7EF^3#5(M%_"4/LPBUP@?T!%A\PGV,K^(S
M8]M&9@"@->"):_H@R0&XKLV4SV+_^-] ,>$V>Y^)3EK-25K-(_ [&>I(SALI
MZR[T[@1E@<8#9H:_2"P76Q[F7]SW[H29DJ6;6NRJ73X=+6B.Z";M1;!PT-Z(
M#=B#7BA,I-VO7/[. 4XSL1%I:*(=AD]/+;LHE#:'Q&2QE "?L.Y==#WQ8.EQ
M3ED*V[6 R)'O== % &8[!I[FOO=DRWVFH&!9\4*HG--ZNV&1+# + 8$/%+W4I+)C)+D?#&,CT(+K*9
MY(=3Y<\(CHW[R<$)54RJ/TDJJ)+H+*NX#TC!!:M%AKU-
M5V#"#1A*Q^*$6R":'''6PH&W38>H[7"\BM#RD]2?7/XHXQ <>3_N)@YQ)M#S
M.:SGKR3M3306W%2)6)J1F4!90E8PJ 2L+0%6'Q\Y$Z[%()I,;-,6GMUD3>DR
M,"-/KB2[C&0/KP=U#F"^14(M6K.;@ 6#'G4W$L'6E+GZ'%1^5V;-H/(R=_A6
M(TAAHCV-..]GSW>L6NPO3O!Y!^:L65(?4!)@BG#\J-]<&^7"_\)3+&]VKW05
M-Q(L S ).4D _'L!2B.;8RR&HVD1"? HK31II'@:[[3]0
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MDF6:@DP]P!7B:A!5[A!MXF(,!1L52+4U]1%)[email protected] X>*Y5MPL%]LY+GG!;AV"Z6HXC/V?>XGC]CSDIW!VTE
M-3JW9/2UEIHJ;6QM(7IX^KE<4KO^
M[;$)\"OW:Z^\_;7W5_KV\[[^I$D9U(QGN=SZ*WMX%P#++?#+L!'0XT#&%ZO"
M;[%'=XGCK78J-8DBO"P"+[?WS$G+K!UVB]NM%QE<^;3&(+DGO.\%>
MB2Y5^34[VX=]E6]R9M34YF;F9M[@J@36G&0*TR2)7 0R,3!B8,3 RM.<\2;'
MSO_,@^"=DJWKBEW.PK=]BGGQVM%5E1N/\[9>T_3\R/% \"Q1J4+=P;\G>SY_
M>_[V"$ZO=9H&$5R>!%>8ET*MNH3,$.>!?VV-UQ6#KGFUO4"])(C@%96;"'O!PE]7(0,R-FMA=#QI'4:7U
M=C..F6P_"UE#MI:N^I&O&-D!MB#\-Q#X$<;+P5EZY\G"*Y<[X20$+)%SIDBS$ 6J\G99WM.)
ME>"+AMQ*;TR7(NFD-)Z6AI%?5*WL)Y^C&^4&A6'"O*!:1;^65C
ME>5L+T(>MR.JC^&SAR=ZY F^:R$H$D0W(8B.F5E.@H@$$0DB03='Y:V2(")!
M1()H3YC&YVP2\I-,3=T//7QP_E;"NJ?6!H??Z
M;:UN# 9#?=1NR+Z,NJZVFY7ORRB3OT1O.W,S+"H>G4+OQ0.^T?R+4]:; E1,
M>@UE E"83H45781%=\"W^_G)4:'WRO*=R8A9;PSLA8MI%6*RX5>3!R*3"+L5FRS 544!CD&$
MBY]A+Z+OL/?L)H-.EME+V,(N:0SN\'A(;3J/@@5!-)O'[9C'N+PXS&9K/QGQ:O46?7B)+^'ZD<'*[' Q@'T]
MX&:.X15JL]?0AT83.$2KW3/Z@_:@E_"*UJ@QK#"O2!/7S"6L<$8! FLYT#/3
MGYX)]I,RGF8J"7@I^SSH^52Z!#5C5H^W*
M1;(H])(OI $FOJ&6CSMNKW;/QDIMOB(>O'(EI64IKEWN4OP+-7@\II$CH>!5
M='<\W"EQ>8SMICW6^V @Y>70.3<<"6%O!F%'S/:5?Z'!7(*80^5C=H,(RR<5
MG"4A!KIYON+P(+@D'RA]J)C2IE<# :U6HW"(E.7L7^O*KQ#;*9W0)$Y#G*9.
MG.:Z;,ES*C>AITQP:)<8.'F*MGYSS0:-9FY#*/;!IBQ(4[2$)T%^T_1T3,T8
MT=,56.^EHS[*&J2LP(IE-
MM?R%/W=-$PXB!*S]Y'LN_&F**=.!3- \/A5[:(S:VE!K:NWVH-W6]*'6[\CT
MRM:@WU75"J=7RH_[4[$_&L=11]TL/>S0&
M$;>V7_O;W *VH/SBW8M%WJF=FO(Y'G _\;V9DC"20'FVPZG2![![,^X']TI>
MT.I&C_#0)< T70 LGRZH,<  #BD8OOPF'G^G-0[FTJEB.R)U=V:F2KZELMM)>KL[,S4?80JR..%% 4F[-;]^ 9"2
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MU#,II[=!*%^,O$[0)(C'XEH>L-01>U/OY2!9&DN_A6\)E8NJJ5*6GR7S8N5[1\X[3 ^4L290^)>' V3<;J3=%QHHI>
MSLE[^@.9Y&(UG&5BE[/R+2TN<.1R5)^_I[R4JM4'6BJA
M2852?G_[@WQ/RE';ZA?*\7#R@D*7J-5*0A57K&[OR=YE88.4V[$TEHIV)?]/
MBO:8LA<2$1RI?HFNC*$;LTG@!U(*0_G4@ET7[TGV-_8+65+K?;:"1W6G18'_
M'QKGE*_8TP+3^K*'TW[607*0U%HYYX(^@O68+(:BV8+VDD<6;V7)+(*L#TPR
M:Z'@"SU7D$%JDB4I%$=/Z;U2<+("2\B!"F04D2=+*ZY*RLH*FUCR1/D6ED62
MFZJKX./M4,NGB2]SP2Q5NBF;O37APKA*"J5]$[;PDA1^2KO=6W,H
M;$+&Z'CA2[V\:U$.^?6YEGM4,U*5SW)AD?W"F,6RODU^J<[92Q&7P- @6FKD
MTLX)<4[9XKI;=A?$2A4*:9465+82(8O9],3M.J47HHRIN$>H>EZH?+_H_#Z3
M%BO+"L5;;FGEJ1-)N,5*E$NE>L@7SE#I8HC5/=^LTB*W[-F.5RWGXV\$A9Y1
MA:7D+Z$XLX*>CPJ__U29OZ7[CJ'73%43%JJU&W;+I:E\S5?>K%!$7"%BKX]"
MIMG"DY,>=BG[*0GE7XHA!L4;+;X(@\)]E')'>:!""A50J3\+R2J<QO"85X3ND[D,)E&#HE%Y:[
M69KU7*V8ONJ4R6INZD]W%IR%5[^4&TB+(>M=AMG24AXB+H*G?BD"J65\>2W,
M:S)GC'R94LX^7*BJ^D]T'CU-!*[(E^)G?TKC.T:FR<.*%2OC2L7;O@@E:4[(PY3)"$9(II2BCWTI)*B*A![7;%Z)9
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MJR=*G\IDUR=AR+-1/+X6:FY<] =>]^IJ=.WU1C?>\*ILT=$:
MNMT+B\^0U'T+(BD&8PL*J:'%1;HOD,I=Y6Q4APK)V[;TJ-@.^:!IA=:UI4#/
MB5=NM[MIA%6;MZ1(PSA\EF'UTX:52*_I0O&:.[)+=PKP)?CR(+YBYF%_E9 #XVHS;4#T=IVVOVM
M17EO,^B@:1V"3H,L5)V$JZ^QS4W=AY/S6 &%U:GG)/BF
M0,-PX=X6LA9<.,1')AFJ^@C7L*NOO5/=1:OIQT7_9-- $ _=JKEIL!6_QS5#,=7H:);'N#B-B,<1BNTA7
MR^EUM>$L:B]=30_'/K(T/9=-)%8ZMPIP"*!HH&B>W-=SACU]">ZF*!H-
M@^$VM]]<;=;YN>AM^HF*.[X^#O5)KY:]3G?IVCD:CEKMFXN;SM7-S56[U[GJ
M]LO);YW+T:#3MKAKI_JX9LY;D8Y7]".K!'SSC9]F"_MSZ E)KBY_>]C>!:?_
M#<* QD1P;<:#VUQEG49WG+&-!_UX%=N#*5:' +@A?
M]* >7?US]-OE-?F5C:5FER-*_+.BC;4:$I:$X9PD#[%X6IK?IL$XH,6XJ5^B
M*(^3C/E3=?7%+[__?/V;&J54/M(A1>?F%P3;9W?/NA>ZQ?B^E[[R/L]V%B.#
M2O)]GQ+V38U+D]/A%K1+U,B.RR0)O_AY.%/]K(.8%.RM2/ K^Q;XB7J:FM%2
MC$W0LL3GT_B\H=;]ZUGD8M3%RC+[:IF>ELS2H5R4(*:"K"<3$!)%,1!E$=RO$XQ
M!*GL85_*=+&#@>?V?Y*3WY)Q+J^*Z01RV!CC
MT>)IK[U4U8:??9NI$2:ZA'Y]9TQM8];.R#]9S(7KZ#R9*IEFXBM9=UO,*%JA
MH2/M@)I=)U^!G$>IS$RJID^^L",?L_%9,"S-)%X##E\8['2!?,L^:$PB.7(#O7:Y>Q'R6=:Z.T.7E9X[*4'QW1>
M#M"2$QGEZ)-8CAN3\P"*L0_%S(?EK,9Q.3,DC^74$!'#R="E4%+/IE7*<2*W
M\R<#>_)XK$1"D/<-C7;HQLHL>1DO*D]I+);$%6#F7#I?933?.AL*40_#=3B:
MO8BY&%!TK!T(Y<+D))4XF\HQ(T+]Z]G'L=:_IHWTVG;1^SDBQ=S3@F./QE/N
M61L\91Y/Z9GA6,Y,+,:EJ#&L++A7PR,6L\RVTW!!G(K(+9@(XR:^*28)5A'9
M:!4H+2[S#G+4URM'>JB\[?I?=;+;6<87F<(=HB$8B,7HN,QO<*!5R6?:1DPI.(^'DJELXX)@*]2;Q!#_-2$2<99*SJ(UJN
MTQV@P3OBI-WR>P^4I);CQ
M/M?Q>H4?4AQC3/U+VW7:GKX*OKUI9@K[(!XVM(H/V@S:;+,VD[#OXPU?,9Y]
M-/IS^PY+V+Z7V6L=T(I6P3=!'&3L8W#/QK_$&8WO G'O*$U9EE[,?Z7_2?AE
M2--TE\YH@YN;ZXM1UQN,+EVWTQUYPV&_Z(S6=7O#_M#VSFB/=")4$DI-ME(=
MT7B0ROZ<3SJG':4/VG"_/0UWM"N:B+[RF"?6!5W0T 7-HMO1!+YY N9:*MR)%G,R2C DZTS"*
MOTLD6IBD*9DQ3E+Y%N1?Q<61N$Z-KU].8!97!,E83GAGJ3S1'3ODEODT3QD)
M8OES3L5Z/RS6BLF>SQ_36$Q;SPQ,FVJ[,!L
M7_>T?7".@<7Y.N6,D5_%WZ8IN19J;%Q-%NMDW'6D=%4%W'7B7/)I$(K@OAJ?
M9+RDY?;GWJ=G5F!DP8G&<"(@L0E;SY#LW%3.!*IZDBDLAYQ)RWH=EJ>S..C9UQU-K)>IO S2S,>^#+'7*21
M\SC(M/74L5J87*?=Z3CM(?H'(\(Y>=&!05+1&0X\%F\([B)\,M6'U%+&!
M,^ACO->18J>:="G5QBZ5@#2M2!IV'&\@_,J6/M';"#]$\A!Q&B3R#8GLMCW'
M?<@8CU0+
M\S"1JD%^"N)[EF;%\%V:2BCO"PYZ[=O@ @?X6"U0/][72;U-'1L-OM7CTV;\OF
MFPW++#[*R\^#3#S>?P6_]67I$NS@66_=4[("[AOD839:Z?J(UPN! N"!<&J8ECUT1BKWA.J(7>0NQV]Q3:,
M6I5!6MUBL2ABW ]H2&9TQCCR&LAK(-^'?!_D G(!N8!<0"X@%Y +0T(/@X+]
M2F,2N?F)V'[&5#/.,9LE:;!+UX0&1OX H2.I;:35@HA!Q"!B$#&(&$0,(@81
MLU'$<%#4T.%*!E-Z!M!?T%^F@4RANZ"[H+N@NZS$
M\6Y+LYWPO%;PG3:P+U0;5!M4F\:P4A]4&JZ9/6FRYTJMG!3IR;&0)U=P6W?T
MKH!NMM$*? 6^ E^!KVRA%?@*?-74@64G'O3Z<3'LO3XL>'(1-8S#C*,/^ ?\
M _X!_X!_#*2/)6Z3643#Q+FGCB?FO(+M3& [S'D%^YG$?ICS"OX[(O]ASJM.
M!L6<5\PGTJ#A4&&TW.0!!\AF]._> '>H3]M&K]/5%OSO2S13& S)2 NL7'-$LXK\'$04(@H1
MA8A"1"&BS1!1.+@X_=)(0O0K-^PDOC&-Y0;=WM&(9@4/(?=\6H@0M!>T%[J5
M0W=!=T%WU5IW59[E@1:#%H,6@Q:K.'[L0WM5E W[,:-B^VNO7_GWRK["(&8?
MRF:?KM?Z[J>5C?XG3[-@,C_]7D^XWJ]31BZ32##&_/N4I-.$9ZK-)J'QF(2+
MIILDB.]9FD4LSE)"%2CDQ89V_/4R<5NRJMKEF/D2[QXD\;DD7+' *^:SZ);Q
M1Z7>=AWBM=R7V>9]]D\H9W)'DR04UB@E[X.89-,D3\7^TQ_.37UM5;+9AHX?
M*T]Y8O5D)UWUE" 6!KWXO/HS<<(C&CY1\ZZ\9OE@)=K$9V%87O/W=ZUWZK/0
M6_[B\QI"?0TBEI+?V /YG$3TA2\147X7Q,4B:9XEBR\*QT5]\Q",LZFX6A"B
MU*B"/4,Z2]GYXA\_/=>0C^M>S= _:MG>VM.8[9/\Q9HZW>\VZ_&U%J7X/:ET]1]%O4 
MM^((VXB&=G; 'URGV]4'0K6::^1]J-"K26+);E:$ C.R7:<5O ,U!C5F""M"
MC6U-JO?:>GYMI-6CK-4%]OP#=%N==)LI;&6$^C)&0XE(L3.LG"*FO/M#O2A+
M#CLKSVI]Y8RF.9_ODWFM76?/;JNE2X!,>;1^-
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M95<=<\"J0RX@%Y +R 7D G(!N8!V%&*0>C7-/H".A(VL;>$%30E-"4T)3
M6J\IWQO@2NX%*+""4X$V@/HTCBFA/O4&XZW3T],*OM.8P/PQHX(N:Z]?\^^_
M_9BG'^XHG9U_\:=LG(?L]\GHG@:A?,A-PK_0D'U9]G+[S/PD]H,PH%F0Q%_E
M-5\%52["Q/_S'__SO_[V\EF7=";'*WQD-&7C49JF+$N?WB>H'DO2?F:3O[^[
MN?):;N__N?_^>O6.!&/Q!?6S#Y?NA7?1ZE_W.[W!SWW=[E\.
M^U?]=_]X]JI6R?XUB%A*?F,/Y',2T==U\LKM81"S#^6@#M=K???3RJO_3YYF
MP62N]>U_XLE,$H0^V$^%HNGD>#K+"6"N1DGH:1E2K(I
MSRB25,R24)AAU+R?BS^07DJ'B;N2/)4_$3ZP_F;?'5"
M2NPE!YK6N_*8)X9/3FI1CPD$^>/B\^KOQ F/:/A$;[ORFN6#E4 2GX5A>J<]"V_B+S[NS[D,PSJ;GP^'9H"4$H]_];J'K?/G.9RD[7_SCI^>ZZW%M
MJ\<=C_JOM?8,:_L3DV)IW>%WFS7L6B-0W.^V#[S_M+>?^.>;M'E+8),VQP='
M:0F\O0MVC/; ?Z1LDHV.PK;73&?1;>,/Y)6LN!K;KE@S>X>(>H6)EK0T*3$7K45Z-$L%R_V,?*K
M86:TVDQ3#0EFG-X\NJXTOM:KHF3Q2^K5H@EN>Z"O"^Z^]#*%F9WG_V) +5[MOOF"OR^.%LI3E[&^OUT:&709]NL1>WZ
M]FG4QZ9HC:K=.\A#M?*P/63$8F%I&BX&2Q00A18CJ=47"$Q/G6 #X:HO]JY/RZWW[L ]>;9M+^RZ*0H2\'1([FDD
MMW.T]@T-E]S&9[N+"J\ICP53I9\8_S*EG%W0-/!'
M\?@J"/.,C7>N+QSTO5YGV+L>==N]WM7%8#2Z2H(7-Q4DEP$#
M"9,T)3/&22I?"@G2E4+$BBH.A_N19KBC'6EVA:';:NDK+1QHJ2SLG[@RT.[:
M/*LVC]*^ W.K_=,B1HY1M?)URADCOXJ_35-R+93HN)HZ!C,BFI2<*(QG(CBT4.IJBX_5YU__.))ORV"^DJX
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M?&9^+W8_%KP:)N"[-TEWZ[5QV1OV6U[L:>.ZP/>KWKB_;7=5OQ[ORKH>M
MH>W]=K[(+/6'6]54TU\A(N&LZ+6>)82&X:*;CJ0SC>??IT5ZN[R1/E ^+@YX
M6?F&RO3W+.?^5%R3D@>:JM8^0J[&LMD.C0G[)G^.$=G41_QMG/OJE\4OXTJCG66E-17U[CF;>T+D'G7N>W&YWZQVK-F])FL X
M)QR=>Y"$,H"[T+D'W(=^*>8P*SKW@!.-X41T[CF4:3\7X?@I)?I52EL![S!B
MK'45E+(;CVL%[\C[@(>A8F:HUF%(-6G2+2K
M<P4;51[3:W>HCI;J(5M.#H2\T+/N(1)3_R60)-1Q Z0#*HDJX
M@ B)$!(M):+;U>:RU44B$!2]0MB?6GREG*@:
M/D-=9P/J.CN.USI>MR!3> '1[VG!/2?NRP4M9!/8I^.X&K/8:&CVU)_24'FN
MMVS\E=KT. NR^;^",?LEGLA:6OFH$CE]PY/H^EO&>$S#RUPX21'CZ<7\$T]D
MT7,ZBL?ETG:J3;_Q!NZPW1E<7H^N;D:C0?NZYZG:]';7[71'7=MKT[].65GJ
M+;0"*39=%XK=S,BL(>9R"\.%^^QKN:*Q0#HYR\">WVUW/;=7F
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MT46!4.V+[[H#VQ&J!>E(5-".S$JZ$<[^R@/.QD3P.1/,5!"1A(J*QZ_S_X=-9VIZ1.9-AQ<6X? C2B_
M"^)BD33/DL47A<^DOJD I-O1 M(=](%3/3#+4I^4@OKX @/R;V'9)6!3%A4H
MY4AV0,^9![\Q#&$SBH1SMW4[P?T8V)R L$I/5%II\IZSB 9R;B89DBB18..3
M#A$VWG\WXDC:F.AN6#UFQI07?]RD?"UQT4+C]/S?S:G
MK]5]GPI=0^YIF#-Y;CA9?^:(N%VZIFW$[3#K.YKURYQS*6&SA._8JG1[W'=M
MN@:[GKZ>P3!?]3=?'Q/9NHWQ: _Q.D&2RX:L AIT[JZU6A6-(4![3@THQWT!
MB%O &3^+I]!PY7&_SYA$R,5W>R(:^U?#P;5WT^G>M/K]8!C5?,9]&M4-; -NHCL/W81BN<
M4[N CU:0U(@3&$MB16?0ZE1.+BNXQH $F,5&&I#*)X1PW(&V1B&FO-V3"$A#
M#F>$Y.Q2EMS LQC/:6F$XN$TI@G&:!?P27V-T6"H[3S E'<+4U2EW'B[Z-D&
MFJ*N!U0;#-$ND]TXHY.,<9@C<5^GI:T!CREO^+A"LGV+Q+H,VIZ\=4ZK316C
MD R%9-6IO;XSZ!K01]$*OM.H3S4#=G:#V*S'[/P2WXN;$SXOL;@[PW*N1CP'/?BLCVXL!V6(T?A^DDT$^]=XG"2"0D6))/428,T
MDU]F3R;F/H.GO(3@8!QN(_$H&(=[^GFV5FW>DHC5N.Z\0-.\A:99@]1\SN,^CI XLW9/R=>6)EG$_07)%R!\ZP7]$\HOJ*%#(+.KOS[MO/=WDF5PW[
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M-,W$G1 0,@^;D?>\]?7.P7O) =>>UVMGDI#VY:V;U:RPN;DM;
MH])FB M2!:_.0TWN@[2J.8T;,ECU:=C8[^KK'+POT4QA*42Z%MB\YHCF>XV]
M5 \E&HQLG6.\9VEW%H^K2;A7 OPUA8A&C6,U)@_E.JWN\6H23.&%JCT). Q0
M-% T3^[K:!R!TA0ULW=-P+,]KJ[7+H#]TQ'&8S9AG+,QX>R>Q3ESQ"5^F$N>
M)V$B!4$.L']Y%6-+=&\%@-=X
M-!,0<#M,11VV]&4>K>::JM.1!BDWXTPT%!@4V'ZD:CM>'PKL!"#>6M:77J])
M3 9IFF]?(EYK9*+KM%K:&KB:\LZKMOLP[S66B'Y;F_&IBSP@\G^=MJ,H$;O_
M+\T R3T8)"]L446=[P#]0VA[?-O7(-GM#P#:-1&T6\N8#KA=HS)2=8+3R>RY
M>S3*F,(+]0N8CSY0P6258T6NTRA]9$VF?/OC^\-;A=O 11I3'8>W"]^N]??Z
MMN&?"Y#M#4\BF<+F,0TO\U2\&L;349;QX#;/V/AKN+@?7UZ.KMC=P>SVO<^G>7!<=QCO#5FLTLKW#^-='
MU'.AN0>>V_\I70":R>VR7WE*TFDPF[&Q0P+Q[SR**!>+&!\=!SW^,;FYV&)W1T1G]=-P'9#PZHX/9T!G=('OF3BUC_B($M'#Y2/1WX6W+\ RVZ!8O78J%CL<"?ZL*?#@Z#0/:Z!T(H/:L!I,"?
M-MV=!GU.F^C4"RL:[$? P:N@HM_RZ)9Q6>[\Q]+(*W=IE[FT8, M&=!^7)MV
M!OR7^H*-/[SFJXT$J>@=>^W//\M2.'(E?%=R0P-._DG#G!V:TMY>8QPQRW.\
MD'+]FRJ[)#CDBOE,:0W9"7H75.)1.#L!+:-; ,BNO[ON\/M=W)[VJG5K::M<[
MQDA4NS]TNOJ.3NLB.HC[]"4>K$-0>=Y9'Q*AU9ALZ=36R\&Z7""V/D4>O31]:KW/F]A%-(9HZR,[Y,F\:(IPJ#=K0TQJI]ED'U2Q'LU5-/OI3#9@6YW[:6M\Y-Y$849B,P1#V'D8>2C:CG\%IG WTS.E'.H;.<0TN=Q2XE'.J!O\_D
M/].]JS;:K4[OLNM>NY>MX<65-[R\O.FJJ@WOYJ+EWK2.V7M%F?0>]I$*I*@4G"B\-<6;/QV#.\HB;A*()X'D5T3"B"Z ^M*H*P
MM Z@Y%[5SL!LEPRT.MXQ_>Z1O;FTLE0P3\Y@H(_!J5O#ZR.4B_QV,)E&KDYXOH_,J*I$JD\-5]2OSYCT;V65'_7-X[:=KMMWVMH'4=<[&PLHW:NA
MOUA,T3VS"/SEM+&4\7O@Z#:=IPCYT-I)LT%)Q&:B>U=U]6'6S\I-D1UW.ZG8H O4A3'F0)+9/-
M#4<(0) ?[^1A..@[G9X!N,JFG5F\#KH\VL(T8?AJOM[BH[S\/,C$+_BOG<(K
M!Z,(D+?ICWDJ8&B5I*\6Q9I-6>G&)065Z:(SN7[@ZH9IS=;A5@4-[X*X6"3-
MLV3Q1>$+J&^,[>_=/["_=\\J:*MAMZ._]QJ9-PX>!_J\39_ETZOXSK=H;X,?Z,3^&@!8U 09#A34&K#[S*KIG/8RK0+RTHV%#P=^J^=)8\0<;A5BJYK%4[ZP]0"AU@E#*
M,H.SX5@094''.S0M6/JA!UZX-N
M=W3A=;N7[1NWU5?3*MJ=2^^J[1US6D45):%?IXQ,:,#)O: 6D_5^+)J%R9P]
M+?I+R0--"1._'U'9UR%/A>I0I8%%^9_\]+# 7=("XDCH(]W/R9LL=\J:V.W,
MGZ856E?!6$%Y8D]/>6*[T?6%&/QA@YN\7&[WM-FE8Q2X?9UR831^%7^;IN1:
MJ+&ML];@KHJYJP'EE2I-]4C%MNN ^PS)G)M?@E0!/^I,EH+9P&R;F&UKU)PE
MZJ[*K,CUMQE3W0G%BXG(^R FM)C53M2;YTS;4>*C(9[ LO]]K#=O>Y=]=WK4?NZ==TN4+3=]LW-Y64=4+19DM%P!2)+XS@77TP4
M$0E=H2)A!1F+Z1I!*B/8DO 2,\LR.59#_.T%I^VXM%+JRI, 18(Q\Q.N%G$N
M<_"O86?6UWKM0QGGZ900==J:39,\I?$X_4'+T)"Z38
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M^F&2BL?L!&#I7/GZD$EV<@O
M\43""B2IWV2&AF(U]EGO[S,FCZ3C.Y(61$X)Y8R,V40L9"S!,GX2S<0VY%^2
M":$Q43TD9CQ(&:&W29Z1AVG@3\7],RJ+7HBXD\9^0$,2/+XOA;RYIT&H8!_9
ME&;R&W:O@&+BASB[RT/*PSFYG:M6?OXT8!.2+)*7U&IC
MGYT1B:&2C2%I/%^"$?L_I1M6);<4"#I=JJNNOS$_SX3F(+]/)H'/^)/'DJF@
M[0NNV/$5;@NJ$O\X]*?4<\BM[+4H"$9HV1U3T3&3H8SB&RV_$B=Z%EMRM'@W
M,;UC/!6,FJA53EDH6-OWA84L8$CBQ2]>:A*G9V0D_L8E X5S1W'CZDNC1/)+
M*)E)JG'U@,5/I1G/?6D6Q#/"L,#4K>Y+%?
M_E4LO>!CQ;KRR7](ZS0F7S+Q97IFJI*Q32F^)OV192+
M18R/#D\<[D>LQ]O0LO3(<,2!&2U+K8(C&G8[L)C'CBD/ZO/61\-4ZU/Y9J%3
M=^$N-$RUG_O,U6V;L.--[6&)AJE@-ML;IAY[3MP)E>!O"<^F9!2)"WQZ2M&U
M^^S%B!H'.X[TNJ[3Z6EKU6(WV^R5X$-_"#-;([email protected]\?=I7!:P&/;$>O6)GT;R&,*GU3M*< A:+)(
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MH,V@S5 )88O]DM^F&8VS@(;A7';R?ZNK>IA(M2FG=:C._MGFINGR
M:669Q=L X3530C9/\W@R_".?S4(F[Z#A!0WEH($O4\:RQ]O27:: N)?=JV[O
MXN:J,^A>]"]N6KTKMYP"?AX(
M[@S\5U[!+_$]2[-(%]7-,!*G6NS*E('OY3@ H40^9(Q'JJ1+*3+U*7BDN:SE
M$NKJQ6Y>^W4+*GZ4?JYVYH'V%_?R!0#,+SS"GA8T?Z?;)$"[8;?;O7ILWI;-
M-QOKO*VW]67I$NR0!M@:A%H!.:W/S"%S"?X!_X!_P#_@'Q/I8XG?9!;1S*O,
M,:SXIAQAS<;D,DDSZ#*PW5'8[F>>I"GY(^9,_*;DOI]I$+^=5P;[@?TJ8[^/
MB9P%#OX#_QV%_VYHP,D_:;A]DWI]!**TJSV3^./MR1D9W+/;G)&5^+JX+
M3BO,QB-JC"@2,P9OU>_JJT Q_Z7X'!
M-N5E5VV787XA%Y +R 7D G(!N8!<0"YPD+PK;2\3/I,ED(S<)O%XEQ/D[;N-
MZ:3D:3OW.4.W@W ?:45S[%1]A,N%8$&P(%CZ!>N]OL:8FVCRR"35Y?"UB^,/
MD#O(747>8AM&K0UD.]#O@]R ;F 7$ N(!>0
M"\B%(:&'0<%^I3&)W/PD\!>]@\=LEJ3!+ET3&ACY X2.I+:15@LB!A&#B$'$
M(&(0,8@81,Q&$<-!D0W#!FV8_WR\$5TGHIA^A=5Q>CU]",B-4[ILX")D92OW
M#*"_H+], YE"=T%W07=!=UF)X]V69COA>:[email protected]@7Z@VJ#:H-HUAI3ZH-%PS
M>])DSY5:.2G2DV,A3Z[@MN[H70'=;*,5^ I\!;X"7]E"*_ 5^*JI \M./.CU
MXV+8>WU8\.0B:AB'&407;F=#(HYKYA/I$'#H<)HN<]C,$:#C2/T#?0-] WT
M#?0-] WT#?0-] WT#?1-L_6-)<=[EH]9VH=@)VU^TG.U5>.:\IJKMLPPP#66
M!T@#I '24*&C!;F 7%@O%SU76QN NL@##I#-Z-^] >Y0G[:-7J>K+?C?EVBF
M,!B2D198N>:(9A7Y.8@H1!0B"A&%B$)$FR&B<'!Q^J61A.A7;MA)?&,:RPVZ
MO:,1S0H>0N[YM! A:"]H+W0KA^Z"[H+NJK7NJCS+ RT&+08M!BU6O_+OE7V%0?5GXH1'-'RBYEUY
MS?+!2K2)S\*PO.;O[UKOU&>AM_S%YS6$^AI$+"6_L0?R.8GH"U\BHOPNB(M%
MTCQ+%E\4CHOZYB$89U-QM2!$J5$%>X9TEK+SQ3]^>JXA']>]FJ%_U+*]M:_78O"V;;_9Q7_%17OYV"_ O2^=D
M!_<:/521%CA*XS;P#_@'_ /^ ?\W0 QSL
M9Q+[H0R /[A.MZL/A&HUU\C[4*%7D\22
MW:P(!69DNTXK> =J#&K,$%:$&MN:5.^U]?S:2*M'6:L+[/D'Z+8ZZ393V,H(
M]66,AA*18F=8.45,>?>'>E&6''96GM7ZRAE-W59+EP"9\I*K
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MM )?@:^:.KKNQ"-_/R9R)O^"_(_(?)O[J9%"+)OZ:0C),8UJ]KS/$+*:C
M,42#C2+T3+/U##I70]] WT#?' T.;^@<7%.X!5V\:Z6$K( L&Z&A[$"\=X;Z
MX.Y6\\RA/I0E1X>8GVMY,&+*RZXZYH!5AUQ +B 7D O(!>0"<@&YP*'UKK3%
M/-T=B#7H#RK/!)C"&%4;(X/DRUXK51_1PIDD1 PB5NTQ7.=HC(5C.,@=Y&[I
M-58O>*;(T$E"M9I%9.:,L;).U#S'=?5A:#=0QQ2&0=K0(*M5-XFJO"$SY IR
M!;F"7$&N(%?P "V*N@S*"N/U*Y[72&O=/3TPJ^J]H+,4@]
M&N>>0$="1]8V\(*FA*:$IH2FM%Y3OC? E=P+4& %IP)M /5I'%-"?>H-QENG
MIZ<5?*JWO?EJAXG_R- LF\],3\H3K
MO4DX8=2?2J!+-F7DQ3I?>^C7(&(I^8T]D,])1%^8FE(&2C97FQ@S7Q8Z!$E\
M+NE2_'XVY8R12-P\30F+QVR\]0K>VM;1]_$KY?[TT42V78=X+?>E [?79F@\
MWGY#KSQIVXV(5;^JJ2I9=5I-8\5I*A?X4?!?$]RS-
M(A9G*7E@G(DO4L'O"H,59V>FBHYMHOY5D-P7WW/J9SD-242SLD7F0O@ODTB8
MG_GW*4FG"<_4V!G%?.%B",V3=T75C?62-,%]8EN3)!1>=$K>!Y)3DSP51$A_
M.#?US5;)B1O:X*X\Y8FW+L=+J:<$0J?'Q>?5GXD3'M'PB;/IRFN6#U9>!/%9
M&);7_/U=ZYWZ+%PD?_%Y=S:+*+\+XF*1-,^2Q1=%P*6^>0C&V51<+0A1.F^"
M-T,Z2]GYXA\_/7?&'M>]>GZ[=.@&:\_DMS\!+I;4;W^WV6-'*.[^+:6TNY2 '-9T(R6]]OG'T[/L29/H=&6
MQP'#UH=A,Y3+V)R)^(7,1RJC4 4LQP<'X/J+&Y/P[3J^'8L^CL42#
MO3QH&FB:-C1-O6+)8SHW64(FP7WQH9JV7W4K+1IT*P)$U?=
M]/75;X@\V1Z]&R=]  @"('@J_==UNAX @F8X(M"1T)'0D="1-O.=1N<2(&J;
MUONO*8L)NZ=A3C,AY0I+N0J4G"2<).)+PF8>+Y'$);)8
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M5J1KC< SVG$*X+:^J\\F!6H
MZYB]W68,;V'K];Y!8@7(XX$$2+Z)NS-U:P#> 7AG/O;,L-L!O+,A# ' "< [
M\*5M?&D*\$[0T*0D3Y71Y4=ZN^K59HG@,N'!JFH>\5X Q#,@[5-[&$O;:??U
M97RLYII#LSW(70.'!P5V? 7F>0 2GP#((#VU>CEDLJ5#+CQM\7HGV0/E6[?@
MWP4T9!THR',ZPZ$N 3/E55=MZV'2:RT1+1<2@3!_1ZNRC/6K$"*MQ#RQ= TZ
MF+B!H-,@"U4GX>IK[-%==^&RY BPTB0UHRF;)N%XT55.-2"$&RCNLB$2@/>J/L->=QH%H9RE//2?!-_KN:\M?:N'"N
MTX(+A_C()$-5'^$:=O7UIJ^[:#7]N.B?;!H(XJ%;PU;'M!65%=7W-!:1%,0)
MXF3\^52[9[L=*_HGS-866\%;?#,41DFLN\.(6 RQV"[2U7)Z76TXB]I+
M5]/#L8\L3<_)R/?S* _55)4QFW'F!U2-CU*#4HI!5>J+*F3/.A%[WW/\D;N^[_A.SS ^(RG'!M%IBN3H^O&0(#9."KR, XS7CN*_L4Q#($N^/"BITB
M U(?M]%S6MVC94=J[U4B9C,@/5D?X72=80?":4C(9W_JZ9/+P6
ME[S8\UY:JG76(>*J<-WYP#X/)%3-"QE5CYB=7\0TJ)+CKMZY7B2<-5H^%B\GTTY8R02-T]3PH3Z&^O91QV4T!DQ
MD>':8#CS& Z6PICU%A_EY6_WU1_Y/L^%U$I)_5U( ">7.>=26C\&]#8(@RS8
M +G'^]C)(W_LG5_XYNE41(E*]\@>^V(+<::<6%J^F/#Q-:#;_KH5KCSF2FR 1$
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M(&-5']%RG>X K541)^[email protected]@2?A2+4ZGIP!!$:(31:)-\\I H0&.UF
M4D)V1\-*T0CU<=H\1Z.$U=YI0T2$B&@G=Z[30T2$B&@[^JG:Z4H$JG:SE)R6
MIV_J7T/&*2&,@D2]E;MS];F!#9$H#"A[>T 976D,4H A_+(Q2+AE8Y!3-^,T
MWN_G:3NBLV85QV)O[,[EFDKZ4\,$ZET&8]>7/6B9=U16\.9]@XW]+I9>F8@>[*6AV![ZT@B]-:79W,GZM,DI=1B+B-U3;
M]B4$=N'Q[L/'M0/^>!-H,V.XQH,=W7>&4&$*U]ZRT^[@"BO5X<7?]K
M<70-6*UV6.UE$@D5,"?)1% ]%4^@\9CRE[@!.=;Y81KX4T(E#C=]; 5)LD0$
M"#X+[AE)&;\/?*:*\=)\-DMX5MY5/(_7&=5@LS@Q&!HPIL>5S=1@T8(O_M9R)$B=C]?VD6)'$5\K,I@U6?RI7W
MTA;I*UTYE&Z/K%8=V$8[-_Z T-8@V]<@V>T/AI#!!BX&=N(_P)-/^/)?3!F*:&/B/HPB()L
MM1%?$I,@2Q=X=]6\^L7>]EF(H!29"Z)I>1B9))P(?3@M@/9)2/)8KEHB_.EL
M)AB-9@E/U67R^W' F6"O977 &;F1?XF??R\!^(&$@<4J:TA#$E'^)\M29Q67
MOS720R(99_%X63%S
MGX1YI,IK%H4Z$QJ$8IE"]G,NX7[9Z@**9(3Z@:+H1_RP*AAZMI-BYW_EJ[M8
M$$@N*WU1%[0@2[PLP9EP]0(=(JG' QH*7<+\::QVL2A'"NFMY&F9+A$^X)31
M7"K)^8(LX'DE+_R<=WBC/$*RLW
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M,1R^^\]U[,[!\5-!,^F5+JKWYFE%PL5,]V$R6SG!5#BEI/ EB
MP->." GR^0@I50/18H/4X#^H5\LMRIJ)8[9Z&.5M=
M"BO/J)P7-3.R#DI6!_+O8AZQ'D]Q!0S\/'PN^)K(8:[G4IUN4/",+>L0RQ[+"
MZLFE9E+AYJ%D'CEYC$QX$LGZH?2Q!F]#M>E+0_!4H4M5_]\P^TO8ATB^]-\G
M7X3T!A-A;.-L5-!8K/)3(K3=O/C_I9G8PA@,^KW+RUY_Z/8\=]BZO&[W6YW"
M&'3[5S$GU\2[/R+:TJS1<4V&>YF2H B1)5 ,+6%H#L\U@]BULS
M%F8M1'N?9TLE+12'> .\J+)6\P%9PN]^]%JM]H_RSS_*"]^5UV?SF;A^,?_QG7STCR^>_8__^=N/\CG!N?S_
M?_Q_4$L#!!0    (  HQJTC7N^^>+PT  $"-   1    >FQT<2TR,#$V,#,S
M,2YX6IMVH(D*0O275ZBB2=&:J2D KIF=FG*6$+T+8M
MT9),POSZE>0+!MNR9>@..[BJ*VULG>MW='0D7_3QEQ?? PO$.*;DHM4[ZK8 
M(@YU,9E>M+Z,VOW1U6#0^N733Q__U6[_>?EX"ZZI$_B("'#%$!3(!<]8S, ?
M+N)?P811'_Q!V5>\@.UV2 3TP0MWS[DS0SX$4 B&QX% -Y3YUV@" T]GF#D2A4\I$2L-4A=%I!-D;B'/N)SZ*"+UDR(^7FGXU#J<2?PYD*J?^10
MOW/<[;WKGIST6D#:2?BYA\G7I/GS\_/1RYAY1Y1-9]KN]MH*C# 2;JD#A8Z[B$;;G$O809[@\9GVBM61U*$%.G;J,.HAOB-]
M-*]M%5(1L2N%-*\Z"IF"KD"=+(GZU8[IVNI4NW>\G1:K/FFG14RW"RW..I Y
M"FH)FR/:Z&7N00(%9&6F&)K^?DYN8H::ZE]N13A2!$KP6SN1'#E'
M4[J0(T= !%NJS'12):7ET<4_VBLF-94)&),US;)R@LTE3'[5R:UK;%V$K56)
M:=3!U@J@%V=FK4%"I(^VU@&3!>+".D!29-'QUN%!(';TX-NS461%%1ZV5PSJ
MJ<&Q8ZU$3*,.ME= S)F]!C&1/C+H  FA0C-2I^*3\SDF$QJ>D>?4D'T>C]N/
M: )T(7L>C9KF :O3E
M<6"8^&D]"LAC@;'(541].NYU3WK=+FB#:\P=C_* (?DC8@0T)[!B];&SR6"#
M=<"1.R2?]/&F5R+BJ(F!<*,;5Z9;[RFY9-')V.G64/0=AP7(O<5PC#VL8NH:
M"8B];3$JYFL"[[1[2D2 U)RP)M(TK\/'MQK-$&RA'0?T0*1 .T&
MV0*FI;"^MX UE@$B(0VFB7<&L@8E:@J_&S0S[$IQ/+7 ,>'> +CF<2[48C._
MHG*Z"1T10.\.BH#M,/]6E5(*]XDEW)'0GT%*+%C);0(A#Z*=8UX9WN-Z\#8P
M)HYY8-0-'/$'9 P2L:.T7,"T%,X/%G!&,D LI,$T[7XUPUKVB?OY6X#G*N;O
MD=@9MB;FI1B_M<-8RP*0N""1]C.0\AJX$T<]P;&'MH4U8F*"[T3.Q[N]RO"]
M"5D>%CX<\^'D(66$[":CP/((=F:[DS$^MUDM@'JB''6R%WQ9"
MS&L/O=RU!RD.T E("]0=,A*IKJ6$@I54$(MM0J 2.O8)>GM9YGS=RZV@MP^(
M \W>]>$:!D)2(H:IVW?_&X1U[(^,%Z,"I4&44Z?O((BD3IJ%U@JLU&JBRQ+<
M'SH&51J+CKN]X[Q:8Q>I)SXZI.B0=9F/P\FO!$HM;DB?(&(%NHF'N:YXEU-7
MI+@!R0ZL\6N045ZX@G,LH'>+($?#L8>G6E7K,J&^!'->?Y=3'*11A9NHJNNA
M0* E@I3(@\S9M9&YDMH??_\ ",4T4?!J43"<(P;5S^^8 TIEE.*?J>[*\$]$
M-A%0%@$/ 7-FTD?K3;X0AAPJZYR_D?L$7RX1D>K8+\3O6FYII&3NOI5%2JQ&
MIF%:$R!5 ;$N30"M SE"<\C""GW*$*IUPZ8F^])PR*P%&XM">7TE#:S$-8BO
M0V*Y'ES.R;PH_"YG4=C?KGI](+T2;X-7*2L#8'(F
M)O^IV=A(^E)W((U7Q!.DF:ZO[1_6I*S,QP^02?-F2&"I\ ZQ6^=; N1;W?.L
M@01OUJ0?=ZR/^:S-,-Y6KE?KKBK!2_%'V@!#9 IKU-?
M6CB3;? "#8B$"]U2ODM8"P2803ZI"W):&@C%@3=*8--]4Z!$,TMY=7= IWB:
ML3VNB>U*P %!&;\6KYXCD<6A6 [(A#)?:U49.R,3 UC=I I*WLY/':J91\@.
MI/@=$#8W$+/?H1>@X>0&$UDY8.@-"!=,^Z=ZURKC8[YK<)QSUT!Q!)JEZC@)
M4Y#BVN 4>\)VFE^1G7E:?YRS'E@!M8.3)_G#.9KX3>X4WI
MPQKL";Y80)2F,2>_LYSD%U5]FOPP'6V;T7)(S=GK[#0;_VFW'V2:&DC-R13+
M#M[G'*FG?2T R)":X_XT-^YC)D!ST0\ '[3_[?M!$0=S=SC-&7CW :)9!"*
M!J%LD!8.(NE-6&BPLF?T<@[F=4:T&LQ+P<\\P5$$?O[Y1&"#MP; LG O9&"N
MU4]S:O6"Y'QXU;DT6RV./B VFD&&*F.Q26>N5C[D5"O*X8J%>BX9:":'ZW;;
M[%9 ;LY?'W**E"P(!YF:-OPY#(3ZTJ#Z6*G^K1[AID*:)Z?SWO(:>X' "S1"
M3LV7N7O?&KSV/4A9^S*
MZ[.'-W ](D\5UP^0B>43@X1#Q^Y^5B$#\U#V-F_G4HU%Q/OJWBTY5N*?^;5BRKXK^0TX&Z"\-F?>W2)
M4'ZCG>)=351I"&2^5%HA!&+1Q6V;P-A ZUX>_;C8J"RM-#PR7SRM$!Y2>KL)
M$>L0>41<,.SHYXYELR^DQKNR05*+$@EMN$P29"MI/R"KS,Z^_O\^;G
M9:#^LR?K'SL;6VQ$)]8VXM#;<$2[[0$XYOH;P1C.1BU;>!>QYRJTQ$QY(KE@$2N*OC ;SBY;>[.X<"^2W0+AY
M0;C/WKE+?8C)0%Y09K1 V'"NOX?UI!NZ 8M60CL9]5?J+F1G5#K<4#:"7NJ.
MW#UZ$4_/R%[email protected]$C$?/^*BXXT)_C2FQ;#L>=9P0GO$ID], Y?>90N
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M]>&!++$8T730N])[S>+-8;.DS>O'7 <<$<1XM2:4"U-CBU0K4#0/H
M)'J8X@X2*-GRWY#G1AU)*2@39OI+&&G+;$GWKR9_0$P/"+*SZL6JO!2Z'I96
M%/O7\S;53Z_G]DD-^VT8O'Z??6#40R2&]#OJKZN&/U//DL6J1^.R[BGBM2>6Z
M!\<&\\;+59.T>=%H_KL&XBI)599W]&)-I.O^>\[":A5*L@Z81XRV]YY
MY?N/+,._3^A%7'JRUDG<4HMTB]I(Q&QV7BV.EERRW*@ -T_^N*HNO(O*G1GR
MX:>?_@=02P,$%     @ "C&K2#F\:L6/(   FE4! !4   !Z;'1Q+3(P,38P
M,S,Q7V-A;"YX;6SM?5MS&SF2[OO^"A_OC;DVQQ'N%L.VWUZ]ZD"
M5ZFF*=)3)&6K?_U)4)0MR1)9+%:!=.\\6!:I BKS0R)O2 !_^Z\O%Y,GE[&=
M-[/I3T_I7\C3)W'J9Z&9GOWT]-/0?X** -.__)E'IX^0>:F\P[]KY_\ZY?\Q9WG/_/5T[2JJF>KOWY]
M=-X\]"!V2Y_]]\]O/ZQ8A&8Z7]BICT___A]/GORMG4WB^YB>Y/]_??_F:WL_
MFTWF?CGYM$#8_^)G%\_R$\^>VTEN^^$\QL6+V<6GV11AGR,!F8Z_GKQA3;-H;W\3).EW$O+C;W-1H+;Z;XNL6LO=J+^,=Z&97L
M^2+KEOF+V7316K]8VLG/=K%L]Q>H'3LOP>10_)0B_5T["TN_^,VVK9TN]A.N
MS7V-R<*GV"ZN3J;AU;^6S:>,WR]QL2\K'?HW=\2.9>V(EGHW%XI_=Q
MV3Q%6VOSQ^%'L6O7XS+X;MGZ9S&U'1V(4=Z
MW;A ?(B?;'NM[\[:&'=QF??K=5RVNOEKG3L8A-AIB--YS*^9H\4(.:USVV'L
M0&W7'HJ0^\ZV"-QY7*!9G.Q/^X/=C<7(!S3QUU)YFE[8^?GKR>QS/_PW]E2$
M?(PSVGB.SS27\Q%J.0TQFD+0U'(>[5?-%<9'U[,ITN[>3U,PNSWWZSL9#/?09+[]SD*2]UTU+9V Y"&?68/XUUL/YRC,[B-
MHD<>'YZ0C@.[N=7P9)TN%WG9,R\BKS[G]-5L@08#KV&(&TQ\[\_MZO@ZR(;XMLV>2M]71J/
M3>3)9+*NDCE-&Q_L*A!CO&QT$.;SY<6G731%S^[&9N05=CR[BO'AAX;@;:I=^WW[%96_WQ]'KFO)O8Z0F:
MW\NF;%L<[;^AIB)=7'RTU-\>[VU34V#X8(S!I41'GB,#*RP!%CP
M%7&$:*WX72Y7!G/6KK$>CM?S)K0VQ_>DJ?/ODK7ZPYLZ^_(WO=%N>LGGLUS
MB4/N$9I%O+AIGTN,1QG/V?BP(6=C2\H:C)]M^WO,L_G%;+[H/B<>;%9+GB(Q
MA$&4$G\PFD 9K\%5.%Q4&\VU[24?[ >6CX$1*R<:[V=7=K*3IKS?HC:\,3NUKP8VCG"5PS"D(L5(@A)*@$-FHN*%<5;WD1/W /6@GK^,.3L4C#6MFO&(*?:6*, Z1DP0L"@,DB1 HE:&BK)>3RV-!-U&I?Y]%CM_\Y7#CZUMICA/UYP^,/";'J^#]1C-
M1 ,Q<0&4!(@!9&11\]5ZC?.95)$PX[SP$B5LM4W%*]9[VBH'VY5)R69
MJV0$CLX'1KU$H+$)"B03AGEG*\W[I0?*I(C&F?C# E;:1&\^#Z",6\__VP7L6WL9(X4
MGZ;W<1[;R[C)Y=C>&$65><^3 C#.H][7:$'FYS'\8S8+NPO(XZUK$97V":,-JRUJGF@24%41D%1YJJ,W
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M=_JNO96HLH6 *FH'4C&#+"0)@G'K)#."\V->Y#E6N=P7Y/^=TAC#P\M"=NR/$?ZF#@XZ!I].E2XES=XZ!W[&'N?*1MD5?N
M<@QM&95WFZ+Y]?%(/S?3YF)Y\75RKZ=6PK@\90Y5V[^^;MB3LW7EM%76&
M.0TV$ ,,#2M$3AGXJ-"(FJI*1A\D1-W.VYOI(B)[BS=3/UGB0+Z9#@+9X]W6
ME4@D).I!^Z#!Q0JC):H\<&W1P8G!)[UW/<&8@6EI>;F_*:0L]B5V$6WEZ.6#
MZ=*=VM=>>)MDD*"-Y: "%V"HJ(!Z)S"*9R[Z?CM'RH2=1R]U_3 ^"O%Z'R]L
M@U:LS<=3SG&49A/W-[IZ>Z4EH:5R%%D3/0A%'0-!'0B1"O
M$M7$]:O@.!95-[Z<[0MH:?FZ'3"OSJ^1,Z);$"I8R&Q(2!P(S3WB)2X3#'F]SF(US3OLJ1=F3]=A.4+I5LY Z(XQQ2
MY7)6)$6H1(C,,^WQYX^BJ@<>T@US:4\(2T^:MQ')C9OAN95P?QD_M='?.95Q
MVVSJ_X::)B4C]Q$8U0DX2^BT*XO6S4DGJ.0RZKV+:HN%2>5$L"SDXV7$A[Q$
MY]])FAS^\!>OC6;DM1 O#9'/N7XE3S1_SO6"5_C"S.K0'O<-K&QH;;
M$7%5A6XU-V"31:I4Q/D8:,ISU.8ZUNC),5>A'9W0;-!;98:GL(6]Q=0OLZGO
M*Z_?VF['1+D8M-$1!,.PP"NC@'MN08O$=95WO-)MWNEQQSY'*;+CCM!!K.QN
MU[B5,;%W:>J3*^W80^V]H911"LF$"EC 8-<1*H%(02M7N>2K;=G2PT&P:SZO
M=Y^U89KPQ!,0$QS*LF,@#+50(7R>!ND)Z9=4+F,@1Y&&^[N5"X);8H][-\@Z
MY?5V[JL.)" $"+_$6 1\I3U$;P*$I!T7^9A(>E1RAF^-PTG:
MU][0NR2!1YQO(A@+5GD#5 H,CJVOE#2>.MO/DRI377=$3MXWEL
MHTV+N&^,<*>O.B7"'<^;R)RPH'BJ< KFW':LN)'),*'[G8=?YJC2(Q*TO4 ]
M2/)@_^O0BU1Z=K[%O @UXY9W[WJY>*%ME*NUJ4W;7U8/U$Y2;46B(&2E<8)5
M I@B!K2T22G"F8ETBS(9DX$.Y_7>?JY6.HDJ&NQ0I@#"$0\R54'T&Y?[&G#WQ*)+)GY_G.8K_Y_GLW;Q,;87M_:F
M;Q",AQZO*Q4Q2K$*M! *.SG+A7:%CJ8' R$3IG#V_-&
MF?G[Z"/**UKO?+5SEZ/;'VU6!\\)MXX#2]J#9HZ!"C)Z:E+%V;9%^(/N
MZ1Q,# 9&J>1!@V5/U3SH_2^##?>>J!08WG50%2L!JBK/"C2LY43D;2\X:P0I? #"8,XX!50$;>SJ9GW?V !YZN
M4<(I)1X]Z7S36331 ;,JX&^5$@IYXN*8:]<'B R&0:7 8'^[2W;?2&''GFI9
M!>>(C_D*+ W"Z#RW!('(K33"NGP?UM$["7L)R?B(%;$HQW>2P5$X%'N)QL#P
M%'$<%W9ZUJ"+>\T^$OKJ2]Z[BN*;CU#^W$PF&QW*[;Y6RZC 5#*Z.NH;Y/87@Z%P*1%W?!/0?*C+8N9_/Y]-$.YY
MMGZ+JTU!R):FM8U5"KDRS&A!(207@ D:@:+C';WRVJBX11!&9[H;?S55/A+!
M%7!G&"IV+_.YI@JD=U;X?.V?"T><:Q]VJ.Z'77OA5%;&MZ=;'KH84&@="0O@
M5## 0U(0-95@N!(I!A]5..9:Y=[C\_@X]T>F8'*]\_7:#S>H7=!.\62!5&BG
M*24$J$H1I/6$:4:,[.G.%!_V7L/U2%9];Y#*2,#.MYX.="_H\276AI>#P7 J
M& &M+Y+;+@^\!'FV+;YE\V< 2,3A8Y77#3MF0[]K4"%74CFM@AN4B$XD1O?$1+)I"
M9BIO)#OF,HRAO,0A ?KA-UV/MJ>ZN-782R;& *I4.NQV!J]S3NS!1G72R4?I
M,;0.DH/-!2CY7A10@22NN'0F]?,ABEN,O:1A4(1*U.CMDA1[(+?"5)3*HT/$
MA'40C:K 8+0$1)+*>X=?]$P?%#<,P^>.!H&K3 G/M5E;$;QM5?Z!IVO$2 ?\
M![)2J.:\3B!(/F[1N60H)X'*?N5Y9;()^P[4]W4Z R!4PC^875S,IIU&_?ZC
M=4J!5)6I\IJ! :$I!Q<_YP$,^ #PE4DD6*_1:VF<;PRK;39GIV]PC%U/AF4S2Q
MO7$M!+&4QPJB"!X2KS2(0- 'T\%:'X00IE^,6:8^9V"1&06P0G[&EHM,'G$Y
M'FE56^U<166 J(3$UZ)CI1V+H!C7G HIDI!';']N&Q6W,C=+;MMZ^LSEP
M/H^+QG_S4HKL /ZPP)\K"$]3KJ%]/9E]/M =-P_5\5Y?DH1&HLU9IY?Q^O^-
MV;SNW=1".8.&AH%)24(5N<[WP'&03DLE*N^\VY;\'P>,O-4).7C7SBX;1/[Y
MU:_S?(_)ZV:*,H.#>N(7S>6VRI?NG=0J:*>Y0]UNLU$&G8PWZK""D1;R83^MC)4[3S3Z+1]*Z&]V9SKW4(6D6*RGR+ET-D7L"
MJ(894)LXC]&A/MZ[ZF;,8[S'&O'O')XQ(2VSE\''&.:O$<$W\_DRVS:T*-^R
M!1L3;5O:UBY$S[4AR'+*"PM<0#)HW+WCRCFKN O]BE'+Y& *"=$8.)80G:^G
M8*X<_(\S# )_:Q;GV5%$?H'SVW*]?E(N\)M%LN(>C;95WA\++H*2*?
MIY7D'JS#CX;H1'6^/'CKN:];W>T_@;HJB&\! 7SUQ2N]\/N
MZ?P_T$F='*$\R 0Z$H]>A" @K6 @F O&,BN:]0_&P7^>57_05CXQ%5BQ5*=(J]-N"7":575HX!D?S$";FT21[+[3^&SB/^>GSN/A[Q YW43CGI
M&88AS.9K@I@2N791 <5)%:QD6IE^MU^6T52']HB'@;2,7'VK/]@L.M^>JY.-
MW@MB0+AH047*P7 70%,G/ LA*7',=Z..-6C?R\9>F!79.9+OOFQ6H.'OD[@:
MCVDXN9BUB^:/;4G&+LUKK9*BU*&%]M8#,SB]5- >.&$F"&.2Y\>\GZ20L(P$
M98FR\EU3TX\D1JW5EC@OP6#L!Y1; UQI!?FT6V>#(43WBYP.ZAP/+2>#@5=P
M7]JU%OQHOZR/,UPG*CP& ='F[18*?7^;O'%5OUJQ
M@V:&A]-,N+>;?L7;\.:Q*=YQK1
MH$%ID-I:J+A2>;^?#2[*4+%^>3UYT,!J:!DKAF[/Y,YE,\\K'[/VY6SI%FDY
MN3G_855L^S[ZV25&!:O:O!>H6L_B:4J;4CV]^JL=440*SD!7J)F--SYO":G6
MN2P6%<+<2YC*G"@VLBR5QK: %OMZF/-O+4+[C/]_IJ 
MC:IF>_,Z>.5=SQ-TJS^5&(V$Y4&$Z$:3;DX@
M;VQ7!V9-LB2!X"&!I-R#MMJA8Q>)(%PX1_L="T#)GUQN]D/Q( *SOJ#@)L1\
M\**"G22I2X@('G6UYIX;X_HMH-+#5EN,+V(CP7L0
MV;MW-,].8G:O;2V%YB*8/,D2A>A47EZ4"B2ZCBE$Q-[U2^Y)LMP 33D_GX( B0"LXU'J&*_Z
MQ?KT3Y'(/BC2)4JI4XI^<9I>??'G=GH6W]M%/)T^O""]J7)ZAVYJ1JFHO$!M
M36*5T;!@6."@E+2&6^E%ZKV?CZL,G"MREK] VUN])
MZ7# Q(96-=FJT70X[#:I?#'-[EM#A.JL6B
M;=QR5/JKCZV=SJU?UQ:L/JU'./QS>;TVTV&NCO/"
M6J>@N*,,B+0R'YR#+D4E./H5(:@H3=#TF+=@%Y6M'>2ZZ(@<4-Q_G:*#,&G^
MB.'_7N_!NY7F_5HT?-(V<_S32_PX/;OV,/80^'U?66M*:;+YU"BN#$9.V9=U
M*4*%#@8Q&$^IGFJZ3/!YC")_@#'YWU>G66A?VTA>P'"%F<7]_'44?NMTBI*N
M_<&D<+3,XHV-1-F[/CUIB>/Q#>3G,!7F^WSE$8%>JK6VFKMC05C<6Y6M/*@@LSU$C(I
MPO.MPCU7X\IXK_N.S/VRDKV@*5&I;R=Q?G.?Q<8+EN\]61.CN#;*@7*I@DJI
M!,%IEZ^'Y2H93GAUS*%Y[Y&Y7WR_-RP%1OG%;+ZJEMRV-GKGN=I9[F,D"8C3
M&(\I(B (C,:+3/5E
M7%.]R6)O;EEKKP)E"%F,H@*3U7V(KW&[_[-GQPL K(
MQOLXC_B:O(CY$A779+:J7]TN&1O;U3I0YXD,D(]4!$](!4)R#DX35(E6B^"/
M^;J78>5B:*A*>'MQ%<0@Q=>G9WR#8I/C]VBC6M,J)IMTOOJ.@]+X4N\"@:1Y
M(EQR5+3'?"3 L/(P*$Y%BNBN0]EKH[DF=7,,\%B3VE+F4=EYL))X<%1)D$1(
M9% XET_($#TWZI91#,>:*!@0[U*K<(C"[*X[MEW#;&Y8,^VT2#*"\U2!"<0!
M"\9!,LFA7Y^D2_VV79;1,L@J
MH;DF1 GN\D:>O9=91ZX:'S0O/@1"XRV"O9SY9?:N\JE,.'\65V^F.&4N[APK
M,?3-$*]MTZYN\SI-ZU-2[>3-%+W_Y9WMY85?^S)? C,YU-L_YK7ZT5Y^2P,6
M>,7(2**.MM.S)AF3Z;3I9V\7BZ6;;R]_7^M
M6S83-K:[>YOH7(SRZHN?+%?U(+-9^-Q,-EV%UZ5YG4_Q#CI$4(*2G/)%PRQ%
MON:1.F58=!@2'F19&^V 9'I,U*8(YR\C\8Z&[ 
M9H#>ZZ2EB=$ZH,9$B!:#YICM#E/2Y[ORO.7'7)TZO'C,C@'C B[=;HQE/CY^
[email protected]^:EXYC,4]!:+0FZ:)Y9C?H"OE@HI*,69LO]6L4@'L48E??U2/4^#P
M]9OBUYX]UEHB#(Q@[$XM@Y"D!Z,QV"(8> 66;*7CMINV#AO8'I_0]<3U*,7N
M]6PYG-6]Z;#FPB9?18-T.@$BQ H8EP8BI0B72]:I?CG\,AO#CE#H>L)ZG#*'
MSPXK<_ALS5.4W#B1Y$Q&@$O_IW%F%8! ]L4[Y=@M[QA/+=.ZN9X5P9QT$8%;*-
MK2#PB":7LL@=(T*Z?L=8%5HL.J@)&0S3DI9CW(4.?$%>MGL7KV^$+/2: YJ\
MWU9"CA)P&5M[%G]97KB>-SB=DU@[LCLZ7#VDG))*IX
ML)YBN&HB!\*X !L$95HB>.28=VR,*@^S R%8QU"
ML*'2&,4FP<":O"KAK ;MB2 D^.!IOV+C,JGW@PO@*!"/9VOO&:5;!*\Y2.]F
M:)(6C9U,KE:\H5?Q;9O^R$O;]Z@;UPU87Q3]SK:+VV=P%'_?R)A^B&=9"@N4
M['S_IN*LC2LQJPOKO[OJY5Z%9=&7GDQ6VKC)-SQL?'#LD=A(Y!RU^:_C?-$V?G7L!3[V*X::!QW&U1]/K\4IGP^_
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M'RVG=XN@H3^-\MLW\8DW.IW&MIU=/@L:FH<.Q'[\^:;(KO[ZR[^G
MBW\%A" #>(W/?^YOM;B_R_[ZRWQR>S<- +UIKUMJ-"J6V?C=)/TRF4X6DVQN
MLT4ZF3;L;^7K.A/$9E=9463C3]G7;+;,CI)B_[LZ$^'M+'QND1?W1W5^UULZ
M[?9\$:>AN9C@\^4LMOZ83R>C21T1
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MV;S[CM9'%75KH6NA7=&"^-C5ES>
M!&.PJD<['F^_(S45N[]5^]VZ6"[B?F#C%9!GO#8K[/Z4?ICW]NU:*M?7JQ'
MSL=I.E-A^?TZJ9TAT<:[NQ:QYM)5_Q7/=3@M1F6?-W]]V.UMXMYDMG@SGMR^
MV3SS)EBUCSNV(S6PS/:+&85TU=\'+5OL3_A[#,'FL]?C["I=3A<->[?S/=WT
M-;]-)[/CN_KH-6WV=/7BU[?9[9>L:-K-Y][18A]OPJN*T?)+]GH+2,.>[GG3
M<_T-!)F$B2\\]2X\LGDP=NFX'-/UI[)OP7D<9^../E8SU;/C7M1)U>RX"_L3
M+GOX^,'YD?WU:?_GX\?#YX.5_MQH6XVTJW3^937
M_B0N9>0U@)M$\__<_#B)J=SCY32[N%)?0Q_B*N;SXC*=/@BA!'&SMXOL=MO!
M\%@V_>LOH4=)H_"@BML]XS)9AET&L$,5&/D5CY)WFQT<-)H5@M
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MB\V9J\7]=\NHPE"L^8:$$L6XL,PG([?3H'!VMDMJ[?P_ES%(1_."8-S4 ]'P+U3IQ?
M+S\763I?%OJ""R8N[O$@7V8$3
MQ-YVB39*!])[%$0-KIRWBNDMXRUJ9,CB\R5$FV#UPHG;V^ !3-+IQS2X C6X
M\,SSB2%.&29DX#ME.'ASZ/O& T*J49R+G#,'C@>I#]UGQ6)UM'^QAN(NGT\6
MU0S8W2HAPE! #3**6&H5$!B:4D05IK\F/*!GS(/6H.J!#;M]^LVYFIAT-5_L
M84;--R1*488 5I)ZIBQ%AN*MC80\Z&G+K"9+^MF![0:ZT[)F-%K>+E<'!_Y6
MY/-YK&R03J,D?PNXZ^PJCV+@>/
M ?6D'&Q$K@0*X(+-X9%&5!,D.,1V(R V0J-!6=2G9LV!:'VGPU_>/,XH["+)
ML$XEPGX2#3<]*1-A[[\7M[E_5R._L$[SA$,%J8GYQS21
MEE#J(T-HS;6'':W'O3](;T-;NJCGE9.VSO;),AH$8CK+&6,"("<
M@&(KGF'#S?8_1E5YM^B\.!(,;>T>A.Z/7[3MI,A&B_*S^Q?KYYY-()  "T*D
M02P8*U)1+V2:!&B)I'7(8(,^%-F8['5G&O1^L
M<76ZYP;UB'%EG5U+!I]A*CRK]FZ8*?;;!/_L*6\*G"43C_ETZG/B]_38KPO
MAG7XVQ(+. 7:HIC0KIC V&UCNA9;U"@9H>O!W,UN9_?H]4"H_5W?PYW]#1-I
M#,62*L>#5 A(:'D91;""X$8G ;H[*=2E)O,.<3LY03;_G&3SM_/Y,MLWV1SV
MH@0:[#@E($RSG%!*'6=;(+"QC>:9[LX6#89 1^)X=R8*62(5Q=I@:H60&F&]C998 0:5D3DAHGW@F%)
M+.8>3Y/<947H^_JP\EV$<->E?KV=*EGU*%X>L7C8K7?USI14
M-$X$4 8P[*626&'G/9*KX6T!$$[AJO2:CH;X]L333@GJUZG>_XK$&($9\L&C
M\T9KHZ#GH@0@3'@]&115)TQ:4^/.VM2MPC34L$4*(1
M@9HC 4G0 @30E3@AU\R-Z:U@=5L<>+K-VC)N_6RS[\ B]*#.AGM5ZP1SI CW
M7"&KC(/$46E*D8768,@9&.WILRY7C@;N#\&9 :9K#)HJO5/D1< ]:#[Z&5_7##H78TRH!5GBO-62"861$H#K=BB@H;<2!SBJ==,F!]D#J@0=^6034
MET460/"3;_%OU338W2C10# )@',4NC#).4*@+P4,PC3Q,A'+M\X4QJR1\ODY*K]%E$X9.5C5
M:6L2-%@U3 14VEO@H33(2VBK,/7 AP>5^FQV5V2C
MR>;2][MIME+';+PI7;KZ^4[Q]C"GK4\D0AC*LUP9CH<
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M!V.HJ3Q/A*N5PK.G5=8#5<1IC$Z_43/
M?I"]3I+%GE8)#4NQ8UY:@Q5%EEB-MB)Z3>A@$W):T5OEY'$L4"^2$T-+N!D:
M%?JGP*9VUY-.5\?5][=,*.3*,61-,/T-P5@K8DI1E3-]Y5[5\V1:T=F//&@5
MH%-,!_I>9[/13;#L?SO<4'C4- DR4>@@  01@EE8:H,OMQ%6$%UE+Y^B-&WW
MUL(Q$)V$#V5_#U\C?FB:!*L/#S>9M3XV5_&@%LA?.
MDS,P* 9"CU-LRL7XS_Q3-LHF7^/<66E3[&J2>.:DQ5P0BA$,LR^W4I3"4:B&
M5!39,B)T\$^K"LJ+OXW.,)())Y8D'H'L;60DTM#QUU$&H"
M2+.TVOZ&;O.P8HN@G&(-_Q@,Y1C@O\[@(>OW@V:!HB!\+7@W E# '%<&N!(Q
M0Q$9]O#M(*#<')SN]K2:[^9<+!>A959,\K$:_S,XNS&.?<(M'E<4>7"VBUB2
M/,@1S[=\#)TK?NQBF$OGY8U!=7:!CGIO AP6$FH4G7H"'>7.0QD6:F"DY!A7
M;>AVM#QOS[#6%>Z!;/7/DC=]><*9AX(#R)TFW#!& G8;T+!4NJD_8#G4_Z_\M8Y6,J_LP'[V?S+3K!B&#&)-#",1@!)HYM1:)HN!<]G4*M3RX):@O/%T&5H87/
MSI0A;3C;Z]EU=OU].EWD96E3D\\7^=4F!O!#Q:AT-OZ4C=(F*R["
M+)_&=[EO=P'XJMLC^_AV8J#A<O?K;'Z7C297DVQ)Q)>!@
M+:$CM?7$*VP7H!?'@Z&9.4-1?^]J?S#=?9\#*W>']K1*-,!6"0RY0-*'>1-(
M&.=+23RAS(!&B27=W6Y]O*;RKJ#IPY_)@B4_RF^S=_O/0#UZ+H$<(,25HJ'7
M6D.%.;)EK"P,C&'5L#Y-6/ 8P'K97)HO+DH[=^]NTH/G$L8!1PHPCB2G\7"G
MU;X4@PC3:,^_L^VCT^C]&,!ZT/L3AV6/[I\\FSC@H#+>2Z251H(JA$$I#N:X
MTV9'7T^C_6-"&N*W8\?DUD]_>3M:J"%WZ?A/%2;[X\"SKQ9?IY'H%U4G/
MR3T]75MGCW1?L\12S!C RCJH#2&<61-8[1%07DBMJC) NMX"_;'OL?/U]SAW
MMDZ\<4 :)Q$/HUI89:CV&[&1"A@,8!.S';7MW*-L"YNA;D)V7Q];&^\(0(8'
MS($VT .&2IRD CU%31O&P%I0?X/2V(=!=LIR(*V5.1;!P&>$*R0- T!SK0PL
M13;.B,&&P5K59X-ZQ\V ^T-P9F@ALZ%3Y01.=5N%;X5S3'I$#<-AO8^W[%E2
M+O14H&%EZ+:JJYJ%;P\#Z)33PZ_S[&HY?3>YVF>\UFB=$":@]THJBH3@DG"B
M62FR(VA80;=.S-CV43JS@E.,
M-;Z!SG+3:*NNLZA>YZSJ#\F^2;A?I/V5$ ][44(@P8! Q3@)ZS/B"##S?322
M1DENG57&ZYY2;0/6-W/6.UG;+?*'14 W8>ZZU*E^4Q)\!&-@!%]]QI';&^R>.7,7/O?5#*[?*VO)75+C/U9;XHTE'M6:?J/0D-
M8#MJC&%.6&BJ<05"580L!D6A4\[,77ZM%K1_,K3:@' 3+ EQO9Y]_
MSV/_Z_II-=Z4Q&N#N406*@X#) Q)N#4/&04#.WT[$%8= ^%0V'0LAQ)"K/%8
M.JT),P!JA+ MQ586#*O6^("8GD2QCCB5')*J;42:*J8* $COED:AGAA?&L9Q)Y9]R!S:G-,L":C
MGC9,H!#:6QN6?6+5N.!NAT3/B0ST9-R?"];:*$ID9A
M3(/E@*SAA()R29<:BV;[8. E$*(Q2%TEG>[)L]SFR1Z6:=EAYN?'93&Z61T!
M??C(K[,B&^77L\F_L_'G])O.9N'3B]/U\C*[2]?EB]1UD:W/6I\P.36>;GC4
MOWNFXF=Y]S%S!9W%'F6IU+S8-Y)I['? HN8'&Y"Z9&:K>))
M)[#]H9DTM#3381.H=^*\3V?I=58KN_3'1Q,DJ3."6>&X7E5-T5R7PEC%>KH@
MJ*;GU)FF\E91.IOB+0P: CP309QXHAUK%?Z[$4L1V]/NTRF-C#9P.;M"'(P+
MC^(]\0A!# E +/RC--N!\H,U'([45NV*',T >G$\&-JR/Q3UGTSM/H]YI?,:
ME?J?;9!@JZSF@AM!*;!*"6K5UD)2 SM#TH)^=FC\*%3Z4/?R[FX=M$BGO\ZR
MV[MIOMKA*2.-E]G7K(C9H^4/]C'AT']I,8[':-[GXU79
MA]AD50-Q#<7#-\6*)OLXU\/G$T8L=E +3! %2@OB@=^ [K05C>:RSC*GNJ#I
M\$ ^P9Y1IQ=[AR^-8S9U_.0\GT[&\7#'P\3]TWWX8QKW]&ZR15#BM,]>?"_G
M&TL'S&_\-/^]5Q@>=2#PMC==Q
MCK>SJ[RX?70JK.5/^G12;#).MB6=W\[FBV+Y*"NHWZ^><'=SV[/UQGW0Q+M)
M^F4R#5+&4K_I?%EDXXO9IRQNN\>*PK/QASQN&*__N:JY5&=#M-7O)$83:+17
M6CFB-:2$""(99B#/Y," ?ZG[P%@]]O_WK_YV$E:(8W=R_"\Y$U09QO1:YZ*@9P4##W!%391=8VL>W!P]MV=H/2:EE\*D%E##1RWK>9=+.H0Q3\LJ886A3XK+IV.0V]G=\O%
M?(4'K(Q7[VF5:("(DPX:!3F!F@,)MB)JH_NZ':=>H*WBR-%PG8@1J!$C
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MMO#+V;C:M'F^01(,-Q)$@7&7%^DB.W""V-LN481Z
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MYD2S.T2ZSRTZ+5E: K,'KCR YS#"[&^8< (&;U[^ L?LS#IQ9A;IK>V\ETN9A\?6"QG?#X
MM J=&C_ID/NVCH'XL#*MKW=>#8R+*Y<6LR#55M)W-4Y.M_6)1" E,0/!=6<$
M8@FP=)MK:(CCI/+R]8YRWD8WV7@9JR >*6?5R>EV/Y1@ABR4W&'LF(?6,$-$
M":8-#D0_#OO>X]/]$^=)?:H30C[4X]-'0J'OGW]!15)8AU]-('&0&<@)HM$3
M8EHK7>I%\F;1AXX/:I^*F3_ZE8/12A]1C&?[^B&]S2K3A:J:)HI"@)2EVD @
M&49.*UP*&_>U!YMO-@@&U&+ET6B_<(H-+1'M13*K=T:Y5;G$++M]I25=X-/#^K_E,T7Q62TJHL6
M.OMK0'_^Z?+72@KL;9<8%P:/M8YS*SU"7&%A2S&5']AV36"P^: 
MC4A6,VV8YPXX1Y%ASB%>BA0^VJCP0V<;+_V,_D;(G,R0J+UXJMM\N?<*P%;>
MGW H/%-&8RNQQTX%[V,[1@B7P[K"_>31B%-@WM6NS0\!TT[CS:O[2&+)W6)Q
M_[E(9_-TU&5-T%V?.V&0=T>7Z@1OJYHFC# M% Z+'9,,64VDI@)I1S$%RM.J
M?,*N@[*[M*'O'_VF=NSU@/$1,3X7;]X98VU/O
MSM!I=X@--4):3^**@&?]ER0.,:^XD@PJH)CC2,.MCHQ4C0Z0]!:_[(0>3RSU
MCK#LQ8/[WL/*(-#3AQ/)!!=<(X@MDMHHK#3;#F#CP6 CBUTH;0\OCH+K!?!@
M:.&_8:K_ +7_>[KX5U0F WBCROB3Q$YBU.#+,J"[TPE__L%$"&. ECK>H!?^
M5(Q[77:.<]E7+9QZ[M(QX.8MPM!$1SNXM[FT(Q;BF+]/OTUNE[?!@9GDXUTJ
M//0]";,"4\,@Y(*%OREO81#-:TPHYASW57KU< VW8COV@5DO,_77;+;,HD/^
M0)C]N?$[VR02,(0-YX S X@#R"E3@HAELRHGG<5:.W,GVL*GC]#;:!0#+?-/
MV2B;?(UV:VT65#5-'(7>$R&UP@8)J+V0O!26(MIH_Z6S"&QG9&@9IJYB7)=K
M;[/[*V&>?NB$L:9-9SYE=S&A=G;]H%=UXDUUFB<>("$0 ]XA:CPQV+@P!5#G
M* =AU%=M1'0=<]HC@[[?_+)^Q*GVVQ*""9=:0X @CQ4&-9!\#0OSW/N>PNE[
MXTWMJG=GS*DKS(8:
M$5L!^-CT\MX8FC3S^I:5CO;)!Q)Q()1;; 5+I;4
MT!Z6XF'O]&!C1\/918@IA&
M% 5?R&@ 9%@]4;EV,J#["O/5\Q!:P#9O"8DFZHG73BYOU_['RCW=KZ@=CR?!
MRM&"@U@/5B" K8&$E1UUJ-E].YUY^"VKK!U,>IA1M]>*_BW+KXOT[B;>\UIA
M9NULDP!M*%7.$FN"0*-"[ZC^$J?!&W69%
MZ&1E;NW3AQ,EO >6!JL40>"$\Y+K[7KG>JL27,\&:$$O>/J/,[[],PJHF$>(0:.&%ADX J;9=994I
M5])SI,=VX][M(M3'*KGIZQJ&Z")L<-GG1>UNE$C@K0O3
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MYI5\BM)6'50JGTFL) S$:P>)%CXL+*,[1
MW4F0-K1XA/A]'/18+?[A:U6E*Q\^EQ! A#$XF 1GK*-,8B^<$+0$U6 UW%S?
MAMSXT?,;#J8_"=L*N$.S3,^8IR?(MLQ'OST4,':XTES:TRJ!P7:@DGA!B;,P
M8(XY*T5$2/95_;3F]L!)E?PD&;,M5)OL+7[,BM6&P6RT%O:YHHO[DT'JOR'>
MLZ:5UZ$7RA!)G%9AE'+DD$;6N .]A'5M?W[3-C'VWV0&LK',&)H?-3Q"G"9+JMH=^OY48AW4" EL
M(3)<6L>\AJ4($O:U[5_3%&E)&\^E136"HP>-FGR^".MC+;T^>38!'&((*,4R
M+H= .^FW9I:TS?9W.O-;NM'NL:#TL?F:S;/PF7CGM\V^9M/\+LJ_R?JJO$8D6XMLYQJYS!7FHM2I&9H(T.?W?F<'3#@_9AZN7@X'2ZOL7W?5K\EL6L
MPKJTJ&J:6.4M]=(;Q(*?+!R$?ANB(8)6YH?TIR?VY.N]8*$>4&L5,[+(#,+BZG3IA3\N;[03
M.'O@T?8NFW4IC^=[_R&??__SZ:7A_RQ?]FBT_9*+^>
M3?[].&:WAX:]?#]1U!!,C?/6J[#TQRR@TA+4,0-H4.;Q"5D\1&V<\R!8%RCV
M>;'Y47P.GF(T/-N1A$%KG"1("FZ' Q?SM;B_NW(I]W'./IAH:CU6GB@"C0:<:8-CIBPB1.%X5G=0'MD)B#HH^#L[*;OW&.E\OKQ=
MR_'SH.A.7@%N02 1=P9Y:"3"E)8!':Z9J#J)UA%H9W50% !.#91A$"HBE0""
M0K>!D%'9U]V<71\4K4V4S@Z*'H;S4 ^*-CL+@0 5#FB/( <*,1U\P1)]%@M_
M]L.Q$R6SU%;\WK,0AT$X!&_A#%++A8HW.1OAE:!($0P0*3>(N&0>#399IB$W
M^L@Q;X;I3\*V N[0G"T]^#Z)6[O_M;)-(9PS2$$A++7,T_(N6*;*<
M23ZL6I6G5?"N,."1F/8UI>WSD/4.#]FGD^+OZ73YT,V,CF?,MHY7[^V+7G?W
MT8002I5B#ED<9@?*K(!;*UT8U"@L,N1MR,9>R5!4,(1E>Q?,^V3]>SX-KYE.
M%O>?TL5>/[O[KP<6*"^4U9JOSDUXCK0O(3<:-DK/&/*VY5&L'Y0NSHW^GR;S
MWWR19:ORP-E\T2?YG_MV F1 EP(;ZT,H*X3&M(P+,$JR)
MED1(K!$GD')60FAY7_?,=;T]5)LHG6T/'8;S"]L>\D0PQBG"A'-/*316EK)+
MKU]V/=':BM^_/700A$,PW\X@VFZ0Q8!8:B6#E'#LL,$EJ"+\YERVA^IRHX^P
M>S-,?Q*V%7 'OCUT3CSMGY^ME\JB6DO+-./2QDJY6,A@^VQ$#*KX Y3*JJWD
M TIE'89JDSS8TAU\KD#.I_FRHLQ1O=9)Z+G2V!OFK"(:,T?TUBQA0 _L]K0A
MD*,[=/O>?#YLVWDCDL9("@NQ] (A:Q6#'I4B(2,:[6*<5Q&LIK/)\[email protected] >
MIDP3I#&ABFO(E= 8 CV].!/$QE&K*=60\*#
M;VX$P\QO5W) !W97[PF#8"?'_NSH_(]L,$PL=8DP0!(&E9NN6,=KLPKTAIR<,8QBTK9E.I3C#0*-PPY'V+HXZEMC9US>8_O
M;UHW^A&Y.H&2OON44&F TB[X?BYZA8Y[L@T@.*H;+5!#/F'>=$"=BX;.>0 -
MO#Z.E!(S)+ F4ECF+,-(;'U-#AJ=.F _ATJ_:CE)8EX0]F=N7D,6>L^)Q 0B
M91P4S O.RUJ+0%I7M5_P,S[ISM:N<_-J
M$Z6SW+S#<'Y9N7F,&XVU9]I:K8P/5HI06]F%[.E*V1/EYM56_-[6?%TS-+
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MA[&3-]8Q@C%72%MAO2,,<&$X=8Y!#RVNREKYN8>1Q5LP@H$NE5;KB^=T-N]!$;;H;I3\*V
M N[00@)GS-/>^?GLB>7+7^O<5[V[72(MQ-@P(*PEB"!.A-MBSH-7?EZ>9*>*
M?GK!=6NX#F%Z:YR8OLTH_)1/I\&OCHU.5@4XC72K"
M4/+B2E8W]F2&K):7,3X^+*L"OWWU(3%>8R&DX 00YZ"%W.$M2RAI5-=W>*.B
M8VKV/X(::>^L!\_P3I8J1>.11<6QQBHL\H(@68*//&QD8P_ON/5+&3I'*>^L
M1\[?5]HYZWL$ -?*?AF<$GD54H4.]_4&&X,#'7:(=
M5H0H(:5F+,R3$#BZ5AH"6HD_7+"B&\8/<.0>J/FS'JXOL6B0-I1QH#6(EWM:
MRI@WOE2?HK917L?P5LD_S,#M5OUG/7H?.\O#'+T']C%X_-X+"*R12$C*+5)J
MJSZ+R LIH?>'&;W=JO^L1^_&55\6V7R80_>0#B9><^\ 1(P3)+D%A JS55SX
MSQ\M3'3FX[9#W?+F)I^.)[/K> 3C6=2JAMB!KTL@
M)4(K&BP1CADQEE$"2U"D@HW,T.$M9"T%:[H%MP?&;3"9?\JF:;PU/3^>=4U?
MF3@9!B*UT#L(35A N<%N:P%S\.*JIC9E7D\ G^3(UNJ7F[D\IAZJT6+R-4SY
M/X]M[:218!8;  311C#FO,5!LZO*@H9 4%F*Y>>QK2SA@,MXKPBB#&"($$"2
ME!#&:QM>QK&MVD3I[-C683B_K&-;%DJ%H3!::F"T(UIC7\H.,'W9I>=J*W[O
ML:W#(!R"DWT&IV"0Q%C)8(M8'@L5 4R$W $MD2+X_*4:3%]^1G\1
MCD,]CH$I8 @+\BYAUX=;-I;Y4Z&["#E4?#+A$ACE(?%**RRUW?S7AE$E)+-4 (0>9
MI="5RZOB!# LIDQX,8H/P
MY9&]-8T,F>1G>,*56V45]\;&P\126()IZ00IY5"CN&[KNY8O;SATJZ8ACY&G
MF2[!WW??[B;%Z@V=#HZZWTZ<4!0J 8P P EAC+.EYZ= 6(B;C(K6+VQ\>:.B
M(_T,>3B<[0%51+STABE'&"644FN4+E5@PG^:#)'6+VI\>4.D!:
M.@6(A]#$(\36NA*4&&EN0E_^QZ)OMY />=+>#+6+Y6*^2&=1ZHY/-N_]8 (1
M)@I9K;D)YJ&,R0I@"RQJ=E_[\(Y>M9 )- 3XSXO7W94QV_6M!#."K27!Q5%4
M>\CHVLI9KT@/\V_=
MMZP83>;[H^H'ORP1$CDB.-$68HXU<@:;$A"+<*/)=G@'##JB9]=PG\'D^CW:
M;R?SF!>ZE-
MB#:U< 9D?S!__'">K1SA'XO)J)-SEH?U(#K)V&F 3."%!\9;#[email protected]
M=C\L[,[X:%%[email protected]/>ZA1;:&VDM->+!'D)F:8$.V -$X@"2TL5$(?YR_ X
M3SM:3J:N$=OAZT^=:G D]RN'MU
M%G#7&>[8F[^\B;_Y$IK_UW_\?U!+ P04    "  *,:M(/<\)(Q.>  #UC0@ 
M%0   'IL='$M,C Q-C S,S%?;&%B+GAM;.R]>Y.<2+KF^?]\"K9G;:?:+-4-
M[N! SYP9Y@?4O+*BOR?_N#\R?[#U::[XI]EG_YMS_\\O$5
M_AB_?OV'__'?_]-_^S]>O?K?T8;ZE7\])&:-7;[=-]"\]&CK6S_;W]@O]H,0O?TC3<__@X@#
M3[TMTZHXEKNN8F+"FGJYT_K?>TG6J,GZ=5#U__RW/Y\2>61>L7ON;6BUW&ZK
MSZV@/FZ$<^I_X\ZY@E?5]_>I1D33M&]UI%)K?L\X7EL9S
MGKSXV9"LVAV*ZEBFG]C'%[%4?]NX$?7"&+H(17$0L/^S8SQ$1@3!33W6&,*?
MD4P\D2^JOE*9<7Q6K_/;HKQK6Z=7OR9SGLI1R;2=JH ZZ;-^;11:K<2%:?6,
M:0+@4K%\G0Q3RN@%G*F[Q4NV=^67;9[]L_U^XR*OBD.V;W^#\_U[]M(R5>UO
MW]TF6@U7<6F,6UBF-Q5HG6LR?(,*\A;L.9LR<<['DYR3&
MG;@Q,&<1&@$?LNJW3]O/AW23$-]UPP3Z-$0^@6Y@)VX;++1M']!8I!$E&<)P
MN^F1*JN1Q>KX1MCUSUVK@7PDGL$[,;1*V&:$DL\;,X$]12?7P3'5) JM;Y!V#\GQ=TVRS<>I@Y%
M24ABB#U 7!*!,6(2N9Y:0X@_SE)DZN0IMXD$#)5M&)GQ4A.;7K)QIC;2Z)%0
M0TGZX5T$D5)I6HN)ZUF]%606"J6FJ'6M%=3Y-+D\DKH
MI2N;2X)I=4FA]Q>E^>[KW;;\K6W:L:=[#G5LVP6N"Q'K>\9@"!NX$5;L HH%
MF[^U->K3U1D4=%>Z1VC.6.6F%[>G<_4-'WDEUD&4LWDE)-.6SLM=116?Y%DV
M!!T:@I2"D+4$ Y+$"."0('<<0$N0+]8D4PVV*,OT=!^%_96EF4%K==)L';W)
M"[>$>"9I]%IY)IO.BSQ3\HF79WBW*XYY77U(=VGVK9D"Z)N"":(A@7[@>A X
M;ICX) R&<)Z#A992201#U>S."B&*2GSC-#IFCD35%+V
M":[IW!Y2%NM;FA_3MVG=QZ*^@V+L A*$@1\!&@$?#K%<0$.A
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M%
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M)#2AMAUB-[0=ST_"9 B(XH!KT%U#F(6(E;7JU&G%:Z8\J0SXJ(=2KZ2M/*5.VZD'5.PY'9^/5F1A!:,F8O%YR267#@2]Y
ME_CGU.[NBGRZ)QI3F[HA#IS(Q4&8H,!WZ1 9A+$C-K6F'L_X#%LCT2?>YG5:=/ZM-7E]0V(DS?1VXTYK1DQDZW6Y)8.])]S4 D'$6PS@"
M">O* NJ[<(A((EMHOXQ*G%DQISCZI>2G,,^,6JG"L84'O28LXF.6M+&K8Y5\
M)M<9I>B.-)OZ3JSC1XX3);$#/$"+C&M=\48$0()NKA0^HEF\!!XI5Z2A<][U]'SJN!$B#F!1<> 3WW&&
MD#9-!$]"4 BT!'ZDA[#4+)4$D2DW==!HL:&K*9=$N"1C[DKA))7*2X22]X<7
M4]&VRJIWM^?GK>-\_S'[DF>WV6Z;U_VV9Z;@?7'(=EE:G>Y\\&S;32*$ (P)
M<$@00V=HK@68,50$8T:%&,9I037P>MY4BT6^$+$>/\ZWQ5W
MZ;B(>%PQ[ 0A1C8$- E=Z'AQ8LA [/&>CB#[>'.?>Z?H=(/-8NOD
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MJN @YQCK/.:)0:D7U3HWREJ&2-?]F1J*53=U'2S2DWV5Y5K5GEWU+AZ@HB" */.RP=AH%B8\!#(:H+G:$6DNJL0SSJ)?7?E?;
M1P(%1W54+>4)#*^+/YTPZ/,W:T?Q9.1)<6!I9=-DQQ0TNJ7
MZD#2PJ-'(J-&W+ZM@RD*^E\:)1)T0I@;W2J9-T55;=S H;9ONXX3)I 0S_%L
M-$1"R$92Y!!XOF%V-!JLINP&?A2Y+#=$3!,DAR&_9-G1KXK[J1%T?<>]68"<
M+.%!B(2!*X.(3 ;7,"+M!O\Z4=;)2*NZ"]13JUE5 SV: -M/$@=XR'6(VP3N
MPB$((J$Y+ND@ACM+@RXKZS^3OCWRQQLKGU@%IME(/L+,XJ$89D;[!LK0T;[9
M%]%=LV<".# T &^#:F?
M0!KA874?<@$6NJ5,,93I"?=&G0X4J3K*V>29STS!UD_KX[FR)X":N24TZ=14
MHTB/Q>O@E*YD+IM*.CT2VUW3-,L2EF=<-%M[CBSVN[%G$J6W19EV/_=I^SVM
MZ/>ZW#*3LWQ;/K2WJS'1S+J:>7AH97?4W1 -"B.PL01
MZ<8MJ7..[N#G5OW S+K1+]IJ6[ @>1M^/T89BK8=SSJF7;?^E)IURFTHXO[G
MV_1NK$<)=K=0WEB/<[2&))?8_66DM":;LLN_(^NH95;AQ+,[V=90.F+U&U/2
M5Z-1FJ?-0EL*8.+'40)!$D.7L-HT&@8S41AZ0@J)=0?E2L:"4=%*@FS9DH!GDD:)C"LGWI5,S>_KWCS(D[EW5P3"A6R
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MV3FZY^?G6L>*_7R6-S]P?VRG-)\V])3Y::I4^;"Z@N(4H^U8CKUBJY/I@'T IK  !'DT! C)^9=DV]8
MA3D\G(0W1#B7;O7:K59\?\SWJU:_-22P6(=3S>\)7LQ4D.O@QES)%HM\+()[
MQ'=?T_WQD/83C_3R\._;\O]IV;H=Q.&",1.R-JR
M@0_B*([\! _Z["01NLAE/E6&.])#(F.[HR?)(^*<9V-][email protected]:;DO5KF]1U
MZ"Q=Q'RUQCI+5ZP"F;E@S>RMUU4.$Q7+_&6]CCIF@;PO-_HOY#SW&4I-=/P]
MJS8D=)'MVAB[49#8KD.)YP8^AB!@,4)/Z"96_J<:)G\KA#44F11!7@L8P\=;
M,YZ(\9++#C-G&@W93U!*W*%U4$9"]^6Y1)*9"WWE/Z=-5WF#$@JP'X2>BQ!C
M";3MQ.XCA$GL4.'OG/.Y\WSII+C;9KG,M\YKC\#7;L 9J>_])5/,??&= R]]
M\X(^K>BK%U7^W'[+AK[\78_W:R1'\_@5-XB. .7_$&,!MC1$*/')A@@-R;JV#!)+:
M"QWOBR -MM_/8F 0!KS6F*'!N0M3-)!R:R4TD--^20,%!WAIT TNL'_2]CQ;)@&W=A>HT9J($#0)3X""IO=#[email protected]/4)[4Y?OW[ 5[N[U+NT[GQ@\2:C-P$>JA$"8!
M#0)OD!I#+-3(6$3@C'22&KQ8IM0XYYC67F!BM*3_.&;UPS!9M,BHB@E'IR:.
MEBS =?![60LNIY.6+P_NVJ19H7FNLHG:MV<=UIKU0C<)/)<2A]5AT$=#1 #"
M1*A24(AC>MU!NTCUT61T(TZR7ZID*">O9_)2<)9?UD8S!+[NT11(-3B[$A[J
MR.02:]K<>8E._SS4_]B\3\O;HKS;LGQ;3GY(J[K,=G6Z;X7\DF=UU4Z8AJEUIM1JI5HGK5;W+;9J!3&FW?EI
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M8D1)A[/K&%'2DLFS)_'I<$>13OT8.ZO^H6LN9NY;;(0Z
M$0 !) Z(_9!0E$3.$"%T!/<-"SS7,(T^I-_2_)C*SKB)&,0YPV;(&\$9M?9*
M[H7FSTX.3,V72?BT#CY(*;^<#Y/.GO?;;\XY>'=['L?V'>C8G@?#9ENI'=$P
M&5*&@
MO]#U%@GN)DVKE/WLU^9X)?8]'8K[ILG2'WD^4 MBUX\(I3[!-(9)&$7!>$Y*
MX-E"NTPUQ#/>SN@D=H>7G41*@D:+PWSHF=M<,1A=]76X,&$9/G&8-D$LG9:O
M@V%:,[K<(ZO=+>[^4=I>),,"_[PM?TO/[JP>PN*$>$F8Q !!Z 34<9)Q:9(;
M>%"HTZ0:S/1:QK8YT'R&HS[97I6RK9Q=K3D=%>Q_==(N[%R6:2_9-=59T^7T
M.FBF+YW+;IU>GW@Y]M)/0JS0[%6GGDY
MIMN!',<5_ =G=_*![2]&-:?LMVZ?,2WA;YM[1JKN%HD%Q]:FYU
M/?_[9BKJ;5'_>UI_2'?%ESS[Y^/EPQOLQ2[T8IJ0!$/L-J><#3-347/"F= U
M;JM0;)B^O^3EJ.LQ?G=,N> M<*LPC/G'547"OSY/*FOG6I6T>U^3XM
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M!M<)0:=;1Z_(_/SPY&+2+(
M]E$4P^9J&>"Z& (4JI%]9T^'IE @?2+%APTW73#U1FRU5/?7YM
M7ZW/L-G^U.7X8[P% L<6_1AO@]RQ1LN_%7R''QDK@V=:)"LI]!41NY.&2[A^Y_/Z7?ZX@Y_=L&P)#8GJT":8->C
MCAW['J4> C'PL$@W6%-(PTV'5F7#AO?LAP9FB75K=7G+UU-=P%:QVGUT]"21
M<;B59_W:_[?1:;5"9UZ R.?>1-]0L_WKZ.[I3JHP^LJ*'I605RS0OCN8_"*D
M%SD.MFUD1P[K"E+B)4$RA"2.+\0[I4"&*?>^S/)==M_L 60?YB.EHF5)Z?[]K>'5DYUJ0=%$-@8XM". ]>W QP'_J#'BV@L@C%S*@PSKA=N
M#6FZ=JV[W#I[K7@TRI:V>X*GYXEL';&?(LYC[PQ##
M]"]5^NZ6LN[[W;9.JTU",4!^[&#LVQ$DHW6W+AW>W
M'QG$LMMLM\WKEWK"OI\ AR2N%R=QTQ].'#KTA&$",>&?\3,0W#!UXC*KF<[#
MV?!1]VEEO 0R9SO/?-W"[email protected]'5JK7>WUIG>)]:+46VFPA"9-ENX4"0GQ$P4
M#N<O#'J_AGDID^D5,[W#8@W@M^GO9X'+(F>_W'77USXO(TQL.[ ]
MU[8!#&(<$8SP("-B2D2:R-J#&Z[./J2[].*C?21:K%&MWWJ^9O>BKHM5:4SJ
M=;?7TTH7=72B'6^L<-;1TC>77C'32RXX#+S-RK]M#T?6,4FR?)OOLNWA=5[5
MY?%,RL9.H$MA1*&74!:2_6\0CF@G2&C!NIZ(IH=WF4BK5=GTNT>=UIE0P1%?
M/3YSCN[.;K'@2.[+[JZ'G5QF3HW5:BV,=5!2D;BU&43_!K
M1WX("$Y"U+1F"8Q]/(;S<2!X*9-D$,/4&W6)7KLDZQD?SF:Q2XQ@HZ3U<.J:
M2Q-H4C9V'3123^/)!4M:?!$^#N!T\D!_SF5(XQA$CAT2CR#JL=]YP]V8/@K%
M5@S)1S%,GEG#BYT4NY5?R;PH^[I.OBC(8]K
M.Z<5G1':Y#RUP#RZLL!\;*KAJCK>=9]P<^18<]/OI[2\%RHZ/G3](L0E.9JEO(#KK!I\E
M>&.-+\.GJ9?!W-9G(T4U40^LX/U81T6R!B.>VP^]AK(Q?E['E."_%N2JW;Z.LF8[RT%FF G7=
M#U2M4&T_3JEHFRLEZ5
M54Z1;ZUEND -:;PX5U,_-IE:3:K6D.N/7CT^5W9S58Y*[\V_8-6HYH?)BE%#
M22W:=239MVR?YOM6=P(\)P+ (8UZ)[8]#]&Q.O=LM'C'44CM7-W&?2_*>LC2
MPWX%74>Q,EVPXVBL.%=3+8XOR9#JCUXK/E=T[^\/K<#M(=JR[[HYR3E-:Y)5NT-1'=EW?[9(U<.Q3VF,HM"-70]0F(!V
M@81+;1C$8B.C.@,;KJMZ?58KL&5]LY3+@E7(F4SKL=MG2JU?
M%UM^)>+C%,]-%,=*T&PDM4O*FO./^PKUHMC_GAV:.XQ9IX6]Q-GG0\/NM*Y.
M*O#GYF;C7NOF$A#/?W#KITP3D-!F\#JKI2N;RAE:='O%RZT-Z:"Z%?;\MZ\>'
M& VX1!"Z@1_Z./(]2(CM1'8<@(AZT -AE%#.+TPYCKEOK)=FM=H>'Q:V5-OB
M);IV4[WCV".2"(!"$,0^ 3XA!*/$Q\F  ;NS0D@'QYF]S7='P_INUN'/H60
MHL0AK,_!6D6]2 )LH?WL,TLSW$X9LFEOE3C+QSHE9 T96.[P'-9#8NBB/7DA]K5QY[0D/N".DV/UU\AVJ^-
M.,&*:-'BY!SI_T%*4G":0*X0S6ZCOIG%4Y<3FVL09.&FNGM
M]BXEQ=TVRS?8(
M&*P"?$/>:J$VKZTSTOMDES"")9Q>,T=ETN&"H;1/ZJ>'!9C@)/)M$%+B.Z$'
M;#C&-]_2\G.A?G[82W%$OK1S2=P?W'!V6%U8]^Q'OFZKU-H5=W>LFUZU
M1V/]*YR)Q>OR.KXR#7EPGXDEY@S_C&Y5EUFSR+Z-^$N>U=6'C[_T,6/*VB:$
M4-\G80* CV$PCO'B1*P7JA;)^*SM(*X_9JZ59_W$!%9_E#RM3]%:WCG;N5P5
MG:55,M30S.R$5Y-SL3H\7@>Q-.7R9+Y5GT-2+8(^$HE0%*/$IS:E'H@1I< ?
M(K&7(E)H"W!&,-X*B,]K_*RJCLT 9],@8+_*ZZ9Q4']-+?KQ_7L=AXSR^LHY
M:6W84,'YZL<'BZZ@]236;A(T#FOHPZ8/VV] _JROL]4V^"[YKZEC>\$"<)Q<^4J3"#%
MD**QU>WZ(9BQJN%4-&<]4YV0E#Y"TNXQDM(!2?<,2563S(VU;=.Q?LKR[D^J
M/\Y:W?"6[RQUC8&B7:2BN;&Z3'ZH.J:3;*Z"$2SU2.-_'17LI7YHWMT _L],X2ES?C;P N@%$3N 3VX7=+3"!@]V$]^0-
MO4'-<>1,9[MK_Y'2->S8%S)R@@EF"F0=W[ZAW(HY7FD#W_)IDTN ,/%H0",2
M4<<%MH^A/XAP8K&)',VA#;?Z)K]KL7:;;L\U M2,W:8(NMC>/#$O52$J7B@_
M$$4EDI/!J*R'XON-XNU]5F\/;]+F9#IZOX?TU5TV;
M *).R]=!0:T97=W>HLLM7MZ]+XO[M*P?WK-7LF;8I?\X9O?=N9R?V(/:-3=(O+%:D6W;991Y8S4RI?:3:+&:
M#WASNRP&/ T&&R$>AVL3Q-/I^3J(IS6CPMP;JHEX3=Q^S7+@ X)<'X,P1K8=
M^1&.G2%R3,6FY77$6P/QI/9%:#%;D7F&?#; O$7V2'#X)D,]"==73CV9C'BI
M)^V6P/C@_9&A88PXK"*G%(4)\&($D0U1$ /B]M$"+P!$<"!0*H;Y$;]6EI4.
MNB170DI[R#VP9]P^X1&\SCG*[YRI<;KGK)D>D%,RXF7/1
MEV5=V3?C4AGB0<1B84*=*'9=G_5@PR%D&&$Q\*@$,DV?YT=TWLBN350SE9-$
M<_DIB"-Y*\U0:<*F*33I<'"P ^;25PT1*8NH%KZA +Q#'.K4V(=F!3KIW]/MZ7HJC8MGBIV_0S9J;7K
MUQO=B%Q)Q^_DFDS'3\+S=W&@Y=JR$]?7E?&H'*K2].-Z5;7OIMU-#JNK'^
M.FG>7.VM5H586TO,SW6@23V-E]M8,K[(0*AZD[)XZ?DU59V Z.'G[7\497S8
M5A7>[8YWQ_;09I+>E^FN71^[<6*;^H$/"0PCZKG0\S =U!$_=C9Y^J7Y-Y_D
M^HXFI7%]H&'W@3[)@OMC;1+XBW4FT=JW&K-NJ7O3]-B>791(9.S0EZ.R0J%P(GP.8IY?<2?)>N)
M"F(^UZ7JDVE=;]-ZXSHNM%T'(]^%R 8^L%%\JM3<:%,7S=/$J:,>6J@7/ZK4
MT/C-T^M[FV;Q7 +R\]JMQG(^B+^=* 7SO'[13UXLZRN8%=)78W)3D-7MH11+
M7^>[XB[]6#.,MS=QG[45F\NW\RK=.(D=QTXSV(I1@NR()#0:ARF"2&SKB.;8
MAL=$+^\O[*Z M+8[AM62X?68L_?2VITS5V%\04MA2%!VYG)0PVPGUAK5MOMV
M3X74"UZ0L2^[R0M9C>6R0LKJS&X*L]I=E.)L@C9U(OC&%%,(*(PC$?6^PEUI"FK'-DP8SM]UETGT+KO%>IFJWH!2)!U
M5N_5N-H70Z_5&L1:3"W[RZS:L9]M9@59<[9N-K4_++R@/LI^2)MEELSP=[?=>]R\QAN74NK$D.+$B[V QL#!PUKSP &!T.DX
MIC08)B_[OI#U4]E*R_(O5FC=%7G]573>WU@)Z *N>?.-H/?&&H4W?8\S!J^-
MM\\:K$1>M2+[41BLF*4PC76XJK7U^SK_]'O1KC7:^'Z _1 0!_L.4X- Z(SC
MQLBS7>WM7X'8YCGL&VC9BIBKL6UKR%=CK5LKRRVFN 7K@NL;./Q4;K7
M>7>&XNM\^)M-2+#'W/2!2SP0@8 $"1PD)3X0.IC'J!##+CBYTSE8:AS/ZBW!OE-0_3]2_7:0L2];K42B#64X(_"
M9QVI"F-;F[_Z:/Z^8]/?MH=C^N[V;5I?_/V&PA#X7NA[GD=(:$<>1L$@S$V:
MP]9T-FR5Y1AN]?;ZK&^-P&88\/;YZ3+=?%R9%$W3A!$"2'8
M#RF!'L4AA>/N-P( D=^.)A%,A!%2F]*Z%GHOQ[IOUJ"H[,:0\5,*9QU:1?[%8'^).*[)$'%6BEB$KM8'KI&\5[#K)$<>7A-6K
M)IA,/GP0DW9*_$AS_&V;'9K#A).B_+@]G%U(\R%M[,D.W1;"]L#ATTGKB>N!
M!.&$N#AQ*"$>3$@ (NK!P$X0].7..S3E_AJ-VRUAVFZ7[Z*&Y2*-9<'O<'H:UVF1;IQ>2H&.[08A 0-T((QP2
M.PD&20'&0B<>&Q4R(]_/! _+W!N@J)#?;!GQ47\UQ2-&_#/9UDEWLZ/VF7)Z
ML!KMB\->Q>H)T,]2@NN _#RI%@M\(;*-^$9C,C?)6J6R37-5?T:;WC-;*-[%'D>/HZN)LY760J\&L
MJ1#6P4S]:5UM &OU3?T&CU-@C$,_3I+0<1V$;0)\A,86=D2AG@L\N,/-R+]!
M[>4QHU,GC1ASF8^%,QLL1L')TUL7A^#+UDW@3Z/OZP"?SH2X;^Z0]$IB]':W
M*X_I_DVV_9P=VJ[H!6TIM*%'PBBQ;6"''FMM,MSV @@B0GM8-8:=$7Z]5NM,
MK/3(K++;PF.P\F"3I;X/;,UZ>NSTXP@XB,8S=&%#B^DX(;3^ 'G(137SD"8UW
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MH],C"W@_-VZK5O@)\6N?^BP$'>!]U?^>9E^^-E_4-U:??DE9O?JY.1ONX]W'>'>NJWN;[+/\R?G$00X2!XR:VYV';"S&!=)"!'9J(? W:@QO^8$B:%W=9
M+M[NT.\R7W-C48/%6AF#5*O7:G5BFPY>)]J8BV5;;#^;Y_D3<0$D2.XJAT!\&H79M]1*;V_37=T@('
MA@7M+]L[S[YM#^)[-8R5D4)[;>;BT=-L&]IG3\EMG72O@-@OFRN*;(W%M6)F
MZ\R2!]K:755LSEW3LXEB#"AT;4!CDL1V0$,:]RJH@UTDC4M8]PTC[A!MK_T(+
M;YZ24^ISSU)HQQT555X.L=#^<\GA:U!(Z(<5QZ+A12)&/(&GN__$]2MTH=H$G
M-*9@6HOI]7M-F_15J\TZE__B/;++% P?5==4)F*T/5L[9L+Y=>S^JR^%+L7L?[;5D_?"JW
M3-VN/4LN>GCT-\W*F4WD.QXAQ/6\T&N&1)(@P-V:13,JD+&&B$EOTT3>#3@]3J8:"*QPOA[*D\_4C3W#&]"%/B!
M'P$'$A!&,88X0D,@'">V+.4X'S\OS3I1"CSC-4V<6P;\4N+32U89)U0G@)-$
M@NZMCSBB"4R01>TF5;:!$$6=T-+%?)/EZ>LZO:LV
MR$51@"&*'10B0"(WC,:V'4X\H?W!RL%F;8"=*;1^;31:K4@]'4P!@Y6ZE6:\
M56FL"=LZ9_=RM$N\4RGN]/H:=FKI\'4@97WB:O1=B=E/KWQ*R[OJY^WW]JK"
MM,R*_0:1 'HQ#O@^Y[OLV$WDFUMVW'V5_Z6M[,1?G
M&G=#?G,T+!>U6A/Z;H8Y9JO5>V/UBJU.\J)%(-!T7;0HY%JVVHN$K_4KZM2U
MQK$QQU?0=C:76S''.RO:\F[/9$N8!6>*LK3:A#8",/9]VT>Q[5(;4!P/]2(,
M(Z&#)>6C&*]_6F%6\PI8Y5EE)'S@KH*1O$WK.3P4K5C.[#M'VI1]AEK25]R9
M;$*K.KJ6MK-R'D\:S7J)8G:H[P8B7>5E]QOF_^0T_G
MPN ZWI;E0Y9_^=OV<$PW/G8"FP2L,1-# @E!P/6'V YUA%:JZ8EH&CM,7;N#
M==?\0OK$'$WN\@%I?F/% #5ZVO[B3.*-M:VM0:75RIP765S.32!,K_/K0)KF
MG J3[ZK@KK&O1=D.C)_=:KR!*/1HA! ):>BY-,#-:8=]* ]2H8$AJ0"&@=9J
M>M5,B%J9[%WM-'P7%L61I?WCQ--Y)SB)M0DQ]SZ:Q
MZU-LLV N1F (X9- Z")PH0<;QL^H18PW8M[P\<68+6(\&65,WW5N!![G%DS 
M0LJI=[^FM:/AIBVB#J0AJ#Q/7\H!VB
MCA-[B(R0+73@D8YXAE'12[323F-W-G+1R+1V_>#IMM4KAA(M3O,19FZ3Q< S
M^-O+:^UM!5H78]3S,HG#M E4Z;1\'033FE%A[@55F"?;4/94C%E#*O"@BVS6
MR7.2/@:@": B!PZ+/5F(8>+'"7]J_HD2K@2-DI@4T^J1TF38@C-@O#-?W&:M
M QZ2VJ=FN@0=X 7"FR+_S7?9?C/TP=B(\J, A$II1TAW;,'].O,W8DI]45:/H(F3E#.5'&L@X#&LGNR_\*DB_Q#4,5]6M8/[]EK7#,1C8#[
M!M7-J%<4AJS[1RF!T+4AB%P$1EBC.!'"I%(@XX-.G;;VG)G)]VO[@O1DEO4]8KV'_:?N]BO\FVG[-#UNQA8S+>,G>&L7G@
ML[+%\1#?H1$1N@)%6]39ALWVO62KWGZ7&ES7Z#0?_)8Q68R 
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MTX\6?DNLCY_>Q?_W_WSWAM /'_^O_QP Q_^O%OU?O[S^].^"2PZTFV7F'1/LI0UF]8H6WD+[V)>ICIR:D>O C&H2
M5S;,*GDB@)?RF.Z?8FW#FDX@03A$;AS0Q M"&XP=3<0:7(*$D8QB'C*-L&.F7-)(]^>
M&9D6 ,]V(DHH)HX=!$GD1<-!M@!3&XB=^J@4RO3H3M_*N2_*]B:WXM;:=8*M
M0Z/8*DZ2YSZ:<,JWB8]+D^'K^,AT)?/D%$*-'LD/I6Y\B)K'>M0E$-LDC%PX
M3D;3V$4B\\42CY]E[EBY(R'CF^RXJ5;+U,=+EQXD%1H#%P5!!
M+R2[!6?+6@("0R?$F#:=D 0D4;-FKH\' EMH,D8^BND)Z*?K='5T$T1LE.HI
M&')0M;.P].+;)^[P=QDD'%T'=33D,=UQD'9&L>]P'M<)_0 [U',##U'L^N&X
MF13Z  FQ2#W:;$RZVG&X87]456-#J.]KK*([P?7MZ2N#=7R#&O/AZU=(.R6T
MH/U\$?TI8.1C0%D3!#N D,CSDI@,)XO"R,;BJ]KEPAC^"KLUVWF1OU+N;JAX
MR=9!Y^"C3LBB2]^?]6<"4AI,70>=="3RW$IX'=Y(#'5L H 1=5S&
M/ @<@&/BPI%X(8XCR3&.%Y\[R^"&CD&-EQT2'LW0:H[T,,9BHQ=\PQ;<)JV#
M"U+*KP]4"&;/W3LH[NZR[CBNYM29(J^S_$N:[]J(0>!3.TSBQ*$DC)TP3H:]
MS9!%%[H0026.Z3F%D[3N)JES<=9/;XLZM=#UK?[Z;>7#QUR.BN'DTLQ'NF;N
M0ETW:*KSI,'6=0!(2R:7'29M[G!? G5]!7T""?#M"&$2^![P/-8["X: 7A (
M\4DAC&$\7=^U([BN7<5)/B3-9*(8DJRKFOVB.6EI6UL_LR+X:D'GQF(?#VI_@J2[
M].YS6@Y_Z@G?_R!>5GP$-%U,8N@[E=#'KH1:03?6Z];LV2]UN'1F@FTJ/JX#
M:DH9/+VD0=$-D>Y@D9^%"2  "7*!"R$ER G"X-3K##P@=&^Y\,-GZ/@5^3F]
M+O$UR:]+--T\SZ;_:L'PQ@7V#71 ^Q/LMZP1=X.@K0=^-Q9[QGVZJ[-OZ4'P
M5BWQ\N;OG!HK:O$>*2OEY0EXZ7#
MO+C@[B%9"_EX,H=[8E@Y,ZZ19#'CXA>,,[-OZ'EG)N"BZN4Z&*.6.(2VN
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M==;S9?MD9SNU.F=LEG/IJ4VA*4UN2]5U, SC_CG=-AKV[_(/:;-'A76-V ^\+?)R^&VTK;+J4],$W02A&V "/81#
M&[E![$78'_2A*(8BXR[SJ3(\/'/VW?:R[[J+@4?I;3UY+M[ZM55^_8M>NAP%
M0;JJ(I2FKK;2,\MC5;-YX#U;@:Z,]//E?:U:F-EYX3HD>AA_^3^SM&R6-SV\
M2;^Q@OJ>51N,W! @&B ?A$[ &H0(C158XF.A.Z8UA9R-_C?6J(XUVI@T6;PK
M6BS([OGMJK-OMU,MBT4]92%(Q]F+
M0;KU*N"S64KR6,8#2ZW6KXR9>G.[ADX##@H3]'5^?ZRK%MC.S^VZ]TUD Y>&
MU(FQX[M.Y-NA/4:,XDAH+9Q*',-T;+58CO5K)T<6>S(&"D+.L'?R[;Y.V(W%
M;:59LCWUB8=C"NZNC%HJF5QCE+([*D0"?<00  I=0!WD^]@#GH-L.D2D;G,L
ML!J1>./,0B2@D4C5L1 )21!)U=[U$$LZ$@TAR[J@0"?81
M@0,I$NQ&OA_'.++]Q'8H36 P! RP(W03FT*8A1@D-7*N
MXJ8\APP8J8=$BXR*7W=(D$:"MJZ71Z*).Z_I)XB3$
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M;@_56"E8#C\,+47S$N>EE'/3@#"P4403%R1.8#L8LD[MV"J+'2*T
ML$(AS!S &C\S54Z)FRC***/^R?-I16B2PI*TK6M#DGPB5W&DZ W_#47E?5%N
MZ_19_&'72Y"'XQA$<1S%H8?B85V9%[B^$(W4(AD&TBC.^ES(=]T4S>2CTGP^
MBH'I9.$ZFDV3/DW@28^_ZR"4IER>7".DSR&1F]32U9_C;?5U^8"7?:?9K3KV_9P/G$*DS!P'1R2, P#&+KQN#@?0=\6&GLR
M*,,XX0;E5BM=&G'FRH&7?ZLH E$X/G;_QF*ZK4&X]3M3;C6:NTN^FU^.FM!;WF$WWF>K=9O.6&=EK6V6W&"J*;CK@OJJP>MI53FZ#8E=MXLAUXBC!$:9N%#F>ZP8C
M01T([;D/X^579IB Y[NCNWS:1L[YP?5#2E:13QWTVN9E_=ID9K6I+7!BKT"!
M\_%VO64M1NA%BGFU1_N.)3)1'RQ3\NNH01;*W< QO[(EP-V&?K;9_LRY]9L@
M( &+&WB8^#[[=1"2L98,$'6%6M3:HIIN7S=]Y?0D\<:Z;4#47CEO[4>9@LUL
M?9YS-KH7L5NP"7YM>.+1^:+D9EXUW0\YQW__\
M;9L=FO/6DZ+\R(*?!J4W,; 3ZCH)29 ;!J&7X& XO@Y%" M-82F$,8S!4=FK
MVZ)\53%M9PN!M#!1Q6(^",[DKACUGC'VI&OF^YFO^C/!- [email protected]*YO&!9
MES?,
M9C%1D$6]?RMH;EVU9PI%RI:NA$3J>5R"2),S$E>4/A?4=VWJ$1(G#HR=Q@A3FHC 2#&482*=J=.")55C^=@THZ>"8X!9OLW;2>Y^4.]V_(-'3J\ 
M8-,>3E!,D_GK0)FN9*[?5JKN$3?4BJJ*B[S.\F8C! O=7<#E0!O'29+X=H Q
M)2  - P1(VFAH:R!G- R[YT8K"1L,T.B9XV9
M(I":DRLACV(2E\31X0DO:3YE]2%]=_LZWV??LOUQV]U]%7HD 3B)*/L/2#PG
M##PTQ+)1(K3,4"Z"8?2-K'AQGSSHE11L(T(Y1YUI<)R*CY
MN [&*.90Z'RS% G3+.#[D![:\S6KK]G]IX(RV-7#K5'8B2& B1=&/H4HI!%,
M1LX!% J=SJ0[MF$JG2NSZL+JM$D>.*+==TEHS6BY&,YDW9Z':=.VB=!.4P&L
ME(.ZLGN)D%I=Y#^S*=]^:6_9&RYG"#T:!X@$U(_L** H\J,A#,%(:#A+^.&&
MZ7?2(WO:B+!;?$@S:I08LT0\,G0BTF,O)D D;=LZ2",O_\DQ1DH^<)\F7F_K
M-LK'79IORZQHVW3(B5T[00&+8=M.""/,_K>/A5TBM)!*+H)A:@Q:I+IODI[Q
M8<.\76+LX'7*S,G@SYDQ 0\U\]9!$,4<+H\"U^ (-TOZ$+_DU7VZRVZS=-^W
M;/%'V4/5T)@=3SN*20)F=$29049;K;5D,3"A),(C_PX\#S;()QX!$\
M#E5A('8_BER(V1@TZ)*]%T7203'Z
/%CW\OAGESF-G.* C:>6ZB".;Q!7<
M*'DB/>O^9MP/8]MAXA-*[email protected]#O'\$6[ 49MYYP^SP.S[&]D=BBIN2D[#
MFS%2?2J>Q\-YYN/?<.SETV#K.EBD(Y&7YN9EO>%N_QSO[P]MMV][^"5/[^X/
MQ4/SNRC-T]NLKCZFW]*RN;9N^(,-0EY$L!U #%R7DM@EXCC]R/MM
MJQ'_OBWW[]F'\'.Q[X[W8/_D=;XK^WS.GQ075;U!+H'4B0+H L_&4> F=M)+
MIQ$)!&_Q7(%@TWW>NMC]]NISDX&U.]-FI=^;7Z?6_I@V,_5W9^F(7A*Z A>Y
MKQM=@5:#=4BCO2_L^
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MJZE5=!0'1_TR:ZFOJZ:9-_4K=P9#_74
M#5\9YS0D=(ULNKP29EG3CJU8H_:O1;&_B!QYD(9N[-* ."Y(* P2.D3V4"@'
M,X5XIF= >V76ET::),Y4[!3DV4Q.2@-M]+,5N!:B77>-!VD:/%\9TW1D= UJ
MVMR2Z?MN(M?'#D"1 V,[.%N@Z&SYGPU5GIF;SFK2_^UW&;U]GM0Y9_^3FKQI"O\_C().;UOZ?;
MWFZ;Z8P^G_:$&#^.O2!) (T=CR(O\FW/'P3&+HQ$ZHT991FN
M/SI!)_;(G!XU9R'Q50@K+1^QBD&P:(P07I^1$Z1?H+360?PE$B\6_U+$:H!'
MV:@TU0[+D5C) \(H5SF^7,S6>K +2GC^/!JVC-%3BYRO-8S
MGDP@3\7!=;!+*8-"W_O$1Y-_'NI_;(9F;?[EU(ZMBW:;V+9*FWUAQ>V']%N:
M']._;YO]9O4#WNW*XY:];OL/K('<-HGKXEW]-2W?W:?EMGE6OTRFZH_DB9W8
M;]J[S0R(1UT/L(9PJSO!CLU2X&'3>M0:)MTIQ_-^;5U80YKM=M5N +[-],8:
M\IAN\V_;A*TQXV&U725X;MAZ"N$%*J]'J#G&__\O"M>+LB]VQW;'
M:_.P?[$7YE%N/^J+<]'T:$JB:5 @&_;-B=G*YIG&R?K>BV6;.BOTHUCK%RS6
MJ3L;/3QI[R-&-B0X@(X?@##Q;<<.G68@,703UT.Q+73GEDHPZU/-IXO3=UM"'$(C0RZP2PWP3FLJL'L]EOI$]:]5PV?&1
M9Y"7 >W9\JU6.(S$6/_DU;PAMK4::Z;#4&$(Q!X
M&$![B -]*-0:%7^Z848_[<'.^_$^,63B@Y0W;QT?F8+^0M=K)/8QO"^+IH\X
M'%[S<#KO^:%;\F$G=N2$<8BPYSB>0P(:H= /;*8DQC$5FH93#F;X4^GU6:/ 
ML[/-'^36SZG[R]<>F=5:L2:'FJM&F/226Q.(TF;T.HBE+YW"T LI>3'@7]/B
M2[F]_YKM^@N?8]MS81A@#P:,EBC!C*%#/ IA+'4YH' 4PP0[UZ-V2:"X?WR@
MFL02K46>:ZP&NV3'%'VGZ04Q3!W'FF36IW9W!,#SV/C1EWS6RBPDF4V*^56H$A;RK=6
M9"K[:VL\M#BV@K49>O(H=+]+8DW$[HC/8U47=PQT;5O4Q<"AV*? M1."8MNW
M W<(E'BAT!97B<>;7O39BY'JA,JXQ=<.-&R4&(=Y/3+2]'OJQ$2;3\&V=33V
M5!(HM+U"HIMB[M)WMX_"]ZTCJ.3,"CJ :OH+7>^(T-C<_KE(P/7]$'G(!96K=TN]=520VTR=G'US\V[IP8;*5,,[GX[)$Q+R\X
MD_-Q'7UCM12>7UBFXH<@79I5Z\,;T_? G<@!(:& 0ALD?A#%\=AH),A/$@G$
M2$19AC-2PW$*5@KAQK"+6IBSR-C<57]>1H^"IZOBCTH>ST-(V1G.(VWRFJ7[
M2Y[5XXYMWTL\/P2$A<(TC#$ _A EIA'7E:RRSS8][M\ILEI)3,$D(GO[P]9
MZ]80!.,X0" ""7'M"(*DN;1D"$(IWVVEDH\V#,PS03(DD+"*@Y9F71*#Y?P&
M"9#2K%%RH!0RC ^33]*\1DEY/U8 207QA99W0MOFSS?C)FS?P:Q#[;AN$%/6
MI\8P]NC8M:90Z)IG+0'GZ?5>VZ[X1O;8"CUF"W6&Y_-9JE^L8O'ACO2UK/@PK!A3YLB^U<7_D47.4YRZU
MMK55?TVMS^F7+,^;XWR*V_8/N@<+'J&F:#0?3&=T5XR;+[)RYN/-)GV:X* F
M@]>!/%W)7)Y IM,C/2#K?YNEU>NJ.J;[C1-#ZGNNS7KRONMY'O71* +&1.P\
M2;VA#3B-P7P>KH %F#@I9723)0N
MDQ^!D?+)"3%3T4,]#'U?INGWK&K&"X;#T$G:_7># 7%#[,$HAAX)@C ",!J7
M&I+ UH=3%16F9X7NBK+._MD._.MDJ9+Q.K ZE^?:"7LF_'0QQ4^#]C^NB;<3
M'DNC5T>Y_0@4UI*G$)#U.:NIHT[=*+$CN[E=/$XHB^38>*P0_-#M.^HTWVOI
MIK\43KR;/BB3[:0SM9S=\Q^J0\EK](_PF?(G(]:A%/.(:S'+\Y$^I>7=Q@1!M.D99(V%(SJ#O$RY
MR,\@:RL2PS/(W+YRS2#K+Z5UM'Z-9GAU!MF4FP+'OT_$WR1)@&#HLH9X GWB
M@"0.QMXPZR-3\1EDQ8 _[ RRJM%\,)W173%NOLC*V<^/G_!I@H.:#%X'\G0E
M\_0X>7T>Z0'9^^U#>VO6!MD)@B2BL4N(XT.G.6!Z'-Z+H+W)TR_;.MU_$KK;
M0D=DKF\O[+Z])R+YO\.TK@]I=U<=H]EI%EDGS?C=UD$UO0Z;H=N--:A<$^<&
M3=*\$[;^1^">>%)"_)/T3 \'GTQ%(]?W ^RB "#BQ1Z./7_LZR,0BAICZP'27(
MCX%#$61&^M EB/1!:1)XL>CDK&*X_\]-SIKJJ_$:_2-\D/S)B/75Q#SB.VG@
MVS8[-!<:)D7Y<7M(/Z:[8YDU'_G;]'O]Z??T\"W]N F(<&)CWW9@G,2^1ZGK$PKX3JHSKV*>E6KIWFHDW5CDF#;#T46>
M6@_IMF3OHG5(*\X>W0QEPC$IO)KB$&OMC+)?W1;EJXH)MT[*;ZQ&N]6)MSKU
M-];CPK/:#%934B+',*REQ"1/;#!<&VZ>Y:"6<&$^#QY%G._\EIJ
MTG]GU<"GWXM/7\OB^.5KDGU+GU-$$S^F,0"^3R+BQ)$-HU%1!+GNVIQ#Q\*U
M:5U8MTQX^QL]I-93.DJUZNP%H[5>;=0S.A=6K]]J$C!8M>HI,"V5Z^P%9Z1Z
MU5& JC4LCY/B=:S6\EEU+:LW4[YZUH"[O(-$UT4]DK A?HR('8:8>!$,$0@"
MQ^ZC4^B[K(=:U-L#WTB1KIA"->@H3[(&%1M.UV8KWSCZ$HYJK?I4$*EG.([3
MPHEQ.=V%L(X!.NU9%69?72-#=LDV*_^V/1S33>@QZ.(H"3P"(T*
G(C:;(^:A] .PD!-O(PI-"C44@19/_/'X78(>:_
ME?
MYE5;3WRLB]UO[^Z;7U9X5V??LOKA4R/P$VO;1LR-WS:4LC8LII$7N01"#%$<
M=\*\!,8A<(5679N78[A)V2JT>HG6H%%P6?8,A<(WQ+RR\A!K7P[BF_6>K?Q7
MGQO]UGD"-]:C KL92\SZMY;B>VE7;C9OGU%9>*1F DD@1W[ 2;(\:-X4$F"2.CDQ;FU
M&:X53G)[WIBI&+27F)Y:8LG",E%E/"G-[D[!-J4?IP(1+!6%VL14^?\858NQ
M[ 7K&;.E(%[IT+O[0_&0IOT5NL^+QH>V>-FOWMU^2'?%E[R9&W[?[MQI9HBK
MDUZ(212R:M*%80A0X&//<0:],(FX)FF75SE']^09J%GT>_-KSC'5Y6T2KIG6
M7([R==20U7"_^$2E=G[*PNO78)3K6B2DMS@7%57TN])&NKR!;SX6J5
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M8S6:6O-^YC//",BNN#/!+54_UX$IY2P*O6^9&(2:L8LC^X(_%K^L&*U&4P>!-]9)HM5J7(A=7,Y-D$RO\^O@FN:<"I/OJACSWC07TWUE
M:'U]=U_V-P<,E+4)ZP)'D8,"!$$-$0,/(^(D$XECND&V"#-RLZT24).
MR4\^M,UEI1C03BZ^%G+1",,F+)H@EPYCU\$K+9D4^E\[,38EQS+/ZF.9LM9?
MDGUO?C4$C.P A;9-J>=0!D/JNDXR!&1B(A$T*80Q3*916=NAN>VU29))Q4T^
M,,UDI!B7'GN8<'MHA$O7'9K D@9;UT$E'8D4VE\Y,2;]+?V:[0ZG()@X -, 
MA-C!X?_;WK?V-G)K6WZ_OZ*  682P+E3+];C#' !/G.,Z;1[NIT$%_D@J*6R
M6_?(*I^2U&F?7S]DO23+MDRRR"JZ<\\C<=MM<>VUR;4WR4TRS0.&<=<(9+'2
M^I3B1UO6G@Z-IMJH\B2G,!8I4E,5>7:LZ,AC'LYHAR9A;NB%+OC22*=173O:
M;'?5?B&V$R\W'ZKREO>>KLF4TAB3, T!"]+$SS!):==D%"5**C&H(>LK10=L
MXO!^ATY[P6@(I[+K1"/1J;H\I,NDI36AEUDZNQ1D@%PWM,B,*4\6?HSQ(ZM3
M+^[NO5MMBLM=<;>=93[$?A*Q'.81C"AC81[UB^LP4II;&6C.LF:]L@TN<'HU
M4$7Q,D&TG(2-S+'1*@,9>JTHVNNDG=$U@XR[H6XF#2JM]4Y#2O=S56YYHP%$
MC/@LR''(\@!3EO?RZL-0Z7&R@4V-IG#W_1 \*CBX%1@-:9LDM0-US3RK!C7M
MPOOY+*'CJEF-14?)U#AV7,44C9%5,!V.I._062SV=_NU>(F5%/=5L5C5-:O\
MZW51%Z]NENW5K/7W7\0XRS(,THA% 8X(3@(.$24=O!@RK/$H[6C8I(;PX&=K
MW_&<^V_>D5'>\LBJ>G3/C\Q1O(-Z-#_*B:I;OM.[I^[(4\$?70_NQ$"QC?[],:H:7@?G!2_+W8S3 #*8)Y!#$"2
MLH3$J-_%#5$"5"YG&]204D*L?CU;A^TT$]X4(^O .9)TDC85;MT8KV9,D4W8
MU/F17OZ?WZ]$/Q0U$LNZ:FO;9(;C\>3-%_S+B@?I_8;W(F_1H/?6 O[(\Z.7F#NW=CV4;#<&V' S3M>LS? B
M.[".@^B,T2!$*,A3'&:0!@ E2=@UD8)0Z0"VT@=;'D#'6+Q"Y^8/-9KDI@K6
M&%)+]X]AC*L:QRV?40HMGMQ0!SWHI8%^HE@)V-U83%;;Q;K=][5W6VXAU0:9B
M3> P7N5T9#Q*U83EB,TC9-X?DUU9<):H?
MB_*VFM]_62U@5
A^+6^5EW$F=*2>S;\6/:B)]?"]$YTZA&EYGF=>;YAUL$Z_%M-9YO7G>
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M#JI]W7%Q*U:#/Q;WHM1D:6RL?U+
MAF6)E8RC
ML&D@]1-?[DTNC8^UK:(-F'Z!5NVXKPY-YW7/,D.*>O[9&C]ZRU
M-$ERSU0_,N\9Q1W @0//2FL"+P?[7T'VQ-'F_9T0U584VJ9H"%"6\L0WR[/0
[email protected],2PN@;@.6I?  :X@::K,GH8MC$*>FD!-SIB";8W"G)Z Z',II
MZ0LVOZ2J0RER0%\'FU :[#)J2P#O>8;[!=X5U6HQ;QN"&6,^ 9 E8>#3C+(\
M17U#%"MMH6E\O&6]K1%Y+23->V9T2).;>%OF2TUF%:FR,F%^2LB9^?  ]MR8
M[@XQH#36D^049%$7#SS,?OTTXY/>/ S3P$<9RU! ,S^'_07UY1XGZ[A-?VD,_"WQ>+?;\NO_[NU
M1HS[J/N#&/+1T9 _6/S,$->@8]HAK0.XU':]XKK_R^M;[_I+5I@?9EF8^(PG
M'ICQ&1ZF4=$\MP7,Q+G <2(D:!KD.5(Z7'3 _#$
M%5?.N$(YO9W.)4/S7F.N44F*E>@ZGRW;8=Z9--J2>4_S:YL\2B\%S]?%MMUH
M%K>=(1SH=WRR;LVA'"Y'P\W97S1>[F4@BPRA'
M<1Y&("(\R8QPW6[,TA@$L4P.8:0A>TE#!Z^YX;8&^'AAOL.H4EUEAER%K&!T
MDO72  -DRX5]&3Y>BO-&N70@L)NUI[35Z^2T:UFL^F:O^6_,HBR+>FV2HFF0I]E0Z(.@]O4I"S\
MB]-,Y=3>9\1!FY)I-4 ?=CFP*\B/:,@_>RD^GZWGMS,6,4Q!F!# HIQD@&99
MKQA!G$L=^U'_5,MCN@?C"33R@UJ1FM='M3U6U(:U)"$&QO4CBU\8V'JL3#^R
M-7&70_N#>K3^4%2KDN<)2S+?%3/"-2--4<8G,#PYB./,Q[3/"F ERF"]L9U'B YB'61 3%($0Q'&4=2U!%$IM,@WY_+$TH\'E
M"6!>C4Q=-92ID]<-FZQI*H<\80:UXX2'5]1#ES5W]$/;@F<49!@;ZAK2*%;3
M5IY& ( 0,PHH"G&.$]3K%:IFC9\**JZ#,BHRO-*J>X$ELL;FYV[^=WQ8S&, $QB_R4^D$2
MA!"'<9\"L4"J1D_[PRVK2;M&?P#E"53R.J)'V.L28ITK-?50I,F ;CQ'P N2
M,8BKZ=5B&/S24)]1U0C,%:F:KR\WR^+;_RT>9CD@ :$A(QF+B
M0.HF#_U/'T#64LA394PK3C@X*Q:Z?+FB%MKX
MG\C%,"9D] +OJ^K1I*A;6D$8TB3!A$' _X>3#!#6IR\$2B]X:#=@635:7(_F
M[^HKI?KTO2X>HS"GIA]:I!G0D)>H>$%&!C,WO9(,-Z$TV)-4\P^V6A<5YBW<
MEM7#C*"$D" )689]EL X!&G0M1)B7UI*=#Y[G-RCQN1UH%03#T6V9-,.>T1I
M)1V2'!G+.!Z9?S;?T"-J>HT8A/Y)KC&$!86927EW5VX^[<[7?
M;44)UVIS.TLB/@V"?IR$"4YPGH:V_3'2Z\QN3CQYB]VFAOQZWV6K,OO-YP_N7A#&$34OX09'@M&V/?FC2J
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M?1@^72&'.($Q!DD<1\P/013Y_@%_'/CM[B[=3!Z&59&K[^UV1NKL[!:;I
M[AO33A=WY63]_[WKIC8OD^W*J7G.(9X [-6(79G]6.H_4\^0IN\ZKLZBCJIS.F[.]U2-J[C?3,J@TCNF32RL].._
M3/IAA[WQDQ2+O> MI3(S1",8QS#+R$)?00S-^M^AYOE1$EP
M'S7F;=0HOA758K4MO/MJM2A^]'[XP(-.398S:[PFN];;26V,]J?O)I_YZR4Q
MCFYOKM]][
MUF*-MXDJQDU[?OK\Y7%UWNOV)0%C6> 3G(=9#E(20MC;1\(8N+$[9-JJ:)BJ\-^WY
MZ5.7MJAQSZ7P=>,82AGU@S!)XS!/B1^#]L5"81S_AQMYBU&3IDE:#K7\;S%M
M,=NGILY9)NM.KB8L1X3\U7(5E;XPY0D#LYWU>\]2[) V]KD$&SZ?/C]1V/6B
M >;6P01'.6-1'"5!D'>FY3!,'#S-,-RH20\Z&$E.WE@(^'ZJ F2[UONG=E#SIGG\;D-CUK3U!-Z:
M=([8.X)N07=_?K\J$H_M>V
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M9UD8$@+%7;U=2R'.)3Q\^*(\3,]G>,VR<2>2&<.=&CC;(@M)<
M3QIIP^K9BN:?JW*[G>$D)@P0%,1IEDIE:&WL]!ASIAD1,RH"IG1ACWIA&HE[?'DH92&,2T#!)LC@,? )PWBC%/=9PFXYW7BR#U[KF[<415 WH@CJ:WW/S_BE>K:Z@N6:/ =ZP>C%=W^5
MHXSN'%BTW,N^Q]AKD!VK<=FT%Z>[email protected]&$0A#5,4,/X?E+"XLP\FL=)>
MWMNQZNW$>;=$^2]YOERV,[UQ(9^.-V?/EZMY7GF=M:B^KA;%\^;V]7JU9=OK
MK?Q7+PR($DAIB**8IBSN
MU\@H0$KGR=VUPK*X_[JI>JS>XCB)7W!KU"9L[I(H.75SUX 1-CU;HU\L'SFZ
M$Z^9O?%9VZ-9'S?:>RAVWL'LBTK)MJJ&-O),ALBSG8\-]*!-\#3
M2YL[[B*6+\[1SF6:#0_X=;[BG[4N6%G5^#5*A%F=2)$F5";\5_HZ^5ONQ][P]AI-=:
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M,^E)!H@9B1FC+/=!0@*01#W2)&?^;%/P:BG9M[&*J-ZIRBCYPH&I1NAN\<3VT1LM$-8>*?ALKN3NZ&A9NEO3;_:IJ
M[B_J<=,,@@!F/LY\GV89QI2;T>+V>98ZYJFOX6@M+VET2=_A>O9Q%S+,>=7R
M.Y&]&]^6;I'5EZ.,?U1F*FK.LLSA/,=9LW'B7-\V%X#F':4]//
M*%J+#D^^S,*8Y0PGD,8)B $ !$/468#Y/]PX2:6.VW*L?/5ED^]L*O'$ 9/,
M)O2[P1N72IO,C/V2@[;W)J_^R4$&Q<)V#+C.QSC!(/?[65!(PM&>8!@*5+WV
MQ^"S"F]+&1VL]9#U[AO7/&,TC%7KH>:7L19)KO:[[8Y/VU:;V^/"RR",8@X*
MH12S0 #-20\V#TG*SSO)(N+'0-[Q1L/889(,+RL8<0G$X2O1I!G41)'A,0DCB! C*9I
M &B'DQ*:CUB#KXW1B>)[B0#WXT1[ !I>'SW*67"U$P&N*V=\LY&M@3].4%/L
M!-]=/%.UWUXHT_*$=!03 GFYW>Z+)=E7O+5F :O1QOJ'+2#:/A&YG&5Y2.,L
MC1$)HC1"(<41[H"0,&(ZU3KF48Q3=]-%ENX!S4?!IUD_+]N_4AH(/A:<)1E=
M)G+0Y.&CLV>Z#6%EYL_%!WMN="0 6#3P5.%M<^E.L5&:8I3&) L2&D4L9X%_
M..N5@3@9MZY\.-[1JLP/NZ9FIB1.)JANEYS(]@5'],L=/D8O.5'SU'3+-$&0
M$TSC &(_%L*=QSGK<"+(@M$V2[413KI+^ATKX;13=5FO?Q]*-\!^ZU-U-4^,
MI62'(XYDM5VLRVVMQ9^WNVJ^V,TP":$/LRCBB2@*&*5^T!TA0CD#V9C;IL.0
M6MX][:XI_JE[U:'+[[T/U6KQ\G,.+OITG*7E\=PYW3K!T?'X(R.]/SHSW]AV
MZEF768QJ9KK*]Q'A#'%A.-J9]- $.?S))?.==M?2+:HV(XK\$),(,Q\SDOK=
M^@SR"O3#BQ^D>VC+604;?JQVM5SBR@_OD32W)
M[,O)*"OIQW%FD49ZTO<1>8VS8F_&:=!KQJ+Q=LB;7R<6L#Q($(@CZA.<9"'P
M">@LB&F4&IV5CHA[I //_?T/$X;>,7N#H?#K:$GMTRW-"YU@=E;RP!L^GW*4E0C_?&-Y =N<#5V":M!#[NV-9ZF>9CZ69I3
MAE#*&,,@[M #AI,)BUX'X9ZT%-9(AN"D2+^=G4W9#O)]"*]Q5B;:V53SFK28
M+KX4R_VZN+HYO@/ITWQ=?"H6^VJU6Q7;:_'=&OU,6620;DTPCYU
M:BG#$66NN-O.PBB",*: 
M@2P(""6,'3 $4:Q6^F&T97>F0 *S5X.V, ]2<(6YN9 =+UB;#\DX8+))4<_E
MP(F1ND_<4$I+MFE,D'09E%76EUN&B\7^;K\6U\O4SSC^NJF*^5J\.?OS?+5!
M!>_5Q?7\VXP&&%/(LAQ'&<@2CC($O>)#G*NHK7TTEA6XQN8=P'D"W59-84=P
MB9SJNN4--24^J[X7WI$!WK,^N_ ^UU9XW(QQ]7DPZVSR/NJ'C(]I;3C5V
M[.O]._ZG ZX10KZ;;'>+XLEX[R)JL#]KBX*? K^ !3Z$6!IF@,_>BL\D1O]8[L>EZ-M'>H1O.X\C:6B\X>L-=EQL\.A1A3
M#I+;0!N[-[@6F,8GX.6MN&E\(?\BTGQ7EZI?W5QN%N5=P<.I %057XK-EF-N
MO]M=>1D$409H)&[:@BGS T( K%$@[&=Y@*5?V#';K$59ZI *B7D$T6LP3G?K
MK1J'YY3#DC<]2DN?',LYK\@S#@QPOO?>,B;L5D,CVJV,?QGQMB
M/J;!SU7#C\FU"=F*/O),TX-$*O<#\VC4&"
M0KP:S2=#8]BAG.'OY5HR'XQNE)75G48WNVJU>?]KM[@+C_,>=#>S:@?8(:#!"[email protected]?TEQ
M/YE$"9OMRMU\;7"9;@ 6I0#6PS:Z1F=AB6Z(:X1W;(6W
M*[W&#C="BB3I0Y?K#+C3[0!AW%J=A3IC+"O<:W$*J \P<8A]@-,P)2"C,,]\
MGW9S*C[-\H&*E ]IQ[),XR<"K7RQA3Z%+=
MD#TCECR]',,0.[)R=;G=[L5%GE<*?GA:NM\H!@'U
M,QQB1&B$&,41ST.;8K\(IGXJNYPYI F+([7)7T11Q@'79/499S@Z-P0-,.O(
M@#-AR>GP,L:.[& 2:WR+\G8C5OEXNZC8%#>KW79&0_44E,=-NPG((F@P]XDV($7J--ROZ\P(Q
M9[1G*)5NZ,Y@*TJS'4Q-;]AJL]H5[_AL;'FYV?%NM>(S;KC=%CR#V(M',^"=
M6&'Z5ST9H,U?Q;SR?IGOQ+;-@TS2,('[Y!31&<^IR68#^Z<:
MMW?JP:T5%UK1W2'TGQ'G4;SJAH*/8VHYP:@Q%@N> ?.QN)NO-MPU5S?->!##
M81;'* Q\%B.#'S,)MX/50U-5)GDWEVYV7W9
M*CX=.(IG!JO])$XQ*_K/ZWUOA5B3.Q)_9X1>EGD]O3?N5^=EW[S%\NIOB6T[
M04  N?ZSG,'41R'% <@#YJ>,8 "3#DM PMB>[,LBL"_TJ4U-ER;:AHK;X'@,
MW:X3= [<99UNN36FS*J^>HM:K&SC(/758]2BWO+.6LQ8DF8I0Z&?I3B)XH@$
M$'5H\C"BEA57"H-]S/G?G=$DA7[B1XPA/\GS@/HH
M[\" 4.UA'4L0K MOZ%L77BFJK0FO:9;'$U[^.\X++_^[9H57Q5UO5GB5C!PN
MO.J>,,EJD<4 ,9(DJ3()TE,600IZ5=!XL2K6GI()T>PJY\>?UC&.^+77/K
MKK@ H"R7?Z[6ZUE",QBF-$LQ@U&*:10E0=]T1 .5@Y=&&E227_43F$<",&\J
M[C;%R,<#96@Z,XR-LNS&>#5KTI-2?.-\R8Y VIYU^]@<@7NWFG]>K>O+-II[
MIW8SWR=11'.,0.SGB>_3!/DII7F:09I@D*HD1<-;LYSZP,6BVO,@?#]_X!^Q
MKH^G]=(.B-71KAU0ZG,
MF'+ZMJ Y?A3UZ6/Y,%\?JR'_2!9$F/H@"H. !CZ#2=<:C(),0YJ4VQA)E:H:
MUX.6%*GSIJ1"5BG3$Z >TK32<\K,ZZJCS:53@J-OQ?-:,Y 569FYGG\KMA_F
M#^+.H5[0($8HB?E_TXSD>1BAI$^X0I($*A*C\_F6Y44\#KNM)W!E?;%&_*VV]W
MY5U1P>57<4=++U\P2W&<8NPSGBV1(( IG[JUK64X\U5$1;<-VWE+ T=(2?UR
M1//0X:(%JWI=GBZ/W= R
MPS8]?2O2.&.*RT*\Z9MBNUV5F_F:%4=KY2A'+ X(Q#RW0RR/*8KZ22+)E&XB
M&-C42,JV+F[GZV'+UMID*BT9C<&CWLK1,3)/0)MV!>D%HEY?2!K*L!O:95S'"D]$I&V_(S.WL)(W&,LP#G01C[*>-3T3X5S'&F=)QS8%.6U:I&I_&(
MQ0#NY,1I1-K4Q*EY@J*3J.FK CUWP?):H_^]#NVI#]
MXC,0&L=="]CK,'@=M^()?
MXV[2$L51/314)JTX9PQ%?8UE>8TUYB\G5=><=>=UV#"+)I7Y^1LA@P@B1/V0
M0@#S! .&2-#B27&0*Q5$VD-A6:T-7;EKT0OF)-B^ RR)L2MWZFJ3/%"+ASGN
M[:CR0#LU]-D$LX9SZ,O-]9^E@+&=\58S3(*0^2D*XPSD44H[')"&2I>&F6_=
MOC(KWI%K@6"C^:\E;JV)+H?LK3;B2MQ::T=>S50F=7C"J^[email protected];I);W:
M3)H74W$79(,$I00PZ%..R&ERL]0&2C??N"JG@!KA6234NJ'7ZM
MBZJ [;:L]L0:$59U-[TU:=6P4%M<==DT+J_BPL<&2)SY( MH#G!&< 2IGX*D
M \* E25?E>;MBZOB[;8V*#:LK7;8M2VM K73RMK3:D)8U7WTQG15PT!=6=7E
MTKRJKKZV\I[D49P "FB 6(9"R& $^J4(H'9]K87FK:NJZM6U-B@VK:I6V+6N
MJARUVZK:T6I$595]]-945=U ;575Y-*PJA[N8)T!QA*<@0@PDFE*3JV*>GJ-I,
M&A;4&4N3E/D$A1E*,7+7N#%^
M9#6)%#=%517+C\778K,O#@WWQ:;8AY3GA%3H >BW"1\--LY3> ,5RXC4NNVH*-I!8*RKV*E]GI,P9+O:OT6C33,DZ2%UN-@9CRW*Q%\LM]:MFTS/W"(Y%!D_47=@G-#OQHU:QSUG\
MC$ ;(6A:/39C0FFPPVAQ&@U8>.8A&R2V+D1A4W*:HR>NEI,4UY15;SU-T;C/" +%N
M)(5&+'GN9BTC[&@NZL%-U^P,^%S[,.$BR#*?X32 AX03^ BH;+3JMS+*UNHP
M.1I H=9BG27V!B[2B2O)6EB3+LT=V)%?DM-@U T-,F#'^24X;68TWGE_MUK4
M#Q;?5D51;Z_^7)7;[8RG8!3A+(P#B@F@,".(-)L9E&#HAYJON6NV9CD]^L"_
M_V6^%7/38O%E4Z[+6\5;X T0*J=*XW*IIDZ/7F)OT7D'>!=>#7"RI]:?Y^N,
M7IGCV@W=,FC/RX^C&V%*0\>>/,J^6.SO]O5[JL['0O.6)&X:?
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M-)NP+&>?=N7B'S]]KO>O%T>X%-\QUZ1/!V_>X4+$I;E8\C0,D2WWQB'F6ACF" 29I
MUVH,@=0I#E-M64^CVF*T53./VZG?&#"83=G,:3PB59.FEL.C"P1:<-X/+;R7
MWZ>Q6MGW ED2]7U#:79#I8Q9\T*MGQF65![R;9*QHTSLZD8<]BWW?"++<[0/
M57&WVM]M+S=?BW9Z.Z,A\ %*PCA+&1"O6?EAU(&)<-Y7RTBN8MH!H5$LH[A2
M>017;/JN>G#>?8/W0BQ4*JY"6O*(Y#KCA*[06TGL 'L_'$/^4?BC1UU/-CO<
M%]X1\O&?9U9G]]P2H%UWN:&XMHU\YM5GZYQ*'0FNUPFWO'565J3QG$0Z)'U'@H]2'>8L%$@RE
M+N*WB\!VY7:'V[LI*V_9(AKZ16HATP?DS;F5&OM/)0?OA',43CP[X22](]$6G25W=EJ7NV>BXSB^
M<.#TM7T;RS%[M^JMC%]Y+R^KA]^KU:X@Y9^;&6 (,!ABDJ<)3@E",4FZAL3!
M<;6[&)4_?M2@5GQ;%-MF$):?M_PC=T4] :DQJU[0J,ZDW'3",HEJ\:@'X]5H
M?EIR.&-?OWA*QYG7G^6HC-NJO-I_F:ZY>?,S=
M%]7NX0/O23OZS_WJ7H36&0P"S%*?A!' 69!FE,*@;]R'1..TD*&6-18]=$X(
MB3(L+D3+U?:^W,[7M0S]68\JG@J(/.&^A5__I.C@J^F2*6?(:=68#M#2+P&P
MJXKBW).:^U6W^-3!]6J\'GV5;K0RT3#0#,4C]G-/8YC4F(09\'YFJ/KAALUG+:QA/AS2V?
M+CTN4JW/9M7BN%[-/Z_6.@6K)JF7S>3]T,'\4Y!]*15NHD]6)
MRK-X-CTT[@HWQ-*&84_OZ[;#G;YH=A/IC_W*Y"Q#,88I"Y,$IGE"<(X9Z9J.
M ,)JFVQ&FK2_I::[0FN665TUM$6I21WL*?[X.L4CR=]3VI2$;P#KKDK>$)->
M%;O!?.G+7#>1Y\G.+,ZSC.&(DL0/4YR0.$MZ:84YR(;JFTI;UH7M4G=I;A"#
MNCIFG#J3 G8$;FKA.H*BI%@Z_+HJ55JVO*I1^@SIB].'JKB?KY9=)59;@ 4W
MR_HFR.8ZC1G)\B#*@LP7#^W1*(M3W&]FY'X>#U4M(R"LRUF+TBL:>.T^1'TC
M:C.U'2IS9GRAJW_C.<&D,'9.Z2I%A4^:6VKA>9^,I)8RK"K)J%$WN:JO9HU\
M57@M<*JOR"<78,Y8$J$,41\'28RBS&=)WF_Z!!@KG9T?WIKEA4,RZ")< V3J
MJJ=-'HT(Y>E]N5,+XPEA2AJH2[:K8+
M4<8I4!_EG$=[* HU@R-YZ[R,.NHH39WM#."3],-"8VN#UQKAP3XOY79T[R5X
M[USVH4(1J'N^U*L(O?XB"LJZ^+GLX^=R7XE-- Z=)R;WHD2>_^F^J%9E?1&/
M^/[\[M&(%7>X<,E=EM6V+EV[+6-5WY>KVYK
M[,TO]7-.CFY?A_'/^YVW*7>>2%S_?6 =JA'WO524.F[?<*!"=62#R\G&H:T;
M'6<^R+,TBUD <):%"/@IPGW5!D-,Y>4/@\TJ!7WUIT#>R]SO9>L&Q]]E.,J7G@2TT;[OD[.3^V\OWO]%/5NZ_'>2#02HZ%OU&U;0'[<)U
MA>K$J@NL"2\Y+;1&#)037'-\[FTY3BW-,LJP
MQ%+X!.0J*EC'JT#H"8C>U8UW .D=4$[ L-IM!6,SK7TWP6#&I2\AD*#DI=5=
MPX0ZL'QKVJ+27O?3C!>_S'>BI8<76B=%<&W%1TS[1W1'R
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M]Y[54+TCK..*JP*)9U35ABO#R[J[<
MU$\7SI(8P8CF,OM[
M_F7QK:@6JV:]M/EV>7]^'[email protected]*CD:^["U;Q?'O'>X/-J@",OA+[&U[GU
M3V-TTS)3JEM#'8EVG4N7U_-OOJ]V7+^5ZR3-85E8OO%P9!#!+
MLS1A@&$**,Z"_N5*%$*JDT9:PS).3BF>1>Q3G:JQ0>QN; 7HK?>GL*18+^M#
MIV)%IKY+@T\+5@OQ9:NHF]549:>JK$ML>UASI"-J8-W,%[9$+/,JJQVT?O2#
M8VA?A:QKIYX%\,R,>!:*:RZR!"8X2P*40Q]BOY\)!WZJDE#916(YV1*Z4=S<
M%(OZ2:/B[GY=/A1%*PCW_*\J9E*6W2*79;GC$;4,K,%=/W';(F]RL9>>XKYX
M=JEP7 4?Q/49&1_'AVYH^4BVEE.,$EN;.+,P!5&21#[.&0J"/"W>W =ST"F!XRUN+<].;-4;IMKY)X^K.C)$=&6E7N*&I-@S3WH%1
MY$XZ!ZX3MZL;KN3URRH?>6)^M1&8Q*N#_%^B2NGK?%V?-DMR"E@4@9S&!- 8
M@!#V$&*4JZ6\)ANVG.'20W;;HO4J#M=;M(_1U%LO?)B+H.
MR51W*D\H9K:]$SJ@GD JR,<=^?475()\.WFL I'GTE8;_G!#4>V8=IJ4VN-/
M5E6?;^Q#?:W;Z4U:LS0@B 4)S-(@" B#,8O[Q8TTH9E*%FJT8=MY*+WV",4?
M*?Q$O
M,U?\CJNA*DR>T5 K#G%#0^V85H[0H4UH*.3Y?QJVR0U<(IK _>TCB5MDEKG*HQ)CM.
M/RV^%,N]N"."[7?[JOAEM5G=[>\^BF/?ZVZ/EI55?R=E7<2VO19G?*^+;SNT
M%O4\_ZH+?&$*5YMR\@'+(SP?T;>
MQ_6O&_(_LLWEE"-*-WPH$ F:090&*"*(^B0'_=YYU$"@,,[TH
M8:#A$8/!HY,"R]>>CQN!== CE3]&-\I,  (SB-$*0X@QR(J(_->TP&4>LYJ1#C3Y=Q]RO:QJ*_?
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M[\5)24]CKNJ[[SBPU_;+J-3FA<\5A:HKXR%='9^ZXKQKD]3=[
M[+6/.O3= \[C2N@ GL]H[1C>1B#A#?!0PLD28Z3($GCD,^544QQ(J7F!INSO0[)
M0?[4HO1:F/T;[ ]> ]032!5>'C!$]'D!GHACQ05#A^E5>--A?)KUGG,P0+?<
M2PY2A#P3=RRPZ<#[#88-*JWU/,5-KZYM<2?0QV);5%^+&64A@9CF"&)&@SA@
M":R;2B*$$T BI6TLG09&" A>#\IK42GN-FD1)[E_9)LS=8%7H,O.QLXSE)S;
MJAG"H!O)[# 33K=3AO-Q4)1CS[_C7_W'OW7?X?\0MYC\Q[_]?U!+ P04    
M"  *,:M(E[*=28"(+SX& H% X#__][?;Z4]?LV(^R6=__QG^#?S\
M4S8;YY>3V?7??_[MTR_JDWGSYN?__;_^QW_^/[_\\G_UQ[<_V7R\O,UFBY],
MD8T6V>5/?TX6-S_]?IG-__CIJLAO?_H]+_Z8?!W]\LNZT4^KOTPGLS^^C.;9
M3]_FD_^8CV^RV]';?#Q:K%Y[LUC<_<>OO_[YYY]_^_:EF/XM+ZY_10#@7^M6
M6Y\H__5+]=@OY8]^@>@7#/_V;7[Y\T]1N-F\0?^;)__C6_F#)\__B5=/0RGE
MKZO?UH_.)Z\]&+N%O_[?=V\_K43\93*;+T:S[W@2QV556%-GEQ^QK-EMF1TFQNZ_>1'@S
MBZ];Y,7]48/?UDNOPYXO2MLR-_EL48S&B^5H^FZT6!;'$^K SE,(V94\J8;^
MH<@OE^/%[Z.B&,T6QY%K=U]]BG"7%8M[-;MT_UI.[DK\WF>+8T5IT&=O(GT>
M?9EF+8?^M&TG0YQ/YA=7'XIL'OM?3>\1ED_+V]M1<7]Q]6ER/9M<3<91Y=' 
MY\M9V?I#/IV,)TU$.+[O$XO8F&>=O>+$ E\L%[%E5DSR2W7YS^7:8"5 H?1-9[/L:M+8M^KI=?T"\2F[&Q5K0W!=9-DAON1QO?8K5C-'IG$'G0QV=IG-
MYEGYFGDTI9=EO..Q)]5@M$U[2#+<#Z,B G>3+>)\,3U^[*]VUY<@G^+THR_.B %]E-?&;R-7LSBPVSM_F\ V%V]YM"M,U4$7][
MM#0ON^I @"IZ62[6HNE8W+^97>7%[>H]^T;B@3CH8]/IKCA['_J&]\FBW
M VBHV.TM.AG.8C2[GD24U7R>E?&6_7NZNK?95PG
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M92?#;<&$Q]T==$
M6HES-9I_6S)K---'F>?/(IX/VS7J"_S54YE-?!I"=G??XXC#9WV'RAP &)K":"06,6Q
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MCOHJFY<5(D93GQW@C&UI&("6VA-HE8GF7'M)G,:U4V"%;<VGV^Z&$3]+B!'02(@(X#ZZ#[5MET:X=G03/^C6HQ;26;>#F+9=
M/"\HBG(H;03!\:/"%C_ZFCAN1S)Y,,E>;*2=%\FZ4D#ZV'N36C _ N\/#-&(
M<(Z@L)A P:6P()H.+2PD2#!*3Q-X?Z[$>A.H 2Q[VP8#E+-2N#( 9XG4TC)5
MB:P$:VE#SC;PWI@A>;^*2#!7N8UA:+L:;-0^6"AI%$\!B@2RW#LC226VEJ!E
M#&* _.N0 <\W=7H >B>_7B;AE3^I)?Q#Q1&AXUYKZGT
MVC"'A:X_,>O!^6S.=,^(#G%-M?:J1FOB_T^:;.SM:!4D=\B6/IB!&"C$+".\
M$M%SQ,YFXZ4_8](=O D8] R&LCC'>L3-7:*'-H&"^&48&S\1+X W'*H'"TF!
MWN?]=;;)TOMRJC_V= 5N^J72[LJ3/Q9)#RZPH,) #965RDC@B'?0K!+.&%!4
M4'V215*MOO*@=!SQ//YY6M_XP I8!+Q
M:%>=YYI$=H9Z2:(_JVNR93X,F7$'$-,0&^+AZ
MX!Z 2@BI<+(56N\^=GKJ' [O:;SL@RNB_W"^'YPG+B%ET"(D,8,,.,FY7)_V
MX)92LB\1L&$D3WV-6BB3X'Q>?!I-']5M>1^5\?G/;/HU>Q?U=S/?U%* XBOWTEMD.TY7;Z #V;Q"S)3Z.@-M'E[,Z1&/)D! 0;$1WF).65G. SM9IV-FO
M.KJUD<]->%U+]/CINNXJ2!J_+*6]H!9K:\L-U;2/8"7!5!G$2UN)* $X
M.HL;""#8N\7Z5PMW-&;,\R-2/2DDP13VV,R\W10*5=]>C7/L:U*>0Q3>2VJ$
MC"L3II@1="V,3T0@F]^.)K,#*;1N%"#@A$MOG*0,"".(
M\F@C(,*.G(_).E[%#3C3"M04)X1O\F+Q.2MN'SDT[[+;+UFQ:][;VBAPK:QG
MQH"X)#6:>HY +: %_'S*_G2AY.>S5U>PIDKU?9O/K@[email protected]'EEH-E
M#"$K&*L$Y1ZU/-4[P/A[#_SI%-H$''HW^F=>?(YOFU]S+8G/W\>+^4;QU
MMP?4L(= B6+<6."T)1@K1@T6E>C"MLVC&B"K^G>(^H%\&&S;ZRXU[B,PQ@4C
MIBS:B!!WQ"@L:X/M7,OZ/@.Y[/+A_'N
MG2-W-PQ.$H>U;<.E3W>8]()Z54*SJ]$-!CAJF,
M?H'ES&B+I$ U;LS2\SF:EY)*1Z*W65$&>3X8XI1A0L9O
MA3([^D9MZ
M=3\!Q;6,(HYZ*B"TSGK_\$%!3%IF2 UPSNL_LM G\&>5!:H490A@)6F4V5)D
M**Y7)G],2(EMF>A\%^6L:-Q\O;Y>I&@'\4^7S^VRPN3::E)/^(
M\X'.KO+R:MQO[;C8K.]0'@)VR@MI<+EM%I6#: V7:GNUS "7EB=G:2\*&2A_
MR\N=^^+OD[Z#5$1I@[GB6$",$' 8UHLL0EKRM_G,ON]VM[\.C8_1RW>8? H%
M<-%=]T@CJ@D2'&*[$1 ;H=$9+8-/S;D#L4Z?9OJL MR/5-,]B8. $$$==D#%
M)8>0T&,*)!? >&^(M*>I][E18E5N]KX\*!UUG\W&]_LR3/]5#BG!()?P_LORZ&-W=3,:CZ9YTBJUM@@&48"D4
MQ8)CQ;Q"@E;B.8S/9\NQ.T6_O+VA$VQ34">[?C[0O9D16]N$\H/SFEB*(1:8
M04Z]K\0#N&T)QP%2IP,-/^=,1Z"V.0#X9K:I:%+>^&#RY6Q1[-HAW-LF,": 
M=4PI2""5B /O5#5D*'C+.]2&R(/CM9;W VJJ+*OJ?J1&Z7M/'@Y$(>@4=X@ 
M;YD!' A2">2I;%FR4V#9)01!)04AE$E*W-H@6+GLYW0
ML! 401/));*F'U&L#4"44!FV+B@UP
M,[XWYZ$#6--Q9:[*W+C5./>G[F]M$Z"&2%J'' ;(_C/,YF=&!
MAO(NH6Q5ANCN;CI9:6"/HE\\&)0R@B&-O"5 8^3+H.ZRA @QVG!$0'@A-*
MJ>.L!@(;V]+*#= ]&P[YCM3!R.FQGIW=[/(OPKT#<6\3SGC]Q66YGFUQC>TM D=.8,J8, AC
M(0&0K$:!4M\RH6* ,V@OZX1NT4VZ,(T.\^PR?@?=+$P;]Q88%HHKY3R'@ LL
MRP-]%21(JK_$]DJ7"].^D$^37;ICZ+M33'T91;=X)>9IR;<@;B?Y,QA
MU$D<[[J>S%T)V_ML\>/LX;Y;4'!98D=3%@T'DCK.8FNZ6  XMG*?\>[)>-0G
M;"NU?H@Z7SS6;?-;+G9W$8P1F"%/(\&-UD9!S\4& !'G]?.Y=B Q7[;6R>E4
M'VGR-EX?K[XOZUCM3_G\
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[email protected][ _YYB4,\K=8L/S+;MF8J(6@YXTYK#$6<"2PVR,2)P%$L
M@&1NWP?1=V;;]OL=/F;C/ HU7?-PI>;/4;$ZCNB/1AEO[;H.GE#DF?(V^ES0
M64NQMQ5@GN'SV>%/S*\6-\9UJ*<$T]6;V==LOEBA8Z:C^7QR-H 6HG4
M!2 TXY*L=+$F, =S5PB/4]KS\ +,6AF)M
M.]7'2=-"&]!P?^- E(J^K?<2$L@4L(@S5D\CVK4LIS3 )>5I"=BY)I+:P=7Q
MGZC)S:'RZKK< _W1/9T$AP&F5FH/  *21N,?/[X- ):U+:LTP+7K4&QAQQI)
M$A)9*_)C%JWX,M/WJCR?=KU"QD[FXVD^7Q:->'E@3T$KR*S!AACD+.%0XO)<
M'66$.<\9;>E)#C!GX[3D[%U%+_W&$.>3>3GN1YJ>77Y:WMZ.BON+JT^3ZUE[B%
M(4),*6>=XAHA[*D6 AIMA5>&XGU72?26,SO.RIAA.?Z/D_D?^\[WO]X@>,L)
MD1YS)QF/'TU<0).5@K:-#J)OZ-5H,I!Q[R,*U9%D24V
M3NV5B%Z3EME?WP-MVNAYK[5I"VP*[FRNK'LQZ/T'0':W#!1RY1BR1BII",9:
M$5.)JIPYGRH.G>C[.8/^3V#' GH1%U7@/G\Z>-0UQ98AD_!:%]88A)2TC-8J>\3.V
M1ZW5OI=/1T&[S.05_VJKYY0F,+J!-L3DRFI99;:NMG?<-ZL>\^GQP'#*C2)SQI8CK5:<1
MQY58!+GSN4ZY-\9T@>LIIJVW#2&6& !&5$,Z)G5+WR$+:EPS/ 
M9*N^'9ZVD.[DS/8+ )',$PLBI3&V%FIJ>1RH@U 30-J6
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M7N[LVGV[RV;S'04!D[T[&&AX:0!@=*^I(]&E!FH%H5<01#3/AL)'\25V)?FN+W8\:.
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M(!P7*8HA@ AV7A'J(*B$-XB>SV(M,5=>/Q+7,6MNXS,(T14%A)8 3A0"@C> 4/U6T/, _0USHM15,I* %_?YN7@9CY8G(;
MT=GEV#]],'BG$.,&*L6!QE:":/4W@F"(56:4>AWF:#NX%SWL"9
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M7"%I&(C.N%8&UI^J,RTO8A]#G#=8CP*:>VW^;9U7+Z=G*URSEOT#H0)J#W
M2BH:'5$NRT4KJT1V!)U/5G@WBF\ZI[5&^#2VJ?4-\XQS196-(FJ*C2?.,E4)
MAQEN29^#;=+7K/B2?X\$Z@C8Q*R9O\WB4+/'-XROQZ[OWXW^F1>K2UW5>+R\
M74Y'B^QR?4/Z2LL-27;$&P(TP''!L<52.THPIO6Y\3JC4-UFQ>+S:;CYC!'4]KM[RG$];DQL 17,<^ MM[I
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MOSF*@MN[#=(J&M7,$;$4:22L\+@"R7/4,C=D@#G,)W(4.X-^$/S_OXHEN[K/$3[@#B5G%)JK02:*B8JP(AOF\=T>!;T&41P4B@@,6,?)39N
MBN$V9./+A@$*H;VUT55Q%E.GI,/UEI%%;7,%Y%]R5^5H>$_'H_?Y;-R62@]M
M@Q*:&H4QC?X.LH83"BI'1&HLVF[Q@K\ZG5I#?*(T[+IBT%\^$1L B1"#3)5U
M+HG2A@NZ4I<&D%K(3Y*(_50]\X]1EDU4>?<^U,YVP2M'E"+( 1O-GC$>0;T1
ME3G#SZH8%",C&_-NN-DW5O0
MW%*O@(O0 "\5MLK5D$2=L%0;"']!5K95PI!XZ?-ET1DMZ\X"$8 *Z"0U$7ZL
M'."458!XVM;''&(MLJ&QLJT.!D7*R=?N;&7=66 2$U9>>PNU%QHIKS"M_1EJ
M6IY#'6"^W?!(V5('PR'EYYNLR$97BYT'# _N*U#OF1$41Y2E4$1X!U0%!X.Z
MI4\YP&R\@5&RM0J&P\CC>1A\60()6(V$YD8+II!'E>@_@6?^_;I@-C
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M;&\IT>^'/,>J->\>S5.0Y/?)XN9CMKE8.,^DT]C6PB)U19LR13-C'JTYA3L"X=Z/9Z#IK5.'P^:/E LX9P:QP7 ,M
M'--<5\)8Q5I>#_ ]<*8K+>>=(IQBK5,5P?@TCBO[8I+OF<5>?3XP: CP3$1Q
M ( 2:Q7_NQ%+$7L^IZ$[GL6Z0#,%23:C^VTVO\O&DZM)=KEWOMK:)C N/#)&
M#> )N1+>#3?/Q.]WB!@JZSF@AM!
M*;!*B;B2J"=Q=4:E=CO0[1:V'(5H JJ\,*AO&U37W=ZHS,OWW$:O#\OH]0D"
M+>4U7@BV7(P/,'S;\4S4&:0IS,OR[FZZ,JRCZ6^S[/9NFJ\VRZO-BD_9UVP5
M**Q^L,OR'-I78(QJJX# "A'BK"%6UI\0LFK?F;/OQRAU08GG5JEGM%.0[R:"
MI\M3J64-\VPVWV@R#GOMZ>O[ATS+Y?%?<-<7K R,6.Z@%)H@"I07QP&] =]J*\RE0W@?%AZ>@$^U\K":DO] F
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M^$=Y3=77T70U#R[,J"CNH\U?U5W+SUEQ^V;V-9LO]A5A?>WQ@)FD3C-FI9.4.*&PDY50
M%+M45XA];XSI ,L4,])XG"]7M7_&661U='+?9XO]]5%W-0O<""85TSPZP@12
MQ*.]KA%COJ4O,\#E2K>$Z1#3!,0I63V+>KO?7?SP\6-!*LH74=&447!RX4M$J"HH) W$NA7XC
M!G*^[26YAQ?0Z+V$0<3H0;8! EA- K8( (;*YQCR*
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M4Z:$E@XQB>.J,?Y9B448!:U@@;X%UKG>Y!'@A;BC7V@]F*OM6G13[^XR:?1F7,2S]K<=]@D[II%X$Y
MK[F%A%KJI2726 1JX5W;8U\#7(WWFN/0$]QIN=8\!6)[HT =Y88J[)"'WE@(
MI:H%=-2>SX'3[E6^G5/'@9QPQ_+#Z+[<(VN^5_FT02#(&0T!A-@Y0GD43/(Z
MKF7;9@ /FSVME;MEJ_(H2--PI:Q@^!*!W71YO4V('Q#R3$E&C'">"@E0/7FS
M^-F=S?S5#V,Z037APOMC]C6;+1L8F-<;!*D\D8R71QN95QYJ8V@E&&/Q<,"T0!U,XZ92$0PFNJ<1T)=P"=39"X!^YT"NU)W.*#W.' 
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M ,UCBSC03%G!*:(T3L6B$I *T9)& ]S_[IU&G8&_++WWEZ6"8
M!Y(ZAXRPCCNJ3'U^ SO/6_HW ]QVZ$*M+T\T'(EGHADKGS7BQ_-'@\ (>480
MP=A9!H44#].OH*BE4S/ Q7D/Y#@2S!2[49>7JQ2 LE;3Y/+-;+/:V[47]7J+
MH%!DNB^O;_;&$1*EPS5&$.XM??']K+A[X$DWF*;9O%S>+J=E/9?54JZL%EAD
M-]EL/OF:K2]N*^L?1]]V;VD>TE,0Q'DI'=/2:F(!$AQ4*8O88-G2
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MD%&6+JFP,][2$=C)HW2K0<[5G-?+X\F$GK1H%)[YUW $A%)("4>^DK 9EI>PO#((,W
MB5G4"N 3,>ABN9@O1K/R#/*!-'K4,E@H+;!&**,T0Y@: 4PE*@2FI8,[R$A-
M8BZU1SGM'D,+'ZI!ZV <<$0J 3510GHF.'&5R$B:EF<=!AFEZ9%8W2.=EEP'
MN$X[6@6!_JN!F9O7-5?/UAT)_S[HQ9'Z\+#"I!!-""8.\-L10B48$*-6P9"!I@:#HA;0>@
MJ"3'2Z.*HZ-8JC[^?9JM.#"[5+=YL9C\>_7S'6QNTCQPP82RRK'H'7KM!,;:
M54);>T;W@)Z6,B\.J':NFA3Y0J]>M+S+-WZU0;!*8.< HHHB;RFE$OM*, U)
MRUL#!F@1!\6Y3I21\%#]&J//HV^;:Q(V%]3O-'@[6P9&K>" <><$1U*KZ'[S
M2E2BZ!G=?C,DWG6KE42EJ=8&^9$UOK@JKSE=E=:*=OI#D=U.EK?S9OHGH
M>51_(:)*@, &61"]=J Y4'(CJK*F;26  6Y!#H*7*765P+S6=V;]7DP6FE;IG9
M,<#%3L*P8V_PGX1_+V\U/8AY+YL'46:5.PE[4,))V/FL
M_.A!1'S6-GB&M= .&,B(Q@)X)NM%%C1G=(S@)(P[#NTV,;SMD_KFQH9-.?Z*
M]>_SV:;\\>Y"C-UU'HB5(+K'W@'*H4.J7$?5(-BVVW,#C.[U2+F3J2--]E;#
M!58,!4"FX(![&E;Q F@*N3;V4][IE$>/#36#OI0+2YGWU __I^+?>B^DH
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M$$IIN7Z '?FS7UKW0X$]A.*^NLG%<[L7/ZF8TN\X^QHG@8E:*4YY@BG^4
M8:FOH^F>7;5#N@E,.NHQIM(12QVA%*D:!*+E^9C%7I;3/4*=HG[=J^/\D!63
M_/)YJLX.OAW23>#0:A\_:<$AA-8KXDGMK7#F6N8M#]#F]<*W'J$^&=]4--A%
M<1]M\]X[")NT#Q(P3JQ%B$MKG"R3T6JQ,?0MLZ,./@YYMU)*9$&Q.!>>'8?T
MV1 ,&.P1MPP:Y1$$V"*G:[%9V\R"@ZN\K@GF9OWNRIV07H?A_$"O4]3I?/WF
MO*0&OIYA)3 X2$^Q*V>EO3
MM:BLZ*2P& *D#:%&<>&YKD4QM&W6QP"+@/6FXYUE%0^#-\'$T>3ZR]>]K ;?
MT?&=!\"50)1Z;Y"24$%.@:T LW$5>S9; :GXF%PG)R:QSXML[J[>>% 4%!B:0&*J*\E-(*PRM@'>#G8WQ3DO  
M_B=3W0F_B=]F$<=I>1_%_UGOKSRJHE&G'ZIB,H^_LO&?L^NU(H[X*HY]9>#$
M,QMG2B89$T9*Q:I;OTWTB,7Y5(D16'E#<7G*Z^]L[SDX (TWL,QO8P:1^%=G:MUIUC* T2H09  U''%+A5-2 ."JN2Q.;R#90?-SIF%W^)\T_+,Y)?HHX3!EQ&>-
M6SV>9E6S7FL1H(CS$L#(>4DPI,8#HZ2)_V828D7W>1@]!;1&TVR^J4<0R;$K
M8/7TR6!D9(J25 N$'6#4 THWXF""VIY+'>!"XFA]/J^,?1202:S]?%7A#Y%CKLG
M4+?0GL+=.<3-"5HRXJBVCI='Z1SAWKI:'$I;[K(-,;S5.5..!3,E-QHEO[SR
M=" ".L !@5!Z;"V%%+!*),9 RY2# 2;J]N;^M@8S 3_>S**)SN:;I)P-CW='
MU[8U"9BZ^!W%Q1]$E!%H22GF6CB&D6ZY4!K@_2-=,Z4C1%-M%K[/9_E3;N_W
M5W8W#)A( ;&$B /L^"J+IPHL,H)4JE3:[X\ZG>*:Q-[4V241&Y//XIB7<=@/
M.RO;N<_3RUF"C
MG@2&6EJ&#?6<>*HKB+7TL!UUQ?G/C\-12C+>'W)GY[9;(1W"GAOM,?(&$QL_
M:5VYF$Q*VO*@GCQ_4]D-H&F.'[=(5P9 MRUE
M-,#@=-=TZ1+7D]%G=FDGT^4BNSR80'7+ &09@:<&4F$0\@!B6@'(XC?3,D@]
M0 9UI/%&/&H+;P(F_9Y-KF_BR-37Z*!=9^^7MU^RXN)J-?B+Y6*^&,W*C-CF
M!&O781#44(2 D65BF**<2%3M-S.*>,'KE!3NFWL9M _!2(RQUQ!!3;"V1
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MIY&1ANF:Y%K:EF>Z!G2%7DI^M >V
M#9)::!WR5D0_R0%M&:*5 .6=?M_]KG *4AP':N>LV-SC^3#![?8_MST>M%&.
M,6.]HO'_#!/4^MK>V;:5>0[?=OU.N=$1KCT9#3^99H6)P[G.B]TFX\F3P6IF
M+63("P,\4P11#JO!(P-:DF) >Z,I#,8QD/8UB3S4Y5\%*>>/HI2[9Y0=#0/#
M<5Y4@)1'UYF1$A%:SX_1E6JYD]YBQ_2[IDN'$/<9,O:C2;$J)WAQM:D!7YO-ET>BDVJYF 2%JG8-86\*8L^4B8+T,8%QZ!_8E
MTJ43]'/$6$]W7XVRLUWPF/#(36P%TLI[Q##0E:C2X/,YU=V-PO/^L#WA=VNS
MQ6@R/9O/MRR5%36JO-:,8 4L5D@RRIC%WD7S?-K/5\WGV6*N9I=O)Z,OD^FJ
MUM&[;%2*<'DQ^UC6/RK61Z_>Y[.B^F>YC3C_7%:-:8+*L>\(0A*A+*9,2<"(
M,%0K7D'(M#F?0Y?=$&F;64BLAP3I"[5H^K[^Z_^99$5YS/3^;7G(5'V;[,JW
M:]9!4"PZ4@(.9\:UZ=C4SNH3\0FW(I-FU8!000=1Z?KK)LL7;4K.E$G?[^-N:
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MZU U[B-0K*-? 8&W!F#MB(1$U=\X-.KS<(T3<@I+SDP$<1M?%*H=H]0(2U#"Q\GUPZ5-?/V=0%P@FH\]NGS\7*
MFM_K?';Y(/Y>"NUN&#B#JPM.%132(AF_10KKK] G<\#.@4J=(IV44JWH]$+ 
MLJJM=IX@#P6 "D?K7N-FH&T901B@SY622D>BG(!&)B_N\F*TR XT3#O;!46H
M9U09@[0QVDC*3!6,H2(N9-J1:4"'^=*1J4N@D_#I]C8KRER[#Z.[LL!@62%I
MNKS,+G^?+&Y>O[:[ =G:=AH,]E(0J*254@HLB:FW%ACF>]-:AW]L,"43$VDA
M!4VS8C&YFD1MK_&ZR^>3Q7X>;F\5M .6&4J4MP1AQ1S@U8*(4M-1YB#0T5T<.I=IJ9
M%J!!CAB&M5'2&^ D%+("U7#;SSGI3K2][2Z1XY%-]'6>L%!"]Q\IA0X(@XR.1EA'6XP-(AQ[
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MRZ,$W[TM:2V79I7Y/B8E>E_E^7-< ]EPMOQMFGO@1#NHLF7
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M>T3KMY/QBK37<96S2CK_1Y'/=QZ3W=D]ZTJN&3C+KLNA?3X_(O:CB#/QCC#0UEMA!(@. ,&.GR0CX-+[)
M+I?3[.)*C?^UG,2/:(K&BQF.IHWN@WS^,[C8H%3#+'TGE+N8/PXG*M 
MB[0^GX-?'PU!I),'=5,N57;9:EC4\I=OF:0(CFUE!:UJ8"' K-&:]!
M)'O/;'T_FZ]I:7T"W?0Y9[XO2[[/YQ^R8G5/]2FF2CIX)>?]8)KP>SQAT*[+SQ(K$4T>(1(1@ QR#A,IN0#&8P/B^N$D
MG^4J7%H>G2H!KVOR?,[+6I#Y[-,B$N,FG\:O(TXCTV6YOMZ/0.L^ ^5>QYE 
M22$Y- PR+D@%D=+Z?/+=CR=)?AK,$_B93T1I2K.X B\K=CN,C0%$:*P5YQLQ
M+(](G@UU$FAZ%[<.!#H!7W[/)MT
M#-8TL%R'=A4_5\P4@L0#2A6@4I67&V[ 4+!M9:4!KB\Z-U@]0WUBWCT2H*S2
M,H[+LLW7V))]VSL,&%MFH:=<$RJUEHJ2&AB'^?F$;OJCS '<[$P1IV+H9K0O
M4;O\YW)]0=FA%-W?8W#,0*F4-8(PQPE'EK *FKC@.)\Z!*?E:.>:.)T9W2;*
MX?9S6T]!&U5><@V0,]8;()QT9@.%@ZKM=>(#W"@[M>'L2 ,)R/C1!P!
MUQ0*7HM*1%ITFO?'1YF_$__(%]NOTD>S21WJ7
MF:G+Q:8BQ8O8?!G9:;;OW\&+ F;(0LD=QHYY: TS1%1@[email protected]<3J?MV_WI
M%9&B /YQ4NG[USO8][6& 7#\5-9^7
MWAF,+D_VN;P?W69[;ZS>US0H"@%2EFH#@608.:UP)6QY4^G9$'<0C&G$XM;:
M2;'FN+V;YO=9MMH7NK@KL=I["][6-D$HJ[SF $EG.904 5R+!R.HBA7QM5/U]B=(1N O)\S*)?-!F7H9MRL+_-)HOYQT^_[270SG;!E"%(:QWG
M<5V&$%=8U$Z6\F=TT5)O%.H2W]0VZ##KLQ'):J8-\]P!YVA"52?*E.
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M/] ?[DGV0YH,?D]60_-.@D/,*[email protected]["JX ?*L[IG0[R>^=%P/CI:
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M .( S]'&@$/"]$W:!U(9(\T
MF#"F3?3,A0!&56(SR\XG-'^\XI\'Y#I'-^T'>\(@?)??K5)4EDDY5"$&B" 8
MH$T)3.818J?.(7D^[D<*T/>;7S8/N3?N+1!,N-0: @2Y!P1K(&M8N/?GDVEV
M/#&V!MK[0CN!H_>AR"^7X\5%\2DKOD[&V9Z ^FN/!^@=)D);A71T-:3RC+A*
M*.EXRUM7ATBA/C6>=XYT.OK,U>QR,\[YWDCYUC:!(XE87#L;;(4#!EKM824>
M]J[ET8,!$NDXY;[.E*/Q;!/<^G0_+U\(Q3:J-?ELOKQ=+RY7<8O=2M[R>'"(:L&!QT(*!+ UD+!J
MH [YEE'( 8:-.E9W-WBFR#R-REG=4/6/++\N1G-V-HF &TH53!YK2E^@*[A1L6LO[>*!['8JM;8+0F,0EM+>"*")=65T-
M5N)9W_8.X '.-1UH^/6HQ=&@)N#,^_C=W*C;K(B#W'OD]>7#00GO@:71X4(0
M..&\Y+HVJ_Y9A8Q
MF:V '4W-ZLV3;,\J8U>;8+0P$$7+)QBEY35QSO)JR BWK>0R1+>BLT^\:U#3
M.0^O>5)-DG2:- \>("$0 SXZXL;'99=QN!*: IRJ/,*9.:C=(]_&[%0U=/5R
M'M\ZGZOQ8O)ULF6_>T^+ "E S"(/D9141U/KJW!.N5!C9^1[=JJ\O ]T4SBA
MF[[email protected]]5V=HH2."MB[.K\99(J*+S;FMS[:5NF24QW!FK6_IT#G![
M8KF(EM6Y;K._!Q#R?:CE.:I]5*TN(D;K:8
M+.Y_GUQFCTS.+@3T_2O[:@?6TNGVG8%:J!"G$E-M 6!41& K>($XHWNN>R3]
M:772ZXQ:EGS4HWEV619;R6;SQ[=RGV):?4@WO;AZ/*1-RKC)YXOYJO[+EW+0
MF^,M3S1D3T'":53
M1D*BI6.<8>LS0&JZHL:J -3.!T^8]3U4BP4YL8PQ
M:!V-'A:.DXS'(O(+.JD8-/L"*KUGD-?L?"R;*HK1['J5&Q GT1<,5G^.BLL#
M\LJ/>T>0DB$#):0B>JA&&\V]JB $YY1MGHIJVW/2DVHJQ6G6KC67M-[*]@2:/[=9%8>S=^K^R?/!8 T]3PN
M(%GTY8",GAR,'X,BM S, G\^1:!:Z2[O#KH4#%@79]C/@,?/!:6$U-@CI^+,
MBZ/S;CDNQ1!(JNC7M]PT&V!PIQ,&' %=BB(&J[DMOFW?W7>/GPL$$&$,CC,>
MUU%X);C1U31H(T1GPX#3>P[' )\B;-T:E@?!9IK */EIY)X
M08FS,&*..:M$1$B>STV)IR7(BW,]76FD37K3AZQ8;=W,QFMA7[LI;7?*=O,>
M@A!6*Z_C*)0ADCBMXA?.D4,:6V_KY_YO+M\ 58
M+$#RD$6!WG:19EOLIX%OK"9"'2M7LH-F?_V2DF:F?!^C3]
MZ23:H3*'C]L%#[]58:".,IZ;VYR;FGM]?_>[7^?US>YI$35WE:XJD:==+G*VL@4LN2)(EG
M(5)$VIS<2IN.J9KP6M2J#R&7$"UZSB3]Z936!"_^\HJAU 30.1?%)KW<5EB;MZN[
MW+GFX>?9DOIY=??OQ=V;Q;O5^]OE?[[U)Q]0X4&>7UGP@H,/$:--M_&<3U4;
M=B[G4LW&4AZ1 24B.64"[48@Q=5Z_T_Y]^@83'IR(96DZ(,1S&CE0^"Y^E[5
M0 !T[5!>H.-@CI0Z!Z0EW__WN\4/Z1?O-C_>[E[WA_5JTXM!\/S3*D. ,P\6
MM4-"(R%$ZVT4WWH=P'<\>$JT$,9CR?BX=*A4>F;5__?E43'3UZO^+7%^
M>?L^+?I=UI#WB]4?NQ=Y+CNCMP=6#C!R&X45U#NBI/,\YSHS(2S/K7MFXYP9
M0,]U%G'2AHUG\$"XRK',#R!>
M+=>_7=WM("&[5%Y]2VPBLJYF(M
M;/N%XLMF..%IN[(8GSU+,K8I)T@6#NNV)1
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M#IXW2V:2-1@1#FZ
MDDHE+1!( Y-2"T8)@F]\-!*^GP0_Y5-D+A0Z-Z8ETRO\__WR[LN/M^G6>+\]
MWW^Y^[!8O_UP=?ND:/K@55"Y2CYD8%+ZW(54)1UR)TPUQE
MZ)AHTPZ= 7;1\P\D-8)Z+5#[email protected]^I7U$@OS6/.=T*?#X;Q-.V% TF3
M-:XM:(5.<*4D=\#K69PDH)Z/ 7(6K%L-)&TGVB%N?*T'DEH3=83LNDGV%@CJ
MG*E'^! ;PE!92F//XCH9R0,#2=N)LH3[_\@IHC$JD9+9+JJ_GZUW@9EXVJ]]WUO?EG[FZOE04UN
M]3T5%1)\-#3=@T&GVZ\(S00@)3ZGI,??E)>2PR*-_TE%@K+/*YS_&$%F+T .?
MSYUN*%7KKQU&*Z2*#3EHL-P%[:3E@KB0+L*6[%\CIO_FHW C('\PY-!.\"68
M'!,(.1BF/%(#"EQ0R-&GJT0C5#>CB&U'71HBY- .@P$4^\E"]U__==37E635'R8E[*DCNW$P2,&YLLRAQG25DD3I
M6F 4^8S:;XQ^^@^.5LGJ?31#OTEQ?+.ZN8FK=?[0*(4A3RVD D)B(%IY)@)8
M3X-CK@;"@[CTS.^BM(-5?YP!TGEPZ^?[8]&FH=90^>BXUD8K040(%*D*O-$2
M$!V;@[=FU*=MEO2O=U?KNS)YU;-R#\_!3OA/FG[E%19;"[GJU"KNN$TW:"V8
MJ87/(NUH-9=X"WSMM'L1\)-FW6];=$9EW;=+J+*]$$ []!HD,"2&^5KX3JN.
MN8RGA]#-CG6WB_=7NVE"%_(5C/^DR9I! \$@:<$_(@?D$[3GYH7;6_
M,_G"[85^!:,_#_(=;312C+.SS4HK8CU2U,2 Y]$!4^$AZL()Z^B[F9/Y. EO
M:(^8OQ+Z%L[9R@5NA;#:&"=ENN!0$F '&B/.ZHN3M1#.%,C]EKHS:<+/L5^=
M2UH-Y,F_'SL^D!]PLU*STV,7'!)J:E!,Y9U;!OV
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MYV1R$1)4_9HL;0ZS4;5QE:15KX-VF)2PIX[K2^/ZSHO<^:[LYV029RDEJW_K63V1BFP^?ZIE0)IC$!PA+% )0(-]=W5*L&G?VF:+VO.AFK)Q'DRH_6']6K3BS'Q_-,J
M;WU$$6.(AH!$"I(W(I4F=JQF[%K-?Z'*L'B63)$)-J11:-&JZ#'W_C$:!8?:
MMV%MZ)K0U+4NO[_6&/-C5+](ETRSQ]F6]O8Z_/5IN=Y^0Z_\.O795= 6J-7$
M:T*"UMX'K U?2\+1#OWGRA2\7.=&Q[9D*DVVGPP3T40O;1 2! "@MZZ&P*>_
MNM%+7N@UXH'U4I1?2=(L$.5,L$1$2GUN.((8:J'DV%#&DNM0P[.LUT6?489?-A?%A+YLS^:/OE_FYS=W6;
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M=04IDRPO17,"Y'A(3WLHCSVE;KO7YU8>F256
MO3_&"[AC[U+?2?Z^6[7II4M5M!#HSRX CS22\B\1$5J>_"
MCJ =:B3R5+Q79]+C_HZ>,X)= L^>+78[I2WNV;AVOE54+!HJ'0@>"'JI&1"$
M&@(1N+JXPL9EVFA03X%M]?N-3KA6"ZE0!"5L4)X9#IQ2EU2F!H)KVM']/*<+
M8MF^*OG(.
M"?X$.#H=@T\IPQ31RH3HG(HQSY:K10_17QH/E\^]?J >K8/EMF_)I5'E5]T#
MO59( W...2DCIQPUV[8>A<@EL\=2BGK:(H^TJ/DZUEHW(=U"^S:!Z=*:_CRT
M^[WXRZL0D#L;'#B!G%LNO0^UT+QA8B!/5O&M*4]6KI:M*<\.T1#'_I%W>JJ=
MUZYUV+D5O.63J@CHDQ11$Z^T14F5\[4H4;N.M>L%^I$*U?9^\1I4]K
M+XO%KXOUYW1M>.9V'ET\W'QC$Z'<9$;Z4SXI@SFJW,N3^38O?!F<_]Q]V\O.A*Z
M/ZBB6BJM=8P4G4-L[__3_[5_+K_^-M_ 5!+
M 0(4 Q0    (  HQJT@A_:0)E@\! /V7%  1              "  0    !Z
M;'1Q+3(P,38P,S,Q+GAM;%!+ 0(4 Q0    (  HQJTC7N^^>+PT  $"-   1
M              "  <4/ 0!Z;'1Q+3(P,38P,S,Q+GAS9%!+ 0(4 Q0    (
M  HQJT@YO&K%CR   )I5 0 5              "  2,= 0!Z;'1Q+3(P,38P
M,S,Q7V-A;"YX;6Q02P$"% ,4    "  *,:M(J.:62APV  #LNP( %0      
M        @ 'E/0$ >FQT<2TR,#$V,#,S,5]D968N>&UL4$L! A0#%     @ 
M"C&K2#W/"2,3G@  ]8T( !4              ( !-'0! 'IL='$M,C Q-C S
M,S%?;&%B+GAM;%!+ 0(4 Q0    (  HQJTARS' =RF(  #@6!0 5        
M      "  7H2 @!Z;'1Q+3(P,38P,S,Q7W!R92YX;6Q02P4&      8 !@"*
) 0  =W4"    
 
end